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0.2 Abstract
Injury to the spinal cord can have devastating consequences. Advances in neuroregenera-
tion have placed emphasis on the importance of biomaterials to deliver cellular therapies.
However, little is known about how the mechanical properties of the matrix aﬀect cellular
behaviour.
The study aims to investigate how the mechanical properties of the matrix aﬀects CNS
cell behaviour at rest and following injury. A synthetic-biologic hydrogel was developed,
which was capable of achieving a range of diﬀerent Young’s moduli by altering the bloom
of gelatin, the molecular weight of PEGDA or the polymer concentration. Astrocytes
when cultured on the surface of the hydrogels had a significantly higher cell metabolism,
viability and increased expression of GFAP when cultured on a stiﬀ (700 Pa) matrix
compared to a soft (20 Pa) or mid-range (250 Pa) stiﬀness hydrogel matrix. Microglia
exhibited a significantly higher cell metabolism when cultured on a soft matrix opposed
to the stiﬀer or mid-range stiﬀness matrix. Interestingly mixed glial cells exhibited similar
stiﬀness preference to microglia and showed significantly higher cell metabolism and cell
viability on the softer matrix.
In order to investigate how the mechanical properties of the matrix aﬀects CNS cell be-
haviour during injury, the BOSE Electroforce BioDynamic Impaction system was utilised
to simulate SCI within 3D collagen gels and resulted in a 3D in vitro model of SCI, that
produced consistent contusion injuries that mimicked in vivo SCI. A significant increase
in astrocyte and microglial metabolism was observed between a mild SCI (receiving an
impaction displacement of 50%) and a severe SCI (receiving an impaction displacement of
100%) within four hours of injury. At twenty-four hours post impaction of the gel, astro-
cyte and microglial metabolism was significantly higher at 80% and 100% displacement
depth, than all other displacement conditions. This indicated that the greater the im-
pact severity, the higher the cellular reactivity by measurement of cell metabolism, within
twenty-four hours of the injury event. Astrocytic expression of GFAP also increased with
increasing displacement depth.
In summary a 2D synthetic-biologic hybrid hydrogel system was developed to investi-
gate how the mechanical properties of the matrix aﬀect CNS cell behaviour and a 3D in
vitro collagen hydrogel model was used to investigate how CNS cells respond to SCI.
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Chapter 1
Literature Review
1.1 Introduction
The spinal cord is the major conduit of motor and sensory information that passes between
the brain and the body. However, the spinal cord is not simply a messenger between
the brain and the body, the spinal cord is capable of information processing and reflex
generation without input from the brain (Lundberg, 1979). Injury to the spinal cord
aﬀects the conduction of the motor and sensory signals across the site of injury, resulting
in impairment or loss of function (Maynard et al., 1997). According to the ‘World Health
Organization’, spinal cord injury aﬀects between 250,000-500,000 people every year and
the majority of spinal cord injury cases are due to traﬃc accidents, falls or violence (WHO,
2013). Young males are most at risk between the ages of 18-32 years (Lee et al., 2014). The
estimated lifetime cost for a 25 year old who has sustained an SCI varies from 2-4 million
US dollars, depending on the level of injury (NSCISC, 2011); Thus initiating a large
economic and social burden on individuals, society and healthcare providers (Alabama,
2013).
There are currently no eﬀective treatments to achieve spinal cord regeneration or
reinstate motor, sensory or autonomic functions (North and Kessler, 2013). Spinal cord
injury can aﬀect anyone at any time, which makes spinal cord injury an attractive area
of study for medical research, as the potential aﬀected population is not pre-defined or
limited to a small number of cases. However, as spinal cord injury is generally a result of
acute trauma, which can be painful and distressing to animals, there has been a societal
ethical impact in the 1960s and 1970s against the use of animals in medical research.
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This has promoted the need to expand the range of alternative methods to in vivo animal
research (Balls, 1994).
William Russell and Rex Burch published the principles of humane experimental tech-
niques in 1959, stating that every eﬀort should be made to replace animals with alter-
natives, in order to reduce the number of animals used in experimentations (Russell and
Burch, 1959). At first, little attention was given to the guiding principles of reducing ani-
mals used for experimentation, however gradually the principles of humane experimental
technique gained traction and theses were introduced as new legislation in 1986, when the
United Kingdom incorporated the principles into the Animal (Scientific) Procedures Act
(Hollands, 1986). Since then, the 3 R’s - refinement of experiments to minimise pain and
distress, reduction of animal numbers used to the minimum and replacement of animals
with non-sentient alternatives, has become an important consideration of modern day
research (Flecknell, 2002).
There are benefits and limitations to replacing animal models with in vitro alterna-
tives. A limitation when replacing animals with alternative methods, is that it is diﬃcult
to validate the alternative and achieve regulatory acceptance (Flecknell, 2002). However
the importance of in vitro alternatives is increasing as a primary step, prior to animal
experimentation, in an eﬀort to decrease the numbers of animals used in research (Schecht-
man 2002; Bhanushali et al. 2010).
The following literature review will discuss the cellular anatomy of the spinal cord,
what has been elucidated about the response to traumatic spinal cord injury, how biome-
chanical properties of the matrix can aﬀect cells of the central nervous system (CNS)
and how experimental models have contributed towards our understanding of how the
biomechanical properties of the matrix aﬀect SCI. The review will also discuss various
biomaterial alternatives, which have the potential to be used in an in vitro spinal cord
injury model.
1.1.1 The central nervous system (CNS)
The nervous system can be broken down into two key parts, the CNS, which consists
of the brain and the spinal cord; including the olfactory, auditory and optic systems
and the peripheral nervous system; which consists of the cranial and spinal nerves and
their ganglia (Heimer, 2012). The nervous systems are separate systems however, the
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motor neurons of the cranial and spinal nerves originate within the CNS and the sensory
neurons or terminal branches are also situated in the CNS, therefore although distinct
nervous systems, information from the brain is relayed to and from the peripheral nervous
system via the spinal cord and connecting ganglia (Heimer, 2012).
It is important to understand the anatomy of the spine, the vertebrae and the meninges,
as there is a functional and supportive relationship between these diﬀerent structures and
the spinal cord. The vertebrae are often involved in the initial SCI, as bony fragments
break oﬀ and penetrate or compress the spinal cord (Snell, 2010). The meninges are
layers of membranous tissue which surround the brain and spinal cord and protect these
structures from injury by cushioning the brain and spinal cord with cerebrospinal fluid
(CSF). However, these protective structures can be overcome in traumatic brain or spinal
cord injury, causing damage to the underlying structures(Snell, 2010).
1.1.2 Anatomy of the spine
The structure of the spine is more than simply nervous tissue, the spinal cord is supported,
stabilised and protected by the vertebral column (Harms and Tabasso, 2000). The verte-
bral column consists of 24 separate vertebrae, 7 cervical vertebrae, 12 thoracic vertebrae
and 5 lumbar vertebrae (Luqmani et al., 2012), 5 fused vertebra forming the sacrum and
4 fused vertebrae forming the coccyx (Middleditch and Oliver, 2005). Anatomical factors
of the spine have a profound eﬀect on the severity of the spinal cord injury. The large
size of the vertebral canal in the cervical region often prevents severe injury to the spinal
cord as damage to the canal does not immediately translate to damage to the spinal cord.
However the small size of the vertebral canal in the thoracic region of the spinal cord,
often results in severe injury as damage to the vertebral canal is more likely to have an
impact on the spinal cord in the thoracic region due to limited space (Snell, 2010). The
spinal cord is shorter than the vertebral column, therefore the segments do not match
the corresponding vertebra. The lumbar region of the spine has two beneficial features
to minimise damage from fracture dislocations, the spinal cord only extends to the lower
border of the first lumbar vertebra, and the second benefit is that the vertebral foramen
are large in this region, thereby giving the cauda equina ample room to prevent compres-
sion. Therefore fractures or dislocations below the level of the first lumbar vertebra have
minimal impact (Snell, 2010).
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The spinal cord originates from the medulla of the brainstem and projects through
the foramen magnum in the skull, to the first lumbar vertebrae in humans. The spinal
cord is also protected by three layers of membranes which encapsulate the brain and the
spinal cord; the pia mater, arachnoid mater and the dura mater, which are labelled in
Figure 1.1.1.
The dura mater is the outermost and thickest layer of the meninges, encompassing
the brain and spinal cord (illustrated in green in Figure 1.1.1). The Dura is a protective
layer, which cushions the eﬀects of mechanical insults in animal models, to minimise
damage to underlying tissue (Maikos et al., 2008). The arachnoid mater (illustrated
in orange in Figure 1.1.1) is the middle meningeal layer, which attaches to the inside
of the dura mater by small protrusions, called arachnoid villi. These small protrusions
through the dura mater into the venous sinuses, allow cerebrospinal fluid (CSF) to enter
the blood stream (Yamashima, 1986). The arachnoid mater is separated from the pia
mater by the subarachnoid space, where CSF flows (Tripathi, 1973). The pia mater is the
innermost meningeal layer surrounding the brain and spinal cord. The pia mater provides
constraint on the spinal cord surface due to the high elastic modulus (approximately
2300kPa) (Ozawa et al., 2004) to prevent elongation or stretching of spinal cord. The
pia mater also produces large strain energy, responsible for shape restoration following
decompression (Ozawa et al., 2004).
The spinal cord consists of a central distribution of grey matter, surrounded by an
outer distribution of white matter (annotated in Figure 1.1.1). Axons which have been
insulated with a myelin sheath, have a white appearance and therefore make up the white
matter of the spinal cord. Whereas, aggregations of nerve cell bodies embedded in a
network of processes, have a grey colour and are therefore known as grey matter (Heimer,
2012).
The spinal cord passes through the intervertebral foramen, in between the vertebral
body and spinal processes (transverse and spinous). A vertebra is typically made up
of several parts of bone, fused together to form a protective casing for the spinal cord.
The intervertebral discs separate the vertebral bodies, they are elastic-like structures with
a combination of collagen fibres and proteoglycans, which can become dehydrated and
narrowed with age and susceptible to herniation, whereby the nucleus pulposus herniates
through a defect and can cause compression to the spinal cord. (Luqmani et al., 2012).
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Figure 1.1.1: Structures of the spine and spinal cord with annotations. Adapted from
Drake et al. (2009).
1.1.3 Cells of the spinal cord
The spinal cord is a large, complex structure; the anatomical organization has been stud-
ied for over a century (Clarke 1851; Hart 1998). However, due to diﬀerences in the
imprecise terms used, the literature is often diﬃcult to interpret (Brown, 2012). The
scheme of Rexed (Rexed, 1952) provided a comprehensive and systematic account of the
cytoarchitectonic organization of the spinal cord, which outlined 9 cell layers (laminae)
in the spinal cord and the dorsal horn region around the central canal. Primary aﬀerent
fibres from receptors in the skin, muscle, fascia, joint capsules and subcutaneous tissues,
enter the CNS through the dorsal roots (Brown, 2012), whereas the aﬀerent fibres that
enter the CNS through the ventral roots are mainly non-myelinated (Coggeshall et al.,
1973) and innervate visceral receptors (Clifton et al., 1974). It is important to understand
that the spinal cord has a complex structure and architecture, but for the development of
a simplified CNS model, the review will concentrate on the main cell types in the CNS,
neurons, astrocytes, microglia and oligodendrocytes.
5
1.1.3.1 Neurons
Neurons make up a small proportion of the cells of the CNS, calculated as ranging between
approximately 50 billion neurons (Heimer, 2012) and 100-200 billion neurons (Soulet and
Rivest, 2008). Neurons are specialised cells within the nervous system, which transmit
sensory or motor nervous impulses from the brain to the body and vice versa. They can
be classified in terms of their location within the body, neurotransmitter released, size,
shape and connectivity (Squire et al., 2013). Hart (1998) stated that neurons are distinct,
polarised membrane-bound entities, separate from neighbouring cells. Neurons commu-
nicate to other neurons using specialised junctions called synapses, that transmit signals
across the intercellular space, resulting in the polarised nature of the central nervous
system (Nieuwenhuys et al., 2014).
Neurons have two types of processes that extend from the cell body. The first process
is a large protoplasmic expansion in neurons (annotated in Figure 1.1.2) which form
the primary receptive surface called ‘the dendrites’ (Peters et al., 1991). The dendrites
receive the electrical signals, they are broad, numerous and taper away from the cell body
(Heimer, 2012). The ‘axon’ (annotated in Figure 1.1.2), is the other process that extends
from the cell body. The axon and its terminal ramifications are the transmitting surfaces,
which propagate the signals to other neurons (Peters et al., 1991). There is typically one
axon per neuron and the axon transmits the electrical signal away from the cell body. The
axon can vary in length, diameter and insulation. Thicker axons are generally insulated by
a lipoprotein sheath called the myelin sheath (annotated in Figure 1.1.2), which conducts
impulses more rapidly than smaller, unmyelinated axons (Heimer, 2012). The axon loses
its myelin sheath as it divides into many small branches referred to as axon terminals, at
the final destination (annotated in Figure 1.1.2).
Neurons of the CNS are unable to regenerate fully, which may be due to ineﬃcient
Wallerian degeneration (Buss and Schwab, 2003). Wallerian degeneration is the degener-
ation of the axon distal to transection and ineﬃcient removal of myelin from the injury
site. Myelin is inhibitory to the neuronal growth cone and therefore if myelin is not re-
moved following injury, then the neuron cannot regenerate (Rotshenker, 2011). Other
factors influencing the limited regenerative capacity of neurons following injury may be
due to defects in injury signaling, the unsuccessful activation of regeneration associated
genes (RAGs) (Mar et al., 2014), the existence of inhibitors to axon regrowth such as
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Figure 1.1.2: Anatomy of a neuron. Annotations of the main structures of a myelinated
neuron. Adapted from EnchantedLearning.com
myelin, chondroitin and keratan sulphate proteoglycans (Huebner and Strittmatter 2009;
Silver 2016) and the subsequent inhibitory microenvironment of the glial scar (Fawcett
and Asher 1999; Fitch and Silver 2008).
In contrast to neurons of the CNS, which have limited regeneration potential, the PNS
neurons have greater regenerative capabilities (Fawcett and Asher, 1999). When periph-
eral nerve segments have been inserted between the medulla and the spinal cord, axons
grew by approximately 30mm. When the inhibitory CNS glial environment was substi-
tuted for the PNS environment, nerve regeneration in the CNS was achieved (David and
Aguayo, 1981). Although many mechanisms contribute to nerve regeneration, the nerves
successfully grew over long distances, when associated with Schwann cells. Schwann cells
are peripheral glial cells, which have been shown to enhance nerve regeneration through
reinforced collagen nerve guides, when seeded with Schwann cells compared to acellular
collagen nerve guides in an in vivo rat Sciatic nerve injury model (Ansselin et al., 1997).
The study showed the importance of the glial cell microenvironment surrounding nerves
in regeneration post SCI. However, the organisation of the spinal cord and peripheral
nerves are diﬀerent. In contrast to the arbitrary distribution of nerve fibers with diﬀer-
ent functional modalities in the peripheral nerves, there is a clustering of nerve fibers
according to function, modality, and somatotopy in the spinal cord. This condensed and
advanced functional neuronal arrangement in the spinal cord, may also contribute to the
reduced regenerative capacity of the CNS due to the complexity of the spinal cord which
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is reduced in PNS axons. Nerve fibers show profound transformations when entering the
CNS from the PNS (Carlstedt et al., 2003).
1.1.3.2 Astrocytes
Astrocytes are the most abundant glial cells in the CNS and can constitute up to 40% of
the CNS cell population (Verkhratsky and Butt, 2013). The name ‘astrocyte’ is derived
from the latin word ‘astro’ which loosely translated means ‘star’, referring to the stel-
late morphology of these structural cells, first described by Lenhossék (1893). Astrocytes
have roles in synaptic network formation, direct regulation of neuron production, neuron
electrical activity, regulation of chemical content of the extracellular space and neuro-
transmitter removal from the synaptic cleft (Ransom et al. 2003; Sofroniew and Vinters
2010).
There are two main subtypes of astrocytes; ‘protoplasmic’ and ‘fibrous’ astrocytes.
The diﬀerent astrocyte morphologies are illustrated in figure 1.1.3. Protoplasmic astro-
cytes are found in the grey matter of the spinal cord and have been described as having
many short, crimped processes, which are often ramified (Privat and Rataboul, 2012).
Protoplasmic astrocytes connect with blood vessels and envelop the synapses of grey
matter neurons to control the extracellular concentration of substances that can interfere
with neuronal function (Sofroniew and Vinters, 2010).
The fibrous astrocytes (illustrated in figure 1.1.3) are noted to have longer smoother
processes, which are largely unbranched and run in between the myelinated fibres of
white matter neurons, making connections with the nodes of ranvier. They can also be
recognised by the presence of vascular end-feet (Privat and Rataboul, 2012).
One of the key diﬀerences between protoplasmic and fibrous astrocytes is that proto-
plasmic astrocytes maintain separate spatial domains, only the most peripheral processes
overlap (Bushong et al., 2002). However, fibrous astrocytes overlap extensively and form a
web of impenetrable processes (Sofroniew and Vinters, 2010). Astrocyte processes radiate
in all directions and express glial fibrillary acidic protein (GFAP), which is the principal
intermediate filament in mature astrocytes. GFAP as a member of the cytoskeletal pro-
tein family is important in modulating astrocyte motility, shape and providing structural
stability. GFAP is expressed at low levels in the branches of the cytoskeleton in astro-
cytes, but is also rapidly synthesised in response to injury, whereby astrocytes develop a
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Figure 1.1.3: A diagrammatical representation of fibrous and protoplasmic astrocyte mor-
phologies. Protoplasmic astrocytes interacting with synapses of grey matter neurons in
the grey matter of the spinal cord. Fibrous astrocytes interacting with white matter
neurons at the nodes of ranvier, in the white matter of the spinal cord.
reactive phenotype, this process is known as ‘astrogliosis’ (Eng et al., 2000). This makes
GFAP an ideal marker for investigation into astrocyte morphology and reactivity.
Astrocytes elicit diﬀerent responses to SCI depending on the severity of the trauma.
In mild/moderate cases of SCI, astrocytes undergo a mild astrogliosis, which manifests as
an up-regulation of GFAP (Figure 1.1.4B). The astrocyte processes do not substantially
overlap and there is no loss of individual astrocyte domains. It is controversial that
there is an increase in astrocyte proliferation, as astrocytes express diﬀerent levels of
GFAP (Figure 1.1.4A), it may be the case that some astrocytes express detectable and
some non-detectable levels of GFAP. Therefore, when the astrocytes become reactive and
increase GFAP expression, an increased number of astrocytes may become detectable and
therefore it may appear to be proliferation of astrocytes, however cell number may have
remained constant (Sofroniew and Vinters, 2010).
In severe cases of SCI, severe astrogliosis occurs and a compact glial scar is formed
(Figure 1.1.4D). There is pronounced up-regulation of GFAP, hypertrophy of the cell
body and processes, overlapping of astrocyte processes and obliteration of individual
spatial domains. There is proliferation of astrocytes and formation of a dense narrow and
compact glial scar by deposition of dense collagenous extracellular matrix by astrocytes.
The deposited ECM contains molecular cues that inhibit axonal and cellular migration
(Sofroniew and Vinters, 2010). The main type of proteins secreted by astrocytes during
the CNS response to damage are chondroitin sulphate proteoglycans (CSPG). CSPGs
play important roles in cell growth, adhesion and migration by interacting with other
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Figure 1.1.4: Schematic representation that summarises diﬀerent gradations of astrocyte
reactivity post spinal cord injury (GFAP represented by a green background) Adapted
from (Sofroniew and Vinters, 2010). A) Non reactive astrocytes in healthy CNS tis-
sue emitting low levels of GFAP. B) Mild to moderate reactive astrogliosis with an up-
regulation of GFAP, spatial domains maintained. C) Severe diﬀuse reactive astrogliosis,
illustrating hyper-proliferation and hypertrophy of astrocytes, up-regulation of GFAP
and overlapping spatial domains. D) Severe reactive astrogliosis with compact glial scar
barrier formation adjacent to the tissue damage and inflammatory cells (yellow circles).
Vast overlapping of spatial domains, hyper-proliferation, hypertrophy of astrocytes and
increased GFAP expression.
ECM constituents such as fibronectin, laminin, tenascin and collagen. They also provide
guidance cues for developing growth cones via inhibitory mechanisms and repulsion, which
in the event of adult CNS trauma, are the most important inhibitory molecules of axonal
regeneration (Fawcett and Asher, 1999). CSPGs mediate inhibition by activating the Rho-
ROCK signalling pathway, treatment with protein kinase C inhibitor prevents activation
of the Rho pathway and encourages regeneration after injury (Busch and Silver, 2007).
Reactive gliosis and the glial scar have been implicated in inhibiting nerve regeneration,
since the work of Cajal in 1984 (Cajal, 1984) and so it is easy to over look the evidence
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of the essential beneficial functions of astrogliosis and glial scarring. Reactive astrocytes
protect CNS cells from oxidative stress by the uptake of excitotoxic glutamate and protect
the neurons via adenosine release and degradation of amyloid-beta peptides (Goldberg and
Barres, 2000). Astrocytes maintain ion balance by stabilising the extracellular fluid and
limit the spread of inflammatory cells or infection from areas of damage into healthy areas
of the CNS (Sofroniew and Vinters, 2010). Despite the positive roles astrocytes play in
CNS injury, neuron loss after injury is caused by loss of target-derived trophic support,
trophic factor responsiveness and insuﬃcient glial-derived trophic support in the lesion
site (Lutz and Barres, 2014).
1.1.3.3 Microglia
Microglia are quiescent macrophage-like inflammatory cells of the CNS, closely related to
monocytes and dendritic cells with diverse roles such as immune surveillance, antigen pre-
sentation, phagocytosis (Cullheim and Thams, 2007) and neuro-protection (Kreutzberg,
1996). Microglia comprise approximately 10% of all glial cells in the healthy CNS (Hanisch
and Kettenmann, 2007). However, like astrocytes, it is controversial whether their eﬀects
are neurotoxic or neuroprotective in diﬀerent injury models (Fawcett and Asher, 1999).
Microglia migrate to the site of the injury and form a dense border of cells to reduce the
spread of the inhibitory molecules and inflammation (Hines et al., 2009), which is also
similar to astrocytes in the process of astrogliosis.
Microglia in their resting state are highly ramified in their morphology (Figure 1.1.5A)
with very active and dynamic processes, highly motile with a continuous degree of ex-
tension and retraction (Stence et al. 2001; Nimmerjahn et al. 2005; Cullheim and Thams
2007). Microglial activation varies with the severity of the neuronal injury, mild injuries
cause hyper-ramification of microglia (Wilson and Molliver, 1994) (Figure 1.1.5C). How-
ever, most types of neuronal damage or SCI would cause resting microglia to become
activated (Figure 1.1.5B) (Streit et al., 1999). During the chronic stages of SCI, due to
changes to the microglial microenvironment, microglia become activated (Streit et al.,
1999), and change their morphology, lose their ramifications, migrate to the lesion site
(Soulet and Rivest, 2008) and are capable of producing nitric oxide, (Chao et al., 1992),
proteases, cytokines (Moore and Thanos, 1996) and free radicals (Thery et al., 1991).
Microglia rapidly change from a patrolling phenotype that removes debris (refer to Fig-
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ure 1.1.5D), to a shielding phenotype (Soulet and Rivest, 2008) at the injury site within
minutes of the injury, moving at a rate of 1.25 µm·min 1 (Davalos et al., 2005).
Figure 1.1.5: Morphology of microglia. A) Resting microglia, B) Reactive microglia, C)
Hyper-ramified microglia, D) Phagocytic microglia. Adapted from (Streit et al., 1999).
In the event of neuronal cell death, microglia develop into CNS phagocyte-like pheno-
type (Figure 1.1.5D). Phagocytic microglia have a strong respiratory burst capacity, can
release cytotoxic enzymes and act as scavenger cells, removing tissue debris and destroy-
ing bacteria and viruses (Jack et al., 2005). In the presence of a neuronal axon lesion,
there appears to be a retrograde response at the neuronal cell body, whereby the axon
retracts and the synapses removed from the perikaryon and dendrites of aﬀected cells.
Microglia have been attributed the main role of removing synapses and ‘stripping’ back
the axon, although reactive astrocytes have also been suggested to play a role in ‘synaptic
stripping’ (Cullheim and Thams, 2007).
It has been suggested that there are two main phenotypes of microglia cells; M1 (neu-
rotoxic, pro-inflammatory (Guerrero et al., 2012)) and M2 (neuroprotective (Kigerl et al.,
2009)) microglia, however this is a controversial viewpoint and some researchers find this
perspective to be limiting and believe that microglial polarisation hinders, rather than
aids understanding of microglial research (Ransohoﬀ, 2016). After acute SCI in mice,
studies have shown that diﬀerent pathways of microglia activation resulted in cells with
a classically activated M1, pro-inflammatory phenotype (Streit et al. 1999; Cullheim and
Thams 2007). However, in a study by Guerrero et al. (2012), IL-6 signalling was tem-
porarily blocked after SCI in mice, damaging inflammatory activity of M1 microglia was
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reduced and functional recovery was observed by the promotion of alternatively activated
M2 anti-inflammatory microglia. It has been shown that an M1 microglial response is
rapidly induced post SCI and overwhelms the M2 microglial response; the high ratio of
M1 to M2 microglia may have significant implications for CNS regeneration (Kigerl et al.,
2009). M1 microglia can produce transforming growth factor beta-1 (TGF- 1), which
is up-regulated when microglia are activated close to lesioned facial motoneurons (Streit
et al. 1999; Cullheim and Thams 2007). Microglia that produce and release interleukin-10
(IL-10) an anti-inflammatory cytokine, are classified as M2 microglia (Zhou et al., 2014).
Microglia co-cultured with neuronal cells can switch from a neurotoxic to a neuro-
protective phenotype (Zietlow et al., 1999) and enhance nerve repair, whereby injured
neurons generate signals that trigger microglial activation and release of trophic factors
to encourage damaged neurons to recover from injury (Streit, 2005). In addition neurite
growth into the lesioned spinal cord is enhanced in the presence of grafted microglial
cells, than with cell-free or astroglial implants (Rabchevsky and Streit, 1997). However,
microglia that migrate to the injury site can cause further damage by the release of
pro-inflammatory cytokines such as, IL-6 and tumor necrosis factor-↵ (Rice and Anseth,
2007), which has been found to enhance demyelination of axons in a mouse injury model
(Probert et al., 2000).
Further research is required to fully characterise microglial phenotypes, in resting and
in injury situations, cultured in isolation and in the presence of neurons and other glial
cells.
1.1.3.4 Oligodendrocytes
Oligodendrocyte precursor cells originate from the floor plate of the spinal cord and pro-
duce mature oligodendrocytes, which are the myelinating glia of the CNS (Lutz and
Barres, 2014). These comprise approximately 10-20% of the CNS cell population (Calver
et al., 1998). Oligodendrocyte primary function is to support and insulate nerve axons,
by the production of the myelin sheath that encompasses a proportion of the neuronal
axons of the CNS. However, whether oligodendrocytes can regenerate their processes and
produce new myelin after SCI is a controversial topic (Fawcett and Asher, 1999). It has
been demonstrated that there was a 30-40% loss of oligodendrocytes in the CNS following
injury due to excitotoxicity and inflammatory cytokine release by microglia (Almad et al.,
13
2011). The oligodendrocytes which survive are said to be inactive, quiescent and do not
re-myelinate axons. New oligodendrocyte precursor cells (OPCs), which are generated
from the subventricular zone progenitors following injury (Fancy et al., 2011) diﬀerentiate
into new oligodendrocytes, which are capable of performing re-myelination (Ludwin 1990;
Blakemore and Keirstead 1999; Lutz and Barres 2014). Oligodendrocyte precursor cells
were recruited in large numbers to demyelinating lesions at the site of injury in the CNS
and have been shown to produce new myelin (Gensert and Goldman, 1997).
The production of myelin by oligodendrocytes should intuitively enhance neural re-
generation, however it has been found that when nerve growth cones encountered oligo-
dendrocytes, a rapid and long-lasting collapse of the growth cone structure and motility
was observed (Bandtlow et al., 1990). When the growth cones encountered astrocytes,
they maintained normal structure and growth, suggesting that oligodendrocytes produce
neurite inhibitors (Bandtlow et al., 1990). This suggested that it may not be complimen-
tary to neuronal growth to co-culture neurons with mature oligodendrocytes, however
the incorporation of oligodendrocyte precursor cells may lead to new oligodendrocyte
formation, that may be capable of remyelination.
PNS neurons have been shown to be capable of significant regeneration following injury,
largely due to the presence of Schwann cells which ensheath and myelinate peripheral
axons (David and Aguayo, 1981), similar to the role of oligodendrocytes in the CNS,
however the Schwann cells also form a basal lamina containing many growth promoting
factors, creating a permissive environment for growth. CNS oligodendrocytes do not form
a basal lamina, therefore oligodendrocytes have not been shown to promote a permissive
growth environment (East and Phillips, 2008). The presence of a Schwann cell basal
lamina may be the reason why Schwann cells enhance the regenerative capacity in the
PNS, whereas the absence of a basal lamina in the CNS, may be one of the reasons why
nerve regeneration is inhibited in the CNS.
1.2 Spinal cord injury
Spinal cord injury occurs in a variety of ways, a large proportion of the injuries are caused
by fast, blunt trauma such as a car accident or a fall (NSCISC, 2011); these can result in
other types of traumatic injury such as burst fractures. Burst fractures are classified as
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fractures to the vertebra under high axial-loading; which can result in transection of the
spinal cord by shards of the vertebra (Choo et al., 2007). The severity of the motor and
sensory loss is dependent on the vertebral level of the injury, complete transection of the
spinal cord at cervical vertebra C1 or C2 may result in instant death due to paralysis of
the intercostal muscles and diaphragm, leading to an inability to breathe (Snell, 2010).
Complete or partial transection of the spinal cord from C1-C8 may result in tetraplegia,
which is the partial or total loss of motor and sensory sensation in all four limbs (Bryce,
2009). Injuries below the first thoracic vertebra may result in paraplegia, which is the
partial or total loss of motor and sensory sensation of the lower extremities (Bryce, 2009).
Tetraplegia and paraplegia will result in the patient being dependent on a wheelchair for
mobility for the duration of their life (Bryce, 2009).
A common non traumatic spinal cord injury is by compression of the spinal cord, which
is caused by a slow force acting over a long period of time on the spinal cord (Bryce, 2009),
such as a tumour, crush injury or dislocation, whereby the vertebra are no longer aligned
and pressure is placed on the spinal cord (Choo et al., 2007). Other spinal cord injuries
occur as a result of a sharp penetrating force, such as a knife, gun-shot wound or shards
of vertebral fractures and give rise to a lacerated or macerated spinal cord. It is also
possible for an infarct caused by a vascular insult, such as a blood clot to cause a spinal
cord injury. These are all examples of primary injuries, which occur instantly at the scene
of the accident (Silva et al., 2014).
The pathophysiology of traumatic SCI can be separated into distinct phases, primary
and secondary response to injury (Oyinbo, 2011), followed by the longer term chronic
response to SCI (Silva et al., 2014). Each of these cellular responses to the SCI are
detailed in the following sections.
1.2.1 Primary response to injury
The primary (immediate) response to traumatic SCI regardless of the cause, leads to
haemorrhage, rapid cell death at the site of damage and delayed cell death in cells that
originally survived the initial insult, due to persistent compression, transection, distrac-
tion or laceration as a result of the initial injury (Oyinbo, 2011). The primary response
is acute and begins within seconds of the injury, whereby structural thresholds are sur-
passed, leading to physical and biochemical cellular alterations such as systemic hypoten-
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sion, spinal shock, accumulation of neurotransmitters and plasma membrane compromise
(Tator 1998; Hulsebosch 2002; Oyinbo 2011).
The first signal of injury in the axon is an influx of calcium ions and depolarisation by
inversion of voltage-gated calcium channels. This calcium influx aﬀects the regulation of
intracellular pathways, axon growth and the generation of epigenetic changes that inhibit
axon regeneration (Mar et al., 2014). When the distal axon degenerates by Wallerian
degeneration; which is the breakdown of the distal axon so that it can be cleared away by
glial cells, the axon retracts to the cell body and does not sprout new axons or dendrites
and therefore is unable to find new connections (East and Phillips, 2008).
In the event of CNS blunt trauma, the blood brain barrier increases in permeability,
which leads to an increase in neuro-inflammation, due to infiltration of macrophages from
the bloodstream and microglial migration from the surrounding tissues. This inflam-
matory responses causes an up-regulation of cytokine and chemokine production from
glial cells; these are linked to the activation of astrocytes, microglia, oligodendrocytes
and meningeal cells, which in turn develops a glial scar; the glial component of the CNS
response to trauma (Fawcett and Asher, 1999).
1.2.2 Secondary pathophysiological response to injury
One of the reasons why spinal cord injury is a major challenge clinically, is due to the fact
that SCI occurs rapidly and unexpectedly, therefore treatment of the SCI is inevitably
delayed by several hours to days before specialised care is administered (Oyinbo, 2011).
This delay in treatment gives rise to secondary injuries, which are caused by a cascade of
biological events that further progress the neurological damage (Silva et al., 2014).
The progressive post-traumatic secondary damage of the spinal cord sets in minutes
after injury and lasts for weeks or months (Tanhoﬀer et al., 2007). This sub-acute phase is
caused by many biochemical mechanisms, such as changes to the vasculature; in some cases
the blood brain barrier is damaged and inflammatory cells migrate into the CNS causing
oedema (Bareyre and Schwab, 2003). Haemorrhaging or thrombosis could also present
risks of ischemia and necrosis (Tator and Fehlings, 1991). Free radical formation and lipid
peroxidation causes further death to spinal cord neurons (Toborek et al., 1999), along with
disruption to the ionic balance, causing depolarizations, increases to the intracellular
calcium ion concentration (Stys, 1998) and increased glutamate release increasing cell
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death and glutamate excitotoxicity (Liu et al. 1999; McAdoo et al. 1999). Oyinbo (2011)
cataloged over twenty five secondary mechanisms of injury in the spinal cord and noted
that these secondary mechanisms are interconnected and self-propagate in a perpetual
cycle, initiated by the primary trauma and perpetuate several other mechanisms, forming
a deleterious network.
Inflammation is the key event in the secondary injury cascade, the immune cells se-
crete pro-inflammatory cytokines, including interleukin-1  (IL-1 ), interleukin-6 (IL-6),
and tumor necrosis factor-↵ (TNF-↵), all of which perpetuate the inflammation which is
important for the clearance of cellular debris, however presence of inflammatory molecules
can inhibit neural regeneration (Oyinbo, 2011).
1.2.3 Longer term response to injury
Days after the spinal cord injury, the chronic phase begins. The chronic phase can take
years and will further impact the neurological impairment in an orthograde or retrograde
direction (Silva et al., 2014). Demyelination of axons in the white matter surrounding
a central core of hemorrhagic necrosis is common in many cases of spinal cord injury
(Waxman, 1989). This impedes nerve conduction and functional recovery of axons. One
of the key inhibitors for regeneration in chronic spinal cord injuries is the glial cell response
and formation of the glial scar (Fawcett and Asher, 1999).
The glial scar impedes axonal regeneration because of the production of inhibitory
molecules such as CSPGs and the hyper-proliferation of reactive astrocytes, which form
a tight mesh of inter-locking over-lapping processes (Sofroniew, 2009). The glial scar im-
pedes also axonal regeneration by changing the mechanical properties of the local matrix
environment (Lu et al., 2011). In response to ischemia-induced injury in glial cells, astro-
cytes stiﬀened significantly, the cell rheology was measured by scanning force microscopy
(SFM). The cell stiﬀness (complex Youngs moduli and Poissons ratio) was directly related
to the density of intermediate filaments produced by reactive astrocytes. This interme-
diate filament production is an important determinant of micro-environmental viscoelas-
ticity, by manipulating the mechanical properties of the glial scar making it impenetrable
by nerve axons (Lu et al., 2011).
According to the work by Zamanian et al. (2012) reactive astrogliosis induces changes
in gene expression and although there are strong genetic markers of reactive astrocytes
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such as Lcn2 and Serpina3n, in all injury conditions, at least 50% of the altered gene
expression was specific to the type of injury, i.e. whether the inducing stimulus was
with MCAO (ischaemia induced stroke by middle cerebral artery occlusion) or LPS
(Lipopolysaccharide induced neuroinflammation). The gene expression profiles should
be taken into account for development of spinal cord injury models to ensure the appli-
cability of the model to the specific injury of interest.
1.3 Models of spinal cord injury
The animals used to study SCI are usually rats and mice, but larger mammals such
as cats, pigs and dogs have been used for pre-clinical testing and SCI models. These
animal models of SCI have limitations, such as ethics, time and animal husbandry costs.
However, these animal models are necessary to prove the safety and eﬃcacy of treatments
or methods prior to human experimentation (Silva et al., 2014).
1.3.1 In vivo spinal cord models
A key advantage of an in vivo model over an in vitro model is that the ECM provides
a milieu of binding ligands for cell adhesion (Wang et al., 1993) and an encouraging
microenvironment, that communicates the mechanics of the ECM to the cell, through
cell signalling pathways (Yoshioka et al., 2013). There are three general classes of in-
jury frequently used in rodents to model SCI; transection, contusion and compression
(Rosenzweig and McDonald, 2004).
1.3.1.1 Transection
Transection models involve opening the dura mater and cutting part or all of the spinal
cord with a sharp instrument, suction may also be used to transect the spinal cord in vivo
(Rosenzweig and McDonald, 2004). Lateral hemisection, whereby only part of the spinal
cord is cut, is often preferred over full transection, as the integrity of half of the spinal
cord is left intact; this allows preservation of autonomic functions such as bladder and
bowel function, lowering the intensity of post-operative care (Silva et al., 2014). Spinal
cord transection is a useful method for research in the field of tissue engineering, when
the analysis of biomaterials, nerve guidance conduits and scaﬀolds are being investigated.
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A section of the spinal cord is cut and replaced by a conduit; the movement of cells into
the conduit is investigated, alongside the changes to the mechanical properties of the
conduit or scaﬀolds (Hall, 2005). Transection models of spinal cord injury in vivo allow
long-term cell culture and analysis, which in vitro models fail to deliver. SCI models in
vivo allow the analysis of a complex system, close to that of the human spinal cord, which
is the preferred method for the investigation into drug or treatment eﬃcacies long term
(LaPlaca et al., 2007). However, SCI by transection is rare in human patients, therefore
many researchers prefer to use the ‘dura-intact’ compression or contusion injury models
(Rosenzweig and McDonald, 2004).
1.3.1.2 Contusion
Contusion injuries to the spinal cord are common, 40-80% of thoracolumbar spinal in-
juries are as a result of high energy injuries such as road traﬃc accidents or falls (Wood
et al., 2014). Models of contusion injuries to the spinal cord (in rats) involve impacting
the exposed spinal cord (without disrupting the dura) with a blunt force, delivering a
weight (Young, 2002) (approximately 10g) using an impactor; the impactor allows precise
measurements of biomechanical parameters of the impulse, velocity upon impact, power,
spinal cord compression and height of drop (Gruner, 1992). There are numerous types of
impactors used in these models, with varying benefits and limitations.
The Multicenter Animal Spinal Cord Injury Study (MASCIS) impactor was widely
used and produced a reproducible contusion injury in rat models. The MASCIS impactor
incorporates an electromagnetic push-button weight release mechanism, which is easy to
operate and reproducible, however the bouncing of the impactor rod on the spinal cord
after initial drop, resulted in multiple impacts. The second impact added variability to the
injury, as the second impact could not be measured, prevented or proven to be consistent
(Gruner 1992; Cheriyan et al. 2014).
The infinite horizon (IH) impactor uses a force-controlled impact instead of a weight-
drop method like the MASCIS impactor. The IH uses a stepping motor, which is controlled
by an external computer to control the impact of a metal impounder and monitor the
force between the impactor and the spinal cord tissue, measured by attached sensors. A
laminectomy is performed before the impaction and 3 diﬀerent injury severities (100, 150
and 200 kdyn) have been used in a study by Scheﬀ et al. (2003) in the rat, inflicting injury
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at thoracic level 10. The limitation of this impactor was that to obtain reliable force data
between the impactor and the spinal cord, the tissue has to be clamped into position and
slight movements resulted in inconsistent parenchymal injury (Scheﬀ et al., 2003). The
spinal cord would never be fixed prior to SCI in humans, therefore the clinical relevance
of these injury pathologies is debatable.
The Ohio State University (OSU) device was similar to the MASCIS impactor, as it
used a computer feedback-controlled electromagnetic impactor. However, the device used
a probe to contact the surface of the spinal cord to determine the starting point and then
compressed the cord by a predetermined distance (0.8 or 1.1 mm) for a predetermined
length of time (Stokes, 1992). The advantage of this impactor over the MASCIS impactor,
was that the impounder was actively withdrawn to prevent multiple impacts, however, it
was often challenging for the OSU impactor to detect the zero point and therefore the
probe displaced the spinal cord slightly at initial loading, reducing the reliability of the
displacement data.
More recently an in vivo contusion model utilised an air gun impactor on T10 vertebra
in a rat model, using a high-pressure stream of air. Similarly to the IH impactor, aﬃxing
clamps to the adjacent vertebrae stabilised the spinal cord, however a dental drill was
used to make a 2mm diameter hole in the vertebral arch, where the injector was inserted
and delivered a shot of air (Marcol et al., 2012). It was possible to vary the air pressure
and exposure times to produce a graded injury, however the locomotor assessment post-
injury could not detect significant diﬀerences between moderate and severe injury, control
and mild injury, therefore the method lacks precision and reproducibility (Cheriyan et al.,
2014).
1.3.1.3 Compression
Compression injuries are diﬀerent to contusion injuries, as they are typically over longer
periods of time, can be low impact for example placement on a modified aneurysm clip
(Rivlin and Tator, 1978) and may not always be a high speed impact. Compression
injuries are often caused by vertebral dislocations, with or without fracture of the spinal
column (Choo et al., 2007). Similar to spinal cord contusion models, compression models
of SCI can also use an impactor, which can produce diﬀerent degrees of SCI by adjusting
the compression strength and time (Fehlings and Tator, 1995).
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There are many ways to compress the spinal cord in vivo, methods used previously
were a modified aneurysm clip (Rivlin and Tator, 1978), which involved performing a
laminectomy and the clip is closed using a specific force around the spinal cord, for
the desired length of time. This model was similar to the compression balloon method,
whereby a catheter was inserted with a balloon aﬃxed to the end and inflated with saline
or air into the epidural or subdural space to compress the spinal cord (Borgens and SHI
2000; Vanicky` et al. 2001). These methods were advantageous due to the generation of a
SCI, which is clinically relevant to an iatrogenic SCI, which may occur during surgeries.
However, these methods did not provide accurate information about the force delivered
to the spinal cord and the extent of cord compression.
Calibrated forceps have been used to deliver SCI since 1991 in guinea pigs, following
laminectomy at T13 (Blight, 1991). The forceps were compressed around the spinal cord
for a specified length of time, using a spacer to achieve a specific width of spinal cord.
The model produced graded levels of SCI and was very economical, however there was no
acute impact component with the aneurysm clip and other compression models, therefore
the compression forcep model is or has not been widely used (Cheriyan et al., 2014).
1.3.1.4 Other models of SCI
Distraction models of SCI are graded injuries, controlled by stretching of the spinal cord
in flexion-distraction injuries (Choo et al., 2007). These models aimed to simulate the
tension forces experienced by the spinal cord in injury. A device previously used by
Dabney et al. (2004) inflicted thoracic SCI in rats; a laminectomy was carried out at the
injury site, then Harrington hooks were placed under the laminae of the vertebra, one
level caudal and rostral to the injury target. The hooks were connected to a computer-
controlled motor that controls the length, speed and duration of distraction to the spinal
cord. The limitation of this technique was that the injury was too slow to simulate human
injuries, which tend to be rapid events.
Numerous chemical models have been developed to investigate the secondary injury
cascades in chronic cases of traumatic spinal cord injury. The benefit to chemical models
of SCI was that the molecular mechanisms and signalling pathways could be investigated.
However, chemical models were limited in that they were not as close a representation
of SCI as other models, and the exact location and extent of the injury cannot be as
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well characterised (Cheriyan et al., 2014). An example of a chemical model of SCI was
the injection of a non-toxic photosensitive dye (rose bengal and eythrosin), followed by
irradiation; this allowed the area of the spinal cord to be ischaemic for a specified time and
duration, to investigate the molecular mechanisms post ischaemia-induced SCI (Watson
et al., 1986).
1.3.2 In vitro spinal cord models
Spinal cord models in vitro often involve either slice cultures, where sections of spinal
cord are removed from a recently deceased animal, and are maintained in a cell culture
environment or isolated/extracted cell models. These cell models could consist of cell lines,
which are genetically modified tumour cells or primary cell (usually rat or mice) cultures
removed from a recently deceased animal and processed to remove the extracellular matrix.
These cells are maintained in a 2D cell culture model i.e. in a well plate or 3D cell
culture model within a 3D hydrogel matrix, scaﬀold or biomaterial (East and Phillips,
2008). Three-dimensional microenvironments provide a better representation of tissue
organisation for the study of cell-cell and cell-matrix interactions (Abu-Rub et al., 2010).
Topographic micropatterning and microfluidics are increasing in popularity for the study
of neurons and how physical cues in the form of grooves and ridges may guide axon growth
and migration in in vitro microfluidic models (Mahoney et al. 2005; Yao et al. 2009).
1.3.2.1 Slice culture models of SCI
Organotypic slice culture models are prepared from nervous tissue and consist of a hetero-
geneous population of cells, which preserves the cytoarchitecture and functional synaptic
circuitry (Abu-Rub et al., 2010). In vitro models of spinal cord injury derived from organ-
otypic slice co-cultures from Sprague-Dawley rat spinal cord, has been used as a useful
tool to study nerve regeneration and to investigate the eﬀectiveness of potential therapeu-
tics and growth factor treatments on nerve regeneration across gaps between spinal cord
slices (Lee et al., 2002). An ex vivo spinal cord slice model has been developed by Raviku-
mar et al. (2012) as an eﬀective high throughput screening tool to quantify the eﬀects
of neuroprotective agents in the development of potential therapeutics to treat neurode-
generative diseases, such as Alzheimers or Parkinsons disease. The ex vivo slice culture
model quantified the eﬀects of diﬀerent neuroprotective agents on the spinal cord by the
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measurement of axon length and quantification of FluorojadeC, used to label neuronal
degeneration (Ravikumar et al., 2012).
The slice culture technique has been used successfully in the nerve chamber model to
study peripheral nerve regeneration in animal models and in clinical applications, such
as paralysis of limbs following trauma (Zhang and Yannas, 2005). The two stumps post
nerve transection are placed in a tubular chamber and filled with a variety of solutions
or substances. The quality of the reconnected nerve is then assayed as a method to
compare the resultant nerve regeneration in the presence of various stimuli. The nerve
chamber is a successful model to investigate the eﬃcacy of various tissue engineered
scaﬀolds with regards to supporting nerve regeneration. Another successful slice culture
model was developed by Gerardo-Nava et al. (2014), which allowed comparison of motor
axon interactions with diﬀerent 3D scaﬀolds measuring axon penetration into the scaﬀold
and axon growth on the surface. Similarly the spinal cord slice culture model developed
by Weightman et al. (2014), used electrospun poly-l-lactic acid nanofibre frames over the
lesion site of a spinal cord slice culture model to provides a valuable, high throughput
tool for assessing compatibility of diﬀerent biomaterials and 3D scaﬀolds or prototypes
for potential future therapeutics.
Organotypic spinal cord slices provide a valuable tool to study neuronal and glial
biology in a physiologically relevant tissue milieu, which provides access to CNS tissue
and cell culture media that can support the CNS slice cultures for several weeks (Dionne
and Tyler, 2013). An organotypic spinal cord slice model developed by Fernandez-Zafra
et al. (2017) to study ependymal cells found that ependymal cells respond to injury in a
manner that resembles the in vivo situation. The ex vivo model allows measurement of
spontaneous calcium activity in response to stimuli such as adenosine triphosphate. The
slice culture method allows experimental manipulations to the tissue, which would not be
possible in vivo, however manipulations to the chemical or mechanical properties of the
cell environment is limited. The main limitations of organotypic slice culture models are
that they are technically diﬃcult to prepare; the slices must be less than 500 µm depth or
there is a risk that the central cells will become hypoxic. There is also a lack of control
over cell types present or ratios of cells or extracellular components (Abu-Rub et al.,
2010).
Although challenging to prepare, organotypic spinal cord slice culture models are a
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valuable tool in modelling the spinal cord response to injury, potential therapeutic agents
and biomaterials where it is not possible or unethical to do so in vivo. However it is
not possible to change the mechanical properties of the matrix using slice cultures and
therefore in vitro cell culture models also important tools for spinal cord injury research.
1.3.2.2 Cell culture models of SCI
One of the key advantages to culturing single cell types in isolation, is that the environment
in which they were cultured can be controlled and optimised, for example to promote
regeneration by incorporating growth factors on a growth promoting substrate (Das et al.,
2005), or to investigate the eﬀects of treating neurons with nanoparticles of cerium oxide to
investigate whether this would significantly enhance neuronal survival (Das et al., 2007).
Some in vitro models apply mechanical strain or micro-patterned surfaces to align
astrocytes and investigated the neuronal response in co-cultures (Recknor et al. 2004;
Sørensen et al. 2007). Mechanical tension was investigated in a neuronal model by seeding
neurons onto adjacent surfaces, allowing the axons to spread and form connections, then
stretching the axons progressively under mechanical tension to investigate a potential
spinal cord repair strategy to bridge large damaged portions of CNS tissue (Smith et al.,
2001). The eﬀects of mechanical shear deformation on cell death and astrogliosis was
investigated on astrocytes and neurons in a 3D in vitro model by Cullen et al. (2007).
These 3D cell culture models were capable of vast physical manipulations, which enabled
thorough examination of how the mechanical properties of the cell culture environment
impact the CNS cells.
In vitro spinal cord models are increasing in importance for the study of stem cells in
regenerative medicine, particularly neural stem progenitor cells (NSPCs) and the condi-
tions to which these cells diﬀerentiate down neuronal or astroglial lineages, which has the
potential to be of use in future regenerative therapies (Ma et al. 2004, Li and Hoﬀman-Kim
2008, Brännvall et al. 2007).
One of the limitations of in vitro CNS models is that they cannot completely recapit-
ulate the complex in vivo environment in terms of all cell types, chemical and mechanical
conditions, however some of the complex in vivo processes such as reactive astrogliosis
and fibrotic scar formation could be recreated in vitro. A 3D spinal cord model was
developed by East et al. (2009), whereby DRG neuronal cultures that were seeded onto
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astrocyte-populated collagen gels, caused the astrocytes to increase GFAP immunoreac-
tivity and adopt a reactive highly ramified cell morphology typical of reactive astrogliosis.
An in vitro model of the in vivo fibrotic scar was developed by Kimura-Kuroda et al.
(2010), who used co-cultures of cerebral astrocytes and meningeal fibroblasts to form cell
clusters, similar to those observed in the CNS lesion site, by adding transforming growth
factor  1 (TGF- 1). This study recapitulated a complex in vivo process and allowed in
vitro analysis of the inhibitory properties of the CNS lesion site. However, one of the
key limitations of in vitro CNS models is that there is no vasculature associated with the
model. A lack of vasculature reduces the potential longevity of the model and does not
allow recruitment from the bloodstream which is possible in in vivo CNS models (Zhang
et al., 2002). Therefore in vitro cell culture models of spinal cord injury are useful tools
for investigating the short term responses to injury and the response of the cells to the
biomechanical properties of the matrix.
1.4 The importance of the extracellular matrix
Aguayo and colleagues demonstrated that CNS neurons are able to regenerate and grow
over long distances, provided that the matrix environment is supportive to growth, as
demonstrated by a peripheral nerve graft (Richardson et al. 1980; David and Aguayo
1981; Benfey and Aguayo 1982). PNS neurons have shown great regenerative capacity of
axons following injury, whereas the axons of the neurons of the CNS do not regenerate.
One of the main diﬀerences between the nervous systems is the glial cell populations (Lutz
and Barres, 2014). The Schwann cells of the PNS are similar to astrocytes in the CNS, in
that they support neurons, however Schwann cells also contribute towards remyelination.
Schwann cells support and guide axons by creating a growth-promoting microenvironment,
whereas CNS astrocytes contribute towards a growth-inhibitory microenvironment by
upregulation of inhibitory proteins such as CSPGs (Allen and Barres, 2009).
The extracellular matrix (ECM) consists of a complex composition of secreted molecules
such as collagen; the main structural component that can determine cell behaviour, and a
complex array of glycosaminoglycans and proteoglycans (Kim et al., 2011). Elastin is also
a major structural component of the ECM and with fibrillin, is responsible for the flexi-
bility in many tissues (Kielty et al., 2002). There are many ECM proteins which support
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the physical structure of the cell and some biological functions by binding other ECM pro-
teins, growth factors, signal receptors and adhesion molecules (Kim et al., 2011). Laminin
and fibronectin are ECM proteins which bind to ECM components, such as collagen or
Heparin Sulphate Proteoglycans (HSPGs) which play a role in cell adhesion (Gumbiner,
1996), growth and cell migration (Evercooren et al., 1982).
The dense and structured part of the ECM surrounding CNS neurons is known as
perineuronal nets (PNNs) (Celio and Chiquet-Ehrismann, 1993). The PNNs of the spinal
cord contain multiple CSPGs, such as aggrecan, neurocan, versican and phosphacan.
The PNNs also contain hyaluronan, link proteins and tenascin-R (Galtrey et al., 2008).
Hyaluronan is a core component of the ECM, link proteins stabilise the binding of CSPGs
to hyaluronan. CSPGs are highly expressed throughout the adult CNS ECM; however,
these proteoglycans are highly potent inhibitors of regeneration in the CNS by causing
growth cone collapse of neurons (Tom et al., 2004) and are up regulated by reactive as-
trocytes following spinal cord injury and inhibit neural regeneration (Tom et al., 2004).
Tenascin-R is a a glycoprotein secreted by oligodendrocytes (Garwood et al., 2004) and
some neurons (Rigato et al., 2002), Tenascin is part of a family of 4 glycoproteins which
bind integrins and cell adhesion molecules, contribute to PNNs, functions in repair, neu-
rogenesis, modulates synaptic function and plasticity in the adult CNS (Galtrey et al.
2008; Šekeljić and Andjus 2012).
Following injury to the CNS there is marked up-regulation of chondroitin sulphate
proteoglycans (CSPGs) such as NG2 and myelin associated inhibitors (MAIs) such as
Nogo-A, which inhibit axon growth and restrict plasticity (Huebner and Strittmatter,
2009). The changes in CNS ECM composition and cellular recruitment initiated follow-
ing a penetrating spinal cord injury versus blunt trauma can be quite diﬀerent. A spinal
laceration that penetrates the dura gives rise to substantial fibroblast invasion via disrup-
tion on the meninges. Whereas blunt trauma to the spinal cord, where the dura remains
intact but the BBB is disrupted, leads to glial scar matrix formation by a large proportion
of reactive astrocytes (Burnside and Bradbury, 2014).
The central nervous system tissues are complex and diﬀer greatly from other tissues;
the CNS is a closed system with a tight blood brain barrier surrounding the brain and
spinal cord. However, similar to many cell types, CNS cells require cellular adhesion to
allow migration, spreading and growth. The composition of the ECM varies between
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organs, systems and species but commonly consists of 10-20% of the total brain volume
(Nicholson and Syková, 1998). The ECM provides a supportive framework to CNS neu-
rons, its role is structural, homeostatic and important for cell signalling (Burnside and
Bradbury, 2014).
1.5 Biomechanics
Biomechanics relates to the mechanics of biology and describes forces and motion within
living systems. Understanding of biomechanics aids understanding of normal function
and applied to predict changes due to injury and proposes methods of intervention (Fung,
2013). In order to investigate how the mechanical properties of the matrix aﬀects spinal
cord injury in vitro, it is necessary to gauge an understanding of the biomechanical prop-
erties of the brain and spinal cord in health, and how the biomechanical properties of the
tissues are altered in disease states; this allows us to mimic the changes to the biome-
chanical properties of the matrix observed in vivo, in order to investigate the response of
isolated cell types in vitro.
The mechanical properties of living tissues are typically calculated by applying a known
mechanical stress and measuring the resultant mechanical strain; also known as the de-
formation of the material (Franze et al., 2013). Most biological materials and systems
are viscoelastic and display both viscous and elastic response to applied stresses (Shetye
et al., 2014).
1.5.1 Biomechanical properties of the brain and spinal cord
The spine is one of the more complex structures in mammalian biology, passive stability
is provided by the vertebrae, intervertebral discs and ligaments, active stability is pro-
vided by muscles. The spinal column allows maintenance of an upright body position
and is subjected to many forces, but ultimately can be flexible or rigid and withstand
great stress (Morris, 1973). The spinal cord is a complex structure with heterogeneous
mechanical properties of the white and grey matter, coupled with vascular tissues, per-
fusion with CSF and encapsulation by the meninges which provide the cord with tensile
strength (Mazuchowski et al., 2003); there are many factors influencing the biomechanics
of the spinal cord (LaPlaca et al., 2007). There is also a sparsity of conclusive studies to
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determine the mechanical properties of the brain and spinal cord, which may be due to
the diﬃculties in appropriately removing and preparing tissues and methods to accurately
measure the properties of the tissues (Christ et al., 2010).
One of the challenges in relating ex vivo measurements of brain stiﬀness to in vivo
measurements is the fact that, once removed from the skull and after perfusion by blood
and CSF ceases, the mechanical properties of the brain tissue can change considerably in
the absence of in vivo pressures (Xu et al. 2010; Weaver et al. 2012; Arani et al. 2015;
Arani et al. 2018). In an eﬀort to reduce variability, post-mortem studies of CNS tissues
should be conducted within 6 hours and tissues should also be stored at 4°C, to prevent
an increase in the stiﬀness of biological tissues (Nicolle et al. 2005; Fiford and Bilston
2005; Oakland et al. 2006; Garo et al. 2007; Cheng et al. 2008; Hrapko et al. 2008).
Other factors which could aﬀect the variability of the measured biomechanical proper-
ties of CNS tissues are the species (Tunturi 1978; Hung et al. 1981; Oakland et al. 2006),
tissue type (Kruse et al. 2008; Green et al. 2008), sample pre-conditioning (Gefen et al.,
2003) and specimen dimensions Cheng et al. (2008). Kruse et al. (2008) used magnetic
resonance elastography to measure the mean shear stiﬀness of cerebral white matter and
grey matter, Kruse et al. (2008) found that the stiﬀness of white matter was 13.6 kPa;
while that of grey matter was lower at 5.22 kPa. The diﬀerence was statistically signifi-
cant (p < 0.0001) and demonstrated the significant diﬀerence in stiﬀness between white
matter and grey matter of the human brain. Similar to the results illustrated in the earlier
magnetic resonance elastography study by Manduca et al. (2001), who found that white
matter of the human brain was a similar stiﬀness at 14.2 kPa, whist grey matter was found
to be softer with a stiﬀness of 5.3 kPa. Velardi et al. (2006) also found white matter to
be stiﬀer than grey matter, and found tissue from the corpus callosum (the white matter
beneath the cerebral cortex, which connects the right and left cerebral hemispheres) to be
stiﬀer than white matter from the corona radiata (white matter sheet of ascending and
descending axons to and from the cerebral cortex). There is evidence to suggest that the
brainstem is globally stiﬀer than the cerebral hemispheres (Arbogast et al. 1995 Arbogast
and Margulies 1997, Arbogast and Margulies 1998). These studies show that diﬀerent
regions of the brain have diﬀerent biomechanical properties, which may also be true for
other regions of the CNS such as the hippocampus, brainstem or spinal cord, therefore
any measurement of the brain and spinal cord can only be an approximation, unless the
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biomechanical properties of the brain are mapped across all the diﬀerent brain regions.
Table 1.1 has been compiled to summarise the studies using diﬀerent methodologies to
investigate the biomechanical properties of various regions of the brain and spinal cord,
from diﬀerent species and highlight some of the conditions whereby the stiﬀness of the
brain is reduced, for example with age (Sack et al., 2011) and disease, such as Alzheimers
disease (Murphy et al., 2011) and Multiple Sclerosis (Streitberger et al., 2012).
29
Ta
bl
e
1.
1:
Su
m
m
ar
y
of
st
ud
ie
s
in
ve
st
ig
at
in
g
th
e
bi
om
ec
ha
ni
ca
lp
ro
pe
rt
ie
s
of
C
N
S
tis
su
es
,g
ro
up
ed
by
sp
ec
ie
s
an
d
m
et
ho
d
to
de
ta
il
th
e
la
rg
e
ra
ng
e
of
m
ea
su
re
d
st
iﬀ
ne
ss
es
.
T
is
su
e
Sp
ec
ie
s
M
et
ho
d
St
iﬀ
ne
ss
R
ef
er
en
ce
C
er
eb
ra
lW
hi
te
M
at
te
r
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
13
.6
kP
a
K
ru
se
et
al
.(
20
08
)
C
er
eb
ra
lG
re
y
M
at
te
r
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
5.
22
kP
a
K
ru
se
et
al
.(
20
08
)
C
er
eb
ra
lW
hi
te
M
at
te
r
H
um
an
(m
al
es
)
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
3.
1
kP
a
G
re
en
et
al
.(
20
08
)
C
er
eb
ra
lG
re
y
M
at
te
r
H
um
an
(m
al
es
)
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
2.
7
kP
a
G
re
en
et
al
.(
20
08
)
B
ra
in
(H
ea
lth
y)
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
3.
07
kP
a
M
ur
ph
y
et
al
.(
20
11
)
B
ra
in
(A
lz
he
im
er
s
di
se
as
e)
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
2.
2
kP
a
M
ur
ph
y
et
al
.(
20
11
)
B
ra
in
(H
ea
lth
y)
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
3.
28
kP
a
St
re
itb
er
ge
r
et
al
.(
20
12
)
B
ra
in
(P
ro
gr
es
siv
e
M
ul
tip
le
Sc
le
ro
sis
)
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
2.
61
kP
a
St
re
itb
er
ge
r
et
al
.(
20
12
)
B
ra
in
(2
5
ye
ar
s)
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
3.
6
kP
a
Sa
ck
et
al
.(
20
11
)
B
ra
in
(7
5
ye
ar
s)
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
2.
6
kP
a
Sa
ck
et
al
.(
20
11
)
C
er
eb
ra
lW
hi
te
M
at
te
r
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
14
.2
kP
a
M
an
du
ca
et
al
.(
20
01
)
C
er
eb
ra
lG
re
y
M
at
te
r
H
um
an
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
5.
3
kP
a
M
an
du
ca
et
al
.(
20
01
)
B
ra
in
H
um
an
U
ni
ax
ia
lc
yc
lic
co
m
pr
es
sio
n
26
0
kP
a
Fr
an
ce
sc
hi
ni
et
al
.(
20
06
)
B
ra
in
H
um
an
Sh
ea
r/
rh
eo
lo
gy
0.
15
-0
.3
kP
a
P
ra
ng
e
an
d
M
ar
gu
lie
s
(2
00
2)
30
Ta
bl
e
1.
1:
C
on
tin
ue
d
fr
om
pr
ev
io
us
pa
ge
.
T
is
su
e
Sp
ec
ie
s
M
et
ho
d
St
iﬀ
ne
ss
(k
P
a)
R
ef
er
en
ce
B
ra
in
H
um
an
Sh
ea
r/
rh
eo
lo
gy
(2
-1
0
H
z)
0.
00
72
5-
0.
00
77
kP
a
Sh
uc
k
an
d
A
dv
an
i(
19
72
)
C
er
eb
ra
lW
hi
te
M
at
te
r
H
um
an
D
yn
am
ic
vi
sc
oe
la
st
om
et
er
0.
00
02
4
kP
a
H
ira
ka
w
a
et
al
.(
19
81
)
Sp
in
al
co
rd
H
um
an
Te
ns
io
n
89
kP
a
M
az
uc
ho
w
sk
ie
t
al
.(
20
03
)
C
er
eb
ra
lW
hi
te
M
at
te
r
Po
rc
in
e
In
de
nt
at
io
n
1.
01
kP
a
Va
n
D
om
m
el
en
et
al
.(
20
10
)
C
er
eb
ra
lG
re
y
M
at
te
r
Po
rc
in
e
In
de
nt
at
io
n
0.
75
kP
a
Va
n
D
om
m
el
en
et
al
.(
20
10
)
C
er
eb
ru
m
Po
rc
in
e
In
de
nt
at
io
n
0.
26
-0
.4
9
kP
a
M
ill
er
et
al
.(
20
00
)
T
ha
la
m
us
,
W
hi
te
M
at
te
r
C
or
on
a
R
ad
ia
ta
Po
rc
in
e
O
sc
ill
at
or
y
sh
ea
r
(1
-1
0
H
z)
0.
3-
0.
4
kP
a
H
ra
pk
o
et
al
.
(2
00
6)
;
G
ar
o
et
al
.
(2
00
7)
B
ra
in
st
em
Po
rc
in
e
O
sc
ill
at
or
y
sh
ea
r
(2
0
H
z)
15
kP
a
A
rb
og
as
t
an
d
M
ar
gu
lie
s
(1
99
8)
C
er
eb
ru
m
(I
nf
an
t)
Po
rc
in
e
O
sc
ill
at
or
y
sh
ea
r
(2
0
H
z)
(G
")
0.
22
kP
a
T
hi
ba
ul
t
an
d
M
ar
gu
lie
s
(1
99
8)
C
er
eb
ru
m
(A
du
lt)
Po
rc
in
e
O
sc
ill
at
or
y
sh
ea
r
(2
0
H
z)
(G
")
0.
34
kP
a
T
hi
ba
ul
t
an
d
M
ar
gu
lie
s
(1
99
8)
C
er
eb
ru
m
M
ic
e
M
ag
ne
tic
re
so
na
nc
e
el
as
to
gr
ap
hy
4.
32
-4
.4
9
kP
a
X
u
et
al
.(
20
13
)
P
yr
am
id
al
ne
ur
on
s
M
ic
e
Sc
an
ni
ng
fo
rc
e
m
ic
ro
sc
op
y
0.
48
-0
.9
7
kP
a
(3
0-
20
0
H
z)
Lu
et
al
.(
20
06
)
A
st
ro
cy
te
M
ic
e
Sc
an
ni
ng
fo
rc
e
m
ic
ro
sc
op
y
0.
3-
0.
52
kP
a
(3
0-
20
0
H
z)
Lu
et
al
.(
20
06
)
C
er
eb
ru
m
R
at
C
lin
ic
al
ul
tr
as
ou
nd
2-
25
kP
a
M
ac
é
et
al
.(
20
11
)
31
Ta
bl
e
1.
1:
C
on
tin
ue
d
fr
om
pr
ev
io
us
pa
ge
.
T
is
su
e
Sp
ec
ie
s
M
et
ho
d
St
iﬀ
ne
ss
(k
P
a)
R
ef
er
en
ce
C
or
te
x
(f
et
al
)
R
at
A
to
m
ic
Fo
rc
e
M
ic
ro
sc
op
y
0.
30
9
±0
.0
25
kP
a
N
or
m
an
an
d
A
ra
nd
a-
E
sp
in
oz
a
(2
01
0)
N
eo
co
rt
ex
R
at
A
to
m
ic
fo
rc
e
m
ic
ro
sc
op
y
0.
05
-0
.5
kP
a
M
oe
en
da
rb
ar
y
et
al
.(
20
17
)
C
or
tic
al
ne
ur
on
s
R
at
A
to
m
ic
fo
rc
e
m
ic
ro
sc
op
y
0.
07
8
kP
a
B
er
ni
ck
et
al
.(
20
11
)
H
ip
po
ca
m
pu
s
R
at
A
to
m
ic
Fo
rc
e
M
ic
ro
sc
op
y
0.
2-
0.
3
kP
a
E
lk
in
et
al
.(
20
07
)
C
er
eb
el
la
r
W
hi
te
M
at
te
r
R
at
Sc
an
ni
ng
fo
rc
e
m
ic
ro
sc
op
y
0.
29
4
±
0.
07
4
kP
a
C
hr
ist
et
al
.(
20
10
)
C
er
eb
el
la
r
G
re
y
M
at
te
r
R
at
Sc
an
ni
ng
fo
rc
e
m
ic
ro
sc
op
y
0.
45
4
±
0.
05
3
kP
a
C
hr
ist
et
al
.(
20
10
)
N
on
-p
re
co
nd
iti
on
ed
br
ai
n
M
at
ur
e
ra
t
In
de
nt
at
io
n
3.
34
kP
a
G
ef
en
et
al
.(
20
03
)
P
re
co
nd
iti
on
ed
br
ai
n
M
at
ur
e
ra
t
In
de
nt
at
io
n
1.
75
kP
a
G
ef
en
et
al
.(
20
03
)
N
on
-p
re
co
nd
iti
on
ed
br
ai
n
Yo
un
g
ra
t
In
de
nt
at
io
n
1.
72
kP
a
G
ef
en
et
al
.(
20
03
)
P
re
co
nd
iti
on
ed
br
ai
n
Yo
un
g
ra
t
In
de
nt
at
io
n
1.
23
kP
a
G
ef
en
et
al
.(
20
03
)
B
ra
in
R
at
O
sc
ill
at
or
y
sh
ea
r
(2
%
)
0.
33
±0
.1
kP
a
G
eo
rg
es
et
al
.(
20
06
)
Sp
in
al
co
rd
R
at
Te
ns
io
n
27
kP
a
Fi
fo
rd
an
d
B
ils
to
n
(2
00
5)
Sp
in
al
co
rd
D
og
St
re
ss
/s
tr
ai
n
re
sp
on
se
to
te
ns
io
n
10
kP
a
Tu
nt
ur
i(
19
78
)
Sp
in
al
co
rd
C
at
St
re
ss
/s
tr
ai
n
re
sp
on
se
to
te
ns
io
n
40
0
kP
a
H
un
g
et
al
.(
19
81
)
Sp
in
al
co
rd
C
ow
St
re
ss
/s
tr
ai
n
re
sp
on
se
to
te
ns
io
n
1,
19
0
kP
a
O
ak
la
nd
et
al
.(
20
06
)
32
The data tends to be variable over a large range of stiﬀnesses, which may also be as a
result of the rapid deterioration in the quality of the excised cadaveric samples, in which
the tangent modulus of the tissue has been seen to increase sharply over a period of 72
hours (Oakland et al., 2006).
There is also considerable variation in the measured biomechanical properties of neu-
ral tissues depending on the method of measurement (refer to Table 1.1). For example
the stiﬀness of the brain appears to be considerably softer when measured by oscillatory
shear rheology (150-400 Pa) (Prange and Margulies 2002; Hrapko et al. 2006; Garo et al.
2007). Hrapko et al. (2008) found the dynamic shear modulus of white matter from the
corona radiata was in the range of 300-400 Pa for a frequency of 1 Hz at room temper-
ature. These biomechanical measurements of the brain using dynamic shear techniques
are low compared to indentation techniques (752 Pa, 1.01 kPa (Van Dommelen et al.,
2010), 1.72 kPa, 3.34 kPa (Gefen et al., 2003) 3.2 kPa (Miller et al., 2000)) or magnetic
resonance elastography (2-14 kPa) (Manduca et al. 2001; Kruse et al. 2008; Sack et al.
2011; Streitberger et al. 2012). The range of stiﬀness measured for neural tissues by mi-
croscopy techniques such as AFM or SFM also appear to be much lower (100-500 Pa) (Lu
et al. 2006; Elkin et al. 2007; Christ et al. 2010; Bernick et al. 2011; Moeendarbary et al.
2017) than other techniques which measure the neural response to tension (27-89 kPa)
(Mazuchowski et al. 2003; Fiford and Bilston 2005).
One of the reasons why it is challenging to determine the biomechanical properties
of CNS tissues, is because the method of measurement yields a wide range of potential
stiﬀnesses from hundreds of Pascals to Pascal ranges (refer to table 1.1). The same
measurement technique, for example rheology, can also show variation in the measured
biomechanical properties of the same samples, if the parameters of the test are diﬀerent;
for example higher frequencies in dynamic methodologies yield higher shear moduli (Shuck
and Advani 1972; Hrapko et al. 2006; Lu et al. 2006; Garo et al. 2007).
In conclusion, the biomechanical properties of the brain may vary with age of specimen,
disease state, species, preparation of samples, length of time post-extraction, temperature
of sample, perfusion of tissue, region of measurement, measurement technique and selected
measurement parameters (refer to Table 1.1). For these reasons, the biomechanical prop-
erties of the CNS are poorly characterised.
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1.5.2 Biomechanical properties of the brain and spinal cord in
disease and injury
It has been found that in spinal cord injury, unlike most mammalian scar tissues, CNS
tissue becomes softer after injury. A striking and unexpected change in brain stiﬀness
has been found to occur following traumatic injury and glial scar formation. In a study
by Moeendarbary et al. (2017), a drop in tissue elasticity by more than three-fold was
observed at 9 days post traumatic brain injury, up to 1000 µm away from the lesion.
AFM indentation was used to measure the tissue 9 days post-injury when markers of glial
scarring were upregulated and found that the tissue surrounding the lesion was softer
than the surrounding tissue (Moeendarbary et al., 2017). Although it is unlikely that a
glial scar is formed in vivo at 9 days post injury, as glial scar formation would require 14
days post-injury (Silver, 2016). It is more likely that the reduction in matrix stiﬀness is
as a result of cyst formation and inflammation.
Astrocytes have also been measured to become softer as a result of injury, in the non-
nuclear regions; the elastic modulus was measured to be 57.7 ± 5.8 kPa measured by
AFM, however in injury, the elastic modulus was measured to be 26.4 ± 4.9 kPa (Miller
et al., 2009). The brain has also been reported to decrease in stiﬀness significantly from
2.37 kPa to 2.20kPa in neurological diseases such as Alzheimers disease (Murphy et al.,
2011) and brain tissue has also been seen to reduce in stiﬀness from 3.28 kPa to 2.61 kPa
in human brains suﬀering from progressive multiple sclerosis (Streitberger et al., 2012).
The stiﬀness of the brain is reported to decrease with age and lose elasticity over time.
In a study by Sack et al. (2011) using magnetic resonance elastography on human brains,
it was discovered that the brain decreases in stiﬀness from 3.6 kPa at 25 years of age, to
2.6 kPa at 75 years of age.
There are a limited number of studies investigating the stiﬀness of CNS tissues pre and
post-injury, however in conclusion there is a general trend observed that any damaging
stimulus to the brain, such as with age (Sack et al., 2011), disease (Murphy et al. 2011;
Streitberger et al. 2012) or injury Moeendarbary et al. 2017 results in a decrease in
the biomechanical properties of the brain, therefore perhaps interventions which increase
the biomechanical properties of the brain or injury site, may have a beneficial eﬀect on
neuronal regeneration.
34
1.5.3 The role of matrix stiﬀness in regulating cell behaviour
There are many physical properties that influence cellular behaviour, such as topography
(Lin et al. 2005, Brown and Phillips 2007), porosity (Pelham and Wang, 1997), hydropho-
bicity and hydrophilicity (Lee et al., 2003), swelling behaviour, interfacial tension and
viscoelasticity or matrix stiﬀness (Woerly, 2000), (Norman et al., 2009).
The stiﬀness of diﬀerent tissues can vary over many orders of magnitude; generally
the brain is considered to be in the range of several hundreds of Pascal (based on rheo-
logical/oscillatory shear data) (Prange and Margulies 2002; Hrapko et al. 2006; Georges
et al. 2006; Garo et al. 2007; Levental et al. 2007), whereas myotubes grow optimally on
substrates with stiﬀnesses similar to muscle (approximately 12 kPa) (Engler et al., 2004).
The cells derived from stiﬀer tissues such as bone or cartilage show a preference for stiﬀer
matrices in the 100 kPa to megaPascal range (Engler et al., 2006). Tissue culture plastic
or glass is measured in the gigaPascal range, therefore many studies using general tissue
culture materials such as glass or tissue culture plastic, are not using a physiologically
relevant mechanical environment for cell culture, which could have an impact on cellular
responses (Wells, 2008).
Matrix stiﬀness, which can be defined as the matrix resistance to deformation, is an
important driver of cell behaviour. Tissues are viscoelastic in nature and have properties
of both an elastic solid and a viscous liquid. Adherent cells attach to the ECM through
focal adhesions and pull on the substrate via an actin-myosin cytoskeleton; cells sense
resistance and respond through the cytoskeleton (Discher et al., 2005). Cells cultured
on stiﬀer substrates have more organised cytoskeletons and more stable focal adhesions
(Wells, 2008); the stiﬀness of the matrix is proposed to be a key property of the cell cul-
ture environment and can change cellular behaviour such as speed and direction of cellular
migration via durotaxis, as a result of mechanotransduction (Discher et al., 2005). Cells
in vivo interact with biochemical and biomechanical cues within their surrounding ma-
trix, these interactions influence cell behaviour, function, and fate of stem cells (Kharkar
et al., 2013). Manipulations to the microenvironment may produce beneficial changes
in cell behaviour to encourage neural regeneration. Suhonen et al. (1996) demonstrated
that grafted cells from the hippocampus adjusted their behaviour to match the local
environment of the olfactory bulb and vice versa, giving rise to neurons which correctly
incorporated into the new structure (Barres, 1999); this study demonstrated how the local
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environment supplied signals to the stem cell niche giving tissue specific diﬀerentiation
cues.
The stiﬀness of the matrix has been shown to be of consequence in the study of fi-
broblast morphology and mobility; fibroblasts on flexible substrates have shown reduced
spreading and increased motility, expressing highly dynamic irregularly shaped focal ad-
hesions, compared to cells on rigid substrates (Pelham and Wang, 1997). Fibroblasts have
also shown the ability to change direction in response to preference for a stiﬀer matrix
by the process of durotaxis; fibroblasts migrated with ease across a boundary from soft
to stiﬀ substrates, however when fibroblasts were placed on a stiﬀ to soft gradient, the
fibroblasts turned around and retracted at the interface with the soft substrate (Lo et al.,
2000). The response to changes in matrix stiﬀness are diverse depending on the specific
cell type (Georges and Janmey, 2005); fibroblasts cultured on soft matrices tend to be
small and round with little or no projections, whereas fibroblasts cultured on stiﬀer matri-
ces tend to adhere to the matrix and spread projections, taking on a stellate morphology.
Similarly, myotubes only supported the formation of myosin striations when cultured on
matrices with a stiﬀness of approximately 11 kPa (Pedersen and Swartz, 2005). These
studies indicate that matrix stiﬀness plays an important role in regulating cell behaviours
such as stem cell diﬀerentiation (Kharkar et al., 2013), durotaxis (Discher et al., 2005)
and direction of migration (Lo et al., 2000), morphology (Georges and Janmey, 2005) and
shape of focal adhesions (Pelham and Wang, 1997) irrespective of cell type.
1.5.4 The role of matrix stiﬀness in regulating CNS cell behaviour
A key study which brought to light the importance of matrix stiﬀness in contributing
towards diﬀerences in cellular behaviours and stem cell fates was performed by Engler
et al. (2006); stem cell diﬀerentiation fates varied as a result of changing matrix elasticity
to closely resemble the matrix elasticity of native tissues such as brain, muscle and col-
lagenous bone. The lower the stiﬀness of the matrix, the higher the expression of neuronal
markers such as nestin and beta-3 tubulin, which suggested that a lower matrix stiﬀness of
0.1-1 kPa encourages human mesenchymal stem cells to diﬀerentiate towards a neuronal
lineage. However, a critique of this article is that there is no specific reference to a study
where the biomechanical measurements of brain tissue originate. The reference used in
the paper to characterise the stiﬀness of brain tissue is the study by Flanagan et al. (2002),
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who cultured primary spinal cord neuronal cells from mice on gels of diﬀerent stiﬀnesses
and measured neurite outgrowth. As detailed in section 1.5.1, the biomechanical proper-
ties of brain tissue is highly variable depending on a number of factors, such as method
of measurement, age of specimen, species and region of the brain, as displayed in Table
1.1, therefore it is inaccurate to state the stiﬀness of brain tissue as 1 kPa without further
clarification of the conditions of measurement and appropriate references.
However, the results detailed in Engler et al. (2006) were found to be in concordance
with a more recent study by Her et al. (2013) who found that MSCs were more likely
to diﬀerentiate into neuronal lineages at 1 kPa substrate modulus, whereas at 10 kPa,
glial cells were the more dominant lineage choice over neuronal cells. CNS cells have
individual matrix stiﬀness preferences, Leipzig and Shoichet (2009) found that oligoden-
drocyte diﬀerentiation was preferential on stiﬀer gels around 7 kPa, however myelination
of nerves was encouraged on gels of approximately 1 kPa stiﬀness. CNS cell types may
exhibit diﬀerent behaviours at diﬀerent matrix stiﬀnesses; astrocyte diﬀerentiation was
observed on matrices with a matrix elasticity of 1-3.5 kPa, whilst neurons shared a similar
preference for softer matrices, with the highest neuronal marker expression observed at
3.5 kPa (Leipzig and Shoichet, 2009).
The process by which cells sense mechanical stimuli and convert this information into
actions that change the intracellular biochemical signalling, is known as mechanotrans-
duction (Cullen et al., 2007). There are many mechanical influences over the cell, such
as fluid shear stress, pressure and elongational stresses such as internal forces, impact
forces, gravity or osmotic forces; these forces can influence cellular locomotion, adhesion,
morphology and cytoskeletal protein expression (Georges and Janmey, 2005). Mechan-
otransduction is of widespread importance across the body, but little is known about the
relationship between biomechanical inputs and acute astrogliotic changes following CNS
injury (East and Phillips, 2008).
The matrix stiﬀness range is important when investigating cell response to matrix
stiﬀnesses, as too narrow a range may not reveal any diﬀerences in cell behaviour, however
too large a range in matrix stiﬀness may not be physiologically relevant. There is a large
variation in the literature as to what is considered a ‘stiﬀ’ or ‘soft’ matrix stiﬀness; the
soft gel in the study by Zhou et al. (2013) was defined as 1.13 Pa, whereas the study by
Jiang et al. (2008) considered 6.6 kPa to be their softest matrix stiﬀness. The study by
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Willits and Skornia (2004) defined their stiﬀest gel to be 17 Pa, whereas the stiﬀest gel
in the study by Lantoine et al. (2016) is approximately 500 kPa (refer to Table 1.2 for
an overview of the range of stiﬀnesses used in studies for investigating the role of matrix
stiﬀness on neuronal cell behaviour). There does not appear to be an agreement as to what
constitutes a ‘soft’ or a ‘stiﬀ’ matrix in neural research, however some of this diﬀerence
may be as a result of diﬀerent measurement techniques producing diﬀerent measurements
for the same tissue stiﬀness.
Neuron-astroglial interactions are important in determining cellular behaviour in re-
sponse to matrix stiﬀness, such as neurite elongation, branching, and axonal regeneration.
However, spinal cord neurons extend more primary dendrites and shorter axons on stiﬀer
gels (Jiang et al. 2008, Georges et al. 2007, Pettikiriarachchi et al. 2010) than on softer
matrices. It has also been shown that in mixed cultures, where the matrix is of similar
compliance to that of brain tissues, neuronal over glial growth is preferred (Georges et al.,
2006). These studies show that modulating the mechanical properties of the matrix such
as stiﬀness, can have a profound eﬀect on neural cell behaviour.
In a study by Georges et al. (2006) it was discovered that astrocytes from dissociated
rat cortices, plated on polyacrylamide gels of diﬀerent stiﬀnesses, displayed small round
morphologies on soft matrices (300 Pa) and highly spread morphologies typical of reactive
glia on stiﬀ matrices (9 kPa). However caution should be taken when interpreting results
from studies where biosynthetic hybrid gels are used to alter the stiﬀness of the matrix,
as the stiﬀness of the matrix may not be the only parameter which is aﬀected by the
diﬀerences in chemistries between the gels. In the study by Georges et al. (2006) the
polymer mass remains constant and the concentration of laminin used to coat the surface
of the gel remains constant, however the concentration of bis-acrylamide linker was altered.
The higher concentration of bis-acrylamide linker in the stiﬀer hydrogels may have caused
an increased proportion of laminin to be bound to the surface of the stiﬀest gel. This
could indicate that there was an increased proportion of cell adhesion molecules bound to
the surface of the stiﬀer hydrogels, compared to the softer hydrogels and therefore provide
an explanation for the diﬀerences in morphology, which may not have been due to the
diﬀerences in the stiﬀness of the matrices. The mechanism for changing the stiﬀness of the
matrix should be tightly controlled and analysed to ensure that there are no diﬀerences in
cell adhesion sites between matrices of diﬀerent stiﬀnesses; this is of particular importance
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in biosynthetic hydrogels.
Table 1.2: Summary of studies investigating the role of matrix stiﬀness on neural cell
behaviour
Matrix material Soft matrix Stiﬀ matrix Reference
Collagen 2.5 Pa 17 Pa Willits and Skornia (2004)
Collagen 47.96 Pa 874 Pa Smith (2016)
Collagen with fi-
bronectin
1.13 Pa 28.27 Pa Zhou et al. (2013)
Peptide 500 Pa 2,100 Pa Lampe et al. (2013)
Hyaluronic acid 1,000 Pa 10,000 Pa Her et al. (2013)
Fibrin (human) 2,500 Pa 80,000 Pa Man et al. (2011)
Fibrin (salmon) 45 Pa 125 Pa Ju et al. (2007)
Fibrin 250 Pa 2,150 Pa Zhang et al. (2002)
Alginate 640 Pa 20,800 Pa Matyash et al. (2011)
Agarose 5 Pa 130 Pa Balgude et al. (2001)
PEG with fibronectin 54 Pa 978 Pa Zhou et al. (2013)
PEGDA with RGD 75 Pa 400,000 Pa Gunn et al. (2005)
Polyacrylamide 500 Pa 5,500 Pa Flanagan et al. (2002)
Polyacrylamide 1,350 Pa 33,150 Pa Urbanski et al. (2016)
Polyacrylamide 300 Pa 47,000 Pa Georges et al. (2007)
Polyacrylamide with
DNA cross-links
6,600 Pa 29,800 Pa Jiang et al. (2008)
Polyacrylamide conju-
gated to fibronectin
10 Pa 100,000 Pa Leach et al. (2007)
Polyacrylamide
coated in fibronectin
10 Pa 100,000 Pa Fehlings and Perrin (2005)
Polydimethyl siloxane 200 Pa 8000 Pa Wilson et al. (2016)
Polydimethyl siloxane 5,000 Pa 500,000 Pa Lantoine et al. (2016)
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1.5.4.1 The role of matrix stiﬀness in regulating astrocyte behaviour
Astrocytes undergo a vigorous response to neurologic insults, which occur rapidly and
can be detected within one hour of mechanical trauma (Mucke et al., 1991). Astrocytes
respond to a range of CNS insults such as infection, trauma and neurodegenerative disease
by becoming hypertrophic, increasing expression of GFAP and undergoing molecular and
morphological changes (Sofroniew, 2009).
Studies have shown significant increases in GFAP expression of astrocytes cultured in
stiﬀer matrices compared to astrocytes cultured in softer hydrogel matrices. Smith (2016)
observed a significant increase in GFAP expression of astrocytes cultured in matrices with
a stiﬀness of 874 Pa, compared to matrices with a stiﬀness of 47.96 Pa. Similarly Georges
et al. (2007) also reported a significant increase in GFAP expression by astrocytes cultured
on a stiﬀ (47 kPa) matrix as opposed to the more compliant (300 Pa) matrix. It is thought
that in soft gels where the matrix is easily deformed, there are insuﬃcient traction forces
necessary for extending new processes, whereas in stiﬀ gels there is suﬃcient traction
for new process formation; therefore there is an optimum range of stiﬀness required for
astrocytes to ‘feel’ suﬃcient traction forces to adopt a physiological morphology (Placone
et al., 2015). The argument for the degree of traction force being related to the stiﬀness
of the matrix is a logical explanation for the smaller, rounded morphology of astrocytes
observed on soft matrices (200 Pa) where there are insuﬃcient traction forces to adopt a
spread morphology, as opposed to the larger, elongated, spread morphologies of astrocytes
cultured on stiﬀer (8000 Pa) matrices (Wilson et al., 2016).
In the study by Min et al. (2015) adhesion and viability of astrocytes, increased as
the stiﬀness of the cell culture substrate increased in stiﬀness, however astrocytes showed
saturation on matrices with a tensile strength greater than 2 MPa. Reactive astrocytes
upregulated intermediate filament (GFAP) expression and astrocytes became stiﬀer with
an increase in matrix stiﬀness (Keirstead et al. (1998); Lu et al. (2011)). The stiﬀness
of astrocytes positively correlated with the density of cytoskeletal proteins such as actin
filaments, microtubules and intermediate filaments measured by AFM (Lee et al., 2015).
These studies demonstrated that as the stiﬀness of the matrix increased, so too did the
stiﬀness of astrocytes as the cells increased intermediate filament expression.
Georges et al. (2007) demonstrated that cell adhesion in pure astrocyte cultures was
low on soft matrices (300 Pa) and astrocytes preferentially adhered to matrices with
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higher stiﬀnesses (47 kPa), however these authors also showed that astrocytes exhibited
the most severe excitotoxic reaction to 500 µl glutamate exposure when cultured on the
softer matrices compared to the more resilient and reduced response of astrocytes to
glutamate exposure when cultured on the stiﬀer matrices. This study suggested that the
biomechanical properties of the matrix may have an eﬀect on the resistance of astrocytes
to excitotoxic damage (Georges et al., 2007).
Moshayedi et al. (2014) aimed to investigate the astrocyte and microglial response to
medical devices with diﬀerent mechanical properties inserted into the CNS. It was found
that foreign body reactions were significantly enhanced around stiﬀ devices (10 kPa) in
vivo when compared to the more compliant devices (100 Pa). In the previous study
by Moshayedi et al. (2010), whereby astrocytes were cultured on poly-D-lysine coated
substrates with a shear moduli of 100 Pa or 10 kPa, it was found that astrocytes cultured
on the stiﬀ substrates showed significantly increased perimeter, area, diameter, elongation,
number of extremities and overall complexity compared to those cultured on compliant
substrates. These studies suggest that the stiﬀness of the matrix and the compliance of
the surrounding tissue in vivo may influence astrocyte morphology and behaviour and
that biocompatibility of medical devices could be improved by utilising softer materials
(Moshayedi et al., 2014).
Matrix stiﬀness can have a diverse eﬀect on astrocyte morphology (Georges et al. 2007;
Wilson et al. 2016), reactivity (Smith, 2016), adhesion (Min et al., 2015) and traction
forces (Placone et al., 2015), intermediate filament expression (Lu et al. 2011; Min et al.
2015; Lee et al. 2015) and response to excitotoxicity (Georges et al., 2007).
1.5.4.2 The role of matrix stiﬀness in regulating neuronal behaviour
The stiﬀness of the matrix has been shown to be a regulator of neuronal cell growth and
is of particular interest within the field of tissue engineering and regenerative medicine.
A number of diﬀerent biomaterials have been used to investigate the role of ma-
trix stiﬀness on neurite extensions. Despite the material, most studies have found that
neurite extensions were longer on softer matrices (refer to Table 1.3). Neurite exten-
sions were reduced when DRG explants were cultured within fibrin gels of increasing
fibrinogen concentrations (Man et al., 2011). Similarly spinal cord neurons cultured on
protein-laminated polyacrylamide gels (Flanagan et al., 2002), three-dimensional engi-
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neered elastin-like proteins (ELPs) hydrogels (Lampe et al., 2013) and three-dimensional
collagen gels (Sundararaghavan et al., 2009) all showed that neurons grown on softer
substrates formed more neurites or longer neurites than those grown on stiﬀer gels. Hip-
pocampal neural progenitor cells have also demonstrated increased neurite outgrowth
and density of neurites in the softest hydrogels (400 Pa), compared to hydrogels with a
modulus of 800 Pa (Tarus et al., 2016).
Recent advances have shown that by increasing the concentration of PEG or collagen
in hydrogels, thereby increasing the stiﬀness of the matrix, the length of neurite extensions
decreased with the increase in the complex elastic modulus, measured by rheology (Zhou
et al., 2013). The results of the study by Zhou et al. (2013) were not isolated and most
studies were in agreement with these findings (refer to Table 1.3 for a summary of the
results of the studies investigating the role of matrix stiﬀness on neurite outgrowth).
The rate of neurite extension of dorsal root ganglion cells was inversely proportional to
substrate stiﬀness, the softer the matrix, the higher the rate of elongation (Balgude et al.,
2001). In agreement with these results, Gunn et al. (2005) and Flanagan et al. (2002)
showed that PC12 neuronal cells cultured on flexible (soft) PEG and matrigel-coated
polyacrylamide hydrogels presented greater neurite extensions and branching than PC12
neuronal cells cultured on stiﬀer hydrogels. This is thought to be because the soft gel
more closely mimics the natural 3D environment (Pedersen and Swartz, 2005).
It has been found that PC12 neurons have a threshold response to substrate stiﬀness
at approximately 100 Pa; at 10 Pa the neurites were very few in number, short and
unbranched; whereas at stiﬀnesses greater than 100 Pa the neurites were longer, branched
and present on higher numbers of neurons. There was no significant diﬀerence between
100-1000 Pa substrate stiﬀness; this suggested that as long as the matrix stiﬀness was
within that range, conditions for neurite extensions were favourable (Leach et al., 2007).
The eﬀect of collagen gel stiﬀness on neurite extension was investigated by Willits and
Skornia (2004), these authors also found that neurite length decreased with increasing
stiﬀness, however the stiﬀnesses used (2-17 Pa) were much lower than the native stiﬀness
of brain tissue (Refer to Table 1.1 for a summary of the literature on the biomechanical
properties of CNS tissues) and the stiﬀness threshold of 100 Pa for neurite extensions,
as suggested in the study by Leach et al. (2007). This is a limitation of the study as
the changes they observed in neurite extensions may have been due to the changes in
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collagen concentration (Scott et al., 2011); the experimental design of each study should
be analysed for other impacting variables which may have caused the diﬀerences in cellular
behaviour, which is claimed to be as a result of the changes in matrix stiﬀness such as
protein concentration or cross-linking densities.
Whilst most of the studies summarised in Table 1.3 indicate that softer biomechanical
matrices enhanced neurite outgrowth, a few studies found that the stiﬀness of the matrix
did not have an eﬀect on neurite outgrowth (Georges et al., 2006) (Norman and Aranda-
Espinoza, 2010). In the study by Norman and Aranda-Espinoza (2010) the stiﬀness of
fetal rat cortices was measured using AFM and polyacrylamide gels were formulated to
match the approximate stiﬀness around that of the measured cortex (309 Pa ±25 Pa);
cortical neurons were cultured on polyacrylamide gels with stiﬀnesses from 260 Pa to 13
kPa, however, no significant diﬀerences were identified between cortical process length
and migration on any of the matrices (Norman and Aranda-Espinoza, 2010). Interest-
ingly the study by Norman and Aranda-Espinoza (2010) and the other study by Georges
et al. (2006) that also failed to detect a diﬀerence in neurite outgrowth on matrices with
a range of stiﬀnesses, also used cortical neurons in mixed glial cultures, whereby the pres-
ence of astrocytes may have caused cell-cell communication and synapse formation which
could have influenced the behaviour of the cortical neurons; cell-cell adhesion molecules
and membrane-associated guidance molecules can influence neurite outgrowth (Tessier-
Lavigne and Goodman 1996; Bagnard et al. 2001). Contrary to these studies supporting
the assumption that glial cell communication may have aﬀected the neuronal response to
matrix stiﬀness, is the study by Lantoine et al. (2016) who used isolated cortical neurons
to discover that migration of cortical neurons was enhanced on softer substrates (5 kPa)
leading to faster formation of neural networks but synaptic density and synaptic currents
were enhanced on stiﬀer substrates (500 kPa). Neural cells cultured in isolation may show
stronger sensitivities towards the biomechanical properties of the matrix than neural cells
in mixed glial cultures.
Contrary to the majorities of the studies, the study by Jiang et al. (2008) found that
primary dendrite length was not significantly aﬀected by the stiﬀness of the matrix, how-
ever spinal cord neurons were found to extend more primary dendrites and shorter axons
on stiﬀer gels. There may be other unknown contributing factors involved which may
pose a greater influence on neurite extension than the stiﬀness of the matrix, however the
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unknown factors may also increase with an increase in the stiﬀness of the matrix, such
as cross-linking density or protein concentration. There is a need for a multi-disciplinary
approach to further elucidate the potential causes of neurite extensions including bio-
chemical analysis of matrices not just analysis of the mechanical properties.
Table 1.3: Summary of results investigating the role of matrix stiﬀness on neurite out-
growth. *Soft or stiﬀ hydrogel is relative to each study as diﬀerent measurement tech-
niques yield diﬀerent stiﬀnesses, therefore stiﬀnesses not directly comparable.
Soft or
Stiﬀ*
Summary of Results Reference
Soft The softer the matrix, the higher the rate of elonga-
tion
(Balgude et al., 2001)
Soft Greater neurite extensions and branching on soft gels (Gunn et al., 2005)
Soft Greater neurite extensions and branching on soft gels (Flanagan et al., 2002)
Soft Neurites were longer and more highly branched (Leach et al., 2007)
Soft Neurite length decreased with increasing stiﬀness, (Willits and Skornia,
2004)
Soft Increased outgrowth and neurite density on soft gels (Tarus et al., 2016)
Soft Neurite length decreased with increase in stiﬀness (Man et al., 2011)
Soft Neurites grew significantly longer down the gradient
of stiﬀness
(Sundararaghavan
et al., 2009)
Soft Greatest neurite outgrowth on most compliant matri-
ces
(Lampe et al., 2013)
Soft Neuritogenesis was reduced on stiﬀer matrices (Tanaka et al., 2018)
Neither Neurons extend long neurites on both soft and hard
gels
(Georges et al., 2006)
Neither Cortical neuron outgrowth was insensitive to stiﬀness (Norman and Aranda-
Espinoza, 2010)
Stiﬀ Spinal cord neurons extend more primary dendrites
on stiﬀer gels
(Jiang et al., 2008)
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1.5.4.3 The role of matrix stiﬀness in regulating microglial behaviour
There are a limited number of studies that investigate the role of the stiﬀness of the
matrix on microglial cell behaviours (Moshayedi et al. 2014; Dryg et al. 2015; Bollmann
et al. 2015; Moeendarbary et al. 2017; Reimer et al. 2018).
Most of the studies involving microglia and the potential eﬀects of changing the matrix
stiﬀness, relate to neural implants such as electrodes, which are inserted into the brain
and elicit an inflammatory ‘foreign body’ response. It has been demonstrated that mi-
croglia upregulate inflammatory mediators when exposed to an environment or material
with increased stiﬀness (Moshayedi et al., 2014). Soft implants that have been mechani-
cally matched to the surrounding CNS tissue displayed diminished foreign body reaction
in vivo (Moshayedi et al., 2014). Astrocytes and microglia attempt to engulf the elec-
trode, increasing the electrical impedance between the electrode and neurons; the use of
a material with reduced stiﬀness decreased the damage caused by insertion and reduced
the intensity of the tissue response (Dryg et al., 2015). According to the recent study by
Reimer et al. (2018), increased microglial cell spreading was observed on stiﬀ hydrogels;
Microglia cells had large spread morphologies and elongated shapes on glass compared to
hydrogels, which are softer in nature.
In a study by Bollmann et al. (2015), it was found that microglia cultured on matrices
of approximately 100 Pa expressed many filopodia-like processes, which were reduced in
number when microglia were cultured on matrices of approximately 300 Pa. The same
study found that microglia cultured on matrices of 1000 Pa showed complex morphologies
with lamellipodia-like structures and increased migration and durotaxis on stiﬀer matrices
(Bollmann et al., 2015)
Microglia are sensitive to the stiﬀness of the microenvironment, a decrease in the
stiﬀness of the matrix, as observed in SCI (Moeendarbary et al., 2017), may cause an
increase in microglial proliferation and migration in response to signals of damage and
repair, however microglia may also respond to signals from a stiﬀer matrix beyond that
of native undamaged tissue and up-regulate the inflammatory response to decrease the
risk of infection from the presence of a foreign body (Moshayedi et al., 2014). Perhaps
microglia are capable of a bimodal response to matrix stiﬀness, whereby an increase or
decrease in matrix stiﬀness triggers an inflammatory response and change in microglial
properties with the change in the microenvironmental circumstances, i.e. softens due to
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injury or stiﬀens due to implantation of stiﬀ biomaterials, however further research would
be necessary to draw any conclusions about microglial cell behaviour in relation to matrix
stiﬀness.
1.5.4.4 The role of matrix stiﬀness in regulating oligodendrocyte behaviour
Unfortunately oligodendrocytes and the eﬀect of matrix stiﬀness on oligodendrocyte be-
haviour is not well documented. Some of the studies that mention oligodendrocyte be-
haviour in the context of changes to matrix stiﬀness, refer to neural stem cell diﬀerentia-
tion (Leipzig and Shoichet 2009; Teixeira et al. 2009) or oligodendrocytes precursor cells
(Jagielska et al. 2012; Russell and Lampe 2017).
The study by Leipzig and Shoichet (2009) quantitatively assessed myelin oligodendro-
cyte glycoprotein (MOG) gene expression during embryonic neural stem cell diﬀerentiation
on matrices of diﬀerent stiﬀnesses, the results suggested that oligodendrocyte maturation
and myelination was preferred on gels of less than 1kPa stiﬀness. This is close to the
range of preferred matrix stiﬀness suggested for oligodendrocytes, and in agreement with
the study by Jagielska et al. (2012) who found that oligodendrocytes had an optimal
stiﬀness of approximately 700 Pa for growth, proliferation, migration and diﬀerentiation.
Jagielska et al. (2012) also found that oligodendrocyte progenitor cells increase their area
and complexity on stiﬀer substrates, but show an optimum in survival and proliferation
at intermediate values of CNS tissue stiﬀness.
Oligodendrocyte diﬀerentiation from neural stem cells did not show a preference for
matrix stiﬀness in the study by Teixeira et al. (2009). The oligodendrocyte cell number
did not change with an increase in PDMS hydrogel matrix stiﬀness, however oligoden-
drocytes had a greater capacity to spread on stiﬀer matrices and the area occupied with
oligodendrocytes was 2-3 times larger than the area occupied by oligodendrocytes on softer
matrices (Teixeira et al., 2009). However the substrate stiﬀnesses in this study were high
ranging from 750 ±150 kPa for the stiﬀer hydrogels to 12 ±4 kPa for the softest hydrogels.
These stiﬀnesses are not considered physiologically relevant, as the biomechanical prop-
erties of the brain are measured to be much softer than these hydrogels by the majority
of studies, as detailed in table 1.1.
The study by Russell and Lampe (2017) also investigated what eﬀect the stiﬀness of
the matrix had on oligodendrocyte precursor cells by using a range of PEG hydrogels
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with storage moduli from 240 Pa to 2 kPa with diﬀerences in cross-linking density. It was
found that the concentration of ATP increased in the softer hydrogels indicating higher
cell viability and metabolism. Larger cell spheroids were observed in the more compliant
hydrogels with lower cross-linking densities. The results also indicated that the stiﬀer,
highly cross-linking hydrogels contained a higher number of cells that had high PDGFR↵
receptor expression, which indicated dediﬀerentiation away from oligodendrocyte lineage;
therefore oligodendrocytes favour more compliant matrices (Russell and Lampe, 2017).
In summary, oligodendrocyte diﬀerentiation from neural stem cells and oligodendro-
cyte precursor cell viability and proliferation is preferred on softer matrices with a stiﬀness
less than 1 kPa; however there were few studies available for analysis and therefore further
investigation is required before a solid conclusion can be drawn.
1.6 Biomaterials for a spinal cord injury model
There are a broad range of biomaterials which can be used for cell culture, ranging from
tissue culture plastic, decellularised tissues, synthetic scaﬀolds, resorbable biomaterials
for in vivo transplantation or with increasing popularity for 3D applications (Hubbell,
1995).
Hydrogels are unique biomaterials that are biocompatible, highly absorbent, hydrophilic
gels that are gaining popularity for tissue engineering applications because they are simple
to manufacture, easily manipulated and can be synthesised from a wide range of poly-
mers, peptides and natural materials; which provide an optimum matrix for 3D in vitro
cell culture models (Slaughter et al., 2009). Hydrogels are useful in the development of
tissue engineered scaﬀolds, which provide structural integrity and allow delivery of cells,
drugs, guidance cues, barriers or extracellular matrix components. Hydrogels capture
numerous characteristics of the architecture and mechanics of natural ECM microenvi-
ronment, have a high water content which eases transport of oxygen, nutrients and waste
(Nguyen and West, 2002). Hydrogels have been known to promote tissue-specific gene
expression (Geckil et al., 2010), closely mimic the ECM and allow for 3D in vitro cell
culture, which has been demonstrated to encourage cells to behave more naturally in 3D
as opposed to on 2D substrates (Tibbitt and Anseth, 2009). Hydrogels can be made up
of up to 99% water, whilst also providing a 3D network with a complex highly porous
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nano-topography, that can be modified as desired. Hydrogels can be made from synthetic
materials or derived from animal components and functionalised to alter the physical and
chemical properties.
The hydrogels used in 3D in vitro models should support CNS cells without causing
a reactive glial or immune response; have similar properties to the brain or spinal cord,
but have the capacity to allow manipulation of the stiﬀness and allow infiltration of
cells, axons, and transportation of nutrients and metabolites (East and Phillips 2008;
Wang et al. 2012). Hydrogels can be formed from a vast array of materials, naturally
derived, typically formed of proteins or ECM components, or synthetically engineered
and designed to possess cell adhesion ligands, desired viscoelasticity and degradability
(Lutolf and Hubbell 2005; Tibbitt and Anseth 2009). The following sections shall address
some of the benefits and limitations of the diﬀerent biomaterial choices for a hydrogel
model.
1.6.1 Natural hydrogels
Natural materials such as collagen or fibronectin are appropriate for CNS applications as
they contain fibres with specific adherence molecules and natural bioactivity, that allow
cellular adhesion and attachment, without having to add expensive cell adhesion motifs
to synthetic matrices. Natural materials are often animal derived and expensive to purify,
but they tend to be degradable by enzymatic digestion, which facilitates infiltration of
cells and axons in the hydrogels (Wang et al., 2012).
Natural hydrogels are inherently biocompatible and promote many cellular functions
due to the endogenous factors present in the material, derived from the natural proteins
or ECM components (Dawson et al., 2008). However, hydrogels derived from natural
materials are diﬃcult to change the biomechanical and biochemical properties of the ma-
trix, natural materials possess batch-to-batch variability (Tibbitt and Anseth, 2009) and
the matrices are often ill-defined and diﬃcult to determine which signals are promoting
cellular function (Cushing and Anseth, 2007).
Collagen is the main structural protein in many connective tissues and therefore is
the material of choice for a naturally derived cell seeded model to mimic the ECM. Neu-
rons cultured in collagen hydrogels have demonstrated functional synapse formation (Fan
et al., 2012), neurite extensions (Willits and Skornia, 2004) and enhanced neuronal diﬀer-
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entiation (Brännvall et al., 2007). A varied network architecture of collagen I hydrogels
can be achieved by functionalisation of collagen lysines (Tronci et al., 2013). The photo-
active collagen systems developed by Tronci et al. (2013) allow cross-linking density to be
controlled, to form a highly stable collagen gel, with a controlled triple helix architecture
and fully characterised system.
Collagen gels can also be formed by a neutralisation reaction of native acid soluble col-
lagen with a base to form a hydrogel scaﬀold, however a comparison between the diﬀerent
methods of chemically crosslinked UV-polymerised collagen hydrogels to pH dependent
collagen gel formation by fibrillogenesis (East and Phillips, 2008) has not previously been
carried out. The pH dependent non-toxic method of hydrogel formation by collagen fibril-
logenesis, allows cells to be incorporated within the gels during the polymerisation process.
This neutralisation reaction is advantageous compared to collagen gel formation by UV
polymerisation, as it allows thorough cell-seeding throughout the collagen scaﬀold, not
simply surface diﬀusion of cells; this may not allow full cell penetration throughout the
hydrogel and the UV can be toxic to cells.
Hyaluronic acid (HA) is an attractive option for CNS research because it is a major
constituent of the ECM, present in the brain (Costa et al., 2007). Hyaluronic acid is
highly biocompatible and beneficial in wound healing (Manuskiatti and Maibach, 1996)
and even plays a role in reducing glial scar formation when implanted into wounds (Tian
et al. 2005; Pettikiriarachchi et al. 2010; Wang et al. 2012). A disadvantage of using
HA, is that cells do not directly adhere to its surface and often collagen or adhesion
peptides (such as RGD) are used in conjunction with HA to enhance adhesion and neural
regeneration; however this is often expensive. The feasibility of using HA as a matrix has
been demonstrated in vivo by implanting HA hydrogels into lesions in rat brains. Hou
et al. (2006) found that the HA hydrogel supported infiltration and angiogenesis, while
inhibiting glial scar formation (Brännvall et al., 2007).
Laminin and fibronectin have been recognised to facilitate nerve development and of-
fer a neuroprotective function in CNS injury (Duan et al. 2000; Zhao et al. 2005; King
et al. 2010). Fibronectin is a glycoprotein commonly found in many extracellular ma-
trices, it interacts with collagen, heparin, fibrin and integrins; thereby playing a role in
cell adhesion, morphology and migration (Alovskaya et al., 2007). Fibronectin is often
used as a coating for 2D cell attachment or as a supplement to collagen gels to increase
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cellular adhesion, but is rarely used as a 3D matrix on its own (Pedersen and Swartz,
2005). A study that supports the use of fibronectin as an additive to PEG hydrogels
for CNS research was described by Zhou et al. (2013), who found that the growth of
neurites increased with increasing fibronectin concentration. However, when fibronectin
was added to a hydrogel where the stiﬀness was controlled by the collagen, neurite exten-
sions were largely governed by the stiﬀness of the hydrogel, rather than the concentration
of fibronectin. Therefore fibronectin can play a beneficial role in neuronal cell culture,
however it is heavily dependent on the stiﬀness of the matrix.
Laminin is also an ECM component important for brain development (Brännvall et al.,
2007) and is therefore used in many neural applications to enhance neural regeneration,
but the importance is debatable. The addition of laminin to collagen hydrogels was
found to reduce neurite outgrowth, without impacting the stiﬀness of the gels, thereby
limiting the eﬀectiveness of the CNS cell culture model (Swindle-Reilly et al., 2012).
Contradictory to this, Marquardt and Willits (2011) found that neurite extension within
PEG hydrogels increased as the concentration of laminin was increased, concluding that
the chemical properties of the scaﬀold increased neurite growth more than the mechanical
properties, as laminin concentration had a greater impact on neurite outgrowth than
matrix stiﬀness. However, this is contrary to a large body of research which provides
evidence on the important eﬀects of the mechanical properties of the matrix on neurite
extensions (Balgude et al. 2001; Willits and Skornia 2004; Yeung et al. 2005; Discher et al.
2005; Man et al. 2011), therefore the interpretation of these results is diﬃcult and hence
the importance of laminin in hydrogels remains uncertain.
1.6.2 Synthetic hydrogels
Synthetic hydrogels such as those derived from poly(ethylene glycol) (PEG), oﬀer a min-
imalist approach to cell culture outside of the body, whereby any other potential con-
tributing factors can be removed from the matrix leaving the minimal polymer structure
and a blank canvas to incorporate the exact desired biochemical composition. Synthetic
materials form inert gels which are highly reproducible, allow for tuning of mechanical
properties and allow for ECM deposition and degradation (Bryant and Anseth, 2002).
PEG hydrogels have been used for clinical applications and fundamental studies of cell
physiology (Shu et al., 2006), however they lack the endogenous factors that encourage
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cell behaviour and promote a permissive cell environment for growth and proliferation
(Cushing and Anseth, 2007), in order to mimic the ECM, some of the complexity of
natural materials must be incorporated.
Whilst advances in polymer chemistry are driving the development of sophisticated
synthetic-biologic hydrogels for 3D cell culture, this is not without its challenges. In 3D
scaﬀolds, gradients and defects can occur which limit diﬀusion of oxygen, nutrients, pro-
teins and waste metabolites throughout the gel (Slaughter et al., 2009). There are also
challenges with regulating the distribution of soluble factors throughout the 3D network
which aﬀect cellular behaviours and imaging cells is often complex as light scattering,
refraction and attenuation can occur in a 3D cell seeded hydrogel matrix, which makes
analysis of cell morphologies a challenge. There is also a limited accessibility for immunos-
taining and extraction of DNA/RNA (Tibbitt and Anseth, 2009).
The limitations of naturally derived hydrogels are that they have inherent batch vari-
ation and a risk of disease transmission (Wang et al., 2012), but also due to the derision
from animal tissues they are costly to buy or harvest. Whereas, synthetic hydrogels are
biologically inert and chemically derived; this decreases the material cost and allows supe-
rior tuning of mechanical properties, whilst maintaining the chemical stability. However,
synthetic hydrogels oﬀer weak cell adherence, which makes it necessary to adopt modifica-
tions such as tethering of natural polymers or addition of cell adhesive motifs (Wang et al.,
2012). There are several synthetic hydrogels such as poly(hydroxyethylmethacrylate)
(pHEMA), poly(n-2-(hydroxypropyl) methacrylamide) (pHPMA) and polyethylene gly-
col (PEG) which have been used in neural applications (Pettikiriarachchi et al., 2010).
PEG is a biologically inert, low toxicity polymer that is reported to repair and protect
cells following spinal cord injury (Samadikuchaksaraei, 2007). PEG is easily conjugated
to Poly-L-Lysine (PLL) to vary the elastic modulus of the hydrogel and has been used to
investigate the eﬀects of the modulus of gels, on neural stem cell diﬀerentiation (Hynes
et al., 2009). By varying the molecular weights and ratios of PEG:PLL, gels with amine
concentrations from 0-3mol·mg 1 supported cell survival and proliferation. In addition,
the molecular weight of PLL incorporated within the gel appeared to play a role in dif-
ferentiation, and NSC migration was shown to be dependent on the elastic modulus of
the matrix, with the highest migration observed in tissues of 3.5-5.5 kPa elastic modu-
lus (Hynes et al., 2009). This study showed that the elastic modulus of PEG gels can
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be easily modified and that the conjugated polymers can also have eﬀects on neural cell
behaviours, making PEG an ideal blank slate to functionalise and manipulate the me-
chanical properties such as stiﬀness, polymer concentration or conjugate with biological
components. Choi et al. (2008) designed a simple UV photo-polymerisation method for
the preparation of a PEG hydrogel, where the stiﬀness was modulated by altering the
molecular weight of PEG and UV polymerisation time. The hydrogel formed in seconds
under UV light and the materials were inexpensive compared to natural materials, which
makes an attractive 3D CNS model.
There are advantages for and against both synthetic and natural hydrogels and it
is diﬃcult to say which is the better option, therefore perhaps the best option would
be a combination of natural and synthetic polymers. The addition of small amounts of
fibronectin (100 µg·mL 1) permits PEG hydrogels to perform similarly to collagen gels
of a similar stiﬀness in terms of neurite growth in 3D gels (Zhou et al., 2013). Similar
studies have also found that the addition of collagen I to PEG hydrogels significantly
enhanced PC12 neurite extensions to the approximate level of collagen hydrogels (Scott
et al., 2011), (Scott et al., 2010). A PEG hydrogel with added collagen would decrease the
cost and amount of material derived from animals compared with collagen gels and would
increase the poor cellular adhesion of synthetic hydrogels, whilst maintaining the chemical
and physical stability; therefore could potentially make an ideal combined biomaterial for
a 3D CNS model.
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1.7 Aims and objectives
1.7.1 Aims
The primary aim of this study is to develop a 3D in vitro hydrogel system, which can
achieve three diﬀerent ECM matrix stiﬀnesses to investigate how the stiﬀness of the
matrix aﬀects CNS cells. The secondary aim of this study is to investigate a mechanism
for simulating reproducible injury for a 3D in vitro model of SCI, to investigate how
diﬀerent matrix stiﬀnesses aﬀect CNS cells in an injury simulation.
1.7.2 Objectives
• Determine the optimal matrix material for a 3D in vitro SCI model, through in-
vestigations into biocompatibility with neuroglial cells and investigations into the
mechanical properties of the matrix environment.
• Develop appropriate methodologies to investigate the eﬀect that diﬀerent matrix
stiﬀnesses have on the phenotype of astrocytes, microglia and DRG neurons in
isolation and mixed glial cultures through cell viability and morphology analysis.
• Determine the suitability and reproducibility of the BOSE ElectroForce BioDynamic
5110 impaction device for use with an in vitro 3D model of diﬀerent SCI severities,
through investigations into astrocyte and microglial metabolism, reactivity and cy-
tokine release.
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Chapter 2
Materials and methods
2.1 Equipment
Table 2.1: Equipment used in this project, make, model and supplier information.
Equipment and model Supplier
Autoclave priorclave London UK
Automatic pipettetes (pipetteboy) Scientific Laboratory Supplies Ltd, Not-
tingham UK
Balance GR200 (accuracy 0;01g) A&D Instruments Ltd, Oxford UK
Balance GX-2000 EC Sartorius, Goettingen, Germany
Bench top Eppendorf centrifuge (5415R) Hyland Scientific, Stanwood, Washing-
ton USA
BOSE electroforce BioDynamic 5110 TA instruments, Delaware, USA
Class I laminar flow cabinet Howorth Airtech Ltd, UK
Class II safety cabinet (HeraSafe) Heraeus, Hanau, Germany
Centrifuge (tissue culture) Harrier 15/80 Sanyo, Japan
Confocal microscope laser scanning in-
verted LSM700
Carl Zeiss Ltd, UK
Freeze drier (Modulyod-230) Thermo Savant
Freezer (-20 °C) Electrolux 3000 Jencons Plc, East Grinstead UK
Freezer (-80 °C) Sanyo Biomedical Europe, BV
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Table 2.1: Equipment used in this project, make, model and supplier information.
Equipment and model Supplier
Fridge (Electrolux ER8817C) Jencons Plc, East Grinstead UK
Fume hood Whiteley Fume Extraction Ltd., York,
UK
Fluorescence microscope (Zeiss Upright) Zeiss, Cambridge, UK
Gilson pipettetes P2, P20, P200 and
P1000
Fisher Scientific, Loughborough UK
Haemocytometer Neubauer
(22mmx47mm)
VWR International Poole UK
High speed, Harrier 15/80 centrifuge Sanyo, Watford, UK
Incubator (Heraeus) Jencons Plc, East Grinstead UK
Incubator (inCu safe 37°C) Sanyo-Biomedical, BV Amsterdam, Hol-
land
ImageJ image analysis software version
1.51g
Liquid nitrogen dewar BIO65 Jencons Plc, East Grinstead UK
Magnetic stirrer (Stuart SB161) Scientific Laboratory Supplies Ltd, Not-
tingham UK
Oven Genlab Ltd, Cheshire UK
pH meter (Jenway 3010) VWR international
Pipettetes Gilson Inc., Middleton, Wisconsin, USA
Pipette boy (Acu) Integra biosciences
Plate shaker (Vari-Shaker) Dynatech Ltd., Billinghurst, UK
Rat toothed forceps (125mm length) Fisher Scientific, Loughborough UK
Rheometer (Kinexus) Malvern Instruments Ltd., Malvern, UK
rSpace for Kinexus rheology software Malvern Instruments Ltd., Malvern, UK
Scalpel handle size 4 Swann-Morton, Sheﬃeld, UK
Scissors, curved blade (HWB003-11) Karl Hammacher
Spatula (231-1059) VWR, Lutterworth, UK
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Table 2.1: Equipment used in this project, make, model and supplier information.
Equipment and model Supplier
Stainless steel spatula, double ended
micro-tapered
Fisher Scientific, Loughborough UK
Straight fine point forceps (115mm
length)
Fisher Scientific, Loughborough UK
Test tube holder Fisher Scientific, Leicestershire, UK
Tethering bars (10 count, cross stitch
plastic mesh)
Darice, Amazon, UK
Topcount luminescence plate reader Packard Bioscience, Pontbeeklaan, Bel-
gium
Tweezers, extra-fine point (T147) TAAB, Berkshire, UK
UV curing rheometer (MCR302) Anton Paar Modular Compact Rheome-
ter, Germany
Vortexer (Topmix FB15024) Fisher Scientific, Loughborough UK
Water bath Grant Instruments, Ltd., Cambridge,
UK
Water purifier (option 7) Triple Red Laboratory Technology UK
2.2 Chemicals
Table 2.2: Chemicals and reagents used in this project and supplier information.
Chemicals and reagents Supplier
Adenosine triphosphate luminescence
assay kit (ATPLite assay)
Perkin-Elmer, Cambridge, UK
Carbon dioxide (CO2) in air (5% (v/v)) British Oxygen Company Ltd., Manch-
ester, UK
Citric acid VWR International
Collagen (rat tail) type 1 2mg·mL 1, in
0.6% (v/v) acetic acid (60-30-810)
First Link Ltd., Wolverhampton, UK
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Table 2.2: Chemicals and reagents used in this project and supplier information.
Chemicals and reagents Supplier
2,2-Dimethoxy-2-phenylacetophenone Sigma-Aldrich, Irvine, UK
DAPI (4,6-diamidino-2-phenylindole) Sigma-Aldrich, Irvine, UK
Dimethyl sulphoxide (DMSO) Lonza Biologics, Cambridge, UK
DNase type II from bovine pancreas Sigma-Aldrich, Irvine, UK
Dulbeccos modified Eagles medium
(DMEM) with L-glutamine (BE12-
604F)
Lonza Biologics, Cambridge, UK
Dulbeccos phosphate buﬀered saline
(DPBS) (without calcium and magne-
sium) (BE17-512F)
Lonza Biologics, Cambridge, UK
ELISA kit (IL-6, IL-10, TNF-alpha) 2B Scientific, Oxfordshire UK
Ethanol (96% (v/v)) VWR International, Leicestershire, UK
F-12 nutrient mixture (Hams)(+)L-
glutamine (1178482)
Gibco, Life Technologies, UK
Foetal bovine serum albumin (FBS)
(A9418-5G)
Sigma-Aldrich, Irvine, UK
Granulocyte macrophage stimulating
factor (GM-CSF)
Sigma-Aldrich, Irvine, UK
Hams F-12 ThermoFisher Scientific, Northumber-
land UK
Hoechst 33258 (1 µg·mL 1) Sigma-Aldrich, Irvine, UK
Horse serum (H0146-10mL) Sigma-Aldrich, Irvine, UK
Hydrochloric acid VWR International
L-glutamine (200mM) (25030-024) Invitrogen Ltd., Paisley, UK
Liquid nitrogen British Oxygen Company Ltd., Manch-
ester, UK
Live/dead viability/cytotoxicity Kit Fisher Scientific UK, Leicestershire, UK
L-leucine methyl ester Sigma-Aldrich, Irvine, UK
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Table 2.2: Chemicals and reagents used in this project and supplier information.
Chemicals and reagents Supplier
Minimum essential medium Eagle
(M0275-100mL)
Sigma-Aldrich, Irvine, UK
Minimum essential medium Eagle (10x
concentration)
Sigma-Aldrich, Irvine, UK
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) powder
Sigma-Aldrich, Irvine, UK
Paraformaldehyde (PFA) Sigma-Aldrich, Irvine, UK
PBS tablets Oxoid, UK
Penicillin-streptomycin (5000U·mL 1)
(DE17-603E)
Lonza Biologics, Cambridge, UK
pH standards (4, 7, 10) Scientific laboratory supplies Ltd
Poly-d-lysine (PDL) Sigma-Aldrich, Irvine, UK
Poly(ethylene glycol) diacrylate MW
700 (455008)
Sigma-Aldrich, Irvine, UK
Poly(ethylene glycol) diacrylate MW
3500
Jenkem Musa, USA
Poly(ethylene glycol) diacrylate MW
4000 (15246)
Polysciences Inc, Germany
Poly(ethylene glycol) diacrylate MW
6000 (701963)
Sigma-Aldrich, Irvine, UK
Poly(ethylene glycol) diacrylate MW
8000 (89510)
Sigma-Aldrich, Irvine, UK
Reduced serum minimal essential
medium (opti-MEM) (11058-021)
Invitrogen, Paisley, UK
RPMI 1640 medium (Gibco) Fisher Scientific UK, Leicestershire, UK
Sodium chloride Thermo Fisher Scientific Ltd
Sodium carbonate VWR International
Sodium hydrogen carbonate VWR International
Sodium hydroxide VWR International
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Table 2.2: Chemicals and reagents used in this project and supplier information.
Chemicals and reagents Supplier
Sulphuric acid Sigma-Aldrich, Irvine, UK
Trigene Scientific Laboratory Supplies Ltd
Triton x-100 (0.1% (v/v)) Sigma-Aldrich, Irvine, UK
Trypan blue solution (0.4%
(w/v))(T8154)
Sigma-Aldrich, Irvine, UK
Trypsin Sigma-Aldrich, Irvine, UK
Trypsin-ethylenediaminetetraacetic acid
(EDTA) (BE17-161E)
Lonza Biologics, Cambridge, UK
Tween 20 Sigma-Aldrich, Irvine, UK
Virkon Du Pont, USA
1-vinyl-2-pyrrolidinone Sigma-Aldrich, Irvine, UK
2.3 Consumables
Table 2.3: Consumables and plastic-ware used in this project and supplier information.
Consumables and plastic-ware Supplier
(6, 12, 24, 48, 96)-well plates plus lids
(Nunclon Delta Surface)
Thermo Fisher Scientific UK, Leicester-
shire, UK
Bijou (5mL) Scientific Laboratory Supplies Ltd, Not-
tingham UK
Cell scraper (18mm blade length 260mm
handle)
Fisher Scientific, Leicestershire UK
Conical centrifuge tubes (50mL) Thermo Fisher Scientific UK, Leicester-
shire, UK
Coverslips (18mm 0.17/-0.02mm) VWR International, Leicestershire, UK
Coverwell imaging chambers (Z365882-20EA) Sigma-Aldrich, Irvine,
UK
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Table 2.3: Consumables and plastic-ware used in this project and supplier information.
Consumables and plastic-ware Supplier
Cryovial 1.5mL nange Nunc International Corporation. New
York USA
Disposable plastic syringe
(1mL,2mL,5mL,10mL, 20mL 50mL)
Scientific Laboratory Supplies Ltd, Not-
tingham UK
Eppendorf tubes (1.5mL) Thermo Fisher Scientific UK, Leicester-
shire, UK
Falcon tubes (15mL, 50mL) Fisher Scientific, Leicestershire UK
Filter pipettete tips Starlab, Helsinki, Finland
Glass Duran bottle (1L, 2L, 5L) Fisher Scientific, Leicestershire UK
Glass cover slips (22mmx47mm) Scientific Laboratory Supplies Ltd, Not-
tingham UK
Individually wrapped, sterile pipette
tips
Sarstedt Ltd. Leicester, UK
Laboratory eco nitrile gloves (Ecoshield)
(PF250)
Shield Scientific, Galvanistraat, The
Netherlands
Microplate adhesive sealing film (96 well
plate)
PerkinElmer, Windsor UK
Optiplate (96 well plate) PerkinElmer, Windsor UK
Parafilm Bemis, Neenah, USA
Pipette tips (20, 200, 1000 µL) Starlab, Ahrensburg Germany
Polystyrene stripettes (5mL, 10mL,
25mL)
Thermo Fisher Scientific UK, Leicester-
shire, UK
Scalpel blade flat edge Swann-Morton UK
Sterile syringe filters Sartorius Stedim Biotech. Goettingen,
Germany
Sterile pot (60mL, 150mL, 250mL) Scientific Laboratory Supplies Ltd, Not-
tingham
Stopwatch Casio Computer Company Ltd., UK
Syringes, plastic, disposable Terumo, Leuven, Belgium
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Table 2.3: Consumables and plastic-ware used in this project and supplier information.
Consumables and plastic-ware Supplier
Syringe filter (single use 0.22 µm pore
size)
Millex Merck Millipore, Germany
Tissue culture dishes (60mmx10mm) Corning BV
Tissue culture flasks (various volumes T-
25, T75, T-125)
Thermo Fisher Scientific UK, Leicester-
shire, UK
Universal containers (30mL) Scientific Laboratory Supplies Ltd, Not-
tingham, UK
Wide bore pipette tips (10-1000 µL) Sartorius UK
2.4 Ethics
All procedures involving animals were performed in accordance with the UK Home Oﬃce,
Animals (Scientific Procedures) Act 1986.
2.5 Cells
The rat C6 ATCC CCL-107 astroglial cell line and rat PC12 ATCC CRL-1721 neuronal
cell line were utilised for preliminary investigations into cell viability to reduce the numbers
of primary cells used in this study. The cells were donated by Dr James Phillips, University
College London, London, UK.
The primary cells used in this study were isolated from male Wistar rats, supplied by
Central Biological Sciences, University of Leeds, Leeds, UK.
2.6 Antibodies
The primary and secondary antibody information is displayed in table 2.4 along with the
nuclear stain used in this study.
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Table 2.4: Antibodies and stains used in this project
Primary antibodies
Antigen Type Dilution Supplier Code
Glial fibrillary
acidic protein
Rabbit IgG 1:300 Dako UK ltd Z0334
Beta3 tubulin Rabbit IgG 1:300 Sigma-Aldrich,
UK
T2200
Beta3 tubulin Chicken IgY 1:300 Abcam, UK AB107216
CD11b/c [OX42] Mouse IgG2a 1:400 Abcam, UK AB1211
MOG Goat IgG 1:400 Abcam, UK AB115597
Secondary antibodies
Alexa Fluor 405 Goat Anti-
chicken IgY
1:500 Abcam, UK AB175674
DyLight 594 Goat Anti-
rabbit IgG
1:300 Vector labs, UK DI-1594
DyLight 488 Goat Anti-
rabbit IgG
1:300 Vector labs, UK DI-1488
FITC Goat Anti-
mouse IgM
1:128 Sigma-Aldrich,
UK
F9259
Alexa Fluor 488 Goat Anti-
mouse IgG
1:400 Abcam, UK AB150113
Alexa Fluor 555 Donkey Anti-
goat IgG
1:400 Abcam, UK AB150130
Alexa Fluor 647 Donkey Anti-
goat IgG
1:400 Abcam, UK AB150131
DNA stain
Hoechst 33258 NA 1:1000 Sigma-Aldrich,
UK
861405
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2.7 Sterilisation
2.7.1 Virkon
A 1% (w/v) solution of virkon was prepared by adding 50 g virkon powder to 5 liter of
distilled water. Virkon was used to sterilise the tissue culture hoods prior to use and was
followed by ethanol sterilisation.
2.7.2 Ethanol
A 70% (v/v) ethanol solution was used for sterilisation purposes and was prepared by
diluting 7L of ethanol with 3L of distilled water.
2.7.3 Filter sterilisation
Solutions that were not suitable for heat sterilisation because they contained proteins
sensitive to denaturation by heat, were filter sterilised by passing through a filter with a
pore size of 0.22 µm to eradicate bacterial contamination.
2.7.4 Dry heat sterilisation
Dissection equipment was sterilised using dry heat, as moist heat may have caused the
equipment to deteriorate. Items were placed in a metal tin sealed with autoclave tape to
confirm sterilisation conditions were achieved and placed in the hot air oven at 180 °C for
4 hours.
2.7.5 Moist heat sterilisation
Items suitable for moist heat sterilisation were sterilised in an autoclave at 121°C for 20
minutes under 103 kPa pressure.
2.8 Measurement of pH
A Jenway 3020 pH meter was used to measure the pH of solutions. The pH meter was
calibrated prior to use with pH standard solutions at pH4, 7 and 10 supplied by scientific
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laboratory supplies Ltd. The pH of measured solutions was modified by adding 1M
sodium hydroxide (NaOH) to raise the pH or 1M hydrochloric acid (HCl) to lower the
pH. Stock solutions of NaOH and HCl were made up as per the following sections.
2.9 General solutions
2.9.1 Antibody diluent solution
The antibody diluent solution was consists of tris buﬀered saline (TBS), containing 0.1
% (w/v) bovine serum albumin (BSA) and 0.1 % (w/v) sodium azide. To prepare the
following were mixed together: 6mL of sodium azide, 300mL of 5% (w/v) bovine serum
albumin and approximately 40mL TBS using a magnetic stirrer. The pH was adjusted to
7.6 by adding 1 M hydrochloric acid or 1 M sodium hydroxide drop wise whilst stirring
using a magnetic stirrer. The volume was increased to 60mL with TBS. The solution was
stable for three months stored at 4 °C.
2.9.2 Bovine serum albumin
A 5 % (w/v) solution of BSA was produced by dissolving 2.5 g BSA into 500 mL PBS.
2.9.3 Dialysis fluid
The solution to dialyse the functionalised gelatin mixture was produced by adding 2mL
DMSO into 198mL distilled water.
2.9.4 Dissection digest solution
The digest solution was used in mixed glial preparations to digest rat cortices. The
digest solution consists of 89% (v/v) Hanks balanced salt solution (HBSS) solution, 5%
(v/v) Penicillin-Streptomycin (stock solution 5mg·mL 1), 1% (v/v) DNase (stock solution
0.2mg·mL 1)and 5% (v/v) trypsin (stock solution 5mg·mL 1).
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2.9.5 DNase
The DNase solution was prepared by dissolving 7.4mg of DNase powder in 34mL distilled
water. The 0.2mg·mL 1 DNase solution was aliquoted into 1mL eppendorfs and stored
at -20°C for up to one year.
2.9.6 Dulbecco’s modified Eagle’s medium (DMEM)
Complete cell culture media for primary astrocyte and microglial cell cultures was pre-
pared using a fresh 500mL bottle of DMEM media, sterile filtered and endotoxin fil-
tered. The media was supplemented with 10% (v/v) foetal bovine serum (FBS), 2mM
L-Glutamine and 100U·mL 1 of Penicillin 100 µg·mL 1 Streptomycin. The solution was
stored in the fridge at 4°C for up to 1 month.
2.9.7 Hams F12 nutrient mixture
Complete cell culture media for the C6 cell line was prepared using a fresh 500mL bottle
of F-12 Nutrient Mixture (Ham), 2mM L-Glutamine and was supplemented with 10%
(v/v) foetal bovine serum (FBS) and 100U·mL 1 of Penicillin 100 µg·mL 1 Streptomycin.
The solution was stored in the fridge at 4°C for 1 month.
2.9.8 Hanks balanced salt solution (HBSS)
One bottle of Hanks balanced salt solution in powder form without NaHCO3 (stored at
4 °C) and made up to 1L with distilled water. The solution was then autoclaved for 20
minutes at 15 PSI, 121°C to sterilise. The solution was stored in the fridge at 4 °C for up
to 1 month.
2.9.9 Hoechst 33258
A 2 µg·mL 1 solution of Hoechst 33358 (Hoechst) was prepared by adding 1000 µg of
Hoechst powder to 500 µL of sterile water. The solution was triturated to ensure thorough
mixing. The Hoechst solution was stored in 100 µL aliquots, at -20 °C for up to one year
and defrosted at room temperature when required.
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2.9.10 Hydrochloric acid (1 M)
A 1 M solution of hydrochloric acid (HCl) was prepared by adding 821 µL of HCl solution
to 2500 µL deionised water. The final volume of the solution was adjusted to the volume
of 10mL with deionized water.
2.9.11 Hydrochloric acid (6 N)
A 6 N solution of hydrochloric acid (HCl) was prepared by adding 20mL of HCl solution
(12 N) to 20mL distilled water.
2.9.12 Immunohistochemistry blocker solution
The antibody block solution was prepared using Marvel skimmed milk and was prepared
on the day of use. A large spatula of milk powder was placed in 40mL of PBS, so that the
milk proteins were in excess. The solution was then centrifuged at 1000g for 3 minutes.
The solution was poured into a clean vial ready for use.
2.9.13 MTT assay
The MTT solution was made by adding 50mg MTT powder into 10mL PBS and inverting
gently to mix. The solution was filter sterilised with a 0.2 µm filter and stored at 4 °C
until use. The MTT solution was warmed in a waterbath until warm to the touch and
20 µL was added to each well containing cells or cellular hydrogel. The well plates were
covered in foil and incubated for 4 hours at 37 °C in 5% (v/v ) CO2 in air. The media
was then removed and replaced with 100 µL DMSO. The plate was then agitated for 5
minutes at 150 rpm, a clear film was used to seal the plate prior to being read in the
MSS2.1 SkanitRE plate reader at 570nm and 630nm.
2.9.14 Paraformaldehyde (PFA) fixative
In a class I safety cabinet 800mL PBS was heated to 60°C on a heated magnetic stir plate
containing a magnetic stirrer in a 1L glass bottle. Then 40 g PFA powder was added
to the PBS and stirred, 1M NaOH was added drop-wise until the PFA dissolved. The
solution was made up to 1L with PBS and the pH was lowered to pH 6.9 using 0.1M HCl.
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The solution was then filter sterilised using a 0.22 µm filter and aliquoted into 20mL tubes
and stored at -20 °C until needed. Cellular hydrogels were fixed in PFA for a minimum
of 4 hours at room temperature, maximum of 24 hours before washing in PBS.
2.9.15 Phosphate buﬀered saline (PBS)
Ten PBS tablets were dissolved in 1000mL distilled water. The solution was stirred with
a stirrer bar on a magnetic stirrer for half an hour. The pH was adjusted to pH 7.2 with
6N sodium hydroxide or 6N hydrochloric acid (prepared by technical staﬀ). The solution
was autoclaved by moist heat sterilisation and kept at room temperature for up to one
month.
2.9.16 Poly-d-lysine (PDL)
Poly-D-Lysine was added to T-flasks prior to seeding with primary cells, in order to
increase cellular adhesion. A concentration of 50 µg·mL 1 of PDL powder was diluted in
sterile distilled water. The solution was filter sterilised using a 0.22 µm filter and sterile
syringe, it was then stored at -20°C until required, for up to 2 years.
2.9.17 Roswell park memorial institute (RPMI)-1640 medium
Complete cell culture media for the PC12 cell line was prepared using a fresh 500mL
bottle of RPMI-1640 medium, sterile filtered and endotoxin tested, without L-glutamine
and with NaHCO3. The media was supplemented with 2mM L-Glutamine, 100U·mL 1
of Penicillin 100 µg·mL 1 Streptomycin, 5% (v/v) foetal bovine serum (FBS), 10% (v/v)
horse serum and 50 ng·ml 1 nerve growth factor (NGF). The solution was stored in the
fridge at 4°C for up to 1 month.
2.9.18 Sodium bicarbonate solution
A 4% (v/v) solution of sodium bicarbonate was produced by dissolving 0.2g sodium
bicarbonate into 5mL distilled water
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2.9.19 Sodium chloride
A (3Molar) sodium chloride solution was produced by dissolving 175.32 g sodium chloride
into 1 L distilled water.
2.9.20 Sodium hydroxide (1 N)
A 1 N sodium hydroxide (NaOH) solution was prepared by adding 4 g of NaOH to 100 µL
distilled water, the solution was stirred until all the pellets had dissolved. The solution
was stored at room temperature for up to one year.
2.9.21 Tris buﬀer
A 2 M, tris buﬀer solution (pH 7.6) was produced by dissolving 242.26 g Trizma base into
758mL distilled water
2.9.22 Tris buﬀered saline (TBS)
25 mL Tris buﬀer (2 M) 50 mL sodium chloride solution (3M) 925 mL distilled water
2.9.23 TBS-Tween
TBS containing 0.05 % (w/v) Tween 20 (TBS-T) was produced by mixing 500 µL Tween
20 into 1L TBS.
2.9.24 TNBS solution
A 0.5% (v/v) solution was produced by mixing 0.5mL TNBS with 4.5mL distilled water.
2.9.25 Triton X-100
A 0.1% (v/v) triton x-100 solution was prepared by adding 1mL triton x-100 into 1L of
distilled water and inverted to mix. This solution was stored at room temperature for up
to three months.
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2.9.26 Trypsin
Trypsin solution was made by dissolving 500mg trypsin in 100mL distilled water. The
5mg·mL 1 solution was mixed on a magnetic stirrer with stirrer bar until dissolved, then
aliquoted into 5mL bijous and stored at -20°C for up to one year.
2.10 Isolation of primary cells
2.10.1 Dissection equipment
The dissection kit used for the dissection of post-natal day 2 (P2) rat pup cortices and
adult rat spinal cord comprised:
• Two pairs of fine tweezers
• Standard tweezers
• Scalpel and blades
• Two small spatulas
• Curved scissors
• Standard dissection scissors
Primary rat cells were acquired from Wistar rat pups at postnatal day 2, by schedule
1 cervical dislocation. Prior to dissection, the dissection kit (section 2.10.1) was dry heat
sterilised (as per section 2.7.4).
2.10.2 Dissection of rat cortices
The post natal day 2 rat cortices were used for obtaining primary astrocytes, immature
microglia and oligodendrocytes. Rat pups at post-natal day 2 were used due to the
presence of reduced vasculature at this stage of development. Prior to the collection of
the rats from the university of Leeds central biological services, the tissue culture flasks
(1x 75 cm3 flasks per rat) were coated with 4mL of Poly-D-Lysine (PDL) 50mg·mL 1
(section 2.9.16) and incubated at 37°C in 5% (v/v) CO2 in air for approximately 1 hour
to coat the flasks. The PDL was then aspirated and discarded, the flasks were rinsed
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with 40mL PBS, which was aspirated and discarded. The flasks were then placed in the
incubator to warm until ready for use.
Prior to the dissection of the rat cortices, the sterile dissection kit was opened and
laid out in the class II safety cabinet. A 60mL pot of 70% (v/v) ethanol (section 2.7.2)
was placed next to the dissection kit and the scissors, spatulas and tweezers from the
dissection kit were placed in the ethanol pot. Two tissue culture dishes (60x10mm) were
filled with pre-made sterile Hanks balanced salt solution (section 2.9.8) to prevent cortices
from drying and 20mL digest solution was prepared in a universal (as detailed in section
2.9.4).
After the schedule 1 procedure, the rat pup heads were stored on ice in a 50mL
Falcon tube. Each head was removed from the Falcon tube and sprayed with 70% (v/v)
ethanol. The snout (as indicated by the yellow highlighted region in Figure 2.10.1) was
held between the thumb, index and middle finger, the eyes and ears were still visible and
the snout pointed down towards the palm of the hand, so that the brainstem and back of
the skull were visible.
The cavity (outlined in red) indicates the foramen magnum, the area of the skull
(outlined in yellow) indicates the snout of the rat and the blue lines indicate where the
skull was cut to reveal the cortices. The foramen magnum (as indicated by the red
highlighted region in Figure 2.10.1), was located and the sterile curved scissors were
inserted into this hollow region. An incision was made on both sides of the skull (as
indicated by the blue lines in Figure 2.10.1), from the foramen magnum around the edge
of the skull, using curved scissors, to the eye socket, aligning the scissors above the ear
and through the eye. Care was taken to keep the inner blade still and the cut was made
with the outer blade to prevent damage to the brain tissue.
Using tweezers the skull and skin were peeled back over the snout revealing the cortex.
A small spatula was inserted centrally underneath the cerebrum and dragged horizontally
in both directions to release the cortex. The cortex was placed on the lid of a sterile tissue
culture dish, the meninges from the top of the cortex and the vasculature from underneath
the cortex, were removed using a pair of fine tweezers and discarded. The cortices were
placed in the prepared tissue culture dishes containing cold HBSS. The procedure was
repeated for each head and the equipment submerged in ethanol between each dissection.
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Figure 2.10.1: Dorsal (superior) and ventral (inferior) views of a rat skull.
2.10.3 Dissection of spinal cord
The adult (approximately 45 days) Wistar rat spinal cord was used for obtaining mature
microglia and neurons from the dorsal root ganglia. The adult rat was culled by schedule 1
asphyxiation in 100% (v/v) CO2 for 5 minutes, the rat was then exsanguinated by incision
through the carotid artery to confirm death. The body was sprayed liberally with 70%
(v/v) ethanol and scissors used to cut through the skin horizontally at the back of the
neck and vertically down the length of the spine. A scalpel blade was used to remove
the connective tissues and muscles either side of the spine. Scissors were used to dissect
out the thoracic and lumbar portions of the spine by cutting through cervical spine, the
posterior ribs, remaining muscle, fascia and through the sacral spine above the hips. The
remaining tissues were disposed of into clinical waste and the remaining spine was placed
in cold HBSS until dissected.
Using a scalpel the spine was cut in half and dissected in two parts. One half of the
spinal column was processed initially, therefore the other half of the spinal column was
placed in a 50mL Falcon tube filled with cold HBSS to prevent drying out until it was
processed. The spinal column was cut again with a scalpel in the sagittal plane in half
and the spinal cord was exposed and the foramen either side of the cord, where the nerve
roots can be traced to locate the DRGs.
Using fine tweezers, the spinal cord was gently peeled from the spinal column away
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from the vertebral body so that the nerve roots could be traced to locate the DRG
of each thoracic and lumbar vertebrae. Individual ganglia were removed by grasping
the axon bundles either side of the DRG body and pulled out, placed on the lid of a
petri dish and the connective tissue surrounding the DRG was removed with a scalpel.
The round transparent DRG was then placed in a universal containing DMEM media
with 100U·mL 1 of Penicillin 100 µg·mL 1 Streptomycin until all DRGs were ready for
enzymatic digestion. Once the DRGs had been removed, the spinal cord was removed
from the spine and with a pair of find tweezers, the meninges were removed. The spinal
cord is now ready for enzymatic digestion to isolate microglia.
2.11 Cell culture
All cells used in this study were cultured in T-flasks with the appropriate cell culture media
(Table 2.5). Cell culture was carried out in class II safety cabinets with the appropriate
aseptic technique. The cells were cultured in incubators at 37°C in 5%(v/v) CO2 in air.
Media was warmed for 30 minutes at 37 °C prior to use to prevent heat shock to the cells.
2.11.1 Cell resurrection
Cells were removed from liquid nitrogen storage and thawed at 37°C. The vials held 1mL
cell solution containing DMSO, therefore the cells were transferred to a sterile universal
tube containing 9mL of pre-warmed cell culture medium. The cell suspension was cen-
trifuged (200g) for 10 minutes at room temperature and the pellet re-suspended in 3mL
of fresh warmed cell culture medium. The cell suspension was transferred into a 75 cm3
T-flask and 17mL cell culture media was added. The cells were incubated at 37°C in 5%
(v/v) CO2 in air until confluent, then they were passaged.
2.11.2 Passaging of cell lines and primary cells
An inverted light microscope was used to view cell confluency in the cell culture T-flasks.
When at least 80% confluency had been attained the media was removed from the T-
flask and the cells were washed with 10mL DPBS (without calcium and magnesium)
to remove any remaining media. The DPBS was aspirated and discarded, the cells were
treated with trypsin/EDTA (5mL) for 5 minutes at 37°C in 5% (v/v) CO2 in air, the cells
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Table 2.5: Table of cells used and appropriate media
Cells
Media and % Foetal Bovine Serum (FBS)
PC12 RPMI 1640 (10% FBS)
C6 Hams F12 (10% FBS)
Primary microglia DMEM (20% FBS)
Primary astrocytes DMEM (10% FBS)
Primary oligodendrocytes DMEM (10% FBS)
Primary neurons Serum free DMEM
Primary mixed glial cultures DMEM (10% FBS)
were then lightly tapped to detach the cells from the flask. When detaching primary cells,
the cells were treated with trypsin for 10 minutes and a cell scraper was used to gently
remove any remaining cells that were still attached to the tissue culture plastic. The
cell suspension was transferred into a sterile universal tube containing 10mL cell culture
media to neutralise the trypsin and centrifuged at 200g for 10 minutes. The waste media
containing trypsin was removed and the pellet was re-suspended in 2mL of appropriate
cell culture media. After counting the cells using trypan blue staining (as detailed in
2.11.3), cells were seeded at a density of 1x106 cells per 175 cm3 flask, in 20mL of fresh
media and incubated at 37°C in 5% (v/v) CO2 in air. The cell culture media was changed
(for cell lines) or topped up with 5mL media (for primary cells) every 3-4 days.
2.11.3 Cell counting
After the cells had been passaged (see section 2.11.2) and the pellet has been resuspended
in 2mL media. A sample of 7 µL cell solution was added to a bijou and mixed with
7 µL 0.2% (v/v) trypan blue; the 14 µL trypan-cell solution was loaded onto a Neubauer
haemocytometer, which was placed under a light microscope at a 10x magnification. The
microscope was adjusted to focus on the grid and a cell count was performed on the middle
square, containing 25 smaller squares, as highlighted by the red circle in Figure 2.11.1.
Non-viable (dead) cells have compromised cell membranes, which allows the trypan blue
dye to penetrate into the cell, whereas the membranes of viable cells are intact, and
therefore the blue dye cannot enter and the cell remains clear. The total number of cells
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within the middle square of the Neubauer haemocytometer were counted, and the number
of living (colourless) and dead (blue) cells were also counted. A minimum of 100 cells
were counted to ensure an accurate cell viability count. In order to calculate the number
of viable cells within the sample, the following equation was adhered to:
(2.1)
Total number of living cells
Total number of cells
⇤ 100 = Cell viability %
To determine the number of viable cells per 1mL of media, the total number of viable
(colourless) cells was multiplied by 2, as the cell pellet was resuspended in 2mL media,
then multiplied again by 2, as the cell solution was diluted in a 1:1 ratio with trypan blue
dye and then finally by 1x104 to convert to cells per 1mL media.
(2.2)
(Total number of living cells) ⇤ (2) ⇤ (2) ⇤ (1 ⇤ 104) = viable cell count per mL media
2.11.4 Cell cryopreservation
After the cells had been passaged, detached from the tissue culture plastic and counted, as
outlined in sections 2.11.2 and 2.11.3 respectively, the suspended cell pellet was split into
aliquots of 1x106 cells and centrifuged once more at 200g for 10 minutes to obtain a cell
pellet. The media was then aspirated oﬀ the cell pellet and the pellet was resuspended in
1mL cell freezing medium into sterile cryogenic storage vials. The cell freezing medium
contained 70% (v/v) supplemented media, 20% (v/v) additional FBS and 10% (v/v)
Dimethylsulphoxide (DMSO). The cryogenic storage vials were placed in an isopropranol
chamber and placed at -80°C overnight before being placed in liquid nitrogen dewars for
long term storage.
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Figure 2.11.1: Neubauer haemocytometer counting grid. Cells which were located on the
top and left side extremity lines were included in the cell count, whereas cells on the lower
and right side extremity lines were excluded from the cell count.
2.12 Analysis of cellular behaviour
2.12.1 Live-dead assay
Cell viability was determined by staining cells with calcein AM (acetoxymethyl) and
ethidium homodimer-1. Live cells contain esterase, an enzyme which converts calcein AM
into green fluorescent calcein, which is retained within living cells, giving oﬀ excitation
and emission spectra at 494nm and 517nm, respectively. Ethidium homodimer-1 can only
penetrate into cells with damaged membranes and emits red fluorescence when bound
to nucleic acids in DNA. Ethidium homodimer-1 is excluded from living cells as it can-
not penetrate intact cell membranes, therefore it was used to label dead cells giving oﬀ
excitation and emission spectra at 528nm and 617nm.
The reagents were stored at -20 °C for up to 1 year and were allowed to warm to room
temperature prior to use. The live-dead solution was made up immediately before use
by diluting calcein AM to 4mM concentration (1 µL calcein AM in 4000 µL media). The
ethidium homodimer-1 was diluted to 2mM by combining 2 µL ethidium homodimer-1 in
the 4000 µL calcein AM solution.
Cellular hydrogels were stained by removing the media from each well and replaced
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the media with 200 µL of live/dead solution into each well of the 96 well plate. The plate
was then covered in foil and incubated for an hour in the dark at 37 °C 5% (v/v) CO2
in air, with gentle agitation. The live-dead solution (200 µL) was then removed from the
wells and the gels were washed with 100 µL PBS by agitating at 150rpm for 5 minutes
on a shaker. A fine spatula was run around the inside of the well plate to dislodge
the cellular hydrogel and carefully removed the hydrogel from the well plate. The gels
were placed on a microscope slide for viewing using the Zeiss upright microscope. The
gels were kept hydrated by adding drops of PBS on to the hydrogels whilst under the
microscope. The Zeiss fluorescent microscope was programmed to use the GFP filter to
capture the calcein AM fluorescence (at 517nm) and the Rhodamine filter which captured
the ethidium-homodimer-1 fluorescence (at 617nm).
2.12.2 ATP-Lite assay
The ATP-Lite assay was purchased as a kit, therefore the provided lyophilised substrate
powder was mixed with 25mL of provided substrate buﬀer solution and inverted gently
to mix. The solution was aliquoted into 5mL aliquots and stored at -20 °C for up to 3
months.
The ATP-Lite cell viability assay was used to determine cell viability by quantitatively
assessing ATP levels. The assay is an ATP monitoring system based on luciferase, ATP
reacts with D-Luciferin in the presence of luciferase to emit light proportional to the ATP
concentration. The reaction scheme is described below:
(2.3)
(ATP+D Luciferin+O2+Luciferase)  > (Oxyluciferin+AMP+PPi+CO2+Light)
Cell culture media was removed from the cellular gels and 100 µL cell lysis solution
was added to each well. The plate was shaken at 150 rpm for 30 minutes so that the
mammalian cell lysis solution was able to penetrate through the hydrogel and lyse the
cells. A volume of 100 µL ATP substrate was added to each well before the plate was
covered in foil and shaken at 150 rpm for 30 minutes. A volume of 150 µL of the solution
from each well was transferred to the corresponding well of a 96-well Optiplate and an
adhesive clear film was placed over the plate. The plate was dark adapted for 10 minutes
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inside the plate reader, the luminescence of each well was read, presenting the reading
output as counts per second (CPS).
2.12.3 Immunohistochemistry method, labelling cellular hydro-
gels
The culture medium was removed from the wells of cells or hydrogels and replaced with
4% (w/v) PFA for 4 hours at 4 °C. The PFA was removed and the gels were washed three
times with triton X-100 (section 2.9.25) with gentle agitation, 5 minutes per wash for the
first two washes and 30 minutes for the third wash step. The gels were then washed with
100 µL PBS three times with gentle agitation, 5 minutes per wash. A blocker solution of
100 µL (section 2.9.12) was added to each gel for 30 minutes. The gels were then washed
twice for ten minutes using 100 µL triton X-100 then once with 100 µL PBS on an orbital
shaker at 40 rpm at room temperature. The 100 µL of the primary antibody diluted
to the working concentration (Table 2.4) using antibody diluent was added to each gel
and incubated in a moist environment overnight at 4 °C (minimum 4 hour incubation).
The gels were then washed twice for ten minutes using triton X-100 then once with
PBS on an orbital shaker at 40 rpm at room temperature. The appropriate volume of
the fluorescently labelled secondary antibody against the primary antibody diluted to the
working concentration (Table 2.4) using antibody diluent (add Hoechst if required 1:1000)
was added to each well and incubated for 1 hour for gels in a moist environment at room
temperature in the dark. The gels were then washed twice for ten minutes using triton
X-100 then once with PBS on an orbital shaker at 40 rpm covered with foil. The gels
were then stored in the dark until ready to view (within a maximum of 4 hours).
2.13 Imaging equipment
2.13.1 Bright field microscopy
The optical Olympus CK-40-SLP microscope was used for cell counting and general vi-
sualisation of cells during experiments.
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2.13.2 Fluorescence microscopy
The Zeiss AX10 Axio scope upright microscope was used for imaging cells labelled with
a live-dead kit to analyse viability of cells in hydrogels.
2.13.3 Confocal microscopy
The Zeis LSM700 inverted confocal microscope was used for imaging immunolabelled
gels and slides. The laser settings used were Laser Diode 405: 405nm (Hoechst and B3-
Tubulin;blue), Argon: 488nm (CD11b or Oligo-4; green), 555nm (GFAP; red) and 635nm
(white or yellow).
2.14 Collagen gel matrix preparation
The baseline collagen gel mixture was the same throughout the study, with varying con-
centrations of cells added to the culture media proportion.
Briefly, 10% (v/v) 10x minimal essential medium (MEM) was added to a sterile vessel
of appropriate size for the final gel volume produced. Using a wide bore pipettete, 80%
(v/v) type-I rat tail collagen (2 mg/mL in 0.6% (w/v) acetic acid) was mixed with the
MEM. The mixture was neutralised with 5.8% (v/v) neutralising solution before the
addition of 4.2% (v/v) culture medium, containing the appropriate number of cells to
achieve the desired cell density.
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Chapter 3
Assessment and development of
hydrogels for a spinal cord injury model
3.1 Introduction
To model the spinal cord and various injury simulations in vitro, the biomaterial should be
as similar as possible to the natural tissue. Hydrogels are often the biomaterial of choice for
a 3D spinal cord injury model, as they provide a hydrated biomimetic environment, similar
to the extracellular matrix (Shin et al. 2003a; Smith 2016; East et al. 2010). Hydrogels
support cell growth and survival, whilst allowing control over the biochemical, physical
and mechanical properties of the matrix (Tibbitt and Anseth, 2009). Variations in the
biochemical composition and structure of hydrogels alters the way cells behave and can
even influence stem cell diﬀerentiation (Liu et al., 2010), however a limitation with many
hydrogels that are commercially available, is the lack of mechanical strength compared
to native tissue, which limits hydrogel potential in tissue engineering applications (Billiet
et al., 2012).
The first step in the development of a 3D in vitro spinal cord injury model was to
assess potential hydrogel matrices for biocompatibility with neural cells and to charac-
terise the mechanical properties of the matrix, such as the matrix stiﬀness or Young’s
modulus. It was important to select a hydrogel system, which could achieve at least three
diﬀerent matrix stiﬀnesses, so that the cellular behaviour could be assessed over a range
of stiﬀnesses and investigate what is a suitable range of stiﬀnesses to elicit diﬀerences in
cellular behaviour. It was also important to investigate biocompatibility of the hydrogel
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matrices with neural cells, to eliminate the risk of toxicity of the material changing cellu-
lar behaviour and not the mechanical properties of the matrix. The hydrogels chosen for
evaluation in this study were claimed by the manufacturers to support good cell viability
of cells seeded prior to the polymerisation reaction, allowing the cells to be seeded in 3D
depending on the formulation. It has been demonstrated that 3D cell culture environ-
ments are necessary to achieve more physiologically relevant cell responses compared to
2D tissue culture surfaces (Pampaloni et al. 2007; Justice et al. 2009; Balasubramanian
et al. 2015). The 3D nature of cell culture systems influences cell structure, adhesion,
mechanotransduction and signalling in response to soluble factors that govern cellular
function (Baker and Chen, 2012). Cells grown in monolayer are flat, they adhere and
spread freely on the 2D surface which forces cells to have apical-basal polarity, whereas
when embedded in a 3D matrix, cells assume a non-polar stellate morphology (Mseka
et al., 2007).
Previous work at the University of Leeds and University College London have used a
fully characterised collagen hydrogel (East and Phillips 2008; East et al. 2010), which is
suitable for a 3D spinal cord injury model (Phillips et al. 2005; Smith 2016). However, this
collagen hydrogel is limited in that any changes to the mechanical properties of the matrix
cannot be decoupled from factors that can also have an impact on cell behaviour, such as
collagen density or gel hydration (Willits and Skornia, 2004). The collagen hydrogel used
in Phillips et al. (2005) has been used for similar neural applications, such as in peripheral
nerve injury and repair (Georgiou et al., 2013), therefore it will be used as a baseline to
compare with commercially available hydrogels to evaluate their suitability for use in an
in vitro SCI model. An alternative approach to using a commercially available hydrogel,
was to develop a hydrogel system in-house, which has the capacity to achieve diﬀerent
stiﬀnesses, support cell viability and potentially have a lower cost per millilitre. There
are many hydrogel systems which have been characterised in the literature, some of note
are functionalised synthetic hydrogels used in applications such as in nucleus pulposus
regeneration (Francisco et al., 2013) and intervertebral disc regeneration (Francisco et al.,
2014), which may also be appropriate in an SCI model with further development and
optimisation.
Collagen hydrogels are popular biomaterials for a wide range of applications such as
bone tissue engineering (Ferreira et al., 2012), articular cartillage repair (Kawamura et al.,
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1998) and nerve guidance conduits (Ceballos et al. 1999; Dubey et al. 1999; Phillips et al.
2005). Collagen has many benefits with reference to investigating cellular behaviours,
however collagen density is a factor which influences cellular behaviour (Gaudet et al.,
2003) and so a diﬀerent hydrogel material should be used to investigate how the me-
chanical properties of the matrix aﬀect cell behaviour. There were numerous choices of
naturally derived materials to functionalise the hydrogel, including hyaluronic acid, algi-
nate, chitosan, fibronectin, laminin, fibrin and gelatin (Slaughter et al., 2009). Gelatin is
derived from collagen and therefore has many of the benefits of collagen, such as a high
degree of cell adhesion motifs (Hoch et al., 2012), however gelatin has a much smaller
molecular chain than collagen. Gelatin can be easily cross-linked with Poly(ethylene gly-
col) methacrylates to produce a biopolymer with adjustable macroscopic properties by
small changes in chemical composition (Pierce et al., 2012). Gelatin when reacted with
hexamethylene diisocyanate can produce amorphous gelatin films with a Young’s modulus
of 60-530kPa (Tronci et al., 2010) and by varying the crosslinker and collagen density, the
degree of swelling can be changed from 300-800%. Gelatin can be easily cross-linked to
form hydrogels with a range of matrix stiﬀnesses, with a range of diﬀerent crosslink mech-
anisms with benefits such as controlled hydrogel degradation (Yamamoto et al., 2001) and
release of molecules such as growth factors (Tabata and Ikada, 1998).
The mechanical properties of biomaterials are found to be of increasing importance in
influencing cellular behaviour, which is important for many diﬀerent applications rang-
ing from intra-luminal vascular grafts (Mehta 1993; Hasan et al. 2014) to high-strength
orthopaedic implants (Vainionpää et al. 1987; Mansmann 2001; Schmieding 2005) and
have not often been investigated in detail (Engelberg and Kohn, 1991). The mechanical
properties of the hydrogel should be analogous to the natural ECM of the tissue (Sen-
sharma et al., 2017). In order to design an appropriate biomaterial for a spinal cord
injury model, it is important to consider the biocompatibility, biodegradability, porosity
and the mechanical properties of the matrix. Natural polymers have advantages over
synthetic polymers, as they closely mimic the macromolecules that cells interact with
in vivo. Natural polymers such as collagen or fibronectin are biocompatible and con-
tain cell adhesion sites for cellular attachment (Kharkar et al. 2013; Sensharma et al.
2017). Synthetic polymers have advantages over natural polymers, the physical, chem-
ical and mechanical properties can be designed to suit the application (Aurand et al.,
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2012). By combining the biocompatibility of a natural hydrogel, with the changeable
properties of synthetic hydrogels it was hypothesised that an appropriate hydrogel hybrid
would be produced to provide a robust platform for investigating neural cell physiology
in vitro (Tibbitt and Anseth, 2009). Various research groups have used an acryloyl-PEG-
n-hydroxysuccinimide macromer that can be coupled to a biopolymer, e.g. gelatin via the
formation of an amide bond following reaction with lysine terminations. Photo induced
gel formation can then be excited by exposure of resulting product to UV light in the
presence of PEGDA comonomer and a suitable photoinitiator (Hern and Hubbell 1998;
Burdick and Anseth 2002; Yang et al. 2005; Francisco et al. 2013).
To aid in understanding how this chapter fits with the development of the spinal cord
injury model, the following flow diagram has been created to outline the work involved
in this project (Figure 3.1.1). This chapter investigated hydrogels which were available
commercially and some hydrogel systems which were developed in-house. The hydrogel
system which aligned the most successfully with the target criteria outlined in the objec-
tives was chosen and optimised further.
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Figure 3.1.1: Chapter 3 flow diagram
3.2 Aim
The aim of this chapter was to identify a suitable hydrogel matrix which was capable
of supporting neural cells and was capable of displaying a range of matrix stiﬀnesses
depending on its chemical formulation.
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3.3 Objectives:
• Explore commercially available hydrogels, obtain samples and test for compatibility
against the outlined target criteria (as determined by the live/dead cell viability
assay and rheological testing methods).
• Develop suitable hydrogel options to test for compatibility against the outlined
target criteria (as determined by the live/dead cell viability assay and rheological
testing methods).
• Identify most appropriate hydrogel and optimise this to enhance biocompatibility
and alignment with target criteria (as determined by the live/dead cell viability as-
say, ATP-lite cell viability assay, rheological testing methods and brightfield imaging
techniques).
The various hydrogels were rated and compared against the following target criteria:
• There was a requirement that the elastic modulus of the matrix could be modified
to achieve at least 3 diﬀerent matrix stiﬀnesses over a 5kPa range, as determined
by rheology.
• There was a requirement that the gel should be suitable for 3D cell seeding and
support the viability of cells after a minimum of one day cell culture, analysed by
live/dead staining or quantitatively with the ATP-lite cell viability assay.
• There was a requirement for the gel to be transparent to allow observation of cell
behaviour in a 3D system to allow analysis by fluorescence microscopy.
• There was a requirement for the gel to allow cell attachment to the matrix, confirmed
by visualising non-round cell morphologies by bright or fluorescent microscopy.
• There was a requirement for the gel to be cost eﬀective; less than £40 per mL of
hydrogel.
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3.4 Experimental approach
The following diagram (Figure 3.4.1) has been created to aid understanding of the devel-
opment process appreciated with this chapter, aimed to achieve a biocompatible hydrogel
matrix for an in vitro spinal cord injury model. The diagram illustrates the flow of the
research through investigation of the eﬃcacy of commercially available hydrogels discov-
ered through internet searches and conference networking. A UV-cured collagen hydrogel
and a gelatin hydrogel with PEG cross-linking were investigated due to the expertise from
the supervisory team (Pierce et al. 2012; Tronci et al. 2013). The decision was made to
develop and optimise a synthetic-biologic hybrid hydrogel system due to the results from
the previous hydrogel systems investigated and investigations into the hydrogel systems
used in the literature for neural applications.
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Investigate commercial options
Objectives
fulfilled?
Photo-active collagen system
Objectives
fulfilled?
Gelatin hydrogel with
synthetic cross-links
Objectives
fulfilled?
Synthetic-biologic hydrogel
Potential to
fulfil objectives?
Optimise
synthetic-
biologic
hybrid
hydrogel
No
No
No
Yes/No
Figure 3.4.1: Flow diagram of chapter structure.
3.5 General methods
3.5.1 Investigating appropriate cell seeding density in hydrogels
and biocompatibility testing diﬀerent hydrogel systems and
hydrogel components
A growth curve was performed with C6 cells in 96 well-plates over a 5 day period to
determine the most appropriate seeding density to be used (dependent on the duration
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of the study). Collagen hydrogels, 100 µL per well, were prepared (section 2.14) with the
following C6 cell seeding densities: 0, 1x103, 5x103, 1x104, and 5x104. Cell viability was
determined over a 5 day period using the MTT cell viability assay as detailed in section
2.9.13. The media was changed every 24 hours.
3.5.2 Investigating the biocompatibility of cells in diﬀerent hy-
drogel systems
The biocompatibility of 3D cell seeded hydrogel formulations were tested by seeding 5x104
C6 cells per 100 µL hydrogel or 1x105 primary astrocyte cells per 100 µL hydrogel in a 96
well plate, cultured for 24 hours at 37 °C, 5% (v/v) CO2 in air to allow cellular attachment
to the gels. The viability of the cells was then analysed by performing live-dead staining
and imaging as detailed in section 2.12.1, ATP-lite cell metabolism quantification assay,
as detailed in section 2.12.2 or MTT cell viability assay as detailed in section 2.9.13.
3.5.3 Investigating the biocompatibility of C6 cells with diﬀerent
hydrogel reagents (such as cross-linkers or photoinitiators)
in 2D
The biocompatibility of reagents was tested in 2D in tissue culture plastic by seeding
5x105 C6 cells per well in a 6 well plate, cultured for 2 hours at 37 °C, 5% (v/v) CO2
in air to allow cellular attachments to form. The cells were then subjected to stimuli
(such as UV light, PEGDA or photoinitiator) for the length of time under investigation
(1-120minutes) and then cultured for a further 24 hours at 37 °C, 5% (v/v) CO2 in air
prior to live-dead staining.
3.5.4 Preparation of the photo-active collagen hydrogel
Collagen was harvested from frozen adult rat tail tendons from central biological services
at the University of Leeds, stored at -20°C, thawed in distilled water (Figure 3.5.1a). The
tails were cut length ways with a scalpel and the skin removed. The de-skinned tails were
dried on a dissection tray for 3 hours at room temperature (Figure 3.5.1b). The tendons
were then removed with toothed tweezers and incubated in 17.4 mM acetic acid for 48
hours at room temperature. The solution was then centrifuged at 1000 g for 30 minutes
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and the pellet was neutralised to pH 7.4 with 0.1 M NaOH and incubated overnight at
room temperature. The neutralised collagen solution was then centrifuged at 1000 g for
30 minutes and resolubilised in 17.4 mM acetic acid and freeze-dried for 7 days to obtain
type-1 collagen.
The method to prepare the photo-active collagen hydrogel was adapted from Tronci
et al. (2013). The type-1 collagen was dissolved in 10 mM hydrochloric acid solution at
room temperature until a clear solution was obtained and then neutralised to pH 7.4 with
0.1 M NaOH to allow collagen fibrillogenesis.
Tween 20 (1% (v/v)) was used to increase the solubility of the reacting monomer with
the aqueous solution. The volume of monomers, either 4-Vinylbenzyl chloride (4-VBC)
or Glycidyl methacrylate (GMA), was added to the reaction mixture with a 25 times
molar excess with respect to collagen lysines (3.3 x 10 4 as determined by TNBS assay
(section 3.5.6)). An equimolar volume of triethylamine (TEA) was added to remove any
nucleophiles left in order to acrylate the reaction, which was continued overnight at room
temperature.
The mixture was then precipitated for 1-2 days in ethanol (99.6% (v/v)) in the fume
hood (Figure 3.5.1c) to remove any unreacted monomer, whilst the collagen product
with bound monomer precipitated and was centrifuged at 1000 g for 30 minutes. The
functionalised collagen pellet was dried overnight in the fumehood at room temperature
(Figure 3.5.1d) and was then used to make hydrogels. The TNBS assay (section 3.5.6)
was used to determine the degree of functionalisation (lysine content) of the collagen.
The dry functionalised collagen product was stirred at 4 °C in 10mM hydrochloric acid
solution containing 1% (w/v) photoinitiator. The photoinitiator solution was prepared
by adding 0.5 g Irgacure 2959 into 49.5 g PBS. The photoinitiator solution is obtained by
incubation at 40 °C in the dark. The collagen was weighed and added in diﬀerent quan-
tities to achieve hydrogels of 0.2, 0.4 and 0.8 (wt%) collagen hydrogels, to achieve three
hydrogels with diﬀerent matrix stiﬀnesses. The collagen was added to the photoinitiator
solution and stirred at 60 °C for 60 minutes. The solution was cast into a 24 well plate,
incubated in a vacuum desiccator to remove air-bubbles, followed by UV irradiation at
346 nm for 30 minutes. The hydrogels were then washed overnight in distilled water to
remove unreacted compounds (Figure 3.5.1e and Figure 3.5.1f) and air-dried following
dehydration to sterilise hydrogels (70% (v/v) ethanol in water for 1 hour at room temper-
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(a) Rat tails (b) Rat tail tendons
(c) Collagen precipitated in ethanol (d) Air dried functionalised collagen
(e) Collagen gels pre-soaking (f) Collagen gels post-soaking
Figure 3.5.1: Type-1 Collagen extraction from rat tail tendons (at diﬀerent steps in the
protocol), which was subsequently used to form collagen hydrogels. a) rat tail tendons
thawed in distilled water prior to processing. b) De-skinned rat tail tendons air dried on
dissection tray. c) Collagen precipitated in ethanol to dissolve unreacted monomers. d)
Functionalised collagen post precipitation in ethanol, air dried in fume hood. e) Collagen
gel discs in distilled water prior to swelling. f) Collagen gel discs after 24 hours in distilled
water.
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ature, then incubated in 100% ethanol for 1 hour. The gels were then air dried overnight
in a tissue culture hood.
3.5.5 Formulation of the gelatin-PEG hydrogel system
A 10% (w/v) gelatin solution was made in PBS using gelatin type B from porcine skin
(medium 175g Bloom). The solution was mixed at 50 °C for 1 hour until the gelatin
dissolved.
A solution was prepared by mixing 0.3 g Poly(ethylene glycol)-bis(carboxymethyl)
ether, 1.12 g N-(3-Dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and
0.67 g N-Hydroxysuccinimide (NHS) with 2.5mL PBS. The solution was stirred for 1
hour in an ice bath at 4 °C to allow NHS activation of carboxy functions of the PEG
macromer. After 1 hour, 409 µL 2-Mercaptoethanol was added to the solution, to quench
the EDC. The PEG-cross-linking solution was allowed to warm, by placing it at 37 °C for
10 minutes.
A volume of 1mL of the gelatin solution at 50°C, was added into each well of a 24
well plate as quickly as possible to maintain the temperature above the gelation reaction
temperature of 37 °C. The NHS-activated-PEG solution (volume dependent on the level
of cross-linking or stiﬀness targeted) was added into the 10% (w/v) gelatin solution in
the 24 well plate and shaken at 100 g for 24 hours at 37°C to allow for the PEG-gelatin
reaction of gelation to take place.
After 24 hours incubation, the gels were washed with 1mL PBS and shaken at 150 g
for 5 minutes at 37 °C. The washing process was repeated three times before gels were
ready for use.
3.5.6 2,4,6-trinitrobenzene sulfonic acid (TNBS) assay
The TNBS assay is used to quantify free amino groups in proteins. The TNBS as-
say was used to determine the consumption of free amino groups in gelatin or col-
lagen, when reacted with either Glycidyl methacrylate (GMA), 4-Vinylbenzyl chloride
(4-VBC) cross-linkers or acrylate-poly(ethylene glycol)-N-Hydroxysuccinimide macromer
(Ac-PEG-NHS). The TNBS compound reacts with primary amines on gelatin to generate
a highly chromogenic product which can be measured at a wavelength of 335 nm.
90
A minimum of 6 samples of 0.011 g of lyophilized gelatin were placed into 6 universals
(3 samples and 3 blanks). A volume of 1mL (4% v/v) NaHCO3 (section 2.9.18) and 1mL
of 0.5% (v/v) TNBS solution (section 2.9.24) were added to the samples, 3mL (6 N) HCl
(section 2.9.11) was added to the blanks. After incubation of the samples at 40 °C for 4
hours, 3mL (6 N) HCl was added to all samples and agitated at 60 °C for 1 hour. The
samples were cooled to room temperature and 5mL of deionized water was added to each
sample.
The solution was then extracted three times with 20mL of diethyl ether. The aqueous
solution (5mL) was separated and heated in a water bath at 60 °C for an hour to evaporate
the excess ether. The solution was then diluted in 15mL water and the absorbance
measured at a wavelength of 335 nm against the blank. The yield of free lysine groups
in the gelatin was determined using the following equation adapted from Kale and Bajaj
(2010) for gelatin of unknown molecular weight (1 = the cell path length in cm, x = the
sample weight in grams, yield refers to the degree of funtionalisation) (3.1).
(3.1)
3.5.7 Determining the mechanical properties of the matrix
Rheology was used to determine the stiﬀness of the matrix using dynamic shear at small
strain percentages, within the linear viscoelastic region of the material (the region whereby
at low deformation the G’ and G" and constant; the sample structure is undisturbed) to
prevent measuring the mechanical properties of the material under plastic or elastic de-
formation. Deformation is the transformation of the material after stresses have attained
a certain threshold known as the yield stress or elastic limit, the deformation may be ir-
reversible (plastic) or reversible (elastic). The rheological measurements were performed
using a Kinexus pro+ (Malvern instruments Ltd) with parallel plates of 20mm diameter
and a plate-to-plate distance of 1-2mm (dependent on sample size/dimensions). An am-
plitude sweep determined the mechanical spectra with a ramp of shear strain from 0.1-5%
with a constant frequency (1Hz). This determined the shear strain range which is within
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the linear viscoelastic region before deformation of the material occurs. An appropriate
shear strain was selected based on each the LVER of each hydrogel (0.1-0.5%) for constant
strain to determine the mechanical spectra over a frequency range of 0.5-5Hz at 37 °C.
This temperature was chosen as the hydrogels are to be used in cell culture at 37°C.
3.5.8 Development of a synthetic-biologic hybrid hydrogel system
Poly(ethylene glycol) diacrylate (PEGDAMW700, PEGDAMW3500, PEGDAMW6000)
was dissolved in PBS to form a 10% (w/v) solution. A 300mg·mL 1 photoinitiator solu-
tion of 2,2-dimethoxy-2-phenylacetophenone (DMPA) in 1-vinyl-2-pyrrolidinone photoini-
tiator was made and mixed with the PEGDA solution at a concentration of 5 µL·mL 1 of
PEGDA solution. The resulting solution was then placed in 100 µL aliquots into a 96 well
plate and exposed to UV light at a wavelength of 309 nm to initiate polymerisation and
form hydrogels. The wavelength of light used to polymerise the hydrogels was limited in
the early development of the hydrogel, due to the limited equipment and available UV
bulbs at the time of experimentation. This method was developed further by the addition
of gelatin by a functionalisation reaction.
3.5.8.1 Functionalisation of gelatin with PEG macromer
In order to achieve cell attachment to the synthetic matrix, gelatin was attached to the
synthetic gel matrix, which allowed cells to bind to the gelatin chain of the PEG-gelatin
hydrogel. An Acrylate-PEG-NHS macromer (referred to as Ac-PEG-NHS) was chemically
coupled to gelatin chains via reaction with lysine terminations of gelatin.
The following flow diagram was developed to aid understanding of the functionalisation
process (Figure 3.5.2).
The first step in the functionalisation process (Figure 3.5.2) was to mix 1 g gelatin
with 1 g Ac-PEG-NHS (3:1 molar ratio) in 5mL PBS, at 40 °C, to ensure reaction is in
the liquid state. The solution was stirred whilst the reaction occurred to maximise the
functionalisation yield of Ac-PEG-NHS reacting with lysines or arginines on the gelatin.
Gelatin was incubated with the following molar excesses of Ac-PEG-NHS to gelatin; 5:1,
3:1, 1:1, and an excess of gelatin to Ac-PEG-NHS at 5:1 to determine the most eﬃcient
ratio of Ac-PEG-NHS to gelatin, in order to achieve the maximum functionalisation of
gelatin with the lowest mass of linker molecules, to be cost eﬀective.
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1) Gelatin reacted with Ac-PEG-
NHS to form Ac-PEG-gelatin
2) Ac-PEG-OH (degrada-
tion product) separated from
Ac-PEG-gelatin by dialysis
3) Ac-PEG-gelatin and unreacted
gelatin frozen, then freeze dried
4) TNBS assay to determine
functionalisation of gelatin
More than 80%
functionalised
gelatin?
5) Ac-PEG-gelatin reacted with
PEGDA and photoinitiator in the
presence of UV to form hydrogels
No
Yes
Figure 3.5.2: Flow diagram for the functionalisation process of gelatin with macromer
Ac-PEG-NHS.
The Ac-PEG-NHS linker molecule was added in excess to the molar ratio of gelatin to
allow for the formation of the degradation product Ac-PEG-OH which was dialysed out
of solution once the reaction had completed (step two Figure 3.5.2). The reaction mixture
containing the unreacted gelatin, Ac-PEG-gelatin and Ac-PEG-OH was transferred into
dialysis tubing containing dialysis fluid (section 2.9.3) which disrupted any aggregation
of gelatin, allowed diﬀusion and eﬃcient dialysis. The tubing had pores of 10-12.5 kDa,
which allowed any unreacted compounds and Ac-PEG-OH (which was approximately 5
kDa in size) to pass through the pores of the tubing, leaving the gelatin and Ac-PEG-
Gelatin inside the dialysis tubing. The dialysis solution was changed 3 times over a 24
hours period to enhance removal of Ac-PEG-OH by diﬀusion.
The dialysed solution was placed in polypropylene universals and frozen at -20 °C
overnight before placing in a freeze dryer for 48 hours to achieve lyophilised Ac-PEG-
Gelatin (step three Figure 3.5.2). The amount of free unreacted lysines were calculated
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by performing a TNBS assay (as detailed in section 3.5.6) to calculate the degree of
functionalisation (step four Figure 3.5.2). The functionalisation reaction steps 1-4 (Figure
3.5.2) were repeated again after freeze-drying to increase the functionalisation above 80%.
When the functionalisation of gelatin was more than 80%, the lyophilised Ac-PEG-gelatin
was stored at -20 °C until required for up to 1 year.
3.5.8.2 Formation of polymerised PEG-gelatin hydrogel
Figure 3.5.3 illustrates the two chemical reactions involved in the formation process of
this synthetic-biologic hybrid hydrogel, to aid understanding of the complex chemistry
involved. The first half of the reaction is the functionalisation of gelatin with PEG
macromer (Ac-PEG-NHS) (red box) to result in gelatin-PEG-acrylate (blue box), the
process is detailed in Figure 3.5.2.
The acrylated gelatin (gelatin-PEG-acrylate) was then incorporated into the synthetic
hydrogel formulation (step five Figure 3.5.2 by the addition of PEG-diacrylate (blue box),
the second chemical reaction in Figure 3.5.3) to produce the polymerised PEG-gelatin
(synthetic-biologic) hydrogel matrix.
The acrylate groups of gelatin-PEG-acrylate, reacted with the acrylate groups of
PEGDA (in the presence of UV and a photoinitator) via radical polymerisation. The
photoinitiator solution containing 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-
propanone (I2959) was made by adding 10mg of I2959 in 20mL Hanks balanced salt
solution with phenol red. The solution was heated and stirred above 45 °C for 20 min-
utes.
According to the stiﬀness of the hydrogel that was required, the appropriate volume
of photoinitiator solution to PEGDA and gelatin-PEG-acrylate were mixed at 60 °C for 4
hours to thoroughly mix the materials prior to polymerisation. The final formulations are
described in Table 3.1. Once the reaction mixture was homogenous (fully blended), the so-
lution was cooled to 37 °C. If cellular gels were required, the cellular pellet was mixed with
the hydrogel solution and the hydrogel solution was pipetted into 50 or 100 µL aliquots
into a 96 well plate and exposed to UV light at 365nm for 3.5 minutes (if Irgacure 2959
was used) or at 405 nm for 5 minutes (if lithium acylphosphinate (LAP) photoinitiator
was used).
The volume remained constant for each hydrogel stiﬀness by reducing the volume of
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Figure 3.5.3: The 2-step chemical process of synthetic-biologic hybrid hydrogel formation.
Reaction one is highlighted in the red box, gelatin with acrylate-PEG-NHS to form gelatin-
PEG acrylate. The second reaction (blue box) involved the addition of PEGDA, UV and
photoinitiator to produce the polymerised PEG-gelatin hydrogel. The segments of the
polymerised hydrogel have been outlined to show the gelatin block (green) the acrylate
block from the Ac-PEG-NHS monomer (purple) and the added PEGDA (black).
HBSS as the mass of PEGDA increased with increasing stiﬀness. The mass of gelatin
increased with increasing hydrogel stiﬀness as a result of increased synthetic cross-links
by the increased mass of PEGDA. The ratio of synthetic cross-links to gelatin cross-links
was necessary to remain equal. The volume of HBSS could not be reduced as per the
increase in mass of gelatin because the gelatin solution would have been saturated and
would not have dissolved.
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Final hydrogel formulations (quantity per mL hydrogel)
PEGDA %
(w/v)
5% (w/v) 7.5% (w/v) 10%(w/v) 12.5%
(w/v)
15%(w/v)
PEGDA 50mg 75mg 100mg 125mg 150mg
Photo-
initiator
0.5mg·mL 1 0.5mg·mL 1 0.5mg·mL 1 0.5mg·mL 1 0.5mg·mL 1
HBSS 950 µL 925 µL 900 µL 875 µL 850 µL
Gelatin 105mg 156.5mg 210mg 261mg 315mg
Stiﬀness 20 Pa 250 Pa 700 Pa 2.9kPa 3.9kPa
Table 3.1: Table of final synthetic-biologic hybrid hydrogel formulations (mass of gelatin
based on 175g Bloom of gelatin)
3.6 Results
3.6.1 Assessment of commercially available hydrogel options
A web based search for hydrogels that could tune the matrix stiﬀness and be compatible
with 3D cell seeding, revealed the commercially available hydrogels listed in Table 3.2.
These hydrogels were described being biocompatible, whilst also having tuneable stiﬀness
properties, and at least 3 matrix stiﬀness variants were achievable by any mechanism.
These commercially available (at time of research (2014-2015)) hydrogels were requested
or purchased from the suppliers and prepared as per the manufacturers instructions.
This study also contained the pre-existing optimised collagen gel system developed at
UCL and the Open University by Dr James Phillips (Phillips et al., 2005) and a synthetic
poly(ethylene glycol) diacrylate system based on the method described previously in Choi
et al. (2008).
A growth curve was carried out to investigate the appropriate cell seeding density of
C6 astrocyte-like cell line seeded into hydrogels and for how many days the experiment
would be viable at each cell seeding density (Appendix A section 9.1 Figure 9.1.1).
The hydrogels were seeded with C6 astrocyte cells as per the manufacturers instruc-
tions and a live/dead assay was performed after 24 hours in cell culture to analyse whether
at least 50% of cells were labelled green (living) and less than 50% of cell were labelled
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Table 3.2 Commercially Available Hydrogels
Trademark hydro-
gel name
Type of Hydrogel Supplier Cost
£/mL*
BiogelXTM Self-assembling peptide BiogelXTM, Edin-
burgh UK
38.4
PRR4 Self-assembling peptide PepgelTM, Manhattan
USA
56.4
PGR2t Self-assembling peptide PepgelTM, Manhattan
USA
35
Extracel kit Glycosil, Gelin-S and
PEGDA
Tebu-BioTM, Peter-
borough UK
32.4
HyStem-C Hyaluronan, collagen
and PEGDA
ESI BioTM, Alameda
USA
34.68
3D life hydrogels PEG-RGD-Dextran CellendesTM, Reutlin-
gen Germany
74
Collagen hydrogel Collagen First Link, Wolver-
hampton UK
3
Table 3.2: *Cost based on quotations received in 2014-2015, inclusive of shipping and
discounts. Stiﬀer gels have an increased cost due to an increase in reagent/protein con-
centrations.
97
red (dead). The hydrogels were assessed by rheology to investigate whether the matrix
stiﬀness could be tuned over a 5kPa range.
The BiogelXTM hydrogel was diﬃcult to image as there was a high degree of back-
ground staining and cell clumping (Fig 3.6.1a) when cells were seeded into the viscous
peptide solution. The viscosity of the peptide solution resulted in the introduction of bub-
bles and clumping of cells (Appendix B section 9.2 Figure 9.2.1) which made calculating
the cell viability diﬃcult however, the proportion of green labelled cells was approximately
63-71% (Appendix B section 9.2 Figure 9.1). The rheology results (Appendix B section
9.2 Figure 9.1) indicated that the gels did not provide a range of gel stiﬀnesses as previ-
ously claimed by the company. These gels did not comply with the target criteria outlined
in the objectives.
The PepgelTM hydrogels PGR2t and PRR4 demonstrated good cell visibility (62% and
83% respectively, (Appendix B section 9.2 Figure 9.1)) with a high proportion of green
labelled cells analysed by live/dead staining and fluorescent imaging. The PepgelTM were
easy to prepare, however the PGR2t hydrogel lacked the RGD adhesion peptide, which
the PRR4 peptide contained. The lack of RGD cell adhesion motif in PGR2t resulted in
poor cellular adhesion compared to the PepgelTM PRR4 hydrogel, showing fewer living
cells which adhered to the matrix and had a less round morphology (Figure 3.6.1b). The
PRR4 peptide hydrogel exhibited good cell viability and cellular adhesion, as observed
in Figure 3.6.1c. The PepgelTM PRR4 self-assembling peptide hydrogels cost more than
£40 per mL for a low stiﬀness hydrogel and significantly more for a stiﬀer hydrogel, as
more peptide was required. These prices did not comply with the price limitation of £40
per mL set in the objectives to create a viable hydrogel model. Insuﬃcient samples were
received for rheological analysis of mechanical properties.
The Extracel hydrogel kit received from Tebu-BioTM, (now HyStem supplied by ESI
Bio), claimed to make 3 diﬀerent matrix stiﬀnesses, however the softest hydrogel failed
to gel. The mid-stiﬀness hydrogel did not show good cell viability (Fig 3.6.1d). The poor
cell viability did not meet the target criteria and therefore was not a viable option for this
hydrogel model. The medium hydrogel was measured by rheology to be approximately
113Pa (Appendix B section 9.2 Figure 9.1), there was insuﬃcient sample to make the stiﬀ
hydrogel.
The commercially available Poly(ethylene glycol) synthetic hydrogel cross-linked with
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(a) BiogelXTM (b) PGR2t (c) PRR4
(d) HyStem (e) PEGDA Mn700 (f) Collagen control
Figure 3.6.1: Hydrogel biocompatibility assessed with live/Dead imaging. The hydrogels
were seeded with 1x106 C6 astrocyte-like glioma cells per 1mL of hydrogel and cultured
for 24 hours prior to live/dead analysis. a) BiogelXTM, b) PepgelTM PGR2t, c) PepgelTM
PRR4, d) HyStem, e) Synthetic hydrogel formulated from Choi et al. (2008), f) Collagen
gel control. Scale bar = 100 µm Representative images chosen.
modified Dextran, containing RGD motifs (manufactured by CellendesTM) was eliminated
due to the cost per mL since it was more than £40. Due to the number of experiments
to be performed over the project, and the need for various methods of analysis, this cost
was deemed too high to sustain and was therefore eliminated as it does not comply with
the target criteria.
The existing collagen hydrogel was the most viable matrix, with the highest proportion
of green labelled cells (Figure 3.6.1f and Appendix B section 9.2 Figure 9.1). However,
the mechanical properties of the matrix were not flexible and therefore cannot be used to
investigate the eﬀect of matrix stiﬀness on CNS cells in a spinal cord injury model.
3.6.2 Development of a photo-active collagen hydrogel
A photo-active collagen hydrogel was formulated with 3 diﬀerent collagen concentrations
(as described in section 3.5.4), however the lowest collagen concentration (0.2% (w/v))
was too low to form a hydrogel. The stiﬀness of the 0.4% (w/v) and 0.8% (w/v) hydrogels
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were analysed using rheology (as described in section 4.3.1), six hydrogels of each collagen
concentration were analysed at 37 °C and the complex shear modulus was found to be
approximately 20 Pa and 250 Pa, for the 0.4% (w/v) and 0.8% (w/v) gels respectively at
1Hz frequency (Figure 3.6.2).
Figure 3.6.2: Stiﬀness of the photo-active collagen gels with 0.4% (w/v) and 0.8% (w/v)
collagen concentrations. Error bars indicate standard deviation (n=6).
3.6.3 Development of a gelatin hydrogel with synthetic (PEG)
cross-links
The gelatin-PEG hydrogel system was developed whereby the stiﬀness of the matrix
could be altered by three diﬀerent mechanisms. The first mechanism was to change the
concentration of cross-linker EDC from 0.075 g to 0.45 g·mL 1 hydrogel (as described in
section 3.5.5). Rheology was performed at 37 °C on parallel plate geometries, with 0.5%
shear strain (as determined by an amplitude sweep that located the appropriate shear
strain within the LVER (as described in section 4.3.1)) on six hydrogels per condition.
An average of the frequency sweep data was produced (Figure 3.6.2a), error bars indicate
standard deviations of the six samples. Changes to the cross-linker concentration changed
the cross-linking density and resulted in an increase in the complex shear moduli with
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an increase in cross-linker concentration, from approximately 60 Pa to 850 Pa at 1Hz
frequency.
(a)
(b)
The second mechanism which resulted in changes to the matrix stiﬀness, was chang-
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ing the Bloom of gelatin from low (60g Bloom), to medium (175g Bloom) and to high
(250g Bloom)(Figure 3.6.2b). The Bloom value is a measure of the strength of gelatin,
determined by the Bloom plunger test developed by Oscar Bloom in 1925. This changed
the matrix stiﬀness from approximately 300 Pa (low Bloom), to 750 Pa (medium Bloom),
and to 1 kPa (high Bloom) by increasing the size of the gelatin fragment bound to the
polymer structure. The limitation of changing the gelatin Bloom from low to high as the
mechanism to change the stiﬀness of the matrix, was that the stiﬀness of the hydrogels
showed large variations between samples, as can be seen by the large standard deviation
error bars (Figure 3.6.2b).
(c)
Figure 3.6.2: Complex shear modulus of gelatin-PEG gels measured by rheology, average
of six hydrogels per condition, error bars indicate standard deviation. The stiﬀness of the
matrix was easily changed by altering (A) the cross-linker concentration, (B) the Bloom of
gelatin or (C) concentration of PEG. All hydrogels were statistically diﬀerent, determined
by one way ANOVA with Fisher LSD post hoc comparison.
The third mechanism to change the matrix stiﬀness, was by changing the concen-
tration of PEG from 5 to 15% (w/v), which aﬀected the cross-link density within the
hydrogel system (Figure 3.6.2c). The stiﬀness of the hydrogels was measured using rheo-
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logical measurements (as described in section 4.3.1). The stiﬀness of the low cross-linker
concentration (0.075g/mL) hydrogel was 10 Pa for the 5% (w/v) PEG, to 60 Pa for the
10% (w/v) PEG and to 270 Pa for the 15% (w/v) PEG at 1Hz frequency, 37 °C. However,
all samples of all cross-linker concentrations, gelatin Blooms and PEG concentrations had
a large occurrence of bubbles throughout the hydrogels, (Appendix C section 9.3 Figure
9.3.1a). After UV exposure the bubbles continued to appear and made the hydrogels
unsuitable for cell culture (Appendix C section 9.3 Figure 9.3.1). Attempts were made
to reduce bubble formation by making the gels under vacuum conditions, however this
exacerbated the problem causing the bubbles to expand the hydrogel mixture beyond
the well plates (Appendix C section 9.3 Figure 9.3.1c) and prevented hydrogel formation
(Appendix C section 9.3 Figure 9.3.1d).
3.6.4 Development of a synthetic-biologic hybrid hydrogel system
A synthetic-biologic hydrogel was designed to cross-link PEG with gelatin, which produced
hydrogel matrices with a range of mechanical properties. Optimisation steps were required
before the matrix could be deemed appropriate for a 3D cell seeded spinal cord model.
The diagram (Figure 3.6.3) has been developed to describe the optimisation process of
the formulation of the synthetic-biologic hybrid hydrogel and ease understanding of the
following results sections.
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Figure 3.6.3: Optimisation process for the synthetic-biologic hydrogel system.
3.6.4.1 Toxicity testing
The following section will outline the reagent toxicity testing part of the optimisation
process (Figure 3.6.3).
The biocompatibility of 10% (w/v) PEGDA (Mn 700 kDa, Mn 3500 kDa, Mn 6000
kDa) solutions were investigated for toxicity with C6 astrocyte-like cells as detailed in
section 3.5.3. Aliquots of 1x106 C6 cells per well of a 6 well plate were cultured for 2
hours at 37 °C, 5% (v/v) CO2 in air to allow cellular attachment, prior to culture for 1
hour with 10% (w/v) solutions of PEGDA MN 700, MN 3,500, MN 6,000, then further
culture for 24 hours at 37 °C, 5% (v/v) CO2 in air. Cell viability was then investigated
by live/dead staining (as described in section 2.12.1), representative images are displayed
in Figure 3.6.4.
It was found that a molecular weight of 700 kDa was toxic to C6 cells, as widespread
cellular detachment from the tissue culture plastic was observed and the cells that re-
mained attached were labelled red (dead) (Figure 3.6.4b). The higher molecular weights
of PEGDA, 3,500 kDa and 6000 kDa were biocompatible i.e. the C6 cells remained at-
tached to the tissue culture plastic and were labelled green (Figure 3.6.4c and Figure
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3.6.4d).
(a) PBS (b) PEGDA Mn 700
(c) PEGDA Mn3500 (d) PEGDA Mn 6000
Figure 3.6.4: Toxicity assay analysed by live/dead staining of 1x106 C6 cells/well of a
6 well plate, exposed (for one hour) to (a) PBS, good cell attachment and good cell
viability (99%) (b) 10% (w/v) PEGDA Mn 700 kDa, complete cellular detachment and
low cell viability (1%) (c) Mn3500 kDa, good cell attachment, good (99%) cell viability
(d) Mn6000 kDa, good cel attachment, good cell viability (95%). Scale bar = 200 µm,
n=4, representative images chosen.
The mechanism of polymerisation for this hydrogel involved exposure of cells to UV
light, therefore a toxicity assay of PC12 cells cultured on tissue culture plastic was per-
formed (method described in section 3.5.3) to investigate the toxicity of diﬀerent wave-
lengths of UV light. Aliquots of 1x106 PC12 cells per well of a 6 well plate were cultured
for 2 hours at 37 °C, 5% (v/v) CO2 in air prior to UV light exposure for 30 minutes at
265 nm, 309 nm and 365 nm, then further culture for 24 hours at 37 °C, 5% (v/v) CO2
in air, followed by live/dead staining (as detailed in section 2.12.1).
The results indicate that trans UV, whereby the sample is exposed from underneath
and the light passes through the sample, was toxic to the cells at 265nm and 309 nm,
however at 365 nm, the number of red labelled cells was greatly reduced, when compared
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to the samples exposed to 265 nm and 309 nm UV light (Figure 3.6.5).
(a) No UV (b) UV 265 nm
(c) UV 309 nm (d) UV 365 nm
Figure 3.6.5: Toxicity assay analysed by live/dead staining of 1x106 PC12 cells/well of
a 6 well plate, (a) no exposure to UV (b) exposed to 265 nm UV light for 30 minutes
(c) exposed to 309 nm UV light for 30 minutes (d) exposed to 365 nm UV light for 30
minutes. Scale bar = 100 µm, n=4, representative images chosen.
A search of the literature for hydrogels which polymerised via radical polymerisation
under UV light was performed to investigate appropriate photoinitiators for use with
this hydrogel. Irgacure 2959®, (Ciba Speciality Chemicals, Tarry town, NY) was the
most commonly used photoinitiator which claimed to be biocompatible and used in sim-
ilar PEGDA hydrogel systems (Francisco et al., 2013). A toxicity assay was performed
(method described in section 3.5.3), aliquots of 1x106 C6 cells per well of a 6 well plate
were cultured for 2 hours at 37 °C, 5% (v/v) CO2 in air to allow cellular attachment prior
to culture with photoinitiators for 1 hour, then further culture for 24 hours at 37 °C, 5%
(v/v) CO2 in air, followed by live/dead staining (as detailed in section 2.12.1) to investi-
gate the biocompatibility of the photoinitiators; Irgacure 2959, DMPA in dimethylsiloxane
and DMPA in 1-vinyl-2-pyrollidinone (1VP).
The live/dead assay results indicated that DMPA in DMSO was less cytotoxic than
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DMPA in 1VP (Figure 3.6.6) and at 1% (w/v) Irgacure 2959 in PBS was the least bio-
compatible as there was high cell dettachment from the tissue culture plastic and low cell
viability (1%) (Figure 3.6.6b).
(a) Cells in PBS (b) Irgacure 1% (w/v)
(c) DMPA in DMSO (d) DMPA in 1V2P
Figure 3.6.6: Toxicity assay analysed by live/dead staining of 1x106 C6 cells/well of a 6
well plate, exposed to (a) PBS, (b) Irgacure 2959 1% (w/v), high cell detachment and
poor cell viability (1%) (c) 2.5 µL·mL 1 (600mg·mL 1 of DMPA dissolved in DMSO) in
PBS, cell detachment present and low cell viability (45%) (d) 5 µL·mL 1 (300mg·mL 1
of DMPA dissolved in 1V2P) in PBS, high cell detachment and poor cell viability (5%).
Scale bar = 200 µm, n=4, representative images chosen.
Further consultation of the literature noted that other studies used Irgacure 2959 in
lower concentrations such as 0.01% (w/v) (Cha et al. 2010; Almany and Seliktar 2005)
or 0.05% (w/v) (Rice and Anseth, 2007). A range of concentrations of Irgacure 2959
were analysed (1%, 0.5%, 0.25%, 0.1%, 0.05%, 0.025% and 0.01%) in 10% (w/v) PEGDA
Mn3500 hydrogels, whereby 1x106 C6 cells per 1mL of hydrogel solution were seeded prior
to the polymerisation reaction. Five 100 µL aliquots of C6 cell seeded hydrogel solutions
of each photoinitiator concentration, were aliquoted into a 96 well plate and exposed to
UV at 365 nm for 60 minutes. The cellular gels were then cultured in Hams-f12 media for
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a further 24 hours at 37 °C, 5% (v/v) CO2 in air prior to live/dead staining (as detailed
in section 2.12.1).
The results indicated that the viability of C6 cells improved with decreasing irgacure
concentration (Figure 3.6.7). 0.05% (w/v) Irgacure 2959 resulted in the highest quantity
of living cells. It was found that 0.01% (w/v) Irgacure 2959 concentrations (0.01% (w/v)
Figure 3.6.7d and 0.025% (w/v ) Figure 3.6.7c) were too low to achieve full cross-linking
in PEGDA-gelatin functionalised hydrogels after 60 minutes UV exposure at 365nm at
room temperature, resulting in low cell viability (Figure 3.6.7). The middle concentra-
tion (0.05% (w/v) Irgacure 2959) resulted in a high proportion of living cells in 3D cell
seeded PEGDA-gelatin functionalised hydrogels (Figure 3.6.7b). The highest concentra-
tion (0.5% (w/v) Irgacure 2959) resulted in limited cell viability (Figure 3.6.7a). The
optimal concentration of Irgacure 2959 with the highest proportion of green labelled cells
was 0.05% (w/v) Irgacure 2959.
C6 cells seeded in 3D within the hydrogel matrix prior to gel polymerisation, had good
cell viability (Figure 3.6.7b). However, when 1x106 C6 cells were seeded onto the surface
of a 6 well plate (cultured for 2 hours at 37 °C, 5% (v/v) CO2 in air, as described in
section 3.5.3) and the cells were exposed to UV light (365 nm) and 0.025% (w/v) Irgacure
2959, or 0.05% (w/v) Irgacure 2959, the C6 cells detached from the wells and low cell
viability was observed (Figure 3.6.8B2 and C2). The UV light exposure at 365 nm was
also observed to have a negative eﬀect on cell viability in the control (PBS) condition
resulting in a lower number of living cells attached to the wells (Figure 3.6.8A2).
Previous experiments (Figure 3.6.5) showed that the longer the UV wavelength, the
lower the toxicity to C6 cells. The photoinitiator LAP (lithium phenyl-2,4,6-trimethyl-
benzoylphosphinate) claimed to be compatible with UV light at 405 nm, therefore the
experiment was repeated with the photoinitiator LAP (0.5% (w/v) in PBS at 405 nm
for 5 minutes exposure and compared with 0.05% (w/v) Irgacure 2959 at 405 nm for 5
minutes exposure, detailed in section 3.5.3.
The negative control conditions of cells in PBS with and without light exposure at
405 nm (Figure 3.6.9) demonstrated reduced cell death compared to the eﬀects of UV
exposure at 365nm as shown in Figure 3.6.8. Although the proportion of living labelled
cells was higher in the 0.05% (w/v) Irgacure 2959 at 405 nm (Figure 3.6.9B2), it was
found that Irgacure 2959 exposed to UV at 405 nm did not generate free radicals and
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(a) Irgacure 0.5% (w/v) (b) Irgacure 0.05% (w/v)
(c) Irgacure 0.025% (w/v) (d) Irgacure 0.01% (w/v)
Figure 3.6.7: 3D biocompatibility assay of 10% (w/v) PEGDA Mn 3,500kDa hydrogels
exposed to UV light at 365nm for 60 minutes, analysed by live/dead staining of 1x106
C6 cells/well of a 6 well plate, containing (a) 0.5% (w/v) Irgacure 2959, (b) 0.01% (w/v)
Irgacure 2959, (c) 0.025% (w/v) Irgacure 2959, (d) 0.05% (w/v) Irgacure 2959, Images
taken 2 hours post polymerisation reaction. Scale bar = 200 µm, n=5, representative
images chosen.
therefore did not polymerise hydrogels and would not be an option in the polymerisation
process.
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Conditions No UV (1) UV exposure (365nm) (2)
(A) Cells in PBS
(B) 0.025% Irgacure
(C) 0.05% Irgacure
Figure 3.6.8: Toxicity assay analysed by live/dead staining of 1x106 C6 cells/well of a 6
well plate. Cells were not exposed (1) or exposed (2) to 365nm UV light and (A) PBS, (B)
0.025% (w/v) Irgacure 2959 in PBS, or (C) 0.05% (w/v) Irgacure 2959 in PBS. Images
taken 24 hours post exposure to UV, Irgacure 2959 or both, n=4, representative images
chosen, Scale bar = 100 µm.
3.6.4.2 NMR analysis for the presence of carbon double bonds as a measure
of cross-linking saturation.
The viability and attachment of cells was poor in all photo-initiator conditions in the
presence of appropriate wavelength UV light. Therefore, it was necessary to determine
the shortest length of time to expose hydrogels to UV light at 365nm, so that the hydrogels
become fully cross-linked but the cells were not exposed to damaging light for longer than
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Conditions No UV (1) UV exposure (405nm) (2)
(A) Cells in PBS
(B) 0.05% (w/v) Irgacure 2959
(C) 0.5% (w/v) LAP
Figure 3.6.9: Toxicity assay analysed by live/dead staining of 1x106 C6 cells/well of a 6
well plate. Cells were not exposed (1) or exposed (2) to 405nm UV light and (A) PBS,
(B) 0.05% (w/v) Irgacure 2959 in PBS, or (C) 0.5% (w/v) LAP in PBS. Images taken
24 hours post exposure to UV, photointiator or both. n=4, representative images chosen,
Scale bar = 200 µm
necessary. Therefore hydrogels were prepared (Table 3.3) for NMR analysis by the EPSRC
funded National Solid-state NMR service in Durham (n=3) to investigate the minimum
length of time necessary to expose the hydrogels to UV light at 365nm to fully cross-link
the hydrogels.
The hydrogels which had been polymerised for diﬀerent lengths of time, were analysed
for the presence of unsaturated C=C bonds. Unsaturated bonds are an indicator that
the hydrogel was not fully cross-linked, as these C=C bonds are replaced with C-C bonds
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Table 3.3: The hydrogel samples prepared for NMR analysis contained 175g Bloom gelatin
(82% functionalisation with Ac-PEG-NHS) and 0.05% (w/v) Irgacure 2959 photoinitiator
solution.
Hydrogel formulation Exposure period to UV
10% (w/v) PEGDA, 20mg·mL 1 gelatin 0 minutes at 365nm (negative control)
10% (w/v) PEGDA, 20mg·mL 1 gelatin 1 minutes at 365nm
10% (w/v) PEGDA, 20mg·mL 1 gelatin 2 minutes at 365nm
10% (w/v) PEGDA, 20mg·mL 1 gelatin 5 minutes at 365nm
10% (w/v) PEGDA, 20mg·mL 1 gelatin 15 minutes at 365nm
10% (w/v) PEGDA, 20mg·mL 1 gelatin 30 minutes at 365nm
10% (w/v) PEGDA, 20mg·mL 1 gelatin 60 minutes at 265nm (positive control)
in a fully cross-linked hydrogel. It is important to ensure a high degree of cross-linking
and saturation of carbon-carbon double bonds, whilst minimising cellular exposure to UV
light to improve cell viability.
The data (Figure 3.6.10) illustrated three peaks at approximately 6.5ppm in the un-
saturated samples (highlighted by a red box in Figure 3.6.10a) which represents the C=C
bond which is broken during the UV polymerisation process. After 1 and 2 minutes of
UV exposure the three peaks are reduced but still visible, highlighted with a red box in
Figure 3.6.10b and Figure 3.6.10c, this suggested that the polymerisation period was not
complete at 2 minutes and therefore longer exposure to UV light was required. However,
the peaks are reduced to noise levels at 5 minutes of UV exposure (Figure 3.6.10d), this
suggested that full cross-linking was achieved between 2 and 5 minutes of UV exposure.
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Current Data Parameters
NAME       jti_20161130
EXPNO                11
PROCNO                1
F2 - Acquisition Parameters
Date_          20161130
PROBHD   4 mm MAS BB/1H
PULPROG            zgpr
NS                   16
SWH           10000.000 Hz
AQ            0.9995000 sec
TE                298.0 K
D1          15.00000000 sec
D12          0.00002000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1718702 MHz
NUC1                 1H
P1                 5.00 usec
PLW1        54.00000000 W
PLW9         0.00100000 W
F2 - Processing parameters
SI                32768
SF          400.1699193 MHz
WDW                  EM
SSB      0
LB                 2.00 Hz
GB       0
PC                 1.00
20161130, 1777/7354,  0 soft 1A, 4mmHXG, 1H, 4kHZ, RT, EH
(a) Unsaturated sample
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm
Current Data Parameters
NAME       jti_20161130
EXPNO                41
PROCNO                1
F2 - Acquisition Parameters
Date_          20161130
PROBHD   4 mm MAS BB/1H
PULPROG            zgpr
NS                   16
SWH           10000.000 Hz
AQ            0.9995000 sec
TE                298.0 K
D1          15.00000000 sec
D12          0.00002000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1718760 MHz
NUC1                 1H
P1                 5.00 usec
PLW1        54.00000000 W
PLW9         0.00100000 W
F2 - Processing parameters
SI                32768
SF          400.1699193 MHz
WDW                  EM
SSB      0
LB                 2.00 Hz
GB       0
PC                 1.00
20161130, 1777/7376,  1min soft 1B, 4mmHXG, 1H, 4kHZ, RT, EH
(b) 1 minute exposure to UV
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Current Data Parameters
NAME       jti_20161201
EXPNO                10
PROCNO                1
F2 - Acquisition Parameters
Date_          20161201
PROBHD   4 mm MAS BB/1H
PULPROG            zgpr
NS                   64
SWH           10000.000 Hz
AQ            0.9995000 sec
TE                298.0 K
D1          15.00000000 sec
D12          0.00002000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1718753 MHz
NUC1                 1H
P1                 5.00 usec
PLW1        54.00000000 W
PLW9         0.00100000 W
F2 - Processing parameters
SI                32768
SF          400.1699193 MHz
WDW                  EM
SSB      0
LB                 2.00 Hz
GB       0
PC                 1.00
20161130, 1777/7379,  2min soft 1C, 4mmHXG, 1H, 4kHZ, RT, EH
(c) 2 minutes exposure to UV
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Current Data Parameters
NAME       jti_20161130
EXPNO                31
PROCNO                1
F2 - Acquisition Parameters
Date_          20161130
PROBHD   4 mm MAS BB/1H
PULPROG            zgpr
NS                   16
SWH           10000.000 Hz
AQ            0.9995000 sec
TE                298.0 K
D1          15.00000000 sec
D12          0.00002000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1718760 MHz
NUC1                 1H
P1                 5.00 usec
PLW1        54.00000000 W
PLW9         0.00100000 W
F2 - Processing parameters
SI                32768
SF          400.1699193 MHz
WDW                  EM
SSB      0
LB                 2.00 Hz
GB       0
PC                 1.00
20161130, 1777/7360,  5min soft 1D, 4mmHXG, 1H, 4kHZ, RT, EH
(d) 5 minutes exposure to UV
Figure 3.6.10: Solid state NMR data showing that the three peaks at 6-6.5ppm, high-
lighted by a red box, represent the C=C bond which is reduced to C-C in fully cross-linked
hydrogels. The polymerisation reaction is complete between 2 and 5 minutes UV light
exposure at 365nm as the C=C bond is reduced to noise on the 5 minute spectra. N=3,
data courtesy of the EPSRC funded solid-state NMR facility, University of Durham.
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3.6.4.3 ATP-lite assay to analyse C6 cell viability in hydrogels with diﬀerent
UV exposure time periods
To investigate how the cells were aﬀected by the UV polymerisation process an ATP-lite
assay was performed (as described in section 2.12.2) after 1, 2, 5, 15 or 30 minutes UV
exposure (Figure 3.6.11). The highest cell viability was observed over 2 minutes of UV
exposure and cell viability was reduced from 5 minutes. The results suggested that 2
minutes would be a good length of UV exposure, however, as the NMR data indicated
that 2 minutes was not enough UV exposure to fully cross-link the gels (as the C=C
bond was still present Figure 3.6.10c), 3 minutes was chosen as the optimal time for UV
exposure.
Figure 3.6.11: ATP-Lite cell viability assay results of 1x106 C6 cells/mL in 10% (w/v)
PEGDA Mn4000, 0.05% Irgacure 2959, 20mg·mL 1 175g Bloom gelatin (82% function-
alisation), polymerised for 0 minutes, 1 minute, 2 minutes, 5 minutes, 15 minutes and 30
minutes of trans UV light at 365nm. n=6, error bars indicate 95% confidence interval,
There were no statistical diﬀerences between 1 and 2 minutes or 5, 15 and 30 minutes,
however there was a significant diﬀerence between < 2 minutes and > 5 minutes, deter-
mined by one way ANOVA with Fisher LSD post-hoc comparison.
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3.6.4.4 Binding gelatin to the linker molecules Ac-PEG-NHS
The following section will outline the turquoise portion of the optimisation process dia-
gram (Figure 3.6.12), which will describe how the binding of gelatin to the linker molecule
was optimised, through investigations into the ratio of reagents, repeats required and
which protein to use, in order to maximise binding of gelatin with Ac-PEG-NHS.
Figure 3.6.12: Optimisation process for the most eﬃcient binding of gelatin with Ac-PEG-
NHS macromer.
As previously described the process to make the synthetic-biologic hydrogel involved
two chemical reactions (chemical formulas displayed in Figure 3.5.3, the first chemical
reaction is displayed as equation 3.2 and the second chemical reaction is displayed as
equation 3.3). The first reaction (equation 3.2) was optimised in this section.
(Gelatin) + (Ac  PEG NHS)! (Gelatin  PEG  acrylate) (3.2)
(Gelatin  PEG  acrylate) + (PEGDA)! Hydrogel (3.3)
Prior to functionalising the PEGDA hydrogels with gelatin, the gelatin was PEGylated
with the Ac-PEG-NHS linker. The linker molecule was expensive and so an investiga-
tion was performed to determine the lowest concentration of linker required to achieve a
minimum of 80% PEGylation. The percentage functionalisaion of gelatin was deduced
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by carrying out a TNBS assay as detailed in section 3.5.6. The higher the molar ra-
tio of Ac-PEG-NHS to gelatin, the higher the percent functionalisation of gelatin with
Ac-PEG-NHS (Table 3.4).
Repeated reactions with Ac-PEG-NHS increased the functionalisation yield further,
compared to a higher excess for a reaction performed once. A 3x excess of linker to gelatin,
repeated twice, achieved approximately 82% functionalisation, whereas a 5x excess once
achieved approximately 48% functionalisation.
In order to be cost eﬀective, it was deemed that 82% functionalisation was suﬃciently
high to be reacted with PEGDA to form PEGDA-gelatin functionalised hydrogels. A
single reaction led to a low gelatin PEGylation and a costly reaction with the generation
of a higher proportion of Ac-PEG-OH. The chosen method was to use a 3x molar excess
Ac-PEG-NHS to gelatin, the reaction was then followed by overnight dialysis in 1% (v/v)
DMSO with 3 solution changes, frozen at -20°C for 4 hours, freeze dried for 48 hours and
then the process repeated once more to achieve approximately 82% functionalisation (as
described in section 3.5.8).
Table 3.4: The reaction ratio of linker to gelatin and the yields of gelatin functionalisation.
The optimal functionalisation yield of gelatin (82%) was achieved by two subsequent
reactions of 3x excess linker to gelatin. n=3, ± standard deviations.
Molar Ratio of Ac-PEG-NHS to Gelatin % functionalisation of Gelatin
5:1 48.48% ± 1.933
3:1 37.45% ± 2.519
3:1 (x2 reactions) 82% ± 3.11
1:1 16.51% ± 1.055
1:1 (x2 reactions) 40% ± 2.139
1:5 11.26% ± 0.702
Fourier-transform infrared spectroscopy (FTIR) was performed to confirm that the
gelatin had been successfully functionalised and the dialysis had successfully removed
any unreacted monomers or degradation products (Appendix D section 9.4.2 and Figure
9.4.1).
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3.6.4.5 Optimising cellular attachment
The following section outlines the purple portion of the optimisation process diagram
(Figure 3.6.13), which describes how the attachment of cells to the hydrogel matrix was
optimised.
Figure 3.6.13: Optimising cellular attachment by investigating the eﬀect of mass of gelatin
or gelatin cross-link density in matrices of diﬀerent stiﬀnesses
The optimal gelatin concentration was determined by preparing 5% (w/v) PEGDA
(Mn3500) hydrogels with a range of gelatin concentrations (0, 10, 25, or 50mg·mL 1).
The gels were seeded with 1⇥ 106 C6 cells on top of the gel, after 24 hours the gels were
moved into a 48 well plate. The investigation was carried out in 2D so that analysis
of cellular projections, proliferation and cellular migration would be easier to image and
could be visualised at multiple time points during the 48 hours by brightfield microscopy.
The gels were transferred to diﬀerent (larger) wells to reduce the likelihood of imaging
cells which were attached to the tissue culture plastic. The gels swelled overnight when
placed in media and increased in size, therefore transferring the gels into fresh plates also
prevented gel folding and reduced the number of cells stuck to the tissue culture plastic.
The initial results showed that without gelatin, the C6 cells did not readily attach
to the matrix, as shown by the clumped highly rounded morphology and the absence of
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cellular projection (Figure 3.6.14a indicating high circularity and no arrows). The addi-
tion of 10mg·mL 1 gelatin allowed the formation of some cellular projections (highlighted
by arrows on Figure 3.6.14b) and a slight increase in cell density and cell spreading by
the decrease in circularity of the cell clump outline in Figure 3.6.14b. In the presence of
25mg·mL 1 gelatin most of the cells had established projections (many arrows on Figure
3.6.14c) and the cell clumps began to merge, as cell number increased and cells began
to spread, reducing the circularity of the cell clump outline in Figure 3.6.14c. Above
25mg·mL 1 gelatin up to 50mg·mL 1 gelatin, there was also reduced circularity of the
cell clump outline and prominent projection formation (Figure 3.6.14d). In order to re-
duce costs, a concentration of 25mg·mL 1 gelatin was deemed an adequate concentration
of functionalised gelatin to achieve cell attachment.
(a) 0mg·mL 1 gelatin (b) 10mg·mL 1 gelatin
(c) 25mg·mL 1 gelatin (d) 50mg·mL 1 gelatin
Figure 3.6.14: 5% (w/v) PEGDA (Mn3500) hydrogels with a range of gelatin concentra-
tions (0, 10, 25 or 50mg·mL 1) seeded with 1x106 C6 cells/mL in 2D for 24 hours, imaged
using brightfield microscopy. The general shape of the cell clumps have been outlined in
red, the higher the circularity of the outline, the lower the cell spreading and cell attach-
ment. The red arrows highlight some of the C6 cell projections, n=6, scale bar = 200 µm,
representative images chosen.
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In order to investigate the eﬀects that the stiﬀness of the matrix has on cellular
behaviour, it is important that the gelatin concentration remains the same in each of the
diﬀerent stiﬀness hydrogels. However, when 2.5⇥ 104 primary astrocyte cells were seeded
onto 100 µL gels in a 96 well plate of diﬀerent PEGDA concentrations (5-50% (w/v)) the
cell viability results obtained by ATP-lite cell metabolism assay demonstrated a decrease
in cell viability with the increase in the stiﬀness of the matrix (Figure 3.6.15).
One way Anova (p <0.05) confirmed rejection of the null hypothesis, a significant
diﬀerence was found between the means of all the diﬀerent stiﬀness matrices from 5-20%
(w/v) PEGDA. There was no significant diﬀerence between the means of 20% and 25%
(w/v) PEGDA and 25% and 5% (w/v) PEGDA.
Figure 3.6.15: Cell viability of 2.5⇥ 105 primary astrocytes seeded on top of gels (2D) of
increasing stiﬀness. Gels had an increasing excess of PEGA-PEGA cross-links compared
to PEGA-Gelatin cross-links. ATP-lite cell viability assay results (luminescence) after
24 hours cell culture, primary astrocyte cells (4 litters, 32 gels per stiﬀness). Error bars
indicate 95% confidence interval. Lines indicate significant diﬀerence between matrices
from 5-20% (w/v) PEGDA, determined by one-way ANOVA (p <0.05) Statistical data
with Fisher LSD Post-hoc comparison.
The cell viability decreased with increasing stiﬀness (statistical significance confirmed
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by one-way ANOVA (p <0.05). However, the stiﬀer the matrix, the less gelatin was
bound to the synthetic hydrogels, therefore less cell adhesion molecules available for cell
attachment (Table 3.5).
The mass of gelatin remained constant with increasing stiﬀness matrices, however the
concentration of PEGDA increased. Therefore the proportion of synthetic cross-links to
gelatin cross-links increased with the stiﬀness of the matrix (represented by dark blue
circles Figure 3.6.15). The increased proportion of synthetic cross-links compared to
gelatin cross-links, decreases the number of cell attachment sites available for cellular
adherence.
The higher the PEGDA concentration, the more PEG reacted with PEG and not
gelatin-PEGA, therefore the lower the molar ratio of gelatin-PEGA to PEGDA with
increasing PEGDA concentration.
The amount of gelatin and PEGDA crosslinks were calculated using the equations
listed in Appendix D, equation 9.1, equation 9.2 and equation 9.3. The ratio of PEGDA
to gelatin-PEGA in the reacting mixture was found to be 1:2, therefore 2x the mass of
gelatin was needed compared to the mass of PEGDA in all stiﬀness variants to ensure
equal PEGDA:gelatin-PEGA cross-linking.
The data in Table 3.5 shows the formulations for hydrogels whereby the mass of gelatin
in each hydrogel was equal and the formulations whereby the mass of gelatin changed in
each hydrogel, so that the ratio of PEGDA:gelatin-PEGA was equal. However, where the
mass of gelatin in each hydrogel is equal, the excess of PEGA-PEGA crosslinks increased
from 4.17⇥ excess for the softest (5% (w/v) PEGDA) hydrogels to 12.5⇥ excess for the
stiﬀest (15% (w/v) PEGDA) hydrogels. Table 3.5 indicated that to sustain an equal
amount of cross-linked gelatin, the mass of gelatin had to increase from 105 mg for the
softest (5% (w/v) PEGDA) hydrogels to 315 mg for the stiﬀest (15% (w/v) PEGDA)
hydrogels.
In order to investigate whether the decreasing cell viability of astrocytes cultured on
matrices of increasing stiﬀnesses (Figure 3.6.15) were as a result of the excess PEGA-
PEGA crosslinks to gelatin-PEGA cross-links or were as a result of the stiﬀness of the
matrix. The experiment was repeated with the formulations displayed in Table 3.5. The
gelatin-PEGA cross-links in each stiﬀness hydrogel were formulated to be equal to the
PEGA-PEGA cross-links. The results with equal PEGA-gelatin cross-links in all stiﬀness
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PEGDA %
(w/v)
5% 7.5% 10% 12.5% 15%
PEGDA/mL 50mg 75mg 100mg 125mg 150mg
Acrylates (M) 2.5⇥ 10 5 3.75⇥ 10 5 5⇥ 10 5 6.25⇥ 10 5 7.5⇥ 10 5
Gelatin/mL 105mg 156.5mg 210mg 261mg 315mg
Lysines (M) 2.52⇥ 10 5 3.76⇥ 10 5 5.04⇥ 10 5 6.26⇥ 10 5 7.56⇥ 10 5
Ratio Ac-Ac
to Ac-Gelatin
1:1 1:1 1:1 1:1 1:1
Gelatin/mL 25mg 25mg 25mg 25mg 25mg
Lysines (M) 6⇥ 10 6 6⇥ 10 6 6⇥ 10 6 6⇥ 10 6 6⇥ 10 6
Excess Ac-Ac
to Ac-Gelatin
4.17 6.25 8.33 10.42 12.5
Table 3.5: The cross-linking information of finalised biosynthetic hydrogel formulations
with equal mass of gelatin in each hydrogel and equal PEGA-gelatin crosslinks in each
hydrogel.
variants (Figure 3.6.16) showed increased cell viability in all hydrogel stiﬀness variants
(except the lowest 5% (w/v) PEGDA hydrogels) compared to the hydrogels with equal
mass of gelatin (but an increased excess of PEGA-PEGA cross-links). Statistical analy-
sis of One-way ANOVA (p <0.05) with Tukey’s HSD Post-hoc comparison showed that
astrocyte cell viability was found to be significantly higher on the 10% (w/v) PEGDA
hydrogels than the 5%, 15%, 20% or 25% (w/v) PEGDA hydrogels. The 10% (w/v)
PEGDA hydrogel had a matrix stiﬀness of approximately 650-750 Pa.
No significant diﬀerence was observed in cell viability between the stiﬀer hydrogel
variants (15%, 20% and 25% (w/v) PEGDA) with equal PEGA-Gelatin cross-links, which
suggests that the stiﬀness of the matrix did not have an eﬀect on cell viability above
approximately 750 Pa. There was no significant diﬀerence observed in the lowest stiﬀness
hydrogel (5% (w/v) PEGDA) with equal mass of gelatin or equal PEGA-gelatin cross-links
(one-way ANOVA (p <0.05) with Tukey’s HSD Post-hoc comparison).
This data indicated that it was important to keep the amount of cross-linked gelatin
constant in the gels of diﬀerent stiﬀnesses and that by keeping the mass the same in each
stiﬀness variant, this had a significant impact on the results.
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Figure 3.6.16: Cell viability of 2.5 ⇥ 105 primary astrocytes seeded on top of gels of
increasing stiﬀness. The gels had an increasing excess of PEGA-PEGA to PEGA-Gelatin
cross-links (Figure 3.6.15) or an equal amount of PEGA-PEGA to PEGA-Gelatin cross-
links. ATP-lite cell viability assay data after 24 hours cell culture, primary astrocyte cells
from 2 litters (16 gels per condition). Error bars indicate 95% confidence interval, lines
indicate statistical diﬀerence determined by one way ANOVA (p <0.05) with Tukey’s
HSD post hoc comparison.
3.6.4.6 Characterising the stiﬀness of the hydrogel matrices
The following section will outline the green portion of the optimisation process diagram
(Figure 3.6.17), which will describe how the mechanical properties of the hydrogel matrix
were changed and what mechanism to change the stiﬀness of the matrix was chosen.
There were two main mechanisms employed to change the mechanical properties of
the matrix, the first was to change the length of the PEGDA polymer chain, and the
second to change the concentration of PEGDA in each gel. The third mechanism to
change the stiﬀness of the matrix was by changing the Bloom of gelatin, this was detailed
in an earlier section (Figure 3.6.2b) for the gelatin hydrogel with synthetic cross-links.
However, changing the Bloom of gelatin was not investigated for the synthetic-biologic
hydrogel as it was not cost eﬀective to functionalise three diﬀerent Blooms of gelatin.
The length of PEGDA polymer chains were investigated from PEGDA Mn250-8000
Figure 3.6.17: Diagram to illustrate changing the stiﬀness of the hydrogel stage of the
optimisation process.
Pa and the most appropriate samples (cost eﬀectiveness, large sample sizes, shorter de-
livery times and matrix stiﬀness) were: PEGDA Mn700Da, Mn4,000Da, Mn6,000Da and
Mn8,000. Other PEGDA chain lengths such as Mn250 and Mn540 produced hydrogels
which were too stiﬀ to measure using rheology, PEGDA Mn1000 and Mn2000 were insol-
uble in the photoinitiator solution and PEGDA Mn3,500 was not cost eﬀective long term
and there were problems with the supplier which caused many delays in production.
It was found that by changing the concentration of the lowest molecular weight
PEGDA (Mn700) by 1% (w/v) increments, a wide range of matrix stiﬀnesses could be
achieved, as shown in Figure 3.6.18. PEGDA Mn700 hydrogels were highly reproducible
eliciting small standard deviations from the mean of 5 samples and a wide range of stiﬀness
measurements from 20-4,000 Pa (4-10% (w/v) PEGDA (Mn700)).
PEGDA Mn4000 generally showed a lower stiﬀness at the same PEGDA concentration
compared to PEGDA Mn700 (Figure 3.6.19) with a range of 20 Pa-2,500 Pa with a
polymer concentration range from 5-15% (w/v). However, PEGDA Mn700 was found to
be toxic to cells (Figure 3.6.4b)and therefore would not be appropriate for use in this
cellular model.
The PEGDA Mn6000 hydrogels followed a similar trend to the PEGDA Mn4,000
hydrogels compared to the PEGDA Mn700 hydrogels. PEGDA Mn6,000 were softer than
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Figure 3.6.18: The viscoelastic properties of PEGDA Mn700 hydrogels with a range of
polymer concentrations from 4-10% (w/v) PEGDA, statistically diﬀerent confirmed by
one way ANOVA with Tukey HSD post hoc comparison. Error bars indicate standard
deviation, n = 5.
Figure 3.6.19: The viscoelastic properties (G*) of 5, 10 and 15% (w/v) PEGDA Mn4000
with 25mg·mL 1 gelatin hydrogels, statistically diﬀerent confirmed by one way ANOVA
with Tukey HSD post hoc comparison. Error bars indicate standard deviation, n = 5.
the PEGDA Mn4,000 hydrogels, the 5% (w/v) (PEGDA Mn6000) hydrogel was too soft
to handle. The lowest concentration used was 10% PEGDA Mn6000, therefore the range
of achievable stiﬀnesses was approximately 450-2100 Pa (Figure 3.6.20) using a polymer
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concentration from 10-25% (w/v).
Figure 3.6.20: The viscoelastic properties (G*) of 10, 15, 20 and 25% (w/v) PEGDA
Mn6000 with 25mg·mL 1 gelatin hydrogels. The higher the PEGDA concentration, the
higher the variability between samples however, all hydrogels statistically diﬀerent con-
firmed by one way ANOVA with Tukey HSD post hoc comparison. Error bars indicate
standard deviation, n = 5.
The largest polymer chain tested was PEGDA Mn8,000 (Figure 3.6.21). This hydrogel
system had large overlaps in the standard deviations between gel samples and the range
of hydrogel stiﬀnesses that was achieved was lower, approximately 100-1500 Pa for 5-15%
(w/v) PEGDA Mn8,000 hydrogels.
As PEGDA Mn4,000 hydrogels had the most repeatable matrix stiﬀnesses, largest
range of stiﬀnesses with the lower polymer concentrations, PEGDA Mn4,000 was the cho-
sen polymer chain length for further development and optimisation of this model. All the
PEGDA functionalised hydrogels of diﬀerent molecules weights and PEGDA concentra-
tion were clear and did not produce bubbles in the hydrogel matrix.
3.6.4.7 Comparing cell viability in 3D cell seeded biosynthetic hydrogels us-
ing 2 UV polymerisation systems
Once all the potential developments had been made to the biosynthetic matrix, the cell
viability of 3D cell-seeded C6 astrocytes was tested in the finalised formulations. The
formulations tested were the photoinitiator Irgacure 2959 which was active at 365nm and
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Figure 3.6.21: The viscoelastic properties (G*) of 5, 10 and 15% (w/v) PEGDA Mn8000
with 25mg·mL 1 gelatin hydrogels. The higher the molecular weight of PEGDA and
PEGDA concentration, the higher the variation in stiﬀness between samples. However,
all hydrogels statistically diﬀerent confirmed by one way ANOVA with Tukey HSD post
hoc comparison. Error bars indicate standard deviation, n = 5.
the photoinitiator LAP which was active at 405nm. The NMR data in Figure 3.6.10d
suggested that between 2 and 5 minutes, the cross-links had fully formed in the Irgacure
2959 hydrogel, therefore 3 minutes was chosen as the polymerisation period, whereas LAP
required 5 minutes to form a fully cross-linked gel. Two diﬀerent concentrations of gelatin
were investigated to see if the low cell viabilities in 3D cell seeded gels were due to the
polymerisation process or the lack of cellular adhesion sites. The formulations giving
excess and equal cross-linking between PEGA-gelatin and PEGA-PEGA are shown in
Table 3.5. The ATP-lite cell viability data after 24 hours cell culture in 5% CO2 in air at
37°C of PEGDA Mn4,000 hydrogels is displayed in Figure 3.6.22 and has been compared
against the collagen control 3D cell-seeded hydrogel which exhibited good cell viability.
The results (Figure 3.6.22) indicated that C6 cells cultured in all fully optimised
synthetic-biologic hydrogel variants had low cell viability. The luminescence emitted
from the ATP-Lite cell viability assay was approximately twelve times lower from the
synthetic-biologic hydrogels, than the luminescence emitted from the C6 cells cultured
in the 3D collagen hydrogel control, therefore the synthetic-biologic hydrogels were not
compatible with 3D cell seeding,
127
Figure 3.6.22: ATP-lite results after 24 hours of cell culture of 3D cell seeded PEGDA
Mn4000 biosynthetic hydrogels seeded with 5 ⇥ 104 C6 cells per gel with diﬀerent pho-
toinitiators, UV wavelengths and either an equal proportion of gelatin-PEGA crosslinks
(cell adhesion motifs) or excess of PEGA-PEGA (synthetic) cross-links (lower proportion
of cell adhesion motifs). Error bars indicate 95% confidence intervals, n=5.
3.7 Discussion
3.7.1 Assessment of commercially available hydrogel options
The aim of this part of the study was to develop a suitable hydrogel matrix for a spinal
cord injury model. The target criteria was a hydrogel which supported neural cell viability
and attachment, was capable of achieving at least three diﬀerent matrix stiﬀness varia-
tions, allowed 3D cell seeding and allowed cells to be visualised throughout the matrix
using microscopy, whilst also being an aﬀordable system. A web-search was performed
to investigate commercially available hydrogel options and five suppliers agreed to send
samples, three were self-assembling peptide gels and two were biosynthetic hydrogels. The
first hydrogel was acquired from BiogelXTM. It is claimed that the company makes tun-
able peptide hydrogels for a range of cell culture applications, which are three dimensional
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and 99% water with the same nanoscale matrix structure as human tissue (Williams et al.,
2015). However, when made as per the manufacturers instructions, it was diﬃcult to mix
cells within the viscous peptide matrix without introducing bubbles and cell clumping.
The resultant gels were diﬃcult to image and the rheology data was highly variable with
very little diﬀerence in stiﬀness between gels (approximately 10 BiogelXTMPa). The unre-
liable rheology data was likely due to the presence of large bubbles in the matrix, causing
the equipment to measure the stiﬀness of the gel matrix with the presence of air trapped
within the matrix. These hydrogels did not fulfil the requirements in the target criteria
for this model.
The peptide hydrogels made by PepgelTM in 2014 were also self-assembling peptide
nanofiber hydrogel scaﬀolds. There were two diﬀerent hydrogels supplied by this company,
PRR4 (which contained RGD cell adhesion motifs) and PGR2t, which lacked the RGD cell
adhesion peptide. The PRR4 peptide hydrogel supported good viability of C6 astrocytes
and was compatible with 3D cell seeding. The PGR2t peptide hydrogel did not allow for
cell attachment in the absence of the RGD cell adhesion peptide, therefore it was deemed
unsuitable for this model system. The PRR4 hydrogel was appropriate for the model,
however the existing collagen hydrogel showed greater cell viability for a lower cost. The
PRR4 hydrogel cost approximately £56.4/ mL for the softest hydrogel variant, therefore
to produce a stiﬀ hydrogel, the concentration of peptide would need to be higher and the
cost per mL of hydrogel would be beyond the budget for the project as outlined in the
target criteria. The PepgelTM hydrogels in 2014 have been developed and are now called
’PGmatrix’ which have been recently used to control the release of bovine serum albumin
linked drugs through the peptide matrix in animal models (Liang et al., 2017).
Tebu-BioTM and ESI-BioTM merged and ExtracelTM was replaced by HyStem-CTM.
Unfortunately the 2014 Extracel hydrogel failed to form the soft hydrogel variant and
did not support viable cells in the mid-stiﬀness variant due to a long incubation period
in the absence of media. However, the HyStem matrix available through SigmaTM in
2015 was successfully used in a 3D printed acid patch to reduce adverse remodelling
and preserve cardiac function after myocardial infarction in vivo in mice (Gaetani et al.,
2015). This suggests that this matrix may be better suited for in vivo applications as
opposed to an in vitro 3D model or further developments were made to Hystem-C, as the
Extracel hydrogel kit did not fulfil the target criteria for supporting neural cell viability
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and producing matrices of three diﬀerent stiﬀnesses, and was therefore was excluded from
this model.
3.7.2 Assessment of photo-active collagen hydrogel
The target criteria for this model were not satisfied by the commercial hydrogels and
therefore the aim was to develop a hydrogel system which was suitable for a 3D SCI
model. Drawing on the expertise of the supervision team the protocol described in Tronci
et al. (2013) was followed to make photo-active collagen hydrogels, which have recently
been characterised (Tronci et al., 2015) and are yet to be used in research models or
in vivo applications. The hydrogels produced were able to achieve varying stiﬀnesses,
however, the method was not compatible with 3D cell seeding, as the collagen was mixed
with the photoinitiator at 60 °C before exposure to UV light at 346nm for 30 minutes and
overnight swelling in water to remove unreacted compounds. The mechanism to change
the stiﬀness of the matrix resulted in changing the collagen density.
Studies have claimed that collagen density could influence neurite length, Willits and
Skornia (2004) demonstrated that maximum neurite length was seen in lower collagen
concentration gels. In a study by Cullen et al. (2007), a type IV collagen conjugated to
an agarose gel system was used so that the stiﬀness of the matrix could be controlled
by the agarose concentration, however increasing the collagen concentration from 300-
600 µg·µL 1 significantly decreased neurite outgrowth of primary rat cortical neurons,
whilst leaving neuronal survival unaﬀected (Cullen et al., 2007). In contrast to this
evidence a collagen gel system with gradients of mechanical properties (0.064 ± 0.005
Pa/mm across the 5-mm long channel, approximately 0-400 Pa stiﬀness range), was used
by Sundararaghavan et al. (2009) to show that there were no changes in cell adhesion,
collagen fiber size or collagen density following cross-linking with Genipin (cross-linking
agent), however neurite outgrowth from chick dorsal root ganglia explants were signifi-
cantly longer down the gradient of stiﬀness than up the gradient. This suggested that the
mechanical properties of the matrix influenced the neurite outgrowth and not the collagen
density.
Although this collagen gel formulation did result in hydrogels of diﬀerent stiﬀnesses
by altering the collagen density, this was also believed to result in changes to cellular
phenotype (Willits and Skornia, 2004) and therefore could not be used to state how matrix
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stiﬀness aﬀects cellular phenotypes. The method is not compatible with 3D cell seeding
due to the use of toxic cross-linking agents, precipitation and dehydration in ethanol,
overnight washing in distilled water and incubation in a vacuum desiccator. There are
diﬀerences between cellular behaviour and morphology when cells are cultured in 2D as
opposed to 3D and therefore a 3D cell seeded system would have been preferential as
monolayer cultures are not representative of the cellular environment found in organisms
(Pampaloni et al., 2007).
3.7.3 Assessment of gelatin-PEG hydrogel
Collagen density and the stiﬀness of the matrix remained a controversial topic in the
literature and therefore the decision was taken to develop a biosynthetic hydrogel system,
whereby the stiﬀness of the matrix could be controlled by cross-linking. The recently
published literature (Pierce et al. 2012; Tronci et al. 2010), was consulted and a gelatin
hydrogel with synthetic (PEG) cross-links was developed. The mechanical properties of
the matrix were highly tunable by changing the mass of cross-linker, the Bloom of gelatin
or the concentration of PEG. The mechanism for changing the stiﬀness of the matrix by
changing the cross-linker concentration resulted in a diﬀerence of 80-85 Pa stiﬀness for
the same % (w/v) PEGDA concentration. Changing the stiﬀness by changing the cross-
linker concentration resulted in lower variability between samples. However, changing
the matrix stiﬀness by altering the Bloom of gelatin resulted in large standard deviations
from the mean. It is believed that this natural variability is due to the range of potential
molecular masses of the gelatin molecules from 20-100,000 kDa, a high Bloom gelatin
molecule can vary from 50,000-100,000 kDa (Sigma Product Information). The stiﬀness
of the matrix was also modified by changing the PEGDA concentration, however when the
cross-linker concentration was not increased with the increase in polymer concentration,
this gave high variability of stiﬀnesses between the samples, as the cross-linking density
may have varied between gels of diﬀerent stiﬀnesses.
Unfortunately bubbles formed during the polymerisation process, which caused a large
degree of variation in the matrix stiﬀness, giving large standard deviations in the rheology
measurements. It is believed that the bubbles were caused by the cross-linking reaction
and the low glass-transition temperature, trapping gasses in the matrix as the gelatin
solidifies. Attempts were made to combat bubble formation by cross-linking under vac-
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uum and varying cross-linker concentration (0.075-0.45g) and temperatures (4 °C, room
temperature, 37 °C and 50 °C), however the formation of bubbles could not be stopped.
The cross-linking reaction would be toxic in the presence of the cross-linkers and at 50
°C, which suggested that this method was not suitable for 3D cell seeding. The bubble
formation would have made cellular imaging diﬃcult in both 2D and 3D, therefore this
hydrogel system was not taken forward for use in the model system.
3.7.4 Development of a synthetic-biologic hybrid hydrogel system
A synthetic-biologic hydrogel system was the system of choice for further development,
as synthetic hydrogels have highly tunable matrices, easily cross-linked and synthetic
materials are readily available at low cost with low variability between samples, there-
fore a web based search was performed to determine options. The paper by Choi et al.
(2008) described the preparation of a PEG hydrogel with diﬀerent network structures and
claimed to use photo-polymerisation for PEGDA to yield cross-linked hydrogels within
five seconds of UV exposure. The reagents were inexpensive, however the matrix lacked
cell adhesion sites and therefore cell attachment was not supported. Cells use integrins to
interact with the extracellular matrix (Hynes, 1992), which can be controlled by incorpo-
rating a variety of signals such as cell-adhesion peptides into the synthetic ECM (Hubbell,
1995). Francisco et al. (2013) and Francisco et al. (2014) used a similar system to Choi
et al. (2008), however the hydrogel was functionalised with laminin for applications in the
nucleus pulposus and intervertebral disc regeneration. The aim of this part of the study
was to optimise the reagents to minimise cellular toxicity and functionalise the synthetic
PEG matrix with appropriate ECM components to allow cellular adhesion, whilst also
producing at least three diﬀerent matrix stiﬀnesses.
3.7.4.1 Optimisation of the synthetic-biologic hydrogel by reagent toxicity
testing
As the purpose of the hydrogel matrix was to support neural cells in a spinal cord injury
model, it was necessary to investigate the toxicity of the components of the hydrogel ma-
trix against neural cell lines, e.g. the C6 astrocyte like cell line. The molecular weight
of the PEGDA polymer chain was investigated. It was found that 10% (w/v) PEGDA
Mn 700 was toxic to cells and caused detachment of C6 cells from the tissue culture plas-
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tic. Cellular detachment was reduced with PEGDA Mn 3,500 and PEGDA Mn 6,000
hydrogels. PEGDA Mn700 has been used in antimicrobial films for water purification
(La et al., 2011) and complex wound care (Aphale 2011; Zhou et al. 2011) which sug-
gests specific toxicity towards bacteria. However, when used in a poly(ethylene glycol)
diacrylate-pentaerythritol tetrakis (3-mercaptopropionate) (PEGDA-QT) polymer sys-
tem, the shorter chain PEGDA Mn575 was found to be toxic to cells, but PEGDA Mn700
promoted cell viability (Soodak et al., 2013), however PEGDA Mn 700 was the longest
chain PEGDA in this study and therefore longer chain polymers may have further pro-
moted cell viability.
In a cytotoxicity study by Shin et al. (2003b), it was concluded that PEG-DA of
higher MW (3400) demonstrated significantly higher cell viability of marrow stromal cells
(MSCs) compared to PEGDA with MW 575 at all concentrations tested. It was found
that shorter polymer chain lengths give stronger, stiﬀer gels compared to longer PEGDA
chains (Zellander et al., 2013) and soft matrices which mimic the brain are neurogenic
(Engler et al., 2006), therefore the longer polymer chain PEGDA Mn 3,500 was chosen as
the preferred molecular weight for this model.
The mechanism for polymerisation for the synthetic-biologic hydrogels was by photo
polymerisation, therefore a comparison of diﬀerent UV wavelengths was performed so that
the least cytotoxic wavelengths were used to polymerise the hydrogels. It was found that
the higher the frequency (short wavelength UV), the higher the level of cellular damage
and detachment of C6 cells from the tissue culture plastic. The wavelengths 365nm and
405 nm were found to be the least toxic wavelengths, compared to 265 nm and 309 nm.
This is in agreement with several studies in the literature which have used short wavelength
UV to induce oncogenic transformation in vitro (Chan and Little, 1976). In order to
optimise the polymerisation process, it was necessary to optimise the photoinitiator and
concentration used in the polymerisation reaction. The initial photoinitiator DMPA in
1-vinyl-2-pyrrolidinone (1VP) was used by Choi et al. (2008), however the results showed
poor cytocompatibility and a large proportion of cellular detachment from the tissue
culture plastic. Poly(1-vinyl-2-pyrrolidinone) has been used to make hydrogels which
have been cultured with fibroblasts. These hydrogels were not found to be cytotoxic but
showed to be cytostatic (Lopes and Felisberti, 2003). In an attempt to improve the cell
viability of C6 cells cultured in the presence of the photoinitiator (DMPA), the use of
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the solvent DMSO allowed the solvent concentration to be reduced by 50% (0.5% (v/v)
to 0.25% (v/v)). DMSO is cytotoxic, however DMSO is widely used in cell culture as
a freezing medium additive (10% v/v), therefore at 0.25% (v/v) DMSO (final hydrogel
solution) DMSO was investigated as the solvent which the relatively insoluble DMPA
would dissolve in and would be less cytotoxic than 1VP. The reduced solvent concentration
improved C6 cell viability, however the cell viability was reduced compared to the PBS
control.
The most commonly used photoinitiator in the literature, which claimed to be bio-
compatible, highly water soluble and used in similar PEGDA hydrogel systems (Francisco
et al., 2013), was Irgacure 2959®(I2959), (Ciba Speciality Chemicals, Tarry town, NY).
Irgacure 2959 was not cytocompatible at 1% (w/v) in PBS, but the viability of C6 cells
improved when the photoinitiator concentration was reduced to 0.05% I2959. The highest
cell viability was observed at 0.05% I2959. However, the absorption spectrum of I2959 is
poorly matched with benign wavelengths of light, in contrast to the acylphosphine oxide
photoinitiators (such as lithium acylphosphinate salt (LAP)), which claimed to exceed
95% survival rate of human neonatal fibroblasts encapsulated in hydrogels polymerised
with LAP (Fairbanks et al., 2009). It was found that when LAP exposed to 405 nm light
for 5 minutes showed increased viability of C6 cells, compared to C6 cells cultured with
I2959 at 365 nm for three minutes. However the cell viability of C6 cells in this study was
much lower than the 95% survival rate of fibroblasts claimed in Fairbanks et al. (2009).
This may be due to the reaction conditions in 2D on tissue culture plastic as opposed
to the cells being encapsulated within a hydrogel system. The next step in the devel-
opment process was to determine the shortest length of time necessary to expose cells
encapsulated within the hydrogel matrix to UV light, whilst ensuring full cross-linking
is achieved. Unfortunately the photoinitiator LAP was investigated late in the develop-
ment process, therefore Irgacure 2959 was used to polymerise samples for diﬀerent lengths
of UV exposure periods. The samples were analysed by the EPSRC funded solid state
NMR facility at Durham University. The samples were analysed for the presence of a
C=C double bond which would indicate whether the polymer chain was saturated (fully
cross-linked) or unsaturated (partially cross-linked). The peak responsible for the C=C
bond was reduced but present at 2 minutes and was reduced to noise at 5 minutes UV
exposure. Therefore it was postulated that the gels became fully cross-linked between 2
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and 5 minutes UV (365 nm) exposure. The cell viability data of C6 cells was reduced
between 2 and 5 minutes, therefore 3 minutes was chosen as the optimised UV exposure
period for hydrogel polymerisation.
3.7.4.2 Optimisation of the synthetic-biologic hydrogel by binding gelatin to
the synthetic linker molecule
The method described in Francisco et al. (2013) to produce a PEG-laminin conjugate was
adapted for use with gelatin. However, it was not possible to formulate the acrylate-PEG-
N-hydroxysuccinimide linker molecule in house due to equipment, knowledge and time
restrictions, therefore acrylate-PEG-N-hydroxysuccinimide was purchased from Creative
PEGworks, Winston Salem. The linker molecules were expensive and could not be used in
the amounts of excess suggested in the study (10:1, 25:1, 100:1 or 500:1 M ratio of Ac-PEG-
NHS to protein) (Francisco et al., 2013) to achieve 100% functionalisation. The TNBS
assay was used to analyse the degree of functionalisation by calculating the free amino
groups in each conjugate, compared to the unmodified protein. Gelatin was commonly
used in cell-laden hydrogels as it was inexpensive, denatured collagen derived from a
variety of sources and retained cell binding motifs such as RGD (Nichol et al., 2010).
Gelatin has had many uses in tissue engineering applications, when cross-linked with
PEGDA it provided a water-swellable and biodegradable system, which has potential uses
as a therapeutic delivery matrix (Fu and Kao, 2009), a carrier for the controlled release of
growth factors (Yamamoto et al., 2001) and can be easily linked to synthetic or biological
molecules to form hydrogel films for in vitro cell growth (Shu et al., 2003). Gelatin was
chosen as the molecular mass (20kDa (low Bloom) - 100kDa (high Bloom)) is smaller
than collagen (130-235 kDa) , fibronectin (220 kDa) and laminin (200-400 kDa), therefore
achieving a high degree of functionalisation with a lower mass of linker molecule could
be achieved. Laminin and fibronectin were investigated for use in this model however a
low level of functionalisation was achieved (1-2%), therefore laminin and fibronectin were
not cost-eﬀective alternatives to gelatin. It was found that 2 reactions with a lower (3x)
excess of linker molecule was more eﬃcient (82% functionalised) than one reaction with a
higher excess (5x excess achieved 48.48% functionalisation) due to the production of the
degradation product AC-PEG-OH in the presence of water, which cannot bind gelatin.
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3.7.4.3 Optimisation of the synthetic-biologic hydrogel by enhancing cellular
attachment
With respect to investigating the role that the stiﬀness of the matrix plays on the be-
haviour of neural cell types, it was the aim to keep the protein concentration constant
between hydrogels of diﬀerent stiﬀnesses. Therefore a range of protein concentrations were
tested with the 5% PEGDA hydrogel with conjugated gelatin. The greatest degree of cell
attachment was seen with 25 and 50mg·mL 1 functionalised gelatin, as the cells adhered
to the 2D biosynthetic hydrogel surface and showed a high number of projections com-
pared to the cells cultured on matrices containing 0-10mg·mL 1 functionalised gelatin.
However, when primary astrocyte cells were cultured on matrices of diﬀerent stiﬀnesses
and the mass of functionalised gelatin remained constant, the cell viability decreased with
increasing matrix stiﬀness. It became clear that as the stiﬀness of the matrix increased,
the probability of forming interpenetrating networks of PEG and PEG-gelatin increased.
Therefore the number of cell adhesion sites would decrease as the higher PEGDA content,
resulted in hydrogels with greater swelling.
Cell viability increased significantly in all stiﬀness variants (except 5% (w/v) PEGDA)
when an equimolar concentration between the PEG crosslinking and the functionalised
gelatin crosslinking, compared to the cell viability of C6 cells cultured on matrices where
the gelatin concentration remained constant, but the concentration of PEGDA was in-
creased. Interestingly, both experiments regardless of cross-linking density of gelatin,
showed a preference for the 10% PEGDA hydrogel matrix which is approximately 600-
800 Pa, compared to the 5% PEGDA matrix, which is approximately 20-50 Pa and the
15% PEGDA matrix, which is approximately 3.9kPa.
The reported stiﬀness of the adult rat brain varies according to method and sources,
but is reported to be approximately 330±100 Pa measured on a strain-controlled rheomet-
rics fluids spectrometer III (Georges et al., 2006) and neural tissue is generally reported
to have a modulus between 100-1000 Pa depending on the source of the tissue, time post-
extraction and method of testing (Engler et al., 2006); (Lu et al. 2006; Cheng et al. 2008).
There were no significant diﬀerences between the viability of primary astrocyte cells on
the stiﬀer hydrogels (15, 20 and 25% PEGDA (w/v)) suggesting that the stiﬀness of the
matrix does not have a significant eﬀect on astrocyte cell viability beyond the physiological
range of neural tissues when the cross-linking density remains constant between gels of dif-
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ferent stiﬀnesses. However, in this study there was a significant diﬀerence in cell viability
reported between the lower stiﬀness variants (5, 10 and 15% (w/v) PEGDA), which sug-
gested that astrocyte cells are more sensitive to changes in mechanical properties within
the range of 20 Pa to 3.9 kPa. The highest astrocyte cell viability was reported on the
10% (w/v) PEGDA hydrogel matrix (approximately 700 Pa) which the cell viability was
significantly higher than all other stiﬀness hydrogels (as confirmed by one way ANOVA
with Tukey’s HSD post-hoc comparison). The increased cell viability on the matrix with
a complex shear modulus of 700 Pa may have been as a result of astrocytes probing the
matrix and receiving cues from the elasticity of the matrix (Buxboim et al., 2010), which
may not have been produced on softer or stiﬀer matrices. These cues from the astrocyte
cells in response to probing the elasticity of the matrix, could have caused the cells to
proliferate or produce proteins, which may have caused the increased cell metabolism.
The increased astrocyte cell viability results on the 700 Pa (10% (w/v) PEGDA) matrix
could also have been due to experimental cell seeding error, as there were diﬃculties in
seeding cells on top of hydrogels, without the cells flowing oﬀ the surface of the hydrogel
prior to cell attachment.
3.7.4.4 Optimisation of the synthetic-biologic hydrogel by changing the stiﬀ-
ness of the hydrogel matrix
There were three mechanisms to change the stiﬀness of the matrix, by changing the
molecular weight of the PEGDA, the concentration of PEGDA (w/v) and by changing the
Bloom of gelatin. The higher the Bloom of gelatin, the lower the extraction temperature,
which gives a stiﬀer material, reduced degree of swelling and produces a material with a
higher Young’s modulus. (Bigi et al., 2004). The Bloom of gelatin was not the preferred
mechanism for the synthetic-biologic hybrid hydrogel as the Ac-PEG-NHS linker molecule
was expensive and it was not cost-eﬀective to functionalise three Blooms of gelatin.
The second mechanism to change the stiﬀness of the matrix by increasing the con-
centration of PEGDA, was the preferred mechanism, as the stiﬀness for each PEGDA
% (w/v) of the matrix was reproducible with small standard deviations from the mean
and large range of potential stiﬀnesses (20 Pa-3.9 kPa 5-15% (w/v) PEGDA Mn4000
equal proportion of cross-linked gelatin). However, the longer the polymer chain i.e. the
higher the molecular number, the higher the degree of swelling and the larger the standard
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deviations from the mean of each PEGDA % (w/v).
The third mechanism to change the stiﬀness of the matrix was to change the length of
the polymer chain. The shorter the polymer chain, the higher the density of cross-links,
the higher the modulus, the lower the mesh size and the lower the swelling (Temenoﬀ
et al., 2002). A similar eﬀect can be seen in lipid bilayers, the longer the chain length of
lipid bilayers, the lower the Young’s moduli (Rawicz et al., 2000). Due to the increasing
variability between samples and increasing swelling ratio with the longer polymer chains,
and lower cytocompatibility with the lower PEGDA Mn700, the chosen molecular number
for this model was PEGDA Mn4,000. The chosen mechanism to change the stiﬀness of
the matrix was to change the polymer % (w/v) from 5-15% (w/v) with the potential
to increase beyond 15% (w/v) if higher stiﬀnesses were required for investigation. This
would result in the lowest variation and highest reproducibility between samples.
This study indicated that despite all the optimisations, the UV polymerised PEG-
gelatin hydrogel did not support survival of cells seeded prior to polymerisation compared
to the collagen gel control. Unfortunately any diﬀerences in cellular behaviour of cells
cultured within this 3D hydrogel system in diﬀerent matrix stiﬀnesses, cannot be decou-
pled from other factors aﬀecting the poor survival of cells in vitro such as cell death and
cytokine release from cells aﬀected by the UV cross-linking process. This hybrid hydrogel
was however compatible with 2D cell seeding on top of the hydrogel matrix.
3.8 Conclusion
The overall aim of this chapter was to explore suitable options for a hydrogel matrix which
will support neural cells and is capable of achieving a range of matrix stiﬀnesses.
Commercially available hydrogel options were explored, however the preliminary re-
search indicated that the commercially available hydrogel matrices available at the time
were either not biocompatible, were not available in a range of stiﬀnesses or were not
viable options due to cost restrictions and poor visibility of cells in the matrix. The most
appropriate option was to develop a low cost, biosynthetic hydrogel with a tunable matrix,
using formulations from relevant publications in the literature.
In summary the photo-active collagen gel was not compatible with 3D cell seeding, it
had a low range of stiﬀnesses and the mechanism to change the mechanical properties of
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the matrix resulted in changes to the collagen density, which could be responsible for any
morphological diﬀerences observed in the cells.
The Gelatin-PEG hydrogel system was capable of achieving a range of diﬀerent Young’s
moduli by altering the gelatin Bloom, the cross-linker concentration and the overall poly-
mer concentration. However, it is believed that the cross-linking reaction would be toxic
in the presence of the cross-linkers which is performed at 50 °C, which suggested that
this method would not be suitable for 3D cell seeding. The Gelatin-PEG hydrogel system
formed large bubbles as a result for the formulation process, and therefore made cellular
imaging diﬃcult in both 2D and 3D, therefore this was not the chosen hydrogel system
for the spinal cord injury model.
The final option was to develop a cost-eﬀective hybrid hydrogel system, which was
biocompatible, could achieve at least 3 diﬀerent matrix stiﬀnesses over a 5kPa range
determined by rheology. The hydrogel was transparent and did not result in bubble for-
mation. This allowed good visibility of cellular morphology through the matrix. Cellular
projections were produced from cells cultured on top of the synthetic-biologic matrix
which suggested that cell attachment to the matrix was achieved. The hydrogel was
cost-eﬀective, however the hydrogel did not support 3D cell seeding prior to hydrogel
polymerisation. The UV radical polymerisation, despite optimisations, was toxic to cells
and therefore the developed hydrogel matrix supports all but one of the target criteria
outlined in the aims and objectives for this chapter.
The fully optimised UV polymerised PEG-gelatin hydrogel had very limited cell via-
bility in 3D when compared to the collagen gel control, however it was the most suitable
option to use for investigating the role the mechanical properties of the matrix play in
astrocyte morphology and reactivity, therefore this hydrogel is only suitable for a 2D in
vitro cell culture model. The collagen control hydrogel was the most appropriate matrix
for a 3D in vitro spinal cord injury model, due to the high cell viability of astrocyte cells
seeded in 3D within the matrix and therefore will be used to investigate how impaction
displacement aﬀects astrogliosis in a spinal cord injury model. However the collagen gel
cannot be used to investigate the eﬀects of stiﬀness of the extracellular matrix, therefore
2 diﬀerent studies need to be performed to investigate the stiﬀness of the matrix and
impaction on astrogliosis.
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Chapter 4
Cellular responses to matrix stiﬀness
4.1 Introduction
Physical forces regulate a diverse range of physiological processes; pressure and shear stress
from the blood influence the morphology and pathology of the heart (Davies, 1995). Bone
is shaped by gravity, mechanical loading and muscle contraction (Weinbaum et al., 1994).
Hearing and touch are governed by neural responses to pressure (Spector et al., 1999).
Matrix stiﬀness is a regulator of cell behaviours including cell spreading, proliferation,
diﬀerentiation and migration for mechanosensory cells (Discher et al., 2005).
It has been found that in SCI, unlike most mammalian scar tissues, CNS tissue becomes
significantly softer after injury, up to 1000 µm away from the lesion. A drop in tissue
elasticity by more than three-fold was observed at 9 days and a two-fold drop in elasticity
was observed at 22 days post-injury (Moeendarbary et al., 2017). Astrocyte cells also
soften in the non-nuclear regions, in naive cultures the elastic modulus was 57.7 ± 5.8
kPa measured by atomic force microscopy (AFM). In injury, the elastic modulus was
measured to be 26.4 ± 4.9 kPa (Miller et al., 2009) or when stimulated with interferon- 
(Lacour et al., 2016). The brain has also been reported to decrease in stiﬀness significantly
from 2.37 kPa to 2.20kPa in neurological diseases such as Alzheimers disease (Murphy
et al., 2011).
The stiﬀness of the matrix has been shown to be a regulator of neuronal cell growth.
Balgude et al. (2001) found that the rate of neurite extension of dorsal root ganglion
(DRG) neurons was inversely proportional to substrate stiﬀness; the softer the matrix,
the higher the rate of elongation. Similarly Gunn et al. (2005) demonstrated that PC12
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neuronal cells cultured on PEG and matrigel-coated polyacrylamide hydrogels presented
greater neurite extensions and branching on softer hydrogels compared to stiﬀ hydrogels.
A significant diﬀerence in neurite extensions was observed between matrices of 200 kPa
and 300 kPa, which is 200-fold stiﬀer than the preferred matrix stiﬀness in Leipzig and
Shoichet (2009) (1 kPa). Leipzig and Shoichet (2009) investigated neural stem cell (NSPC)
diﬀerentiation and proliferation on a photopolymerizable methacrylamide chitosan (MAC)
biomaterial with a Young’s elastic modulus which could be tuned from less than 1 kPa to
greater than 30 kPa. Neuronal diﬀerentiation was favoured on the softest surfaces with a
Young’s modulus of less than 1 kPa.
Lantoine et al. (2016) discovered that migration of cortical neurons was enhanced on
softer substrates (5 kPa). Softer matrices lead to faster formation of neural networks,
however synaptic density and synaptic currents were enhanced on stiﬀer substrates (500
kPa) (Lantoine et al., 2016). Although both substrates might be considered stiﬀ when
compared to the stiﬀness of native neural tissues, which can vary from 100-1,000 Pa
depending on the source of the tissue, time after dissection and testing methods used
(Engler et al. 2006; Cheng et al. 2008). There is a lack of agreement in the data on the
stiﬀness of the CNS, which may be due to the diﬃculties in preparation and measurement
of the brain and spinal cord (Christ et al., 2010). The data tends to be variable as a
result of the rapid deterioration in the quality of the excised cadaveric samples in which
the tangent modulus of the tissue is seen to increase sharply over a period of 72 hours
(Oakland et al., 2006).
In mixed neuro-glial cultures, where the matrix was of similar compliance to that
of brain tissues (330 Pa ± 100 Pa (Georges et al. 2006; Christ et al. 2010)), neuronal
growth was observed. Whereas astrocytes from dissociated rat cortices plated on poly-
acrylamide gels with matrix stiﬀnesses similar to that of brain tissue, displayed small
round morphologies on soft matrices (300 Pa) and highly spread morphologies typical of
reactive glia on stiﬀ matrices (9 kPa) (Georges et al., 2006). This showed that modulating
the mechanical properties of the matrix had a profound eﬀect on neural cell behaviour
and neuron-astroglial interactions. Therefore it is important to investigate the eﬀects of
matrix stiﬀness not only on neural cells in isolation but also in mixed glial cultures to
investigate how the matrix stiﬀness eﬀects neuro-glial interactions.
Astrocytes undergo a vigorous response to neurologic insults, which occur rapidly and
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can be detected within one hour of mechanical trauma (Mucke et al., 1991). Astrocytes re-
spond to a range of CNS insults such as infection, trauma, ischemia and neurodegenerative
disease by becoming hypertrophic, increasing expression of GFAP and undergoing many
molecular and morphological changes. This process is called reactive astrogliosis, which
eventually leads to the formation of a glial scar that inhibits axon regeneration (Sofroniew,
2009). Astrocytes cultured on soft matrices (200 Pa) displayed smaller, rounded morphol-
ogy typical of quiescent astrocytes, however, astrocytes cultured on stiﬀ (8000 Pa) ma-
trices developed larger, elongated morphologies typical of astrocytes undergoing reactive
astrogliosis (Wilson et al., 2016).
Oligodendrocytes showed optimal growth, proliferation, migration and diﬀerentiation
on matrices with a stiﬀness of approximately 700 Pa (Jagielska et al., 2012). In a study
of neural stem cell diﬀerentiation, similarly it was found that myelin oligodendrocyte gly-
coprotein (MOG) gene expression suggested that oligodendrocyte maturation and myeli-
nation on gels of less than 1kPa stiﬀness was also preferred (Leipzig and Shoichet, 2009).
However, contrary to astrocytes, neurons and oligodendrocytes, there is limited knowledge
of the response of microglia on matrices of diﬀerent stiﬀnesses or the stiﬀness of microglia
in native tissue or injury (Lacour et al., 2016). Moshayedi et al. (2014) found that both
rat astrocytes and microglial cells responded to increasing matrix stiﬀness from 100 Pa to
>10 kPa by changing morphology and upregulating inflammatory genes, however there
was a 100-fold diﬀerence in matrix stiﬀness. It is possible that microglia may be more
sensitive to changes in the mechanical properties of the matrix over more physiologically
representative stiﬀness ranges (294-454 Pa Christ et al. (2010)). Further investigation
into microglial stiﬀness and microglial reaction to diﬀerences in matrix stiﬀnesses may
be of benefit to neural scaﬀold design for tissue engineering applications to reduce the
inflammatory response and encourage axon regeneration after SCI.
The previous chapter detailed the development of a synthetic-biologic hybrid hydro-
gel, whereby the stiﬀness of the matrix could be altered in order to investigate how the
mechanical properties of the matrix aﬀected cellular behaviour in three dimensions. Un-
fortunately the photo-sensitive radical polymerisation of the gel was not compatible with
seeding cells inside the three dimensional matrix. The surface of the synthetic-biologic
hydrogel was used to investigate how the stiﬀness of the matrix aﬀected cellular behaviour
and morphology.
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The chapter will describe the method for analysing the mechanical properties of the
matrix by rheology, the optimisations for two-dimensional cell culture and processing of
adult spinal cord and (post-natal day 2 (P2)) Wistar rat pup brains, in order to use
primary astrocytes, neurons and microglia. The organisation of the chapter is displayed
in a flow chart to aid understanding (Figure 3.1.1).
Figure 4.1.1: Chapter 4 flow diagram
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4.2 Aims
The aim of this chapter was to determine the eﬀects of changing the matrix stiﬀness, on
neural cell responses, in isolation and in mixed glial cultures.
4.2.1 Specific Objectives:
1) To develop an eﬀective cell seeding methodology for achieving high proportional cell
attachment on the surface of the hydrogels compared with the bottom of the cell culture
vessel.
2) To determine the mechanical properties of the matrix of a range of hydrogels by
rheological analysis. This objective includes:
• Determination of the linear viscoelastic region (LVER) for each gel and appropriate
shear strain to use for calculating the complex elastic modulus
• Perform a frequency sweep from 0.5-5Hz at an appropriate shear strain for each of
the diﬀerent matrix compositions
• Calculate the complex elastic modulus (G*) for each gel at 1Hz
3) To assess cell viability of astrocytes, microglia, neurons and mixed glial cells, when
cultured on hydrogel matrices of diﬀerent stiﬀnesses.
4) To assess markers of astrogliosis, such as the average GFAP expression by cells
cultured on the surfaces of hydrogels with diﬀerent matrix stiﬀnesses.
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4.3 Methods
4.3.1 Mechanical Assessment of hydrogel matrices
Hydrogels are complex viscoelastic materials which show both solid and liquid behaviour
under deformation (Larson, 1999). A rheometer was used to determine the measure of
viscosity by application of shear stress to the hydrogels and measurement of shear rate.
All rheological measurements were carried out on a Malvern Kinexus Pro+ rheometer at
37°C, due to physiological relevance (as gels were to be used for cell culture at 37°C).
A 2cm flat parallel plate geometry (Figure 4.3.1) was used, as a geometry with a cone
angle is not suitable for hydrogels or solid materials, where there is a complex internal
structure (e.g. cross-links) (Mezger, 2006). Proprietary software (rSpace) for the Kinexus
1.10 rheometer (Malvern Instruments) was used to control the rheometer and to export
the raw data.
Figure 4.3.1: Parallel plate geometry for use with complex viscoelastic materials. The
gap height (h) was set manually depending on the sample thickness. The radius (r)
represents the sample size, and angle relates to the cone angle which is 0 with a parallel
plate geometry, adapted from Picout and Ross-Murphy (2003).
The plates were cleaned with 70% (v/v) ethanol and blotted to remove excess ethanol
prior to gel loading. Hydrogels were placed on the plate (Figure 4.3.2a), the plate was low-
ered to the manually set gap height (Figure 4.3.2b) using the computer software (rSpace)
to prevent the gap height compressing the hydrogel prior to analysis. Any gels which were
compressed by the plate prior to analysis were discarded. The hydrogels were trimmed to
fill the gap between the parallel plates and any excess material was cleared prior to rheo-
logical analysis (Figure 4.3.2c). A solvent trap was placed over the top of both geometries
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to minimise evaporation from the hydrogel and to stabilise the temperature. Rheological
measurements were taken once the solvent trap was in place and the temperature of the
hydrogel had stabilised at 37°C for a minimum of 2 minutes (Figure 4.3.2d).
(a) (b) (c) (d)
Figure 4.3.2: Loading the hydrogel into the rheometer and preparing the sample for
rheological assessment. a) Large hydrogel loaded onto the plate, b) Parallel plate geometry
lowered and gap height set to 1mm, c) material trimmed to fit the parallel plate geometry,
d) Plate cleared of any material debris that may aﬀect the rheological assessment prior
to placement of solvent trap.
In order to investigate the mechanical properties of the hydrogel matrix by rheology,
it was necessary to determine the Linear Viscoelastic Region (LVER) for each hydrogel
formulation of each stiﬀness. The LVER was defined as the range of shear strain values
whereby rheological testing was non-destructive and the structure of the material would
be restored post rheological analysis (the material was not plastically deformed).
It was important to conduct the measurement of the viscoelastic properties of hydro-
gels using a shear strain value from within the LVER, because the results were based
on the basic laws of rheology of Hooke and Newton (Ewoldt et al., 2015). Hooke’s law
refers to the elastic (storage) element (ideal solid); a perfect elastic body. Whereas, the
Newton model refers to the viscous component (perfect liquid obeying the Newton law).
The Hooke Newton model refers to the force being proportional to the rate of exten-
sion (Mainardi and Spada, 2011). Shear strain applied from outside the LVER will not
obey the basic laws of rheology of Hooke and Newton and would distort the mechanical
properties of the material, thereby aﬀecting the results.
The LVER was investigated by testing the material under increasing strain and con-
146
stant frequency, this was referred to as an amplitude sweep. An amplitude sweep from
0.1-10% shear strain was used to deduce the shear strain % in the linear viscoelastic region
of the sample. The LVER was deduced from the plateau portion of the graph (Figure
4.3.3 blue box) before the material started to deform under high shear strain (Figure
4.3.3 black box), the point at which the G’ (the elastic/storage component) begins to fall,
was known as the limiting value (Mezger, 2006). The shear strain % used to calculate
the viscoelasticity of the material from the frequency sweep could be any shear strain %
within the LVER.
Figure 4.3.3: Example of an amplitude sweep for a hydrogel. The LVER is the linear
region (blue box), after the region of instability at low shear strain % (red box) and
before the sample begins to plastically deform at higher strain % (black box).
Once the amplitude sweep had been used to deduce the correct level of shear strain
in the LVER, the sample was removed and changed for a fresh sample that had not been
plastically deformed, the gap height was set and frequency sweep selected. The frequency
sweep is an oscillatory rheology test which varied the frequency at which the material was
analysed, whilst the amplitude of the shear strain was maintained at 0.5% shear strain.
The storage and loss moduli were plotted against frequency to show how the material
changed in slow or fast oscillations. The viscoelastic modulus of all the materials was
determined in the range of 0.5-5 Hz at 37°C, however the lowest frequency was always
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performed first.
4.3.2 Optimisation of 2D cell seeding method
The synthetic-biologic hybrid hydrogel system detailed in chapter 3 Section 3.5.8, had
some limitations which needed to be overcome before the same density of cells could be
reliably seeded onto the surface of gels with diﬀerent stiﬀnesses, in order to compare the
results quantitatively. The limitations were that the gels swelled by approximately 150%,
there was a low volume of functionalised gelatin to be used and the hydrogels formed a
meniscus if polymerised in an open mould such as a well plate. There were 7 methods
attempted to overcome the challenges.
4.3.2.1 Method 1: Transfer gels from 96 to 48 well plates
A volume of 50 µL of the developed hydrogel solution for the 10% (w/v) PEGDA hydrogel
(detailed in Table 3.1) was pipetted into each well of a 96 well plate and exposed to UV
light at 365nm for 5 minutes at room temperature to polymerise the hydrogels. Once
the hydrogels had polymerised, the gels were washed with 100 µL PBS. The PBS was
removed by aspiration and 100 µL cell culture media was added. The hydrogels were
allowed to swell overnight at 37°C. Post-swelling the hydrogels had increased in volume
and expanded beyond the confinements of the well by folding, therefore they were removed
from the 96 well plate with a small spatula and transferred into a 48 well plate (Figure
4.3.4). The media was removed prior to cell seeding and 5 x 104 primary astrocyte cells
were placed on top of the gel in 50 µL media for a minimum of 2 hours at 37°C, 5% (v/v)
CO2 in air to allow cellular attachment. The well plate was then filled with media. The
hydrogels were incubated at 37°C, 5% (v/v) CO2 in air and the cells were cultured for 24
hours before imaging. The bottom of the well plate was visualised by light microscopy to
identify whether cells were lost from the surface of the hydrogel and these hydrogels were
not used for quantitative assays.
4.3.2.2 Method 2: Large gel method
The large gel method was developed by pipetting 100, 200, 300, 400 and 500 µL hydrogel
solution into each well of a 6 well-plate and using a pair of fine tweezers, an 18mm coverslip
was placed on top of the hydrogel solution. The solution was exposed to UV light at
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Figure 4.3.4: Method 1 - A) The gel transfer method, B) The hydrogels expanded in
the 96 well plate and folded prior to transfer, C) Hydrogel on small spatula to illustrate
the pronounced meniscus formation, D) 48 well plate showing the size of the gel prior to
swelling.
365nm for 5 minutes at room temperature to polymerise the hydrogels. The hydrogels
were washed with 4mL PBS and allowed to swell overnight at 37°C. A small spatula was
used to detach the hydrogel coated coverslip from the tissue culture plastic (Figure 4.3.5).
After this method optimisation had been performed, 100 µL hydrogel solution was used
to form small flat hydrogel discs.
4.3.2.3 Method 3: Parafilm method
A volume of 25 µL hydrogel solution was pipetted onto a Petri dish and small parafilm
covers were cut using scissors, submerged in 70% (v/v) ethanol for 30 minutes for ster-
ilisation and left to air dry in the tissue culture hood. Tweezers were used to lower the
parafilm onto the hydrogel solutions ensuring that the parafilm was as flat as possible
(Figure 4.3.6 A & B). The solution was exposed to UV light at 365nm for 5 minutes at
room temperature to polymerise the hydrogels. The Petri dish was filled with PBS to
swell the hydrogels overnight at room temperature (Figure 4.3.6 C). The PBS was re-
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Figure 4.3.5: Method 2 - The large gel method, A) 100, 200, 300, 400 and 500 µL hydrogel
solution were pipetted into each well of a 6 well-plate and overlaid with an 18mm diameter
round coverslip. B) The 100 µL polymerised hydrogel layered on an 18mm coverslip,
supported by a spatula.
moved with a 1mL gilson pipette. The parafilm was removed using a pair of fine tweezers
and the hydrogels were transferred with a cell scraper and spatula into a 48 well plate
(Figure 4.3.6 D & E).
4.3.2.4 Method 4: Multi-well method
The multi-well method required an eight-well mould with a silicon seal, which was attached
to a glass slide (Figure 4.3.7). Four diﬀerent volumes of hydrogel solution (50, 100, 150
or 200 µL) were used to optimise the concentration. The individual components of the
multi-well slide were sterilised in 70% (v/v) ethanol solution for 30 minutes and air dried
in the tissue culture hood prior to assembly. The hydrogel solutions were added to each
well, the lid was placed onto the slide and it was exposed to UV light at 365nm for 90
seconds to partially polymerise the hydrogels. The silicon mould was removed from the
soft semi-cross-linked hydrogels and a glass rectangular coverslip (18mm x 22mm) was
placed on the hydrogels to provide a flat surface for the fully cross-linked hydrogels to
reduce the eﬀect of the meniscus. Pressure was applied gently so that the top of the gels
were in contact with the coverslip. The slide was then placed in a large Petri dish and
exposed to UV light at 365nm at room temperature for 150 seconds to fully polymerise the
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Figure 4.3.6: Method 3 - The parafilm method. A) Hydrogel solution pipetted onto Petri
dish, B) Parafilm 5mm squares cut and placed on top of gel solution, C) gels allowed to
swell overnight in PBS, D) gels transferred using a cell scraper and small spatula into
48 well plate, E) gels in 48 well plate ready for cell seeding, F) reducing volume of gel
solution from 50 to 25 µL. Scale bar (appropriate for all images) = 1cm.
hydrogels. The Petri dish was washed with 10mL PBS to wash the hydrogels, the PBS
was removed and replaced with 10mL cell culture media. The hydrogels were allowed to
swell overnight in the incubator at 37°C.
4.3.2.5 Method 5: Biopsy punch method
Each well of a 6 well-plate was filled with 2mL hydrogel solution (12 well-plate was filled
with 1mL hydrogel solution) and exposed to UV light at 365nm for 5 minutes at room
temperature to polymerise the hydrogels. The hydrogel was washed with 2mL PBS, which
was aspirated and discarded before 5mL cell culture media was added to each well. The
hydrogel was allowed to swell overnight at 37°C. A sterile 5mm biopsy punch was used to
cut as many 5mm diameter hydrogels as possible from the large hydrogel, the small gels
were placed on a glass slide or 48 well plate using a small spatula and were ready for cell
seeding. The procedure was carried out in a sterile tissue culture hood (Figure 4.3.8).
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Figure 4.3.7: Method 4 - The multi-well method. The eight-well moulds were used to
partially polymerise the hydrogel, the moulds were then removed, replaced with a coverslip
and were fully polymerised. The gels were allowed to swell in PBS overnight prior to cell
seeding.
Figure 4.3.8: Method 5 - A) The biopsy punch method used to make many 5mm diameter
hydrogels from a large hydrogel using a biopsy punch. B) The biopsy punch method used
on a gel in a 12 well plate. C) 5mm biopsy punch cut hydrogel on a spatula with a flat
surface and see through matrix. Scale bar = 1cm.
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4.3.2.6 Method 6: Multi-spot slides method
The hydrogel solution (20, 30, 40 or 50 µL) was pipetted onto each spot of an ethanol
(70% (v/v)) sterilised 8 multi-spot imaging slide (ethanol sterilisation described in section
4.3.2.3). Small circles of parafilm were cut and placed on top of the hydrogel solution prior
to polymerisation with fine tweezers (Figure 4.3.9 A). To simplify the method and reduce
preparation time, a large rectangular film of parafilm was cut and placed on top of the
multi-spot imaging slide (Figure 4.3.9 B). A glass coverslip was covered in parafilm and
placed on top of the solutions (Figure 4.3.9 D&E). Three Layers of parafilm were placed
either side of the multi-spot imaging slide, the parafilm covered coverslip was placed on
top (Figure 4.3.9 G & H). A volume of 20 µL or 40 µL of hydrogel solution was used to
fill the spot (Figure 4.3.9 H).
The slides were placed in sterile Petri dishes with lids (or four-slide imaging tray) and
the hydrogels were exposed to UV light at 365nm at room temperature for 5 minutes
to polymerise the hydrogels. The Petri dish was filled with PBS prior to cell culture to
allow overnight swelling of the hydrogels. The hydrogels were separate, flat and even in
volume once swollen (Figure 4.3.9 I). The PBS was aspirated from the Petri dish, the
hydrogels were then ready for cell seeding. During the cell seeding process, the hydrogels
began to dehydrate and fold if the hydrogels weren’t submerged in media (Figure 4.3.9 C),
therefore cells were added as soon as possible. The slide was visualised by light microscopy
to confirm that the cells were attached to the hydrogel and were not attached to the slide.
If the cells were on the slide, then the hydrogel was not included for quantitative analysis
of cell viability.
4.3.2.7 Method 7: Combined method
A volume of 100 µL hydrogel solution was pipetted into the centre of each well of a 6
well plate and an 18mm diameter glass coverslip was placed onto the solution using fine
tweezers (Figure 4.3.10 A). The solutions were exposed to UV light at 365nm for 5 minutes
at room temperature to polymerise the hydrogels. The wells were filled with 5mL PBS
and the hydrogels were allowed to swell overnight at room temperature (Figure 4.3.10 B).
A 5mm biopsy punch was used to make many hydrogels from the large swollen hydrogels
and each gel was placed on a multi-spot imaging slides (Figure 4.3.10C). A hydrophobic
marker pen was used around each well-spot to maintain the separation between gels. The
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Figure 4.3.9: Method 6 - The multiple optimisation steps of the multi-spot method. A)
parafilm cut-outs were used to make individual circular gels, B) one large strip of parafilm
was used to reduce variability and time, C) gel dehydration disrupting the surface of the
gel, D) coverslip covered in parafilm to decrease variability, E) parafilm covered coverslip
on the gel solution prior to polymerisation, F) gel formation post swelling, G) optimisation
step using 20 µL hydrogel solution, H) optimisation step using 40 µL hydrogel solution, I)
Separate, flat hydrogels.
gels were removed from the multi-spot slide and placed in a 96 well plate for performing
the ATP-lite assay (as per section 2.12.2). Each gel was covered with 50 µL media and
the media was changed every day.
4.3.3 Optimisation of dissection protocols
The method for the dissection of rat cortices and spinal cord tissues from rats are found
in section 2.10.2 and 2.10.3, respectively. The method to process the cells from the tissues
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Figure 4.3.10: Method 7 -The combined method. A) 100 µL hydrogel solution was covered
with a coverslip to produce a flat surface during gel polymerisation, B) the hydrogel
solution was permitted to swell overnight in PBS, C) a biopsy punch was used to produce
many gels of smaller volumes and the gels were seeded with cells and cultured on a multi-
spot imaging slide.
was optimised.
4.3.3.1 Primary mixed glial isolation
The cortices were removed from tissue culture dishes containing HBSS and chopped into
1mm3 cubes using a flat scalpel blade. The tissue was transferred into a (10mL) tissue
culture dish containing 7mL digest solution (section 2.9.4) and incubated for 15 minutes
at 50 rpm, 37°C, 5% (v/v) CO2 in air. The digest solution containing the cortices was
removed and transferred into a 50mL Falcon tube, where 10mL fresh DMEM complete
medium (section 2.9.6) was added. The cell-enzyme solution was centrifuged for 10 min-
utes at 400 g at room temperature. The supernatant was aspirated and discarded. The
pellet was resuspended in 20mL fresh complete DMEM media and aspirated with a 10mL
pipette 10 times to mechanically dissociate the tissue. A 10mL syringe and flat ended
18-gauge needle was used to repeat the mechanical dissociation process by aspirating 3
times. The cell suspension was poured through a 70 µm cell strainer (to remove large
structural debris) into a clean 50mL Falcon tube. The cells were plated onto 75 cm3
Poly-D-lysine pre-treated tissue culture flasks, (approximately 1 brain per flask) in 20mL
fresh complete DMEM (10% serum) medium. The cells were cultured in T-flasks for 10
days at 37°C, 5% (v/v) CO2 in air, however at day 7 half the spent media was aspirated
from the T-flask to remove dead cells, and replaced with 10mL fresh DMEM complete
medium. The cells were cultured for 10 days.
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The primary mixed glial isolation process has been summarised in a flow diagram to
aid understanding of the process (Figure 4.3.11).
Chop cortices into cubes and transfer into 10mL dish
Add 7mL digest solution and incubate for 15
minutes at 50 rpm, 37°C, 5% (v/v) CO2 in air
Transfer into Falcon tube, add 10mL fresh
DMEM and centrifuge for 10 minutes at 400 g
Re-suspend pellet in 20mL fresh DMEM and triturate 10 times with a pipette
Triturate 3 times with a 10mL syringe and flat ended 18-gauge needle
Filter cell suspension through a 70 µm cell strainer
Plate mixed glial cells into a 75 cm3 Poly-D-lysine pre-treated tissue culture flasks
Culture cells for 10 days at 37°C, 5% (v/v) CO2 in air
Figure 4.3.11: Primary mixed glial isolation protocol
4.3.3.2 Separation of astrocytes from mixed glial cultures
After the 10 days of culture detailed in section 4.3.3.1, the spent media containing dead or
detached cells, was aspirated from the T-flask. The T-flask was supplemented with 10mL
fresh complete DMEM, which contained 60mmol·dm 3 L-Leucine methyl ester (to deplete
any remaining microglia). The flasks from the mixed glial prep were placed on a plate
shaker within an incubator at 37°C with 5% (v/v) CO2 in air and shaken overnight at 250
rpm. The media was aspirated and expelled over the attached cells to remove any loosely
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attached oligodendrocytes from the astrocyte feeder layer. This aspiration and trituration
was repeated three times to ensure only astrocytes remained attached to the T-flask. The
media was removed and discarded (or used for microglial or oligodendrocyte culture) and
replaced with 10mL fresh complete DMEM. The astrocytes were then isolated, confluent
and ready for use.
4.3.3.3 Isolation of microglia from mixed glial cultures
After the 10 days of culture (detailed in section 4.3.3.1), the flasks from the mixed glial
preparations were carefully removed from the incubator and placed into the tissue culture
hood (prior to any live cell imaging of the T-flask) and the media was gently aspirated
from the cells to remove the dead cells suspended in the spent media. Care was taken to
ensure that the flasks were not subjected to any shaking motion, which may have dislodged
the loosely attached microglia. The T-flask was supplemented with 10mL fresh complete
DMEM. The T-flasks were placed on a plate shaker within an incubator at 37°C with
5% (v/v) CO2 in air and shaken for 4 hours at 150 rpm. The media was then aspirated
from the T-flask and centrifuged at 200 g for 10 minutes and resuspended in 1mL fresh
complete DMEM media. A cell count was performed and then the microglia were used in
experiments or cultured in a PDL coated 25 cm3 T-flask (as described in section 2.9.16).
4.3.3.4 Isolation of oligodendrocytes from mixed glial cultures
After the microglia had been removed from the mixed glial cultures post shaking, oligo-
dendrocytes were isolated from the mixed glial cultures by shaking at 200 rpm overnight
at 37 °C in 5% (v/v) CO2 in air. The media containing the detached oligodendrocytes
was aspirated and expelled three times over the remaining adherent cells to remove any
oligodendrocytes loosely adhering to the astrocytes. The oligodendrocyte solution was
centrifuged for 10 minutes at 200 g and the pellet resuspended in 15mL fresh DMEM
complete media before being passed through a 40 µL cell strainer to remove any larger
cells or debris. The oligodendrocytes were then plated in 75 cm3 Poly-D-lysine pre-treated
T-flasks (as described in section 2.9.16).
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4.3.3.5 Primary microglia isolation from adult rat spinal cord
The yield of microglia from mixed glial cultures was low, which was limiting for investiga-
tions, therefore the spinal cord was harvested from adult rats that had been used for the
dissection of DRG neurons. Higher numbers of microglial cells could be obtained from
the adult rat spinal cord, which would normally have been discarded as clinical waste.
The methods described in Gingras et al. (2007) and Moussaud and Draheim (2010)
were investigated for culturing microglia for an extended period of time, allowing pro-
liferation of microglia when cultured with 5 ng·mL 1 Granulocyte Macrophage Colony
Stimulating Factor (GM-CSF). A combination of these two methods succeeded in provid-
ing high microglial numbers to allow microglial cell seeded hydrogels.
The spinal cord was dissected from adult Wistar rats as described in section 2.10.3.
The spinal cord was placed on a Petri dish in a tissue culture hood and a scalpel used
to remove the nerve roots from the spinal cord. Fine tweezers were used to remove the
meninges surrounding the spinal cord. The spinal cord was chopped into 1mm3 cubes
using a flat scalpel blade. The tissue was then transferred into a fresh tissue culture dish
containing 2.5mL serum free DMEM containing 0.125% (w/v) collagenase type IV and
100U·mL 1 of Penicillin 100 µg·mL 1 Streptomycin at 37°C with 5% (v/v) CO2 in air
for 60 minutes. The spinal cord was triturated 10 times to mechanically dissociate the
tissue and then incubated for a further 30 minutes at 37 °C in 5% (v/v) CO2 in air.
The spinal cord was triturated an additional 10 times to further mechanically dissociate
the tissue before 20mL of complete DMEM media was added. The solution was then
centrifuged at 400 g for 5 minutes at room temperature, the supernatant was discarded
and the pellet resuspended in 20mL complete DMEM media. After centrifugation at 400
g for a further 5 minutes, the solution was discarded and the pellet resuspended in 20mL
complete DMEM media supplemented with 5 ng·mL 1 GM-CSF. The media containing
the non-adherent microglia was removed from the flask, centrifuged for 10 minutes at 200
g and the pellet resuspended in DMEM supplemented GM-CSF media every 3 days. The
media was changed for fresh complete DMEM excluding GM-CSF 3 days prior to use in
experiments, to remove the stimulation to proliferate.
158
4.3.3.6 Primary neuron isolation - Enzyme treatment method
The DRGs were dissected from the spine and stripped of the connective tissue (as de-
scribed in section 2.10.3). They were then placed in a 30mm Petri dish and incubated with
2.5mL serum free DMEM containing 0.125% (w/v) collagenase type IV and 100U·mL 1
of Penicillin 100 µg·mL 1 Streptomycin at 37°C with 5% (v/v) CO2 in air for 90 min-
utes. The solution was then mechanically dissociated by aspirating 5 times before 20mL
complete DMEM media was added. The solution was then centrifuged at 400 g for 5 min-
utes at room temperature. The supernatant was discarded and the pellet resuspended
in 20mL complete DMEM media for a final wash step. After centrifugation at 400 g
for 5 minutes, the solution was discarded and the pellet resuspended in 10mL complete
DMEM media supplemented with 0.01mM cytosine-D-arabinoside (activates apoptosis
in rapidly dividing cells such as glia). The cells were plated in a 75 cm3 Poly-D-lysine
pre-treated tissue culture flasks and incubated at 37°C, 5% (v/v) CO2 in air for 24 hours
before use. Neurons must be used 24 hours post isolation to minimise the risk of radial
glial contamination from any remaining debris such as cells trapped within the collagen
matrix.
4.3.3.7 Primary neuron isolation - Percoll gradient separation method
The second method for primary neuron isolation was investigated to attempt to reduce
the number of contaminating glial cells in the isolated neuronal preparation.
DRGs were dissected from the spine and stripped of the connective tissue, as described
in section 2.10.3. The DRGs were placed in a universal containing 15mL serum-free
DMEM media and were centrifuged at 250 g for 5 minutes. The media was removed
and replaced with 1mL of fresh serum-free DMEM, 200 µL of 10mg·mL 1 collagenase
from clostridium histolyticum in PBS and 200 µL of 10mg·mL 1 Dispase II in PBS. The
solution was agitated at 100 rpm at 37°C, 5% (v/v) CO2 in air for 20 minutes. The
solution was then triturated with a 1mL gilson pipette and 25 µL of DNAse was added to
the solution and this was incubated for a further 20 minutes at 37°C, 5% (v/v) CO2 in air
with gentle agitation. DMEM (5mL) was added to the solution and it was triturated three
times before centrifugation at 500 g for 5 minutes at room temperature. The supernatant
was removed and the pellet was resuspended in 5mL DMEM. The centrifugation step was
repeated and the pellet resuspended in 2mL DMEM.
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The neurons were purified using a Percoll gradient, which has been illustrated in Figure
4.3.12a to aid understanding of the method. The Percoll gradient was prepared by adding
1mL of 10x HBSS to 9mL of Percoll to make a 90% Percoll solution. A volume of 5mL
of 1x HBSS was added to the 90% Percoll solution to make a 60% Percoll solution. A
volume of 5mL of the 60% solution was added to 5mL 1x HBSS to make a 30% Percoll
solution. A volume of 3mL of 60% Percoll was placed in a 14mL round bottom tube,
carefully overlaid with 3mL of 30% Percoll. A volume of 2mL of the cell suspension
was carefully laid on top of the Percoll gradient and centrifuged at 1000 g for 25 minutes
at room temperature. The cloudy layer at the interface of the two Percoll solutions
contained the DRG neurons as shown in figure 4.3.12b. The first 3mL from the top of
the Percoll gradient was discarded as it contained the myelin, neuroglial cells and debris.
The remaining 2mL of the gradient solution containing the neurons were transferred into
a universal with 15mL DMEM media and centrifuged at 200 g for 10 minutes at room
temperature. The supernatant was then discarded and the pellet resuspended in 1mL
DMEM and immediately used on hydrogels or cultured in a T-flask at 37 °C, 5% (v/v)
CO2 in air, overnight until use. This method was optimised from the original method in
DeBoni and Goldberg (1989).
(a) (b)
Figure 4.3.12: (a) Percoll gradient method of isolating neurons from neuroglial cells,
myelin and cellular debris, (b) Percoll gradient separating neurons in the lower band,
from glial cells and debris, located in the upper band.
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4.3.4 Quantitative analysis of live/dead images
The live/dead cell viability assay was performed (as described in section 2.12.1) to qual-
itatively analyse the number of living cells compared to dead cells. The images were
analysed using ImageJ software to acquire quantitative data from the images. Each im-
age was loaded into ImageJ software and split into the separate channels, red, green and
blue. The blue channel was discarded as the live/dead assay labels living cells green with
Calcein AM or dead cells red with Ethidium-homodimer-1, any label present on the blue
filter was background stain. An example of the process has been illustrated in Figure
4.3.13
The green and red channels were treated individually to set the threshold. The lower
threshold was reduced to zero, the upper threshold was tailored so that all the black, unla-
belled background turned red. Care was taken to remove as much background as possible,
whilst including as many faint cellular projections as possible. A constant threshold was
maintained for selection of green and red labelling between all images and a similar thresh-
old value was used for all images (±10 threshold units). Images were randomised to negate
any experimental bias.
The images were made binary, the background was converted white and the pixels
above the threshold were converted to black. The software quantified the proportion of
the image labelled black.
The analyze particles function was selected and a minimum of 10 pixel units (to
guarantee any background would not be selected) and to inifinity (to make sure that large
clumps of cells/pixels would be counted). The summarize option presented a table of data.
In order to quantify cell viability, the total area of the green channel was divided by the
total area of both the red and green channels together ( greenred+green⇥100) and compared with
the total area of the red channel divided by the total of both channels, ( redred+green ⇥ 100).
This produced a % of living cells and a % of dead cells, a quantitative measure of cell
viability.
One of the main diﬀerences between analysing two-dimensions, whereby cells were
seeded on to the surface of gels and three-dimensions, whereby cells were seeded inside
the hydrogels, dead cells were not trapped within the matrix on two-dimensional gels, as
in three-dimensional cell seeded hydrogels, therefore dead cells detach from the surface
of the matrix and are removed with solution changes. This reduced the number of red
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cells present in each image and produced high cell viability data for all two-dimensional
hydrogels. Therefore for comparing the cell preference between hydrogels of diﬀerent
matrix stiﬀnesses, cellular attachment was compared between hydrogels of diﬀerent matrix
stiﬀness, the % area of the green channel was used as a quantitative measure of how much
of the surface of the hydrogel was covered with living cells. Poor cell viability would
produce reduced cellular attachment and therefore a smaller proportion of the hydrogel
surface would be labelled with green cells. High cell viability and attachment would result
in a high proportion of the surface of the hydrogel labelled with green cells, therefore the
% area result was taken from the summary table in ImageJ for each hydrogel and the
averages for each gel stiﬀnesses were calculated and plotted. The results were investigated
for statistical significance by performing a one way ANOVA (p <0.05) with Fisher LSD
post hoc comparison.
4.3.5 Quantitative analysis of GFAP expression by astrocytes us-
ing ImageJ
In response to injury or disease, astrocytes become hypertrophic, extend processes and
increase expression of glial fibrillary acidic protein (GFAP), they migrate to the injury
site and eventually form a glial scar (Okada et al., 2017). The upregulation of GFAP is an
indicator of astrocyte reactivity and therefore GFAP expression in astrocytes attached to
the surface of hydrogels with diﬀerent matrix stiﬀnesses was quantified to identify which
matrix produced a more reactive astrocyte phenotype.
Immunohistochemistry was performed (as described in section 2.12.3). Tiled images
were taken on a Zeiss AX10 Axio scope upright fluorescent microscope in a 5 x 5 square
totalling 25 images per gel from the centre. Hoechst is a nuclear stain which was used as
an indicator of cell density and attachment, as every cell has a nucleus, however astrocytes
may have produced diﬀerent levels of GFAP depending on the matrix environment.
The images were analysed using ImageJ software to acquire quantitative information
from the images, a number of steps were applied to each image to quantify the fluorescence
detected (Figure 4.3.14).
The images were loaded into the ImageJ software and pre-processed, the scale bar was
removed and the colour channels of each image were split, producing a red, green and
blue image. Depending on the secondary antibodies used to label the GFAP produced
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by astrocytes, the red or green channel was discarded, generally red was used for GFAP
labelling and therefore the green channel was discarded.
The second step was to set a threshold for the red and blue channel to discard any
pixels that were labelled with background levels of fluorescence. The lower threshold was
set to 0 and the upper threshold was set to 50. This threshold was maintained for all
images and all channels so that the data was consistent between all cellular hydrogels of
diﬀerent stiﬀnesses and the channels could be compared.
Once the threshold had been applied, the process tab was selected and the image was
processed into a binary image, so that the software could analyse and quantify the labelled
pixels (black) from the unlabelled pixels (white).
The analyse particles function was selected and the pixel units was set from 10-infinity,
so that any erroneous labelled pixels were not included in the analysis, a minimum of 10
pixels together indicated that it was more likely to be a cell and not background labelling
that was not extracted by the threshold. Infinity pixel units guaranteed that if the cells
migrated and merged to form a large collection of cells on the surface of the hydrogel, the
shape was included in the analysis.
This indicated what proportion of all the labelled cells on the surface of the hydrogel
expressed GFAP (red) or did not express GFAP and were unreactive, recognised only by
the nuclear stain (blue). The imaging software produced a results table which included
the data for ‘total area’ of the image which was selected within the set threshold for
the red and the blue channels. Similar to quantifying the cell viability in section 4.3.4,
the total area of the blue channel was divided by the total of both the red and blue
channels together ( bluered+blue ⇥ 100) and compared with the total area of the red channel
divided by the total of both channels, ( redred+blue ⇥ 100). The results will be investigated
for statistical significance by performing a one way ANOVA (p <0.05) with Fisher LSD
post hoc comparison.
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Image > Colour
> Split channels
Green RedBlue
Image > Ad-
just > Threshold
> Manually set
threshold and apply
Process > Binary
> Make binary
Analyze > Analyze
particles > Select
pixel units 10-infinity
Figure 4.3.13: Quantification of live/dead stain using ImageJ.
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Remove scale bar
> Image > Colour
> Split channels
Green RedBlue
Image > Adjust >
Threshold > Set
> lower = 0 and
upper = 50 > Apply
Process > Binary
> Make binary
Analyze > Analyze
particles > Select
pixel units 10-infinity
Figure 4.3.14: Quantification of GFAP and Hoechst using ImageJ.
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4.4 Results
The aim of this chapter was to investigate how the mechanical properties of the matrix
eﬀect CNS cell behaviours by using the experimental approach detailed in Figure 4.3.15 to
investigate cell viability, reactivity, morphology and cytokine release. Unfortunately, the
stiﬀer hydrogels required a large quantity of functionalised gelatin which was in limited
supply, therefore to investigate cellular behaviour on the 2,900 Pa and 3,900 Pa hydrogels
would limit the number of experiments which could be performed and number of diﬀerent
cell types and cellular co-cultures which could be investigated.
In order to conserve the limited resources, it was decided to use the 20 Pa, 250 Pa
and 700 Pa hydrogel matrices and to eliminate the isolated oligodendrocyte culture and
the mixed glial cell with neuronal cell culture conditions in order to have enough hydrogel
material to analyse the cellular behaviours with live/dead, ATP-lite and immunohisto-
chemistry. The project would have liked to investigate cytokine release, however the
number of cells attached to the surface of the hydrogels was limited and therefore the
quantity of cytokines produced, was not sensitive enough to be quantified with a high
sensitivity ELISA.
4.4.1 Mechanical properties of the matrices
The mechanical properties of the matrices were measured by rheology as described in
section 4.3.1. The linear viscoelastic region (LVER) is the linear region, after the region
of instability at low shear strain and before the sample begins to plastically deform at
higher strain (as detailed in section 4.3.1 Figure 4.3.3). The LVER varied between samples
of diﬀerent stiﬀnesses from 0.1-1% shear strain (Figure 4.4.0). The chosen shear strain
for rheological analysis of the matrices was 0.5% shear strain, as this was located within
the LVER of all the hydrogel stiﬀness variants 5%, 7.5%, 10%, 12.5% and 15% (w/v)
PEGDA.
The samples were then analysed using oscillatory rheological testing at 37°C on the
Malvern Kinexus Pro+ rheometer over a range of frequencies (0.1Hz to 5 or 10Hz depend-
ing on the limiting value i.e. when the material began to plastically deform and whether
the location of the LVER was clear) under constant shear strain (0.5%), this test was
referred to as a frequency sweep (Figure 4.4.1).
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(a) 5% (w/v) PEGDA hydrogel (b) 7.5% (w/v) PEGDA hydrogel
(c) 10% (w/v) PEGDA hydrogel (d) 12.5% (w/v) PEGDA hydrogel
(e) 15% (w/v) PEGDA hydrogel
Figure 4.4.0: Amplitude sweeps of hydrogels with diﬀerent polymer concentrations (5%,
7.5%, 10%, 12.5% and 15% (w/v) PEGDA), LVER highlighted with red box, n = 3.
The results of the frequency sweeps (Figure 4.4.1) indicated that at 1Hz frequency
the complex modulus is approximately 20 Pa for the 5% (w/v) PEGDA hydrogel, 250
Pa for the 7.5% (w/v) PEGDA hydrogel, 700 Pa for the 10% (w/v) PEGDA hydrogel,
2.9 kPa for the 12.5% (w/v) PEGDA hydrogel and 3.9 kPa for the 15% (w/v) PEGDA
hydrogel (data shown in Table 4.1). The standard deviation from the mean and standard
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error of the 5 samples was low for the 5% (±3.16 Pa, ± 1.58 Pa), 7.5% (±20.42 Pa, ±
11.78 Pa) and 10% (±86.43 Pa, ± 43.21 Pa ) (w/v) PEGDA hydrogels, however for the
stiﬀer hydrogels, the standard deviations from the mean and standard error were large
and overlapping for the 12.5% (±634.95 Pa, ± 317.47 Pa) and 15% (±1458.68 Pa, ±
729.34 Pa) (w/v) PEGDA hydrogels. However, one way ANOVA with Fisher LSD post-
hoc comparison confirmed significant statistical diﬀerence (p <0.05) between the average
complex shear modulus for all hydrogels of diﬀerent polymer concentrations.
Figure 4.4.1: Shear modulus (complex component) of hydrogels with diﬀerent polymer
concentrations (5-15% (w/v) PEGDA) measured on the Malvern Kinexus Pro+ rheometer
at 37 °C, 0.5-5Hz frequency at 0.5% shear strain. One way ANOVA with Fisher LSD post
hoc comparison confirmed statistically significant diﬀerence (p <0.05) between the average
complex shear modulus for all hydrogels of diﬀerent polymer concentrations. Error bars
indicate standard deviation, n = 5.
4.4.2 Optimisation of hydrogel preparation for 2D cell seeding
The synthetic-biologic hydrogel system was not compatible with three-dimensional cell
seeding prior to gel polymerisation due to poor cell viability, therefore the role of the
stiﬀness of the matrix on cell behaviour was investigated in two-dimensional culture by
seeding the cells onto the surface of the hydrogels. However, the hydrogel system exhibits
a high degree of swelling, therefore using a standard 96 well plate to make the hydrogels
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Table 4.1: Mean complex shear modulus (G⇤), standard deviations to the mean and stan-
dard error of synthetic-biologic hydrogels with diﬀerent polymer concentrations, analysed
by rheology (frequency sweep at 1Hz, 0.5% shear strain at 37°C) n=5.
% (w/v)
PEGDA
5% 7.5% 10% 12.5% 15%
Young’s
Modulus
20 Pa 250 Pa 700 Pa 2,900 Pa 3,900 Pa
Standard
Deviation
± 3.16 Pa ± 20.42 Pa ± 86.43 Pa ± 634.95 Pa ± 1458.68
Pa
Standard
Error
± 1.58 Pa ± 11.78 Pa ± 43.21 Pa ± 317.47 Pa ± 729.34 Pa
was not a viable option, as the hydrogel expanded beyond the dimensions of the well and
the hydrogels folded. The other limitation with using a well plate, was that the hydrogel
formed a meniscus at the surface. The meniscus made imaging of the hydrogels diﬃcult
as the cells were in many diﬀerent focal planes. The meniscus also made two-dimensional
cell seeding diﬃcult due to the majority of the cells being located in the centre of the gel
at high density and few cells spread over the rest of the gel.
An investigation was carried out into diﬀerent methodologies which could support this
model and overcome the limitations.
4.4.2.1 Method 1: Gel transfer from 96 to 48 well plate
The first method detailed in section 4.3.2.1 attempted to overcome the challenge of the gel
expanding outside of the 96 well plate, by transferring the gels individually to a 48 well
plate. The benefit of the meniscus was that it helped to retain the cell culture media on
the surface of the hydrogel, thereby maintaining the cells on the surface of the hydrogel.
However, if the meniscus was damaged during removal and transfer, the cells flowed oﬀ
the hydrogel and the gel could not be used for analysis due to diﬀerences in cell seeding
densities between gels.
The method was time consuming and resulted in damage to the hydrogel by tearing,
folding or disruption of the meniscus. Imaging the cells was challenging due to the presence
of a meniscus, a coverslip could not be placed on the surface of the gel, as an air bubble
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became trapped between the glass and the gel, causing light refraction and decreased
resolution. Oil immersion of the surface of the gel damaged the sample, therefore high
magnification images or confocal microscopy were not possible. The cells were in diﬀerent
focal planes, therefore a large proportion of every image was out of focus. The benefits
and limitations of method one are summarised in Table 4.2.
4.4.2.2 Method 2: Large gel method
The second method detailed in section 4.3.2.2 trialled diﬀerent volumes (100-500 µL) of
hydrogel solution. The optimum volume of hydrogel solution was 100 µL, as this produced
a flat gel which covered the surface of the coverslip with little wasted gel material post
polymerisation and swelling (Figure 4.4.2 A). This resulted in large thin gels with a flat
surface which was relatively easy to seed cells onto the hydrogel surface. The volumes of
gel solution between 200 and 500 µL were too large for the coverslip and resulted in folds
at the edge of the coverslip and wasted hydrogel (Figure 4.4.2 B-E). A limitation with
this method was that there were sometimes micro-bubbles trapped beneath the coverslip
which created small holes in the gel, which caused the cells to run oﬀ the surface of the
hydrogel and attach to the coverslip beneath the gel. The large gels also required a large
volume of reagents for assays and functionalised gelatin and any angle to the surface of the
gel caused surface run-oﬀ of cell seeded media, preventing cell attachment and diﬃculty
imaging cells in diﬀerent planes. The benefits and limitations are summarised in Table
4.2.
Figure 4.4.2: Diﬀerent volumes of hydrogel solution produced diﬀerent depths and sizes
of gel with diﬀerent levels of wasted material post polymerisation using method 2. A)
100 µL hydrogel solution, B) 200 µL hydrogel solution, C) 300 µL hydrogel solution, D)
400 µL hydrogel solution, E) 500 µL hydrogel solution. Coverslip = 18mm diameter.
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4.4.2.3 Method 3: Parafilm method
The method 3 (as detailed in section 4.3.2.3) used small parafilm covers on low volume
hydrogel spots to produce a large quantity of flat, low volume hydrogels, which were
clear and therefore achieved good visibility of cells through the hydrogel matrix (Figure
4.4.3 D). However, the high transparency of the gels (Figure 4.4.3 A) made it diﬃcult to
locate the gels in media and they were easily aspirated into the pipette tip during media
changes (Figure 4.4.3 B), which damaged the gels. The gels were transported from a Petri
dish, to a well plate for culture and then to a microscope slide for imaging. Transporting
the gels often damaged the gels or caused the gels to fold, which disrupted cells on the
surface of the hydrogels, (Figure 4.4.3 C). The gels could not be used for analysis if they
were damaged or folded, it was time consuming, diﬃcult and wasteful. The benefits and
limitations are summarised in Table 4.2.
Figure 4.4.3: Method 3 parafilm method, A) the parafilm remaining on a gel after the
gel had swollen, B) Pipetting errors during media changes caused damage to the gel, C)
transfer of gels for culture and imaging caused gel folding or damage, D) the gels produced
were small and flat.
4.4.2.4 Method 4: Multi-well method
To minimise damage caused by moving hydrogels, a multi-well chamber method was devel-
oped as detailed in section 4.3.2.4, to polymerise the hydrogels, culture and image/analyse
the hydrogels on the same slide. However, to combat meniscus formation and gel folding
due to swelling, the silicon moulds were removed prior to the gels being fully polymerised
and replaced with a coverslip in a Petri dish. Although the hydrogels were only par-
tially polymerised after 1 minute of exposure to UV light, menisci formed and resulted in
trapped air and bubbles between the gel and the coverslip (Figure 4.4.4D). High volumes
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of hydrogel solution were needed (more than 100 µL) to fill the wells. The benefits and
limitations are summarised in Table 4.2.
Figure 4.4.4: Method 4, A) 100 µL of hydrogel solution was pipetted into 4 wells, B) the
gels were partially polymerised by exposure to UV light at 365nm for 1 minute, C) the
silicon mould was removed and replaced with a coverslip, D) the gels were large, thick
and contained bubbles.
4.4.2.5 Method 5: Biopsy punch method
Method 5 produced large gels in a well plate and a 5mm biopsy punch was used to
make many small hydrogels from a fully swollen hydrogel, as detailed in section 4.3.2.5.
Numerous small, identical gels were produced and easily transferred into a diﬀerent well
plate, well slide or Petri dish for culture with cells and for imaging. However, a large
proportion of the hydrogel remained after the small gels were cut, which was wasteful.
The method was time consuming to cut and transfer gels and wasteful. It was easy to seed
the gels with cells, however it was challenging transferring the cell seeded gels from the
sterile hood to the tissue culture incubators, without disrupting the media and causing
the cells to be lost from the surface of the hydrogel. The benefits and limitations are
summarised in Table 4.2.
173
4.4.2.6 Method 6: Multi-spot method
Method 6, detailed in section 4.3.2.6, was developed to reduce the need to transfer gels
once cells were attached, as this often resulted in damage to the gel and cell loss. Many
optimisation steps were required to improve the initial method (such as diﬀerent shapes
of parafilm covers, glass coverslips, volume of hydrogel solution and depth spacers) to
achieve identical hydrogels of an appropriate diameter, volume and depth with a flat
uniform surface. The method required a low volume of hydrogel solution, was easy to
perform and seed with cells, however the swelling of the hydrogels caused the gels to
expand beyond the well spot; this made it diﬃcult to keep the gels separate for analysis.
A 4-slide imaging tray was required for cell culture to keep the cells on the surface of
the hydrogel submerged in cell culture media, however, the cells and the gels were easily
dislodged during transfer from tissue culture hood to the incubator. The transparency of
the gels made them diﬃcult to see when submerged in media, which resulted in damage
to the gels during media changes, as the pipette tip would aspirate the gels causing gel
destruction. Another limitation of these low volume gels was that they needed to be dried
prior to the addition of cells, so that cells would remain on the surface of the gel. However,
when the gels were exposed to air for too long, the matrix began to dehydrate and fold,
which aﬀected the topography of the gels. The benefits and limitations are summarised
in Table 4.2.
Table 4.2: Benefits and limitations of the cell seeding methodologies
Method Benefits Limitations
Method 1:
96 to 48
well
• Meniscus maintains cells on
surface of gel
• Diﬃcult to seed cells onto sur-
face
• Time consuming
• Challenging to image
• Meniscus aﬀects cell density
across the gel
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Table 4.2: Benefits and limitations of the cell seeding methodologies
Method Benefits Limitations
Method 2:
Large gel • Produces a large flat surface
• Easy to maintain cells on top
of the gel
• Good for imaging cells on flat
surface
• Large gel, wasteful, not cost ef-
fective
• Angled surfaces diﬃcult to
seed with cells
• Large quantity of reagents re-
quired
• Micro-bubbles caused cell loss
Method 3:
Parafilm • Small cost-eﬀective gels
• Flat, even surface for cell cul-
ture and imaging
• Diﬀerences in parafilm
changed gel size
• Time consuming
• Easy to damage gel by media
changes or transfers
• Angled gel surface was diﬃcult
to image
• Angled surface was diﬃcult to
seed cells
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Table 4.2: Benefits and limitations of the cell seeding methodologies
Method Benefits Limitations
Method 4:
Multi-well • Expansion beyond the wells
• Large, thick, cost ineﬀective
gels
• Large volume hydrogel solu-
tion for each gel
• Some gels contained bubbles
and meniscus
• Large quantity of reagents re-
quired
Method
5: Biopsy
punch
• Small, identical, low volume
gels
• Easy to transport and image
• Flat; easy to seed with cells
• High proportion of waste
• Time consuming
Method 6:
Multi-spot • Small, flat, identical, low vol-
ume, cost eﬀective gels
• Quick and easy method
• Easy to seed cells
• Easy to image
• Low volume of reagents re-
quired
• Gel dehydration aﬀected to-
pography
• Large volume of media re-
quired,
• Diﬃcult to handle or transfer
gels
• Media changes damaged or re-
moved gel
• Diﬃcult to keep gels separate
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Table 4.2: Benefits and limitations of the cell seeding methodologies
Method Benefits Limitations
Method 7:
Combina-
tion
• Gels cut post-swelling, cost ef-
fective
• Low volume of reagents re-
quired
• Easy to image, small, flat and
on slides
• Easy to seed cells
• Easy method
• Diﬃcult to keep gels separate
• Hydrophobic marker pen used
to separate spots
• Time consuming
4.4.2.7 Method 7: Combined method
As a result of the development of the previous 6 methods, and awareness of their benefits
and limitations (Table 4.2), method 7 was developed as a combination of the large gel
method (method 2), the biopsy punch method (method 5) and the multi-spot method
(method 6). Method 7 as detailed in section 4.3.2.7, used a coverslip (method 2) to
produce a large gel with a flat surface, which could be easily transported. A biopsy
punch was used (method 5) to produce many gels of equal volume, shape and diameter
and a multi-spot imaging slide (method 6) was used to culture the cells, perform assays,
labelling and for ease of imaging.
Although there was waste material remaining after 12-15 small gels were punched
(Figure 4.4.5 A) from the large, swollen 100 µL hydrogel, each gel required approximately
8 µL of hydrogel solution, were small, flat and the same size as the spots on the multi-spot
imaging slide (Figure 4.4.5 B, D & E). This made the hydrogels easy to seed with cells
and image from the multi-spot imaging slide. The assay solutions could be used in low
volumes and kept separate as the solution sat on top of the hydrogel (Figure 4.4.5 C).
A hydrophobic fmarker pen was used to maintain separate hydrogel domains, in case the
solutions were dislodged in transit to and from the incubator. The benefits and limitations
are summarised in Table 4.2.
177
Method 7 was the most successful method and was chosen for use with this model.
Figure 4.4.5: Method 7 A) 5mm biopsy punch was used to make many identical gels from
one large swollen gel, B) the small, swollen gel fit precisely into the imaging-spot on the
multi-spot imaging slide, C) 50 µL media was retained easily on the gel, fully submerging
the cellular gel, which remained separate from other gels, D) flat, uniform surface, E)
highly transparent and transportable gel.
4.4.3 Isolation of mixed glial cells
Mixed glial cells were isolated as detailed in section 4.3.3.1. The mixed glial preparation
was cultured for 10 days in PDL-coated T-flasks prior to use in experiments. The mixed
glial cell preparation was imaged in the T-flask by brightfield microscopy each day of
the 10 day incubation period, to analyse the proportion of cell debris (dead cells, small
fragments of connective tissue) present and analyse the relative cell numbers at each stage
of the incubation period.
A large reduction in cell debris was observed in the first 3 days of cell culture (Figure
4.4.6a, 4.4.6b, and 4.4.6c). Cellular projections began to overlap at day 4 (Figure 4.4.6d),
cell confluency was attained by day 7 (Figure 4.4.6e). however, at day 7 the media was
changed and cell number continued to increase, therefore the cells were cultured up to
10 days, before they were used for experimentation to achieve maximum cell density and
complete removal of cellular debris (Figure 4.4.6f).
4.4.4 Isolation of astrocytes
Astrocytes were successfully isolated from the mixed glial preparations detailed in section
4.3.3.1 and section 4.3.3.2. An isolated astrocyte preparation was removed from the PDL-
coated T-flask by treatment with trypsin and mechanical disruption with a cell scraper
(Figure 4.4.7a) and seeded onto PDL-coated coverslips. The cells were cultured for 48
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(a) Mixed glia at day 1 (b) Mixed glia at day 2
(c) Mixed glia at day 3 (d) Mixed glia at day 4
(e) Mixed glia at day 7 (f) Mixed glia in T-flask at day 10
Figure 4.4.6: Mixed glial preparation in T-flasks, imaged at (a) 1 day, (b) 2 days, (c) 3
days, (d) 4 days, (e) 7 days and (f) 10 days cell culture at 37°C 5% (v/v) CO2 in air.
Scale bar represents 200 µm on images A-E and 100 µm on image F.
hours at 37 °C, in 5% (v/v) CO2 in air, to allow cellular attachments to be made prior to
immunohistochemical labelling with GFAP and staining with Hoechst nuclear stain. A
successful IHC labelled astrocyte isolation is displayed in Figure 4.4.7b.
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(a) (b)
Figure 4.4.7: (a) Primary astrocytes isolated from mixed glial preparation by shaking
overnight at 250 rpm, image taken by brightfield microscopy live imaging of cells in T-
flask, scale bar represents 100 µm. (b) Immunohisotchemistry labelling of GFAP (green)
and Hoechst (blue) in isolated primary astrocytes from mixed glia cultures, as described
in section 4.3.3.2. Scale bar represents 50 µm.
4.4.5 Isolation of microglia
Microglia were the least adherent mixed glial cell type, therefore microglia were isolated
from mixed glial preparations as detailed in section 4.3.3.3. As microglia were the first
cell type to isolate from the mixed glial preparation derived from post-natal day 2 rat
cortices, it was challenging to achieve a complete isolation, as any other cell type that were
loosely attached, would detach during mild agitation and contaminate the microglial cell
population. Any contaminating glial cells in the microglial isolation from the mixed glial
preparation (Figure 4.4.8a) expanded in culture at greater rates than microglia, therefore
microglia were not expanded in culture after isolation from the mixed glial preparation,
microglia were used in experiments immediately following isolation. Figure 4.4.8b displays
an example of the expansion of non-microglial cells in an isolated microglial culture by
the presence of cells stained with Hoechst in the absence of any co-localised labelling for
cd11b.
180
(a) (b)
Figure 4.4.8: Microglia isolated from mixed glial preparation by shaking. a) Isolated
microglia in T-flask with contaminating cells and debris highlighted with red arrows, image
taken by bright-field microscopy, scale bar represents 200 µm. (b) Immunohistochemical
labelling of cd11b (green) and nuclear staining by Hoechst (blue), non-microglial cells
(highlighted by red arrows) stained for Hoechst and absence of cd11b. Scale bar represents
100 µm.
4.4.6 Isolation of microglia from adult rat spinal cord
In an attempt to isolate microglia that could be expanded in cell culture to increase mi-
croglial cell density over time, a method was developed to harvest mature microglia from
the adult rat spinal cord, as detailed in section 4.3.3.5. Microglia were cultured with
5 ng·mL 1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) to stimulate
proliferation and were cultured for 26 days for maximum yield of mature microglia, as
detailed in Moussaud and Draheim (2010). The microglia detached from the confluent
glial cell layer which covered the bottom of the T-flask and proliferated in pure microglial
culture at the air-medium interphase from 16 days of cell culture. The cells were col-
lected from the supernatant and the media was changed by centrifugation to obtain the
pure microglial cell pellet, which was replated and cultured for 3 days in the absence of
5 ng·mL 1 GM-CSF, to remove the stimulation to proliferate.
After removing the floating microglia in the supernatant and replating in a fresh
PDL-coated T-flask, the microglia adopted a classical ramified microglial morphology
(Figure 4.4.9a). After 3 days, the microglia were then ready to be used. However, the
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morphology of mature microglia when cultured for 48 hours on a PDL-coated coverslip
at 37 °C in 5% (v/v) CO2 in air, displayed an amoeboid morphology when cultured
in complete isolation (Figure 4.4.9b), which diﬀered considerably compared to immature
microglia which displayed a highly ramified morphology in the presence of a small number
of contaminating glial cells (Figure 4.4.8b).
(a) (b)
Figure 4.4.9: Primary mature microglia isolated from adult rat spinal cord, a) image
taken by brightfield microscopy live imaging of cells in T-flask, resting (ramified) mi-
croglial morphology. scale bar represents 50 µm. (b) Immunohisotchemistry labelling of
cd11b (green) and Hoechst (blue) of primary isolated microglia from adult rat spinal cord,
activated (rounded) amoeboid morphology, scale bar represents 20 µm.
4.4.7 Isolation of oligodendrocytes
Oligodendrocytes were isolated from mixed glial preparations derived from post-natal day
2 rat cortices by shaking, as detailed in section 4.3.3.4. However, oligodendrocytes were
obtained in low cell numbers and were diﬃcult to isolate from astrocytes and microglia,
therefore oligodendrocytes were not analysed in isolation on hydrogel matrices of diﬀerent
stiﬀnesses.
The oligodendrocyte morphology cultured within a T-flask was similar to astrocytes
but typically longer, thinner, spindle-like morphology with long, fine projections (Figure
4.4.10a). Oligodendrocytes were cultured for 48 hours with microglia on PDL-coated
glass coverslips at 37 °C, 5% (v/v) CO2 in air. Oligodendrocytes were labelled with MOG
(orange) and microglia were labelled with cd11b (green), to confirm cell identity and
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visualise cell morphology (Figure 4.4.10b).
(a) (b)
Figure 4.4.10: a) Primary oligodendrocytes isolated from mixed glial preparation by shak-
ing for 24 hours at 250 rpm, image taken by brightfield microscopy live imaging of cells in
T-flask, scale bar represents 50 µm. (b) Immunohisotchemistry labelling of MOG (orange),
cd11b (green) and stained with Hoechst (blue) in primary oligodendrocyte-microglial co-
cultures, scale bar represents 100 µm.
4.4.8 Primary neuron isolation - Enzyme treatment method
There were two methods trialled to isolate neurons from DRGs of the adult rat spinal
cord. The first method detailed in section 4.3.3.6 was diﬃcult to produce isolated neurons
using the enzyme digestion method, without glial cell contamination from the extracel-
lular matrix and associated connective tissues. A DRG where the collagen matrix was
insuﬃciently removed has been imaged to demonstrate radial glial contamination from
the DRG (Figure 4.4.11a) and immunohistochemical labelling for  3-tubulin (green) and
Hoechst (blue) indicates the presence of many contaminating glial cells surrounding the
neuron by the presence of many stained nuclei (Figure 4.4.11b). The pyrimidine antago-
nist cytosine-d-arabinoside was used to target the S-phase of the cell cycle to arrest the
growth of proliferating glial cells, however this drug has a short half life and was not
successful in depleting the satellite glial cell population.
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(a) (b)
Figure 4.4.11: (A) Radial glia contamination protruding from an untreated DRG. Scale
bar represents 200 µm (B) Immunohistochemical labelling  3-tubulin (green) and staining
for Hoechst (blue) displaying nuclear staining for other contaminating cells in a neuron
isolation. Scale bar represents 50 µm.
4.4.9 Primary neuron isolation - Percoll gradient separation method
The second method to isolate neurons from DRGs derived from adult rat spinal cord,
was detailed in section 4.3.3.7. The Percoll method used a density gradient to separate
the low density glial cells such as microglia and astrocyte and debris such as myelin and
connective tissue fibres (located in the upper band) from the dense isolated neurons (in
the lower band) depending on the relative densities of the diﬀerent cell types (Figure
4.4.12a). This method also used cytosine-d-arabinoside to deplete rapidly dividing cells
such as satellite glial cells.
This method was more successful in depleting the glial contaminants and isolating
neurons, as the density gradient separated the glial cells from the neurons, therefore if
any glial cells did contaminate the neuronal culture, there would be less glial cells for the
cytosine-d-arabinoside to deplete. The enzyme treatment method required a higher degree
of dissection skill to remove the connective tissues from the DRGs in order to enzymatically
separate the neurons from the connective tissues, whereas the Percoll method allowed a
lower degree of dissection skill to remove the connective tissue as the density gradient
would separate the neurons from the debris during the centrifugation step.
The advantage of the Percoll method was that the neurons were highly isolated, how-
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ever the limitation with the method was that many neurons were lost in the upper band
of glial cells and debris, therefore the yield of isolated neurons was low (approximately
4,000-10,000 neurons per adult rat spinal cord).
(a) (b)
Figure 4.4.12: (a) Percoll gradient separating neurons in the lower band, from glial cells
and debris, located in the upper band. (b) Isolated neuron in a T-flask, image taken by
brightfield microscopy. Scale bar = 100 µm.
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4.4.10 Astrocyte viability and reactivity on 2D matrices of dif-
ferent stiﬀnesses
4.4.10.1 Analysis of astrocytes by ATP-Lite cell viability assay
In order to investigate how the stiﬀness of the matrix aﬀected astrocyte cells cultured in
isolation, 5 x 104 primary astrocyte cells were seeded on top of 5%, 7.5%, 10%, 12.5% and
15% (w/v) PEGDA Mn4000, synthetic-biologic hydrogels prepared and cell seeded as per
method 7 (section 4.3.2.7). The ATP-Lite cell viability assay was performed after 2 days
of cell culture at 37°C, 5% (v/v) CO2 in air. The slides were visualised by brightfield
microscopy live-cell imaging prior to analysis by ATP-Lite, to confirm that the cells were
attached to the hydrogel matrix and not to the bottom of the slide. If cells were attached
to the slide rather than the hydrogel, the gels were discarded from the study.
The ATP-Lite cell viability assay (Figure 4.4.13) showed that astrocytes seeded on
to the 10%, 12.5% and 15% (w/v) PEGDA Mn4000 synthetic-biologic hydrogel (700 Pa,
2.9 kPa, 3.9 kPa) have a significantly higher cellular metabolism than astrocytes cultured
on the 5% (w/v) PEGDA Mn4000 synthetic-biologic hydrogel (20 Pa), as determined
by one way ANOVA (p <0.05) with Fisher LSD post-hoc comparison. There was no
significant diﬀerence in astrocyte metabolism between astrocytes cultured on the 7.5%
(w/v) PEGDA Mn4000 synthetic-biologic hydrogels and astrocytes cultured on the 5%
or 10% (w/v) PEGDA Mn4000 synthetic-biologic hydrogels.
4.4.10.2 Analysis of astrocytes by live/dead cell viability assay
Astrocytes were cultured in isolation on matrices of diﬀerent stiﬀnesses for 48 hours at
37°C, 5% (v/v) CO2 in air, as detailed in section 4.4.10.1.
Primary astrocyte cell viability was analysed by live/dead staining to validate the
ATP-lite cell viability results. The live/dead stained images (Figure 4.4.14) showed a
reduced area of green labelled cells on the surface of the soft 5% (w/v) PEGDA hydrogel
matrix, which had a stiﬀness of approximately 20 Pa. The 7.5% (w/v) PEGDA hydrogel
matrix, which had a stiﬀness of approximately 250 Pa, showed an increase in the area of
green labelled cells on the surface of the hydrogels compared to the 5% (w/v) PEGDA
hydrogel matrix, however the 10% (w/v) PEGDA hydrogel matrix, which had a stiﬀness
of approximately 700 Pa, displayed the highest proportion of green labelled cells on the
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Figure 4.4.13: ATP-Lite cell viability assay results of 5 x 104 primary astrocyte cells
seeded on top of 5% (20 Pa), 7.5% (250 Pa), 10% (700 Pa), 12.5% (2.9 kPa) and 15%
(3.9 kPa) (w/v) PEGDA Mn4000 cultured for 48 hours at 37°C, 5% (v/v) CO2 in air.
Error bars indicate 95% confidence interval of the mean, lines indicate statistical diﬀerence
determined by one way ANOVA (p <0.05), n = 5, 25 gels.
surface of the hydrogels. The 12.5% and 15% (w/v) PEGDA hydrogel matrices, which
had stiﬀnesses of 2.9 kPa and 3.9 kPa respectively, displayed cell attachment and viability
comparable to the 10% (w/v) PEGDA hydrogel matrix (Figure 4.4.14).
The images highlighted variability for each hydrogel stiﬀness, although the hydrogels
were seeded by the same method (method 7) and by the same person on the same day,
there was inherent variability between samples. All hydrogel stiﬀnesses showed variation
between samples, images were taken of cell seeded hydrogels with low and high levels of
cell attachment (Figure 4.4.14).
To quantify the live/dead images shown in Figure 4.4.14, the five gels that had the
highest proportion of green stained cells for each of the diﬀerent matrix stiﬀnesses were
quantified using the method illustrated in Figure 4.3.13, section 4.3.4.
The quantified live/dead results (Figure 4.4.15) were in agreement with the ATP-
lite cell viability assay results, a one way ANOVA (p <0.05) with Fisher LSD post-hoc
comparison confirmed that there was a significant increase in the average area of green
labelled cells on the surface of the hydrogels, between the 5% PEGDA and 10% PEGDA
synthetic-biologic hydrogels. A significant increase was also observed from the 7.5% to the
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10% (w/v) PEGDA hydrogels, which was not observed using the ATP-lite assay. Similarly
to the ATP-lite assay results, there was no significant diﬀerence found between the average
area of green labelled cells on the surface of the hydrogels between the 10%, 12.5% and
15% PEGDA synthetic-biologic hydrogels, the 5% and 7.5% PEGDA synthetic-biologic
hydrogels also did not diﬀer significantly (Figure 4.4.15).
4.4.10.3 Analysis of matrix stiﬀness on expression of GFAP
Astrocyte reactivity was quantified by the expression of GFAP by seeding 5x104 primary
astrocyte on top of 5%, 7.5% and 10% (w/v) PEGDA Mn4000, synthetic-biologic hydro-
gels as per method 7 (section 4.3.2.7). The astrocyte-seeded gels were fixed and labelled
as described in section 2.12.3 for the expression of GFAP and stained with Hoechst to
highlight non reactive cells, which did not express GFAP. Representative images of im-
munohistochemical staining for GFAP on matrices of diﬀerent stiﬀnesses are displayed in
Figure 4.4.16.
The images (Figure 4.4.16) highlighted that despite the optimisations in the method
of cell seeding of hydrogels, there was a large variation in cell attachment between all the
hydrogel stiﬀnesses. Images of a low cell attachment density (Figure 4.4.16 row A) and
a high cell attachment density (Figure 4.4.16 row B) have been included to illustrate the
variability between samples, after the labelling protocol and imaging was complete. The
positive controls were astrocytes seeded hydrogels with 50 ng·mL 1 Lipopolysaccharide
(LPS) (Figure 4.4.16 C) and isolated astrocytes cultured on glass (Figure 4.4.16 C (con-
trols column)). The positive controls showed increased expression of GFAP (red labelled
cells). The negative control was a blank hydrogel with no added cells and does not contain
any cellular or background staining.
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(A) 5% (w/v) PEGDA
(B) 7.5% (w/v) PEGDA
(C) 10% (w/v) PEGDA
(D) 12.5% (w/v) PEGDA
(E) 15% (w/v) PEGDA
Figure 4.4.14: Live/dead staining of 5 x 104 primary astrocyte cells (live cells labelled
green, dead cells labelled red), seeded on 5%, 7.5%, 10%, 12.5% and 15% (w/v) PEGDA
hydrogels, cultured for 48 hours at 37°C, 5% (v/v) CO2 in air. Representative images
chosen to demonstrate the range of cell attachment from low (left image) to high (right
image). Scale bar = 100 or 500 µm. 189
Figure 4.4.15: Live/dead cell viability assay quantified % area of gel covered with 5 x 104
primary astrocyte cells seeded on top of 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa)
(w/v) PEGDA Mn4000, synthetic-biologic hydrogels, cultured for 48 hours at 37°C, 5%
(v/v) CO2 in air. Error bars indicate 95% confidence intervals, lines indicate statistical
diﬀerence determined by one way ANOVA (p <0.05), n = 5.
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In order to extract quantitative data from the immunohistochemical images of GFAP
expression, 10 images were selected with the highest cell attachment density of 5 x 104
primary astrocyte cells seeded on to the 5%, 7.5% and 10% (w/v) PEGDA Mn4000
synthetic-biologic hydrogels. The images were processed using ImageJ as described in
section 4.3.14 to quantify the area of the image that was labelled red for GFAP or blue
for Hoechst, out of the total of all the pixels labelled either red or blue. The higher the
percentage of labelled pixels that were labelled red as opposed to blue, the higher the
expression of GFAP and therefore the more reactive the astrocytes. The quantitative
data displayed in Figure 4.4.17 indicated that astrocytes cultured on the 7.5% and 10%
(w/v) PEGDA matrices expressed significantly higher levels of GFAP than the astrocytes
on the 5% (w/v) PEGDA hydrogel matrix. There was no diﬀerence in GFAP expression
between the 7.5% and 10% (w/v) PEGDA matrices. This data was analysed by a one
way ANOVA (p <0.05) with Fisher LSD post-hoc comparison.
Figure 4.4.17: Quantitive GFAP expression of 5 x 104 primary astrocyte cells seeded on
top of 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v) PEGDA Mn4000 hydrogels
cultured for 48 hours at 37°C, 5% (v/v) CO2 in air. The proportion of pixels labelled
red (GFAP) or blue (Hoechst), were quantified using ImageJ. Error bars indicate 95%
confidence intervals, lines indicate statistical diﬀerence determined by one way ANOVA
(p <0.05), n = 10.
In the interest of conserving functionalised gelatin, the highest stiﬀness matrices 12.5%
and 15% (w/v) PEGDA were not analysed using immunohistochemistry.
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4.4.11 Mixed glial cell behaviour on 2D matrices of diﬀerent stiﬀ-
nesses
4.4.11.1 Analysis of mixed glial cells using ATP-Lite cell viability assay
In order to investigate how the stiﬀness of the matrix aﬀected mixed glial cells in co-
cultures, 5 x 104 primary mixed glial cells were taken after 10 days culture at 37°C in
5% (v/v) CO2 in air and seeded on top of 5%, 7.5% and 10% (w/v) PEGDA Mn4000,
synthetic-biologic hydrogels prepared and cell seeded as per method 7 (section 4.3.2.7).
The ATP-Lite cell viability assay was performed after 2 days of cell culture at 37°C,
5% (v/v) CO2 in air. The slides were analysed prior to analysis by ATP-Lite, to confirm
that the cells were attached to the hydrogel matrix and not the bottom of the slide. If
cells were found to have attached to the slide, the gels were discarded from the study.
The ATP-Lite cell viability results (Figure 4.4.18) showed that mixed glial cells have a
higher cellular metabolism on softer matrices. The astrocyte cells cultured on the 5% (20
Pa) and 7.5% (250 Pa) (w/v) PEGDA Mn4000 hydrogel matrices showed significantly
higher cellular metabolism than the mixed glial cells cultured on the 10% (700 Pa) (w/v)
PEGDA Mn4000 hydrogel matrix; there was no significant diﬀerence in cell metabolism
between mixed glial cells cultured on the 7.5% and 5% (w/v) PEGDA Mn4000 synthetic-
biologic hydrogels, as determined by one way ANOVA (p <0.05) with Fisher LSD post-hoc
comparison
4.4.11.2 Analysis of mixed glial cells using live/dead cell viability assay
The mixed glial cell behaviours on matrices of diﬀerent stiﬀnesses were investigated as
described for astrocytes in section 4.4.10.1, however primary mixed glial cell viability
was analysed using live/dead staining to validate the ATP-lite cell viability results. The
results showed variability in cell attachment density for each hydrogel stiﬀness. Although
all the hydrogels were seeded using the same method (method 7) and by the same person
on the same day, there was inherent variability between samples.
There were gels with low levels of cell attachments and therefore a low number of
green labelled cells (Figure 4.4.19 column 1), and gels with high levels of cell attachments
and a large number of green labelled cells (Figure 4.4.19 column 2) for each gel stiﬀness.
The cells on the 10% (w/v) PEGDA matrix were more rounded in morphology and the
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Figure 4.4.18: ATP-Lite cell viability assay results of 5 x 104 primary mixed glial cells
seeded on top of 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v) PEGDA Mn4000,
synthetic-biologic hydrogels, cultured for 48 hours at 37°C, 5% (v/v) CO2 in air. Error
bars indicate 95% confidence interval, lines indicate statistical diﬀerence determined by
one way ANOVA (p <0.05), n = 6, 49 gels
cells were clumped with few connections between cells, whereas the mixed glial cells on
the 7.5% and 5% (w/v) PEGDA matrix, formed connections between cells and more
projections were observed.
In order to produce quantitative results from the live/dead images, which had varying
degrees of cell attachment, 10 images were selected for each of the 5%, 7.5% and 10%
(w/v) PEGDA hydrogels matrices, which had the highest cell attachment densities. These
images were processed as described in section 4.3.4 and the results are presented in Figure
4.4.20. The quantitative live/dead staining (Figure 4.4.19) showed a reduced area of green
labelled cells on the stiﬀer 10% (w/v) PEGDA hydrogel matrix, which was approximately
750 Pa, compared to the 7.5% (w/v) (250 Pa) and the 5% (w/v) (20 Pa) PEGDA hydrogel
matrix. The 5% and 7.5% (w/v) PEGDA hydrogel matrix showed a significant increase in
the total area of green labelled cells compared to the 10% (w/v) PEGDA hydrogel matrix,
as determined by one way ANOVA (p <0.05) with Fisher LSD post-hoc comparison.
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% PEGDA
(w/v)
Column 1 Colunmn 2
(A) 5%
(w/v)
PEGDA
(B) 7.5%
(w/v)
PEGDA
(C) 10%
(w/v)
PEGDA
Figure 4.4.19: Live/dead assay staining of 5x104 primary mixed glial cells, cultured on
5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v) PEGDA Mn4000, synthetic-biologic
hydrogels for 48 hours at 37°C in 5% (v/v) CO2 in air prior to analysis. Images in
column 1 show gels with low cell attachment, images in column 2 show gels with high cell
attachment. Representative images chosen, Scale bar = 200 µm and 500 µm for the 5%
(w/v) PEGDA hydrogels.
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Figure 4.4.20: Quantification of live/dead mixed glial cell viability assay using ImageJ. %
total area of gel covered with green labelled cells, gels were seeded with 5 x 104 primary
mixed glial cells seeded on 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v) PEGDA
hydrogels, cultured for 48 hours at 37°C in 5% (v/v) CO2 in air. Error bars indicate 95%
confidence interval, lines indicate statistical diﬀerence determined by one way ANOVA (p
<0.05), n = 10.
4.4.12 Assessment of neurons cultured on 2D matrices of diﬀerent
stiﬀnesses
Neurons were cultured on the surface of 5%, 7.5% and 10% (w/v) PEGDA synthetic-
biologic hydrogel matrices, which had the approximate stiﬀnesses of 20 Pa, 250 Pa and
700 Pa, respectively. The neurons were enzymatically digested from DRGs dissected
from the spine of adult rats (as described in section 2.10.3). There were 2 methods
for the isolation of neurons from DRGs, by a Percoll gradient (section 4.3.3.7), which
resulted in low numbers of highly isolated neurons (4-10,000 neurons) or the enzymatic
digestion method (section 4.3.3.6) which resulted in higher numbers (80-100,000 neurons),
which may have contained a low proportion of astroglial contaminating cells. Common
contaminating cells were radial glia. Cell counts using trypan blue (as described in section
2.11.3) were often challenging and it was diﬃcult to count only neuronal cells, due to low
numbers of cells, and the diﬃculty in diﬀerentiating smaller neurons from larger glial cells.
To overcome the unreliable cell counts, all the neurons from one adult rat spine dissection
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were used for 16 samples, 12 experimental gels, where cells were seeded onto the surface
of the hydrogels and 4 cell samples cultured on PDL-coated glass coverslips to label with
B3-tubulin and perform a labelled cell count.
The ATP-lite cell viability assay was performed to assess any diﬀerences in metabolic
activity of neurons cultured on matrices of diﬀerent stiﬀnesses. However, no significant
diﬀerences were observed between the cellular metabolism of neurons cultured on 5%,
7.5% and 10% (w/v) PEGDA synthetic-biologic hydrogel matrices, determined by one
way ANOVA (p <0.05) with Fisher LSD post-hoc comparison
Figure 4.4.21: ATP-Lite cell viability assay results of 1 x 104 primary neurons seeded on
top of 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v) PEGDA Mn4000, synthetic-
biologic hydrogels, cultured for 48 hours at 37°C, 5% (v/v) CO2 in air. Error bars indicate
95% confidence interval, no statistical diﬀerence was determined by one way ANOVA (p
<0.05), n = 5, 16 gels.
In order to validate the ATP-lite assay results, the neuron-seeded hydrogels were la-
belled with the live/dead assay (as described in section 2.12.1), however neurite outgrowth
was not observed. Most of the neurons retained a rounded morphology with no projections
from the cell body (Figure 4.4.22). The neurons seeded onto PDL-coated glass coverslips
showed extensive neurite outgrowth highlighted by the expression of  3-tubulin labelled
with FITC and Hoechst nuclear stain (Figure 4.4.22 IHC column). The live/dead images
suggested that the neurons were viable on the matrices as the neurons were labelled green
with Calcein AM.
197
4.4.13 Assessment of microglia cultured in isolation on 2D ma-
trices of diﬀerent stiﬀnesses
In order to investigate how the stiﬀness of the matrix aﬀected microglial cells cultured in
isolation, 5 x 104 primary microglial cells were seeded on top of 5%, 7.5% and 10% (w/v)
PEGDA Mn4000, synthetic-biologic hydrogels prepared and cell seeded as per method
7 (section 4.3.2.7). The ATP-Lite cell viability assay was performed after 2 days of cell
culture at 37°C, 5% (v/v) CO2 in air. The slides were analysed prior to analysis by
ATP-Lite assay, to confirm that the cells were attached to the hydrogel matrix and not
the bottom of the slide. If cells were found to have attached to the slide, the gels were
discarded from the study.
The ATP-Lite cell viability results (Figure 4.4.23) showed that microglia seeded on
to the 5% (w/v) PEGDA Mn4000 synthetic-biologic hydrogel (20 Pa) had a significantly
higher cellular metabolism than microglia cultured on the 7.5% (w/v) (250 Pa) and 10%
(700 Pa) (w/v) PEGDA Mn4000 synthetic-biologic hydrogel, as determined by one way
ANOVA (p <0.05) with Fisher LSD post-hoc comparison. There was no significant dif-
ference in microglial metabolism between microglia cultured on the 7.5% (w/v) PEGDA
and on the 10% (w/v) PEGDA Mn4000 synthetic-biologic hydrogels.
Immunohistochemistry and live/dead staining was attempted, however microglial cells
were loosely attached to the surface of the hydrogels and post-labelling showed reduced
cell density, due to the experimental method and therefore did not accurately represent
the results. There was insuﬃcient hydrogel material remaining to optimise the method
for imaging microglia on the hydrogels, therefore bright field live-cell imaging was used
to demonstrate the cell attachment densities of microglia prior to ATP-lite assay quan-
tification of cell metabolism (Figure 4.4.24). The images (Figure 4.4.24) showed that the
microglia retained a rounded morphology on all stiﬀness matrices. Cellular attachments
or projections were diﬃcult to visualise using bright field microscopy in the absence of
labelling techniques, therefore quantitative analysis was not possible, however there was
a greater cell density observed on the 5% (w/v) PEGDA matrix compared to the 7.5%
(w/v) and 10% (w/v) PEGDA synthetic-biologic hydrogel matrix.
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4.5 Discussion
The aim of the study was to use the synthetic-biologic hybrid hydrogel system and de-
velop a method to seed the hydrogels with cells reproducibly to determine the eﬀects of
the stiﬀness of the matrix on CNS cell phenotype in terms of cell viability, morphology
and expression of markers for reactivity. The mechanical properties of the matrix were
characterised and five matrix stiﬀnesses were achieved from 20 Pa to 3,900 Pa.
The developed synthetic-biologic hydrogel had some limitations, which made seeding
cells on top of the matrix challenging. Seven methods were investigated to produce a
viable cell seeding method. As a result of the diﬃculty in cell-seeding the hydrogels, and
developing an appropriate method, the experimental plan could not be completed in full.
The method to obtain isolated astrocytes, microglia, neurons and oligodendrocytes
were optimised, however there was insuﬃcient hydrogel material to investigate how the
mechanical properties of the matrix aﬀected oligodendrocyte cell behaviour and viability.
4.5.1 Challenges of the synthetic-biologic hydrogel matrix
The previous chapter detailed the development of a synthetic-biologic hybrid hydrogel
system consisting of PEGDA and functionalised gelatin, which allowed the formation of
hydrogel matrices with diﬀerent stiﬀnesses. However, the matrix was not compatible with
seeding the cells prior to photo-polymerisation, due to the low resultant cell viability,
therefore cells had to be seeded on to the surface of the hydrogel.
The limitations of the hydrogel system and the challenges to overcome with seeding
cells on the surface of the hydrogels, are detailed (Figure 4.5.1) to aid understanding of
how the limitations aﬀected the method of seeding cells on to the surface of the gel.
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% PEGDA (1) Live/dead (2) IHC
(A) 5% (w/v)
(B) 7.5% (w/v)
(C) 10% (w/v)
(D) Glass
Figure 4.4.22: Isolated neurons cultured on 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa)
(w/v) PEGDA Mn4000 synthetic-biologic hydrogels for 48 hours at 37°C in 5% (v/v) CO2
in air, with complete DMEM media containing 50 ng·mL 1 NGF and 0.01mM cytosine-d-
arabinoside. IHC labelled for  -3 tubulin, FITC (green) and Hoechst (blue). Scale bar =
200 µm for live/dead images, Scale bar = 50 µm for IHC images. Representative images
chosen.
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Figure 4.4.23: ATP-Lite cell viability assay results of 5 x 104 primary microglial cells
seeded on top of 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v) PEGDA Mn4000,
synthetic-biologic hydrogels, cultured for 48 hours at 37°C 5% (v/v) CO2 in air. Error
bars indicate 95% confidence interval, lines indicate statistical diﬀerence determined by
one way ANOVA (p <0.05), n = 5, 16 gels.
(a) (b) (c)
Figure 4.4.24: Brightfield live-cell imaging of 5 x 104 primary microglial cells seeded
on top of (A) 5% (20 Pa), (B) 7.5% (250 Pa) and (C) 10% (700 Pa) (w/v) PEGDA
Mn4000, synthetic-biologic hydrogels, cultured for 48 hours at 37°C 5% (v/v) CO2 in air.
Representative images chosen. Scale bar = 200 µm.
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4.5.1.1 Swelling of the hydrogels
The first limitation was that the hydrogels swelled by a factor of approximately 150%.
This was challenging because cells added too soon after polymerisation (before swelling
was complete) became stretched, as a result of making cellular attachments prior to the
gel increasing to its maximum (fully swollen) volume and the cells appeared as small
clumps on the surface of the hydrogel instead of an even distribution of cells over the
surface of the hydrogel.
The swollen hydrogels became too large for the initial moulds and the gels folded in
the initial moulds. This made applying cells to the surface of the gel challenging; cells
would preferentially attach to the tissue culture plastic, which aﬀected the cell density
for each gel sample. The gels were moved after photo-polymerisation into a larger mould,
where the gel did not fill the well. This was challenging to seed cells onto the surface of
the hydrogel; if the cells were seeded in too much media, the cells would fail to attach
to the surface of the hydrogel as the media would flow from the surface of the hydrogel
and transport the cells oﬀ the gel. If cells were lost from the surface of the gel then
the cell density would diﬀer between gels and the cell-seeded gel could not be used for
quantitatively assessing cell viability or reactivity.
It was challenging to allow the cells a long enough incubation period in a low volume
of media to make cellular attachments to the matrix before being submerged in media
without incubating for too long in a low volume of media, as the hydrogel would dehydrate
and reduce in volume, which would swell in the presence of media and cause the cells to
stretch or spread in small clumps as mentioned in the previous challenge.
Similar combined natural polymer (gelatin) and synthetic polymer hydrogels have also
investigated the swelling behaviour and found that the water content of the hydrogels
increased with increased polymer and pH changes (Vazquez et al., 1995). Gelatin was
commonly used in studies where swelling kinetics of polymers were being investigated
(Ofner and Schott 1987; Schott 1992) or used as controlled delivery systems for chemicals
or pharmaceuticals from gelatin films (Wu and Yan, 1994), gelatin nanoparticles (Bajpai
and Choubey, 2006) or hydrogels (Welz and Ofner, 1992). The swelling of gelatin is well
characterised and therefore future work should substitute the gelatin polymer for another
suitable natural polymer, such as laminin or fibronectin.
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4.5.1.2 Meniscus formation
The second limitation associated with two-dimensional cell seeding of these hydrogels was
the formation of a meniscus. The smaller the gel, the larger the proportion of the gel
surface was curved due to the meniscus. A curved gel surface was diﬃcult to image as
the cells were not in the same focal planes and were out of focus. The hydrogels needed
to be polymerised in a way that would produce a large flat surface area for cell culture
after the gels had swollen.
4.5.1.3 Finite mass of functionalised gelatin
The final limitation was that the mass of functionalised gelatin was a small, finite amount;
making large volume hydrogels or hydrogels with a large amount of waste hydrogel mate-
rial, would lead to rapid depletion of available resources and would limit the experiments
and number of repeats which could be performed.
4.5.2 Challenges to the development of cell seeding methods
The seven methodologies for forming the hydrogel models and seeding with cells detailed
in this chapter were developed in chronological order to address the challenges highlighted
in the previous method, either the gel swelling, meniscus formation or large gel limiting
the number of experiments that could be performed.
4.5.2.1 Method 1 - The 96-well to 48-well gel transfer method
The first method developed involved forming the hydrogel in a 96 well plate, and adding
PBS to allow the hydrogels to swell overnight prior to moving each hydrogel into a 48 well
plate. The transfer of gel into larger wells often resulted in damage to the gel and the
meniscus made high magnification imaging diﬃcult. The meniscus provided a concave
surface, so cells were in diﬀerent focal planes when imaging, which presented out of focus
cells in every image. The meniscus also caused a high density of cells to pool in the
middle of the gel and a low density of cells towards the edges, thereby causing a cell
density gradient, which could aﬀect cell viability and reactivity results. This method was
therefore not appropriate for this model.
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4.5.2.2 Method 2 - The large gel method
In order to eliminate the formation of a meniscus, a coverslip was used in method two,
to produce a large, flat hydrogel surface, the hydrogel was highly portable and easy to
transfer onto a microscope slide for imaging and cells were seeded on a large flat surface
resulting in all cells being in focus. However, the hydrogels had a large surface area, which
required a large volume of reagents for assays and a large number of cells to achieve a
high seeding density. As the mass of functionalised gelatin was limited, this method was
not cost eﬀective.
4.5.2.3 Method 3 - The parafilm method
The third method used the benefit of using a coverslip from method 2, to provide a flat
surface, but aimed to improve the cost-eﬀectivity of the hydrogels by producing many low
volume hydrogels with a flat surface, using small parafilm covers. However, the parafilm
was challenging to apply flat, therefore the hydrogels were not always level and a slight
angle of the hydrogel surface caused media to run oﬀ the surface and cause a loss of cells,
which caused variation to the cell densities between hydrogels. The method was time
consuming and resulted in challenging transfers from Petri dish to well plate and then
slides for imaging, which was often damaging and wasteful, therefore this method was
determined unsuitable for this model.
4.5.2.4 Method 4 - The Multi-well method
The fourth method used multi-well imaging slides to partially polymerise the hydrogels,
which were then replaced with a coverslip to prevent meniscus formation. The method
was designed to reduce the need to transfer the hydrogels from a mould used to polymerise
the hydrogels, to the vessel used to culture the cell seeded hydrogels and remove the need
to transfer the hydrogels to a microscope slide for imaging. However, the method resulted
in large volume hydrogels, which had partial meniscus formation and bubbles trapped
beneath the coverslip. The method was not cost eﬀective and determined unsuitable for
use in this model.
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4.5.2.5 Method 5 - Biopsy punch
The fifth method was designed to produce many small hydrogels from one large hydrogel
formed in a six or twelve well plate, by using a 5mm biopsy punch. The fifth method
benefitted from producing many identical, small gels with a flat surface, however the
method was time consuming and a large proportion of the gel surface was aﬀected by a
meniscus. A large proportion of the gel was wasted, which was not cost eﬀective, due
to the limited mass of functionalised gelatin available and therefore this method was
determined unsuitable for use in this model.
4.5.2.6 Method 6 - The Multi-spot method
The multi-spot method used an eight spot glass slide to polymerise, culture and image
the cell seeded hydrogels, to reduce the risk of damage to the sample during transfer
for culture and imaging purposes. After many optimisations, the multi-spot method did
allow the production of consistent, identical, low volume hydrogels with a flat surface ideal
for cell seeding and imaging. However, after the gels had swollen, the hydrogels swelled
beyond the well spot and it was diﬃcult to maintain separate domains. It was diﬃcult
to keep the gels hydrated without a large quantity of media or reagents, therefore it was
not deemed to be suitable for this model.
4.5.2.7 Method 7 - Chosen combination method
The final method combined the benefits of methods 2, 5 and 6 to produce a high number
of low volume hydrogels, punched (method 5) from a large gel with a flat surface (method
2), which fitted within the individual spots of a multi-spot slide post-swelling (method 6)
with a small proportion of waste material produced. The hydrogels maintained separate
spatial domains with the use of a hydrophobic marker pen. The gels did not need to
be moved from the slides once cells had been added to the surface of the hydrogels,
which resulted in an easier process that was less damaging to the hydrogel samples. The
limitations with this method were that the hydrogels could only hold 50 µL on the surface
of the hydrogel, therefore media changes were required on a daily basis or the cell seeded
hydrogels would dry out and aﬀect cell viability. Method 7 was the most eﬃcient, cost-
eﬀective and reproducible method, which was easily accessible for accurate cell seeding
and imaging, therefore it was determined to be suitable for use with this model.
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4.5.3 Mechanical properties of the matrices
The mean complex elastic modulus was determined by rheology at 1Hz frequency, 0.5%
shear strain at 37°C for each polymer concentration (Figure 4.4.1). The 5% (w/v) PEGDA
hydrogel had a stiﬀness of 20 Pa (±3.16 Pa), the 7.5% (w/v) PEGDA hydrogel had a
stiﬀness of 250 Pa (±20.42 Pa), the 10% (w/v) PEGDA hydrogel had a stiﬀness of 700
Pa (±86.43 Pa), the 12.5% (w/v) PEGDA hydrogel had a stiﬀness of 2,900 Pa (±634.95
Pa) and the 15% (w/v) PEGDA hydrogel had a stiﬀness of 3,900 Pa (±1458.68 Pa).
These stiﬀness measurements were found to be statistically diﬀerent when analysed by
a one way ANOVA (P<0.05) with Fisher LSD post hoc comparison. The curves of the
complex modulus (G*) showed parallel lines throughout the frequency sweep (0.5-5Hz)
with a slight increase in the elastic modulus with the frequency, which is typical behaviour
of a gel-like structure under oscillatory rheological testing (Mezger, 2006).
The matrix stiﬀness range for use in a spinal cord injury model, should be in the region
of native neural tissues, which can vary approximately from 100-500 Pa with respect of the
source of the tissue, time after dissection and testing methods used (Engler et al. 2006; Lu
et al. 2006; Cheng et al. 2008; Christ et al. 2010; Moshayedi et al. 2014; Smith 2016). AFM
measurements of the rat neocortex and spinal cord were found to be 219-318 Pa, which
decreased in stiﬀness up to three-fold with stab or crush injuries (Moeendarbary et al.,
2017). Although there is evidence to suggest that stiﬀer matrices (8,000 Pa) could induce
an astrogliosis-like, larger and elongated morphology of astrocytes on two-dimensional
matrices, whereas hydrogel matrices of 200 Pa elastic modulus encouraged a smaller,
rounded astrocyte morphology (Wilson et al., 2016).
The developed hydrogel was capable of achieving matrices with a stiﬀness in excess of
4,000 Pa, however the mass of functionalised gelatin available for use was limited due to
the cost of the acrylate-PEG-NHS molecule and the process to functionalise the gelatin
required a large amount of time which was in short supply towards the end of the project.
The decision was made to use the 5% (20 Pa), 7.5% (250 Pa) and 10% (700 Pa) (w/v)
PEGDA matrices to investigate how the stiﬀness of the matrix aﬀected CNS cells, as these
stiﬀnesses were close to the range of measured neural tissues (100-500 Pa) (Moeendarbary
et al., 2017). The stiﬀer matrices 12.5% and 15% (w/v) PEGDA matrices were only used
to investigate how the stiﬀness of the matrix aﬀected astrocytes in isolation to conserve
resources.
4.5.4 Investigation into the eﬀects of matrix stiﬀness on CNS cell
behaviour
The aim of this part of the study was to culture cells of the CNS on matrices of diﬀerent
stiﬀnesses to investigate if the stiﬀness of the matrix had an eﬀect on CNS cell behaviour
as a preliminary spinal cord injury model.
Astrocytes, microglia and neurons were cultured in isolation to simplify the model, in
order to study the direct relationship between the matrix stiﬀness and the individual cell
type without adding a layer of complexity from cell-cell interactions.
A mixed glial culture was also seeded onto matrices of diﬀerent stiﬀnesses to investigate
how the CNS cells respond to matrices of diﬀerent stiﬀnesses in co-culture with cell-cell
communications.
4.5.4.1 Astrocyte cell metabolism changes on matrices of diﬀerent stiﬀnesses
Astrocytes when cultured in isolation on the surface of hydrogels, showed a significant
increase in cell metabolism from the 20 Pa stiﬀness hydrogel to the 700 Pa stiﬀness
hydrogel, measured by ATP-lite cell viability assay and confirmed by one way ANOVA.
However, there was no statistically significant diﬀerence in astrocyte cell metabolism
on gels with a stiﬀness of 250 Pa, compared to gels with a complex moduli of 700 Pa or
20 Pa. There was a slight increase in cell metabolism with matrix stiﬀness from 20 Pa
to 250 Pa, and 250 Pa to 700 Pa, which was not significant but may have proven to be
significant if more samples were analysed.
The trend in the data suggested that astrocyte cell metabolism was lowest on the
softest matrix (20 Pa) and increased with an increasing stiﬀness up to 700 Pa, after which
the stiﬀness did not have an eﬀect on cellular metabolism, there was no statistically
significant diﬀerence in cell metabolism between astrocytes cultured on 700 Pa, 2.9 kPa
and 3.9 kPa stiﬀness matrices.
There are a limited number of studies which investigate the role of the stiﬀness of
the matrix on astrocytes and in particular astrocyte metabolism, however Wilson et al.
(2016) found that astrocytes cultured on a 8 kPa stiﬀness hydrogel matrix exhibited 1.7
fold increase in BrdU staining compared to astrocytes cultured on a 200 Pa stiﬀness
matrix, coupled with flow cytometry to quantify BrdU staining, these results indicated
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astrocyte proliferation on stiﬀer matrices. Astrocyte proliferation on the stiﬀer matrices
may have contributed towards the increase in astrocyte metabolism measured in this
study and should be investigated thoroughly in future work.
4.5.4.2 Astrocyte cell viability changes on matrices of diﬀerent stiﬀnesses
The ATP-lite cell viability assay results were compared and validated against the live/dead
cell viability assay. The results also showed a significant increase in cell attachment over
the surface of the gel between the softer matrices of 20 Pa, 250 Pa and the stiﬀer matrices
700 Pa, 2,900 Pa and 3,900 Pa as determined by a one way ANOVA. In addition, there were
no significant diﬀerences in the total area of the gel covered with viable astrocytes between
the 700 Pa, 2.9 kPa and 3.9 kPa stiﬀness hydrogels, which suggests that astrocytes are
receptive to changes in the mechanical properties of the matrix in a small range, within
a similar complex moduli to that of brain tissues (100-1,000 Pa) (Georges et al. 2006;
Engler et al. 2006; Cheng et al. 2008).
Similarly, in a study by Leach et al. (2007), PC12 neurons were found to have a
threshold response to substrate stiﬀness at approximately 100 Pa; at 10 Pa the neurites
were very few in number, short and unbranched. Above 100 Pa the neurites were longer,
branched and present on higher numbers of neurons, but there was no significant diﬀer-
ence between 100-1000 Pa substrate stiﬀnesses; this suggested that as long as the matrix
stiﬀness was within that range, conditions for neurite extensions were favoured (Leach
et al., 2007). A similar phenomenon was observed for astrocytes in this study, astrocyte
metabolism, viability, and attachment increased on gels up to 700 Pa, then had very little
diﬀerence on matrices above the 700 Pa threshold.
4.5.4.3 Astrocyte reactivity changes on matrices of diﬀerent stiﬀnesses
Astrogliosis is typically associated with an up-regulation of GFAP intermediate filament
expression by astrocytes (Sofroniew, 2009). The astrocyte seeded hydrogels were fixed and
immunolabelled for GFAP and Hoechst nuclear stain. The results showed a significant
up-regulation in GFAP expression between the 20 Pa and 250 Pa stiﬀness matrices, as
well as between the 20 Pa and the 700 Pa stiﬀness matrices as determined by a one way
ANOVA. Unfortunately there was insuﬃcient functionalised gelatin remaining to perform
immunohistochemistry on the 12.5% (w/v) and 15% (w/v) PEGDA hydrogel matrices.
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Other studies have shown significant increases in GFAP expression of astrocytes on stiﬀer
matrices compared to softer hydrogel matrices (874 Pa vs 47.96 Pa (Smith, 2016), 200 Pa
vs 8,000 Pa (Wilson et al., 2016), 300 Pa vs 47 kPa (Georges et al., 2007)).
Studies have shown that astrogliosis results in an increased number of astrocytes
present in the area of injury by induction of astrocyte proliferation (Sofroniew and Vinters
2010; Wilson et al. 2016). This increased astrocyte attachment also aligned with a study
by Georges et al. (2007) who found that cell adhesion in pure astrocyte cultures was low
on soft matrices and astrocytes preferentially adhered to matrices with higher stiﬀnesses.
It was found in the present study that astrocytes have a higher metabolism, greater at-
tachment and an increased expression of GFAP when cultured on a stiﬀer 700 Pa hydrogel
matrix when compared to astrocytes cultured on a soft 20 Pa hydrogel matrix.
4.5.4.4 Mixed glial cell viability and metabolism changes on matrices of dif-
ferent stiﬀnesses
In contrast to the results of the ATP-lite assay analysing the metabolism of astrocytes
cultured in isolation, mixed glial cultures of astrocytes, oligodendrocytes and microglia,
showed a decreased cell metabolism, with an increase in matrix stiﬀness. A significant
decrease in cell metabolism was found between the 20 Pa and the 700 Pa stiﬀness hydrogel
matrix. A significant decrease was also found from the 250 Pa to the 700 Pa stiﬀness
hydrogel matrix, determined by one way ANOVA.
The live/dead assay results were in agreement with the ATP-lite results and indicated
a decrease in the total area of the gel covered with green labelled living cells, cultured
on the stiﬀer 700 Pa matrix compared to the softer hydrogels 20 Pa and 250 Pa stiﬀness
hydrogel matrices as determined by one way ANOVA. However, the softest 20 Pa matrix
and the 250 Pa stiﬀness hydrogel matrix did not show any significant diﬀerence in cell
viability by the proportion of the surface of the hydrogel labelled with green cells.
Mixed glial cells did not attach to the hydrogel matrix as strongly as astrocytes in
isolation, therefore many of the samples after labelling procedures had a low number of
cells attached to the hydrogel surface of the 20 Pa, 250 Pa and 700 Pa stiﬀness hydrogels.
Immunohistochemical labelling for GFAP was attempted for the mixed glial cultures,
however most of the mixed glial cells were lost from the surface of the hydrogel matrix
during wash steps and as a result of the staining procedure the results could not be
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analysed further. There was insuﬃcient time and quantity of hydrogel matrix available to
optimise the IHC procedure to fix, loosely adherent cells on the surface of the hydrogels.
Optimising labelling procedures would be performed for future work.
Most studies in the area of mechanosensitivity to matrix stiﬀness have investigated
the response of neurons (Balgude et al. 2001; Flanagan et al. 2002) and/or astrocytes
(Georges and Janmey 2005; Wilson et al. 2016) to matrix stiﬀness in isolation or in
neuron-astrocyte co-cultures (Georges et al., 2006). However a study of individual glial
response to matrix stiﬀness, in a mixed glial co-culture could not be found. This study
found that mixed glia had a higher cell viability and higher cell metabolism on softer
matrices, whereas astrocytes were found to have a higher cell viability and cell metabolism
on stiﬀer matrices. Therefore future work should investigate how the mixed glial cell-cell
communication aﬀects glial cell response to matrix stiﬀness in more detail.
4.5.4.5 Investigation into the eﬀects of the stiﬀness of the matrix on neuronal
behaviour
Neurons derived from the DRGs of the adult rat spinal cord did not firmly attach to the
surface of the synthetic-biologic hybrid hydrogels. There was no statistically significant
diﬀerence observed using the ATP-lite cell viability assay on matrices of 20 Pa, 250 Pa
or 700 Pa stiﬀness hydrogels, as determined by one way ANOVA. Similarly, the live/dead
assay and immunohistochemical labelling for B3-tubulin did not highlight any neurite
outgrowth on any of the hydrogel matrices of diﬀerent stiﬀnesses.
The importance of three-dimensional cell culture environments should not be over-
looked. In the study by Fawcett et al. (1989), they were also unable to produce ax-
ons from neurons in two-dimensional monolayer cultures, whereas the three-dimensional
model reproduced the behaviour of axons in vivo allowing the neurons to grow and
spread neurites. Three dimensional cell culture systems have advantages over two di-
mensional systems, secreted molecules in monolayer culture are rapidly diluted in the
culture medium. Whereas in a three-dimensional matrix these molecules are trapped
in the extracellular space (Fawcett and Asher, 1999). Cells are mechanically bound to
and supported by their extracellular matrix. Forces are transmitted diﬀerently to cells
in two-dimensional and three-dimensional environments, for example fibroblasts increase
collagen and glycosaminoglycan production and express increased levels of growth factors
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in three-dimensional versus two-dimensional culture Pedersen and Swartz (2005). In a
similar study by Lampe et al. (2010), they did not find a significant diﬀerence in B3-
tubulin gene expression of neural precursor cells on two-dimensional PEG hydrogels with
diﬀerent macromer weight percentages with stiﬀnesses ranging from 1 kPa to 100 kPa
compressive modulus (native brain tissues measured at 3.4 kPa, therefore stiﬀnesses not
comparable with elastic modulus). Future studies should investigate how matrix stiﬀness
aﬀects neurons in three-dimensional cell culture.
4.5.4.6 Microglial cell metabolism changes on matrices of diﬀerent stiﬀnesses
Similarly to the ATP-lite results for mixed glial cultures, microglia showed a strong pref-
erence for the softer matrix. Microglial metabolism was significantly higher on the 20 Pa
stiﬀness matrix compared to both the 250 Pa and 700 Pa stiﬀness matrices. The increased
cell metabolism on the softer matrices may be as a result of proliferation. In cell culture,
microglia detached from the bottom of the T-flask and migrated to the medium-air inter-
face, where they were able to float and proliferate (Moussaud and Draheim, 2010). This
behaviour was observed in the present study, mature microglia from the adult rat spinal
cord were cultured with granulocyte macrophage colony stimulating factor (GM-CSF)
in the T-flask, microglia detached from the bottom of the T-flask and migrated to the
medium-air interface, where they proliferated in suspension. This suggested that strong
cell attachment was not necessary for microglial proliferation and it may be that the mi-
croglia respond to the soft hydrogel matrix microenvironment by increasing proliferation.
This hypothesised increase in microglial proliferation on the 20 Pa stiﬀness matrix, could
also explain the significantly higher mixed glial cell metabolism on the 20 Pa stiﬀness
matrix, when compared to the 700 Pa stiﬀness matrix, despite the majority of cells being
astrocytes in the mixed glial cell population, not microglia.
Unfortunately, the method for labelling microglial seeded gels using immunohisto-
chemistry resulted in detachment of cells from the two-dimensional matrix during the
incubation and wash steps, resulting in an absence of cells in the images, therefore live
cell imaging using brightfield microscopy was used to qualitatively assess cell attachment
on the matrix prior to staining. Cell attachment was poor on the 250 Pa and 700 Pa stiﬀ-
ness matrices, the numbers of attached microglial cells were greatly reduced compared
to the numbers of microglial cells observed on the softest 20 Pa stiﬀness matrix. The
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increased numbers on the 20 Pa stiﬀness matrix supports the hypothesis of microglial
proliferation on the softer matrices.
4.6 Conclusions
The decision was made to use the 5%, 7.5% and 10% (w/v) PEGDAmatrices to investigate
how the stiﬀness of the matrix aﬀected astrocytes, neurons, microglia and mixed glial
cultures, as these stiﬀnesses were within the range of stiﬀness measured for neural tissues
(100-500 Pa) (Hirakawa et al. 1981; Miller et al. 2000; Lu et al. 2006; Christ et al. 2010;
Bernick et al. 2011; Moshayedi et al. 2014; Lacour et al. 2016; Moeendarbary et al. 2017).
A softer matrix (20 Pa) and a stiﬀer matrix (700 Pa) was important to characterise the
response to matrix stiﬀness outside of a normal range and yet still clinically realistic for
neural tissues. Higher stiﬀnesses would have been used to accompany the lower range if
a larger mass of functionalised gelatin was available to make stiﬀer hydrogels.
The chosen method for preparing and seeding the hydrogels was the seventh method,
developed as a result of the knowledge acquired from methods 2, 5 and 6. Method 7
utilised an imaging slide to culture and image the cells, a coverslip on top of the hydrogel
solution during UV polymerisation to cross-link the hydrogel with a flat surface and a
biopsy punch was used post-swelling to ensure all gels were the same size and shape. The
method was successful and allowed analysis of the cells on the surface of identical matrices
with three diﬀerent stiﬀnesses.
The results in this study indicated that astrocytes when cultured in isolation, have a
higher astrocyte metabolism, viability and show an increase in GFAP expression when
cultured on a stiﬀer 700 Pa hydrogel matrix compared to astrocytes cultured on a soft 20
Pa hydrogel matrix. However, no significant diﬀerence in astrocyte metabolism, viability
and attachment was observed in matrices between 700 Pa to 3,900 Pa, suggesting that a
threshold response was observed at 700 Pa and an increase in matrix stiﬀness beyond this
level (up to 3,900 Pa) did not further eﬀect cell behaviour in two-dimensional cell culture
in this study.
The investigation into how the stiﬀness of the matrix eﬀects neuronal cell behaviour
did not show any diﬀerences in neuronal cell behaviour on matrices of diﬀerent stiﬀnesses.
No significant diﬀerence was observed by ATP-lite cell viability assay, live/dead staining
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or IHC on matrices of 20 Pa, 250 Pa or 700 Pa. The live/dead images and immunohis-
tochemical labelling for  3-tubulin did not highlight any neurite outgrowth on any of the
matrix stiﬀnesses in two-dimensions.
Microglia showed a preference for the softer matrices, microglial metabolism was sig-
nificantly higher on the 20 Pa hydrogel matrix compared to both the 250 Pa and 700 Pa
hydrogel matrices, respectively. The live/dead cell viability assay and immunohistochem-
ical labelling were unsuccessful due to the poor cell attachment of microglia on the surface
of the hydrogels. However, live cell imaging showed a greater number of cells attached to
the 20 Pa matrix compared to both the 250 Pa and the 700 Pa matrices.
Mixed glial cells shared a similar matrix stiﬀness preference to microglia and elicited
a higher cell metabolism and a higher cell viability, on the softer 20 Pa and 250 Pa
matrix, compared to the stiﬀer 700 Pa matrix. There may be cell-cell communication be-
tween astrocytes, microglia and oligodendrocytes which encourages an increase in cellular
metabolism and reactivity on softer hydrogel matrices (20 - 250 Pa).
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Chapter 5
Investigation of the eﬀects of
displacement on astrogliosis and
microglial phenotype
5.1 Introduction
Understanding of SCI has increased during the last decade; SCI consists of two distinct
phases, the primary injury and the secondary injury cascade. The initial impact causes
a primary injury as a result of mechanical impaction to the spine. The primary injury is
followed by secondary injury, which is longer term and is caused by complex pathophys-
iological mechanisms (Anwar et al., 2016). This study has concentrated on the primary
injury after the initial mechanical insult, to a 3D in vitro cell-seeded collagen type-1 hy-
drogel model, to experimentally model the immediate eﬀects to astrocytes and microglia
in the twenty-four hour period following SCI.
The immediate physiological response to injury of the spinal cord, leads to the pro-
duction of an inhibitory microenvironment, which results in neuroinflammation, initiation
of secondary inflammatory cascade and development of a glial scar (Anwar et al., 2016).
Astrocytes and microglia coordinate the innate immune response of the brain and spinal
cord (Anwar et al., 2016). In response to spinal cord injury and contact with cellular
debris and myelin, microglia become activated, hypertrophic and transform from a qui-
escent ramified morphology, to a de-ramified functional role (Lee et al. 2007; Witcher
et al. 2015). Quiescent microglia, present a ramified morphology, but upon activation,
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microglia typically exhibit two other basic polarised states dependent on external sig-
nals. M1 microglia are classically activated pro-inflammatory phenotype, or M2 microglia
alternatively activated anti-inflammatory phenotypes (Durafourt et al., 2012).
There is evidence that microglia produce neurotrophins (Mallat et al. 1989; Elkabes
et al. 1996) and other neuron survival-promoting eﬀects (Rabchevsky and Streit, 1997).
However, there is also strong evidence to suggest microglia also play a neurotoxic role via
a variety of mechanisms involving nitric oxide, (Merrill et al. 1993; Matsui et al. 2010),
reactive oxygen species (Barger et al., 2007), glutamate (Barger et al., 2007), proteases
(Shields et al., 2000), and neurotoxins (Piani et al. 1991; Chao et al. 1992; Giulian et al.
1993). Thus microglia can be both beneficial and detrimental to regeneration post SCI
(Streit et al., 1999). Activated microglial cells communicate with other glial cells and
neurons, to determine whether activated microglia will elicit a neurotrophic or neurotoxic
influence (Streit et al., 1999). Activated M1 microglia initiate a cascade of neurotoxic
responses channeled through multiple signalling pathways such as TNF-↵, IL-1  and
IL-6 (Rothwell et al. 1997; Pan et al. 2002; Pineau and Lacroix 2007). Inflammatory
cytokine expression can be identified within two hours of the initial spinal cord injury
(Pan et al. 2002; Pineau and Lacroix 2007). M1 microglia can be recognised for the
expression of cell surface marker CD11b (complement receptor 3) (Durafourt et al., 2012).
Whereas, M2 anti-inflammatory microglial cells are polarised via the IL-10 signalling
pathway (Thompson et al., 2013).
In response to the initial SCI, astrocytes surround the lesion become activated, hy-
pertrophic and extend overlapping astrocytic processes. The web of astrocytic processes
provide a barrier around the injury site and eventually form a glial scar (Okada et al.,
2017). Glial scarring permanently impedes axonal regeneration and functional recovery in
both rodents and humans with SCI (Lee-Liu et al., 2013). Reactive astrocytes within the
glial scar produce inhibitory extracellular matrix proteins such as chondroitin and keratin
sulphate proteoglycans, which prevent axonal regeneration (Silver, 2016) and reactive as-
trocytes increase expression of glial fibrillary acidic protein (GFAP) (Fawcett and Asher,
1999). The expression of GFAP is measurable and can be quantified in vivo or in vitro
studies, to measure the reactivity of astrocytes following SCI (Smith, 2016).
Pro-inflammatory cytokines, such as tumor necrosis factor-↵ (TNF-↵), interleukin-1 
(IL-1 ) and interleukin-6 (IL-6), are strongly associated with pathological pain (Zhang
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et al., 2012), are secreted by astrocytes and accumulate quickly in the lesion site after SCI
(Bethea et al. 1999; Chi et al. 2008). Release of TNF-↵ and IL-6 can be quantified with
an Enzyme-linked immunosorbent assay (ELISA) and are a useful indication of astrocyte
reactivity.
Animal models of SCI are useful tools to investigate the primary response to SCI, as
the conditions of the injury can be controlled, which is not possible in human cases of SCI.
Rats oﬀer several advantages over other animals for models of SCI, due to their low cost,
vascular anatomy and comparable physiology to humans (Anwar et al., 2016). However,
the translation of therapeutic modalities applied to mitigate the induced SCI in animal
models has met with limited success (Varma et al., 2013).
Road traﬃc accidents remain the highest cause of SCI in North America, Europe and
Australia (Cripps et al., 2011). Contusion models of SCI are designed to inflict a transient,
acute injury to the spinal cord similar to those experienced during road traﬃc accidents
(Cheriyan et al., 2014). However, due to the complexity of human SCI, no one animal
model can encompass all aspects of spinal cord injury. Each type of SCI model detailed
in Table 5.1, was designed to investigate how diﬀerent mechanical insults, such as strain,
compression or laceration, may aﬀect the spinal cord of the animal in diﬀerent ways.
Table 5.1: Types of spinal cord injury in animal models, adapted from Anwar et al. (2016).
Injury type Description of injury References
Distraction Stretching of cord (tension) Choo et al. (2007); Min-
Te Choo et al. (2009)
Compression of
cord
Compression of cord (such as
crush injuries or tumour com-
pression)
Cheriyan et al. (2014)
Dislocation Displacement of vertebra Choo et al. (2007); Min-
Te Choo et al. (2009)
Contusion Displacement and damage of
cord (such as burst fracture)
Choo et al. (2007); Min-
Te Choo et al. (2009)
Transection Partial or complete separation Rummery et al. (2010)
SCI rodent models have been created by a wide range of methods and devices, however
contusion models of SCI are the most clinically relevant models (Zhang et al., 2014).
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Some of the more common in vivo contusion devices are listed in Table 5.2, along with
the mechanism of contusion, and associated strengths and weaknesses. The MASCIS
impactor was first introduced by Gruner (1992), who used a weight-drop method to impact
the spinal cord (Gruner, 1992). Unfortunately this method suﬀered from a secondary
rebound impact from the impaction rod, which aﬀected the reproducibility of the method.
The method has been optimised since 1992, but does not produce reproducible lesions in
rats (Zhang et al., 2014). Recent advances in the field have driven the development of
computer operated impaction devices, such as the OSU impactor or the BOSE Electroforce
BioDynamic chamber used in this study, which delivers highly reproducible, validated
impactions with measurable force, displacement and velocity data. However, most in
vivo animal models require vertebral stabilisation to create a reproducible SCI, which is
generally a weakness of in vivo SCI models, which are not clinically relevant to human
SCI.
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The optimal choice of model for a study depends on the goals of the study (Cheriyan
et al., 2014). Where the goal of the study is to investigate isolated cell responses to
specific injury conditions, an in vitro model may be the most appropriate option, as
systemic factors can not be easily isolated from an in vivo model system.
Chapter three of this thesis detailed the development of a synthetic-biologic hydrogel,
whereby the mechanical properties of the matrix could be changed. Chapter four of
this thesis investigated how the mechanical properties of the matrix aﬀected CNS cell
behaviours in two-dimensional cell culture. The current chapter of this thesis details the
development of a BOSE Electroforce impaction system for use with an in vitro SCI model
and how the BOSE Electroforce impaction system was used to investigate how a contusion
injury aﬀects astrocyte and microglial reactivity when cultured within a three-dimension
collagen hydrogel model. Astrocyte and microglial reactivity will be quantified by the
expression of markers for reactivity (GFAP, CD11b), cytokine release (TNF-↵, IL-6 and
IL-10) and cellular metabolism (ATP).
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5.2 Aim
The aim of this part of the study was to determine whether the BOSE Electroforce
impaction system would be suitable to investigate how impact severity aﬀects the cells of
the spinal cord in a 3D in vitro spinal cord injury model.
5.2.1 Objectives:
• To determine if the BOSE Electroforce impaction system can be used as a contusion
device for use with an in vitro 3D collagen gel model.
• To develop an impaction protocol to produce repeatable impaction profiles with
diﬀerent impact severities, similar to impaction parameters in spinal cord injury in
vivo.
• To assess the viability of primary astrocytes and microglia after impaction at dif-
ferent displacement depths within 3D collagen gel models over twenty-four hours.
• To assess diﬀerential expression of cellular markers such as GFAP and CD11b (as de-
termined by immunocytochemistry and imaging techniques) after twenty-four hours
of cell culture, post impaction at diﬀerent displacement depths.
• To assess the eﬀect of impaction displacement depths on the levels of extracellular
IL-6, IL-10 and TNF-↵ expression in microglia and astrocytes, as determined by
Enzyme-linked immunosorbent assay (ELISA).
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5.3 General methods
The experimental approach for this section involved the production of 3D in vitro type-I
collagen gel matrices seeded with astrocytes or microglia. The cell seeded matrices were
subjected to an impaction injury with diﬀerent displacement depths, to investigate if the
severity of the injury could be precisely modified using the BOSE Electroforce BioDynamic
impaction system. The cells seeded into collagen matrices were then analysed using an
ATP cell viability assay, immunolabelled for expression of GFAP or CD11b and the culture
media was analysed for cytokine expression and quantification.
The primary astrocyte or microglial cell seeded within the matrices were from cell
cultures pooled from four to six separate animals to account for donor variability. Each
experiment was repeated at least four times accounting for variation in the assay reaction.
5.3.1 Cell isolation
Primary astrocytes were isolated from postnatal day 2 Wistar rat pups using the dissection
protocol detailed in section 2.10.2 and isolation protocol detailed in section 4.3.3.2.
Primary microglia for culture in isolation, were isolated from adult Wistar rats using
the dissection protocol detailed in section 2.10.3 and isolation protocol detailed in section
4.3.3.5.
5.3.2 Preparation of 3D cell seeded collagen hydrogel matrices
The basic type-1 collagen gel matrix consisted of 10% (v/v) 10x minimal essential medium
(MEM), which was added to a sterile universal container. Using a wide bore pipette, 80%
(v/v) type-I rat tail collagen (2mg·mL 1 in 0.6% (w/v) acetic acid) was mixed with
the MEM. The mixture was neutralised with 5.8% (v/v) neutralising solution before the
addition of 4.2% (v/v) cell culture medium (the appropriate media for the specified cell
type), which contained the appropriate number of cells (1 x 106 cells per mL hydrogel
solution) to achieve the desired cell density. The required cell types were retrieved from
several flasks from diﬀerent litters to account for donor variability. The hydrogel solution
was distributed using a wide-bore pipette in 100 µL aliquots into a 96 well plate and 10
minutes allowed for the gels to set at 37 °C, 5% CO2 in air, before cell culture medium
was placed on top of the hydrogels.
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The cell seeded collagen hydrogel matrices were cultured for 2 hours at 37 °C in 5%
CO2 in air prior to impaction to allow for cellular attachments to the gel to be formed.
5.3.3 Installation of the BOSE ElectroForce BioDynamic 5110
The BOSE ElectroForce BioDynamic 5110 applied compressive loads onto in vitro spinal
cord injury models in a closed sterile system. The BOSE ElectroForce BioDynamic 5110
was installed inside a class II cell culture hood, so that hydrogel preparation and loading
into the impaction rig was performed aseptically and free from contamination (Figure
5.3.1). A water bath and pump were added to the system so that the media could be
maintained at 37 °C for long term injury simulations and injuries which required the
hydrogel to be submerged in media prior to impaction. The BOSE ElectroForce BioDy-
namic 5110 was connected to a desktop computer, so that it could be remotely controlled
using WinTest7 controller software, to set the requirements of the injury stimulus such as
displacement depth, force or velocity and the results were recorded during the impaction.
Figure 5.3.1: BOSE ElectroForce BioDynamic 5110 installed in a tissue culture hood.
Water bath was used to maintain media temperature at 37 °C. Media bottle attached to
the pump, to fill and empty the BioDynamic chamber. Equipment attached to desktop
computer with WinTest7 controller software.
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5.3.4 Sterilisation of the BOSE ElectroForce BioDynamic 5110
The BioDynamic chamber contained many removable parts, the components which were in
direct contact with the inside of the chamber, were removed from the chamber or loosened
and sealed in an autoclavable bag (Figure 5.3.2a). The reservoir bottle, BioDynamic
chamber, impaction shafts, impactor tips and tubing were thoroughly cleaned with 1%
(v/v) Trigene and 70% (v/v) ethanol, before being sealed in autoclavable bags (Figure
5.3.2b). The autoclavable bags that contained the chamber, components, reservoir bottle
and tubing were placed in the autoclave for moist heat sterilisation at 121°C for 20 minutes.
(a) (b)
Figure 5.3.2: BOSE ElectroForce BioDynamic 5110 removable parts, a) BioDynamic
chamber, sides and impactor shafts, b) Reservoir bottle and tubing, sealed in autoclavable
bags and prepared for moist heat sterilisation at 121°C for 20 minutes
The rubber diaphragm seals were removed and cleaned with 1% (v/v) Trigene and 70%
(v/v) ethanol, but were not autoclaved, to prevent degradation of the rubber parts. The
tissue culture hood and equipment within the tissue culture hood was sprayed liberally
with 1% (w/v) Virkon and 70% (v/v) ethanol before and after use.
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5.3.5 Impaction tip design for the BOSE ElectroForce BioDy-
namic 5110.
The impaction shafts that were supplied from TA Instruments for the BOSE ElectroForce
BioDynamic 5110 were not appropriate for use with this model, due to an indentation
in the shaft (Figure 5.3.3 A) which prevented compression of the gel (as the gel sat in
the middle of the indentation well). Therefore impaction tips for the BOSE ElectroForce
BioDynamic 5110 were designed as illustrated in Appendix E Figure 9.5.1. The engineer-
ing diagram was submitted with measurements to the School of Mechanical Engineering,
University of Leeds, for manufacture of the custom impaction tips for use in this study.
The objective for this part of the study was to manufacture suitable impaction tips to
be used with the BOSE Electroforce impaction system to determine if the BOSE impaction
system could be used as a contusion device for use with an in vitro 3D collagen gel model,
with impaction profiles similar to impaction parameters observed in spinal cord injury in
vivo.
There were 8 potential impaction tips designed, four impaction tips for use with low
volume hydrogels (100 µL) (Figure 5.3.3 B) and four impaction tips for high volume hydro-
gels (1mL) (Figure 5.3.3 C). The middle of the shaft was removed and could be replaced
with the low volume impaction tips (Figure 5.3.3 D). The rounded impaction tip (Figure
5.3.3 E) was an appropriate size and shape for the 100 µL collagen hydrogels (Figure 5.3.3
F) and was chosen for use with this spinal cord injury model.
5.3.6 Impaction protocol
The impaction protocol was designed to investigate the eﬀect of diﬀerent displacement
depth conditions on astrocytes or microglia, in order to emulate diﬀerent impaction severi-
ties. The BOSE Electroforce BioDynamic 5110 was utilised throughout the study to apply
an injury to the spinal cord hydrogel model. A 20N load cell was installed to measure
force during impactions, however due to the soft nature and low volume of the materials
used, the force diﬀerences generated were beyond the sensitivity limits of the load cell
and could not be distinguished from background noise.
The BioDynamic chamber could be filled with media using the pump system and the
water bath to maintain the media temperature at 37 °C. The closed media loop system
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Figure 5.3.3: Custom made impaction tips for the BOSE ElectroForce BioDynamic 5110.
A) Original tip of the impaction shaft, B) Four low volume gel impaction tips, C) Four
high volume gel impaction tips, D) The hole in the impaction shaft head where the tip is
inserted, E) Chosen rounded impaction tip, F) Impaction tip above the collagen gel. For
scale of impaction tips, see engineering diagram for measurements (Appendix E Figure
9.5.1).
was useful for long term work where the impaction tip moved at low velocity causing
minimal media flow in the chamber. However, for short term primary SCI studies, the
impaction velocity was too high, which caused the media to flow strongly during the im-
paction protocol and dislodge/move the hydrogel oﬀ the platen, often causing inaccurate,
unrepeatable impactions and therefore media was not added to the chamber during the
impaction protocols in the optimised protocols.
The BOSE impaction rig was controlled by WinTest7 software, the schematic dis-
played in Figure 5.3.4 was prepared to aid understanding of the impaction protocol. The
WinTest7 software was loaded, the correct project file was opened, the ‘mover power’ was
turned on and the bottom impaction platen was raised to meet the top impaction platen,
when the force data increased, it was clear the platens had connected and the zero point
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was recorded. In order to prevent damage to the load cell, the displacement limits of the
software were changed so that the displacement limit resulted in a gap of 0.05mm between
the platens, therefore an overshoot of the complete displacement conditions, would not
have caused an emergency stop to the protocol or damage the load cell. As a precaution,
the force limit was set to 18N as the maximum force the load cell could detect without
damage was 22N, therefore any experimental error that resulted in a large force, would
have executed the emergency stop procedure, which would have prevented any damage
to the load cell.
After the zero point was established, the bottom platen was lowered to 4mm below
the top platen and the hydrogel was inserted onto the centre of the bottom platen. The
impaction tip was then lowered to the point at which the tip touched the surface of the
hydrogel; this was the 0% displacement. The height was recorded and the diﬀerence
between the height of the zero point and the height of the top of the hydrogel (0% dis-
placement) was used to calculate the impaction displacement depths i.e. halfway between
the zero point and the top of the gel would have been 50% displacement. The impaction
parameters were set in the block waveform, which allowed ramps and dwells, i.e. changes
in displacement depth and delays in the movement of the impactor tips. The velocity of
impact was set up to 3000mm·s 1, the impaction tip was removed at 3mm·s 1.
In order to maintain the same impaction protocol for all hydrogels, the starting height
was set to 0mm, and a ramp of 30mm·s 1 was used to ensure the same starting point for
all impactions.
The protocol was set to dwell for 0.1 second so that the software would start recording
0.1 seconds prior to impaction in order to capture all the relevant data, due to the high
velocity of the impact and limit to number of measurements taken per second. When the
impactor was at 0mm prior to starting the impaction protocol and there was no dwell
period, the software was not able to capture the start of the impaction event.
Spinal cord injury events can be high velocity, high impact and therefore the maximum
capable velocity of the equipment (3000mm·s 1) was selected and the displacement depth
calculated as a percentage from the diﬀerence between the zero and top of hydrogel.
However, to prevent an overshoot of the displacement depth, 0.1mm higher displacement
depth was selected to be reached at 3000mm·s 1 and then another ramp was used to
achieve the target displacement depth at the lower velocity of 3mm·s 1; this would also
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Open WinTest7, load project, turn mover power on
Reduce gap between platens to Zero, record distance and set limits
Lower bottom platen by 4mm and insert hydrogel
Raise platen to touch hydrogel; this was 0% displacement distance
Calculate the distance required to achieve 50%, 80% or 100% displacement distance
Set ramp to 0mm start height at 30mm per second
Dwell at 0mm start height for 0.1 second
Set ramp for impaction at 3000mm per sec-
ond to 0.1mm above desired displacement depth
Set slower ramp at 3mm per second to desired displacement depth
Dwell for 0.01 second to ensure full impaction event is recorded
Set ramp to remove platen at 30mm per second to 0mm start height
Remove hydrogel, save measurements and repeat process for next hydrogel
Figure 5.3.4: Schematic to detail the steps of the impaction profiles for the BOSE Elec-
troForce BioDynamic system used in this study.
account for any elastic recoil in natural tissues. The impaction protocol dwelled at the
target displacement depth for 0.01 second prior to the recoil at 30mm·s 1 to the starting
position, which released the hydrogel and captured the data from the impaction. The
block waveform programme impaction parameters are displayed in Figure 5.3.4.
The impaction protocols for the three displacements used in the study, (50%, 80%
and 100%) are displayed in Figure 5.3.5. The direct axial command showed the input
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Figure 5.3.5: BOSE ElectroForce BioDynamic 5110 impaction protocol diﬀerences be-
tween direct axial command and performed actions by the impaction rig.
parameter as written in the block waveform programme, however the impaction rig was
not a virtual simulation and therefore has limitations in performing the actions as pro-
grammed. The impaction platens require acceleration to reach the desired displacement
depth at the programmed velocity and cannot abruptly cease movement at the desired
displacement depth within a viscoelastic hydrogel material without some recoil and read-
justment. There was a 0.01 second delay between the action being read by the software
and enacted by the rig, which can be observed in Figure 5.3.5 as the diﬀerence between
the programmed displacement and the axial command.
5.3.7 Imaging protocol for quantitative analysis of cellular via-
bility in hydrogels
In order to evaluate the eﬀects of impaction on cells in hydrogels, one tiled image was
taken for each gel; the image captured the whole gel for analysis. A coverslip was placed
over the hydrogels so that all cells on the surface of the gel were in the same focal plane
and therefore would be in focus. The centre of the gel was located, a minimum of 5
x 5 tiled image was selected, so that a minimum of 25 images were generated for each
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impacted gel.
In order to quantitatively analyse the number of living or dead cells, the images were
processed using ImageJ proprietary software as described in section 4.3.4.
5.3.8 Determination of cytokine release by ELISA
The following ELISA solutions were prepared prior to the start of the assay (for rat IL-6,
IL-10 and TNF-↵):
• Substrate solution (R and D systems DY999 colour reagent A and colour reagent B
mixed 1:1 immediately prior to use)
• Stop solution (1M Sulphuric Acid)
• Normal goat serum (R and D systems DY005, specific for IL-10 ELISA)
• Reagent diluent (1% (w/v) BSA in PBS, which has been passed through a 0.22 µm
sterile filter)
• Wash buﬀer (0.05% (v/v) Tween 20 in PBS)
The ELISA protocol is detailed in Figure 5.3.6. All steps were performed at room
temperature and the plate was sealed with a clear plastic film cover for all incubation
steps to prevent evaporation. An orbital shaker was used to agitate the plate throughout
the incubation periods to allow for thorough mixing of reagents and all antibody solutions
and Streptavidin-HRP were made to the working dilutions as per the specific ELISA
certificate of analysis. A microplate reader was used to analyse the optical density of each
well, readings were taken at 570 nm and 450 nm. The readings at 570 nm were subtracted
from the readings at 450 nm to correct optical imperfections in the plate.
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Capture antibody was diluted in reagent diluent to 4 µg·mL 1
96-well plate was coated with 100 µL per well of the capture antibody
The plate was sealed and incubated overnight
Each well was aspirated and washed with 200 µL wash buﬀer, repeat 3 times
300 µL reagent diluent added to prevent non-specific antibody binding
The plates were incubated for 1 hour. The aspiration/wash step was repeated 3 times
100 µL of sample or standards in reagent diluent were added to each well
The plate was incubated for 2 hours. The aspiration/wash step was repeated 3 times
100 µL detection antibody in reagent diluent* added and incubated for 2 hours
The aspiration/wash step was repeated 3 times, 100 µL of Streptavidin-HRP was added
The plate was covered in foil and incubated for 20 minutes
The aspiration/wash step was repeated 3 times
100 µL of substrate solution was added and incubated for 20 minutes in the dark
50 µL of Stop Solution was added to each well
The optical density of each well was determined using a microplate reader
Figure 5.3.6: ELISA protocol for rat IL-6, IL-10 and TNF-↵. All steps performed at room
temperature, Refer to list at start of section 5.3.8 for solution compositions, *reagent
diluent with 2% normal goat serum for IL-10 ELISA only.
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5.4 Results
The SCI study was performed at the University of Leeds, on a Bose ElectroForce BioDy-
namic 5110, as described in section 5.3.6. The matrices used in this study were neutralised
collagen hydrogels prepared as described in section 5.3.2, seeded with 5 x 104 primary glial
cells, derived from post natal day 2 rat cortices or mature microglia derived from adult rat
spinal cord, as described in section 5.3.1. Each hydrogel was seeded with the appropriate
cells (astrocytes or microglia) and cultured for a minimum of 2 hours at 37 °C, 5% CO2
in air to allow for cellular attachments to be made, prior to impaction. The gels were
analysed at either four hours or twenty-four hours post impaction injury.
The impaction protocol, described in section 5.3.6, and the cell seeding densities,
remained constant throughout the investigation for astrocyte and microglial cultures.
The displacement depths were set to either 50%, 80% or 100% displacement based on the
initial height of the gel. The negative control was a cell seeded hydrogel that was not
impacted, the positive control was a cell seeded hydrogel that was not impacted, however
it was cultured with 50 ng lipopolysaccharide (LPS) to stimulate reactivity. The rounded
impaction tip (Figure 5.3.3 E) was used to create a spinal cord injury model, as it was
an appropriate size and shape for the 100 µL collagen hydrogels, it also resembled blunt
trauma to the spinal cord due to the rounded tip which provided compression as opposed
to piercing the collagen gel with a sharper impaction tip.
5.4.1 The eﬀect of impaction displacement depth on astrocyte
viability and metabolism
The ATP-lite assay was performed as detailed in section 2.12.2 to quantify cell viability
and metabolism, by providing a quantitative measure of ATP production within metabol-
ically active cells.
The ATP-lite assay showed that the luminescence emitted, was higher in the impacted
hydrogels compared to the non-impacted hydrogels at four hours post impaction (Figure
5.4.1a) and twenty-four hours post impaction (Figure 5.4.1b). Astrocytes emitted signifi-
cantly higher luminescence from the ATP-lite assay when impacted to 100% displacement
depth within the collagen hydrogels than any other displacement depth, four hours af-
ter impaction, with the exception of the positive control, which was cultured with 50 ng
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lipopolysaccharide (LPS) (Figure 5.4.1a), as determined by one way ANOVA with Fisher
LSD post-hoc comparison.
(a) (b)
(c)
Figure 5.4.1: Primary astrocytes (5 x 104) seeded in collagen hydrogels cultured for 4 or
twenty-four hours post impaction (0%, 50%, 80% or 100% displacement depth) at 37°C,
5% CO2 in air. ATP-lite assay a) four hours post impaction, b) twenty-four hours post
impaction c) 4 and twenty-four hours post impaction. Error bars indicate 95% confidence
interval, lines indicate statistical diﬀerence determined by one way ANOVA and two way
ANOVA (variables of time and displacement) (p <0.05), n = 6.
At twenty-four hours post impaction, astrocyte seeded collagen gels, the lumines-
cence emitted increased with increasing impact severity. A significant diﬀerence in cell
metabolism was observed between the following displacement depths: 0% to 80%, 0% to
100%, 50% to 80% and 50% to 100% (Figure 5.4.1a), as determined by one way ANOVA
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with Fisher LSD post-hoc comparison.
The positive control, which was not impacted, but contained cells cultured with 50 ng
LPS, decreased in cell metabolism from four hours to twenty-four hours post impaction.
However, astrocytes seeded within hydrogels that were impacted to 80% or 100% displace-
ment, increased significantly from four hours to twenty-four hours post impaction (Figure
5.4.1c), as determined by two way ANOVA with Fisher LSD post-hoc comparison.
An impaction to 50% displacement depth was not a severe enough injury to stimulate
a significant increase in cellular metabolism from the uninjured 0% displacement control
at four hours or twenty-four hours post injury (Figure 5.4.1c).
5.4.2 The eﬀect of impaction displacement depth on GFAP ex-
pression by astrocytes
The 3D in vitro collagen hydrogels were seeded with 5 x 104 primary astrocyte cells and
subjected to impaction injury to 0%, 50%, 80% or 100% displacement depth and cultured
for twenty-four hours prior to fixation and immunohistochemical labelling for GFAP. The
cell seeded hydrogels were also stained with Hoechst nuclear stain, to locate astrocyte
cells which did not express GFAP. Immunohistochemistry was performed as detailed in
section 2.12.3 and the labelled astrocyte seeded collagen hydrogels were visualised using
the Zeiss AX10 Axio scope upright microscope. A tiled image of each gel was captured
as described in section 5.3.7. The tiled image of the astrocyte seeded hydrogel was then
processed in ImageJ, as described in section 4.3.5, to quantify the proportion of each
image that was labelled positively for GFAP, by setting appropriate thresholds to remove
background, so that the image analysis software analysed the particles that were the
minimum size and had the minimum level of fluorescent intensity as detailed in section
4.3.5. A minimum of six gels per displacement depth and control was used, which was
repeated six times with six diﬀerent litters of rats to account for biological variation
(minimum of 36 gels per condition), the average proportion of GFAP positive pixels per
image increases significantly from the negative control which did not receive an injury
stimulus and increases signficantly with increasing displacement depth (Figure 5.4.2), as
determined by one way ANOVA with Fisher LSD post-hoc comparison.
A representative set of tiled images of astrocyte seeded collagen hydrogels, that have
been impacted to diﬀerent displacement depths (0%, 50%, 80%, 100% displacement depth)
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Figure 5.4.2: Primary astrocytes (5 x 104) seeded in collagen hydrogels cultured for
twenty-four hours at 37°C, 5% CO2 in air, subjected to impaction at 0%, 50%, 80%
or 100% displacement depths. Analysis of GFAP expression by astrocytes, quantified in
ImageJ. Error bars indicate 95% confidence interval, lines indicate statistical diﬀerence
determined by one way ANOVA (p <0.05), n = 6.
and 0% displacement cultured with 50 ng lipopolysaccharide (LPS), are illustrated in
Figure 5.4.3. The images have been highlighted with white outlines to show some of
the key features of these astrocyte seeded collagen hydrogel models. The area of the gel
where the impactor made direct contact, has been outlined as the zone of impact. A
lower proportion of GFAP positive cells were observed within the zones of impact. The
area surrounding the zone of impact contained a high proportion of reactive astrocytes
expressing high levels of GFAP and were labelled the zones of reactivity, adjacent to the
zones of impact.
5.4.3 The eﬀect of impaction displacement depth on cytokine re-
lease by astrocytes
The media was collected from each gel twenty-four hours after impaction in order to
investigate the extracellular release of cytokines Interleukin-6 and Tumor Necrosis Factor-
↵, to investigate astrocyte response to diﬀerent impact severities. The positive control
included astrocyte seeded collagen gels, that were cultured with 50 ng Lipopolysaccharide
to elicit a reactive phenotype. The negative controls were media from acellular gels (for
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(a) 0% displacement (b) 0% displacement with LPS
(c) 50% displacement (d) 80% displacement
(e) 100% displacement
Figure 5.4.3: Primary astrocytes (5 x 104) seeded in collagen hydrogels cultured for
twenty-four hours post impaction (0%, 50%, 80% or 100% displacement depth) at 37°C,
5% CO2 in air. IHC labelling of astrocytes for GFAP with Hoechst, zone of impact and
zones of reactive astrocytes have been highlighted with white outlines. Images a-c scale
bar = 500 µm, Images d-e scale bar = 1000 µm.
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ELISA only) and wells which did not contain the primary antibody. An enzyme linked
immunoabsorbant assay (ELISA) was performed according to the protocol in section 5.3.8.
There was no significant diﬀerence detected in TNF-↵ secretion between astrocytes
that had been impacted to diﬀerent displacement depths (50%, 80% or 100%) and astro-
cytes that had not been subjected to an injury stimulus or cultured with 50 ng lipopolysac-
charide to stimulate reactivity, after four hours or twenty-four hours of cell culture post-
impaction. However, there was a significant diﬀerence between the media only control and
all astrocyte conditions, which indicated that the assay was successful in detecting TNF-↵
secretion by astrocytes, however there were no detectable increases in TNF-↵ secretion
by astrocytes as a result of impaction in this study, as determined by two way ANOVA
(p <0.05) with Tukey HSD post-hoc comparison (Figure 5.4.4a).
A significant increase in IL-6 secretion was detected in all astrocyte seeded hydrogel
conditions between cytokine analysis performed four hours post impaction injury and
twenty-four hours post impaction injury. At four hours post-impaction injury, there was
a significant decrease in IL-6 secretion by astrocytes that had been subjected to an injury
stimulus with a displacement depth of 80% and 100%, compared to the non-impacted
control (Figure 5.4.4b). There was also a significant decrease in IL-6 secretion by as-
trocytes that had not been impacted and astrocytes that had been cultured with 50 ng
lipopolysaccharide.
At twenty-four hours post-impaction there was a significant decrease in IL-6 secretion
by astrocytes that had not been impacted and all other conditions of astrocytes that
had been subjected to impaction at diﬀerent displacement depths. Similar to the TNF-↵
ELISA results, the media only control was significantly lower than all astrocyte seeded
hydrogel conditions. The results were analysed for statistical significance by performing
a two way ANOVA (p <0.05) with Tukey HSD post-hoc comparison (Figure 5.4.4b).
5.4.4 The eﬀect of impaction displacement depth on microglial
cell metabolism using ATP-Lite assay
The 3D in vitro collagen hydrogels were seeded with 5 x 104 primary microglial cells,
isolated from the adult rat spinal cord (as per section 4.3.3.5) and subjected to impaction
injury to 0%, 50%, 80% or 100% displacement depth and cultured for four or twenty-four
hours at 37 °C, 5% CO2 in air. The ATP-lite assay was performed as detailed in section
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(a)
(b)
Figure 5.4.4: Primary astrocyte (5 x 104) seeded collagen hydrogels cultured for twenty-
four hours post impaction (0%, 50%, 80% or 100% displacement depth) at 37°C, 5% CO2
in air. Analysis of a) TNF-↵ expression, b) IL-6 expression. Error bars indicate 95%
confidence interval, lines indicate statistical diﬀerence determined by two way ANOVA
(where the variables are time and displacement depth) (p <0.05), n = 6.
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2.12.2, to quantify cell viability and metabolism of the primary microglial response to
diﬀerent impact severities, by providing a quantitative measure of ATP production within
metabolically active cells.
The displacement depth of the impactor was controlled using the accompanying soft-
ware to the BOSE Electroforce impaction system (WinTest 7) and was set to either 0%,
50%, 80% or 100% displacement.
The ATP-lite assay showed that the luminescence emitted, was significantly higher
in the microglial cell seeded hydrogels that had been impacted to 100% displacement
depth, than the non-impacted hydrogels and the microglial cell seeded hydrogels that had
been impacted to any other displacement depth, at four hours and twenty-four hours post
impaction (Figure 5.4.5), as determined by two way ANOVA (p <0.05) with Fisher LSD
post-hoc comparison. There was a general increase in cell metabolism detected between
four hours and twenty-four hours for all conditions, however this increase in emitted
luminescence was not significant.
Figure 5.4.5: Primary microglia (5 x 104) seeded in collagen hydrogels cultured for twenty-
four hours at 37°C, 5% CO2 in air, subjected to injury stimulus over a range of dis-
placement depths. Analysis of cell viability and metabolism by ATP-lite assay, four and
twenty-four hours post impaction. Error bars indicate 95% confidence interval, lines in-
dicate statistical diﬀerence determined by two way ANOVA (p <0.05), n = 5.
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5.4.5 The eﬀect of impaction displacement depth on CD11b ex-
pression by microglia
The 3D in vitro collagen hydrogels were seeded with 5 x 104 primary microglia cells and
subjected to impaction injury to 0%, 50%, 80% or 100% displacement depth and cultured
for twenty-four hours prior to fixation and immunohistochemical labelling for CD11b.
The cell seeded hydrogels were not stained with Hoechst nuclear stain, because the
blue and the green spectra had an emission overlap which made separating the colours
challenging using ImageJ thresholding techniques.
Immunohistochemistry was performed as detailed in section 2.12.3 and the labelled
microglial seeded collagen hydrogels were visualised on the Zeiss AX10 Axio scope upright
microscope. A tiled image of each gel was captured as described in section 5.3.7. The
tiled image of the microglial seeded hydrogel was processed in ImageJ, as described in
section 4.3.5. To quantify the proportion of each image that was labelled positively for
CD11b, an appropriate threshold was applied to remove background, so that the image
analysis software could analyse the particles that are a minimum size (10 pixels) and have
a minimum level of green fluorescent intensity. A minimum of five gels per displacement
depth and control was used, which was repeated five times with five diﬀerent litters of
rats to account for biological variation (minimum of 25 gels per condition).
There was no significant diﬀerence (as determined by one way ANOVA with Fisher
LSD post-hoc comparison) between the average proportion of CD11b positively labelled
pixels per image of microglial cell seeded collagen gels that had been subjected to diﬀerent
impaction displacement depths and microglial cell seeded collagen gels that had not been
subjected to an injury stimulus or cultured with 50 ng lipopolysaccharide (Figure 5.4.6).
5.4.6 Eﬀect of impaction on cytokine release by microglia cul-
tured in isolation
The media was collected from each gel twenty-four hours after impaction, in order to inves-
tigate the extracellular release of cytokines Interleukin-10 and Tumor Necrosis Factor-↵
to investigate microglial response to diﬀerent impact severities. The positive control in-
cluded microglial seeded collagen gels that were cultured with 50 ng lipopolysaccharide
to elicit a reactive phenotype. The negative controls were media from acellular gels and
241
(a) 0% (b) 0% with 50 ng LPS (c) 50%
(d) 80% (e) 100%
(f) Analysis of CD11b expression by microglia
Figure 5.4.6: Primary microglia (5 x 104) seeded collagen hydrogels cultured for twenty-
four hours at 37°C, 5% CO2 in air, subjected to impaction at 0%, 50%, 80% or 100%
displacement depths. A-E) IHC labelling of microglia for CD11b, scale bar = 1000 µm.
F) Analysis of CD11b expression by microglia, quantified in ImageJ. Error bars indicate
95% confidence interval. No significant diﬀerence was detected by one way ANOVA (p
<0.05), n = 5
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wells which did not contain the primary antibody. An enzyme linked immunoabsorbant
assay (ELISA) was performed according to the protocol in section 5.3.8.
Cytokines IL-10 and TNF-↵, were quantified at four hours and twenty-four hours
post-impaction at diﬀerent impact displacement depths to model microglial response to
diﬀerent impact severities. There were no significant diﬀerences detected in TNF-↵ se-
cretion between microglia that had been impacted to diﬀerent displacement depths (50%,
80% or 100%) and microglia that had not been subjected to an injury stimulus or cultured
with 50 ng lipopolysaccharide, after four hours or twenty-four hours of cell culture post-
impaction. However, there was a significant diﬀerence between the media only control,
the control without primary antibody and all microglia seeded hydrogel conditions, as
determined by one way ANOVA (p <0.05) with Tukey LSD post-hoc comparison (Figure
5.4.7a).
There was no significant diﬀerence found in IL-10 secretion in all microglial seeded
hydrogel conditions at twenty-four hours post impaction injury (Figure 5.4.7b). There
was no significant decrease in IL-10 secretion by microglia that had been impacted and
microglia that had not been impacted or were cultured with 50 ng lipopolysaccharide.
However, there was a significant diﬀerence between the media only control, the control
without primary antibody and all microglia seeded hydrogel conditions, as determined by
one way ANOVA (p <0.05) with Tukey LSD post-hoc comparison (Figure 5.4.7b).
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(a)
(b)
Figure 5.4.7: Primary microglia (5 x 104) seeded collagen hydrogels cultured for twenty-
four hours post impaction (0%, 50%, 80% or 100% displacement depth) at 37°C, 5% CO2
in air. Analysis of a) TNF-↵ expression, b) IL-10 expression. Error bars indicate 95%
confidence interval, lines indicate statistical diﬀerence determined by one way ANOVA (p
<0.05), n = 5.
5.5 Discussion
The aim of this part of the study was to determine whether the BOSE Electroforce
impaction system would be suitable to investigate how impact severity aﬀects the cells of
the spinal cord in a 3D in vitro spinal cord injury model. The study successfully defined
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an appropriate impaction protocol to produce repeatable impaction profiles using the
BOSE Electroforce impaction system, which would provide injuries with varying severities
from mild to severe SCI representative of spinal cord injury in vivo. The study also
successfully assessed cell viability, reactivity marker and cytokine expression of astrocytes
and microglia as outlined in the objectives.
Although neurons, astrocytes, oligodendrocytes and microglia play important roles in
SCI, for the purposes of developing a simple 3D in vitro model, whereby the response of
individual cell types to diﬀerent impaction severities could be investigated, it was deemed
that only astrocytes and microglia would be used to seed the collagen gel matrix to
determine suitability as an impaction system. Astrocytes and microglia were the chosen
cell types for investigation in this study as astrocytes have a critical role in astrogliosis
and glial scar formation (Okada et al., 2017), whereas microglia play an important role in
inflammation within the spinal cord following injury, which may be beneficial or harmful
(Streit et al., 1999). Astrocyte and microglial cell metabolism were analysed by the
ATP-lite assay, which measured the quantity of ATP present in each cell by the emission
of light. The ATP-lite assay is a quantitative method to determine cell viability, but
it can also give an indication of cellular reactivity by measuring increases in cellular
metabolism between the control gels with the same cell seeding density and the cellular
gels which had received an impaction injury. Cellular reactivity was also characterised by
the expression of cellular markers for GFAP (for astrocytes) and CD11b (for microglia)
labelled by immunohistochemistry. Cytokine release (IL-6, IL-10 and TNF-↵) was also
analysed by both astrocytes and microglia, four hours and twenty-four hours after injury,
to investigate whether impact severity had an eﬀect on extracellular cytokine release, as
measured by ELISA.
5.5.1 Impaction
In order to simulate a spinal cord injury in vitro, a mechanical rig was required to im-
pact the hydrogels in a controlled and measurable way. Previously, the Infinite Horizons
(IH-0400) impactor had been used to induce spinal cord injury simulations in tethered
and aligned collagen hydrogels at the University of Leeds (Smith, 2016). Similar im-
pactors to the IH have been used recently to simulate traumatic CNS injury for in vivo
models (Hooshmand Mitra J and Anderson 2014; Carter et al. 2016; Gattlen et al. 2016;
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Visavadiya et al. 2016). However, the displacement and velocity parameters of the IH
impactor could not be controlled by the impactor software, this resulted in the impactor
tip piercing through the hydrogel to the base of the mould. The displacement could
be controlled manually, however this was not accurate, measurable and was challenging
(Smith, 2016). Therefore the BOSE ElectroForce BioDynamic 5110 was purchased by the
University of Leeds, to be used to apply compressive load onto in vitro spinal cord injury
hydrogel models in a closed sterile system.
The BOSE Electroforce BioDynamic series has been used previously to compress col-
lagen hydrogels (Busby et al., 2013) and can control the force, displacement depth or
velocity of the impaction. The BOSE ElectroForce BioDynamic 5110 was installed within
a class II safety cabinet, so that cell seeded hydrogels could be placed aseptically into the
Bose machine for impaction without the risk of contamination. The components of the
Bose system were successfully sterilised between studies and media could be added to the
BOSE Electroforce BioDynamic chamber by the use of a closed loop system and a pump,
which circulated the media.
The BOSE Electroforce BioDynamic impaction system had the potential for long term
impaction studies with the installed pump system, which allowed constant circulation
of the media. However, for the purposes of this study, it was decided to study the
primary response to SCI following the most common cause of SCI, which is a contusion
injury following road traﬃc accidents (Cripps et al., 2011) and therefore a transient, acute
impaction with a short duration was necessary to model a contusion injury (Cheriyan
et al., 2014). During a burst fracture SCI, one or more bone fragments from the vertebral
column are retropulsed into the spinal cord and cause canal occlusion (Wilcox et al.,
2003). This study aimed to use the impaction tip to represent a blunt bone fragment in a
burst fracture SCI, to compress the spinal cord with diﬀerent degrees of canal occlusion
to model mild, moderate and severe SCI.
The BOSE Electroforce BioDynamic Impaction system was easy to use and programme
with the required parameters, with consistent and repeatable impaction profiles. The sys-
tem allowed micrometer measurements of the displacement depth, velocity up to 3m·s 1
and force data from approximately 1N sensitivity. However, during the experimentation
period, the sensitive 20N load cell became broken, which did not allow measurement of
force data for all experiments. In the absence of force data it was diﬃcult to draw com-
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parisons between clinical injuries and other injury models. The impaction velocity was
programmed to 3m·s 1, which is deemed a high-speed injury and comparable to other in
vivo contusion models (Choo et al. 2007; Zhang et al. 2008). However, this velocity was
not validated, therefore the velocity at impact with a 4mm acceleration may have been
lower than the programmed velocity.
The impaction parameters were programmed so that there would be a delay of 0.1
seconds prior to impaction. This allowed the software to collect data immediately, so that
it was capable of capturing the full impaction event. As a result of the high speed of
the impact, the impaction was not recorded in full without this delay. The displacement
depth of the impaction event was calculated as a proportion of the total distance between
the top of the gel and the bottom of the gel, therefore the displacement depth could be
set to the required displacement depth (i.e. 50%, 80% or 100% as per the requirements
of the experiment).
A block waveform programme type was selected, so that a series of ramps could be
used to achieve the impaction protocol required for a burst fracture related SCI, similar
to the mechanical responses exhibited in human (Wilke et al. 1996; Tencer et al. 1995)
and bovine spine (Wilcox et al., 2003). The first ramp achieved the high velocity 3m·s 1
impact with a high degree of accuracy, set to 0.1mm above the desired displacement
depth. Due to the elastic nature of the material, the impactor tip recoiled approximately
0.25-0.5mm after reaching the desired displacement depth, therefore a second ramp was
required to slowly achieve the required 0.1mm at one thousandth of the speed (3mm·s 1).
This slow ramp enables the software to capture the full impaction event and overcome
the elastic recoil of the hydrogel, whilst achieving the full displacement depth required
with no overshoot. This slow ramp is designed to represent the elastic recoil of the tissues
in vivo, whereby the bone fragment having penetrated through the spinal canal at high
velocity, is then slowed by friction and elastic recoil of the tissues, applying forces against
the propulsion of the bone fragment. The point at which the elastic recoil is greater than
the force driving the penetration of the bone fragment, gives rise to the third ramp, which
removes the simulated bone fragment (impaction tip) at a slower velocity than the entry
velocity due to loss of energy. The third ramp is programmed to remove the impaction
tip at 30mm·s 1 back to point zero. This impaction protocol was designed to be as
physiologically relevant as possible and was compared to other in vitro simulated burst
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fracture studies (Tencer et al. 1995; Wilcox et al. 2003).
The BOSE Electroforce BioDynamic Impaction system was suitable for delivering
repeatable, highly tuned, high speed, impaction profiles for this in vitro SCI model. The
software and BOSE Electroforce BioDynamic Impaction system was capable of more than
time allowed during this study to investigate, however future work would involve creating
more impaction profiles and analysing the eﬀects on neural cells under compressive loads,
pre-determined forces and over longer culture periods to model not only SCI but traumatic
brain injury also.
5.5.2 Cell metabolism
The ATP-lite assay was used as an indicator of cell viability, as the assay was designed
to measure the production of light, caused by the reaction of ATP in metabolically ac-
tive cells, with D-luciferin and the enzyme luciferase, to produce oxyluciferin and light.
However, in this study all displacement depths have resulted in increased ATP-lite lu-
minescence, compared to the control hydrogels that did not receive an injury stimulus.
This increase in cellular metabolism with exposure to injury stimulus indicated that the
ATP-lite assay was also a measure of cell reactivity, as cells that are reactive, become
hypertrophic, extend processes (Okada et al., 2017), proliferate and increase expression
of proteins such as GFAP (Fawcett and Asher, 1999), which would require an increase
in cell metabolism, thereby increasing production of ATP and therefore producing more
luminescence from the ATP-lite assay.
The ATP-lite assay was performed on astrocyte or microglial seeded hydrogels four
hours and twenty-four hours after impaction in order to measure the immediate primary
response to injury. It was unknown whether four hours would be enough time to detect
a significant diﬀerence between injuries of diﬀerent impact severities, however astrocyte
seeded hydrogels emitted significantly higher luminescence from the ATP-lite assay when
impacted to 100% displacement depth than any other displacement depth, four hours
after impaction injury. If the ATP-lite assay did not indicate cell reactivity and was
solely an indicator of cell viability, then it would be presumed that the impacted condi-
tions would have a higher proportion of dead cells compared to the non-impacted control;
therefore the luminescence emitted from the assay would be lower, however the lumines-
cence was found to be higher in the injured cellular models compared to the non-injured
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cellular models. Therefore the ATP-lite assay was used in this study to quantitatively
measure cell metabolism, viability and reactivity. There was a significant diﬀerence in
cellular reactivity between a mild SCI (50% displacement depth) and a severe SCI (100%
displacement depth), measurable within four hours of the impaction stimulus.
At twenty-four hours post impaction, astrocyte metabolism was significantly higher at
80% and 100% displacement depth, than all other displacement conditions. This indicated
that the greater the impact severity, the higher the cellular reactivity, by measurement of
cell metabolism, significant within twenty-four hours of the injury event. A complex astro-
cytic response to SCI has also been found within twenty-four hours following traditional
weight-drop techniques in vivo Sprague-Dawley rats, which showed high concentration of
extracellular TGF-  within the impact zone, following histologic and immunohistochem-
ical evaluation (O’Brien et al., 1994). A pronounced astrocyte response was also present
in the spinal cord, defined by up-regulation of GFAP and thickening of cellular processes,
within twenty-four hours after lesioning by incision using fine iridectomy scissors in mice
(Schnell et al., 1999).
When astrocyte metabolism was compared between four hours and twenty-four hours
post impaction, astrocyte metabolism increased significantly for greater impaction sever-
ities, i.e. when 80% or 100% displacement depth was achieved, compared to when 50%
displacement depth or no impaction was received. Similarly to the results elicited by
astrocytes, the ATP-lite assay showed that the luminescence emitted was significantly
higher in the microglial cell seeded hydrogels that had been impacted to 100% displace-
ment depth, than the non-impacted hydrogels and the microglial cell seeded hydrogels
that had been impacted to any other displacement depth, at four hours and twenty-four
hours post impaction. The increase in cell metabolism between non-impacted microglial
seeded hydrogels and microglial seeded hydrogels that were exposed to a severe impaction
injury (100% displacement depth) at four hours and twenty-four hours, show that mi-
croglia produce an immediate response to injury. Other studies have also shown evidence
of increased microglial activation present at twenty-four hours post SCI by spinal cord
lesion using fine iridectomy scissors (Schnell et al., 1999). The early time-course of mi-
croglial activation has also been shown by immunolabelling for OX-42, which is marker
for ramified microglia (Perry et al., 1985) and an antibody designed to detect CD11b
(Jeong et al., 2013), in the ventral horn of the spinal gray matter of Lewis rats, twelve
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hours following a spinal cord lesion (Popovich et al., 1997).
There was a general increase in cell metabolism for microglial seeded hydrogels de-
tected between four hours and twenty-four hours, for all conditions and displacement
depths, however this increase in emitted luminescence was not significant between four
hours and twenty-four hours. The same cell seeding density was used for both astro-
cyte seeded hydrogels and microglia seeded hydrogels, however the relative size of the
cell was not taken into account. Astrocytes are larger than microglia and produce more
ATP per cell, therefore a higher seeding density may have been required for microglia to
elicit significant diﬀerences between conditions. Future work would increase the seeding
density and see if there was a significant diﬀerence in cell metabolism from four hours to
twenty-four hours post impaction injury.
These results indicate that this model can be used to accurately quantify astrocyte
and microglial cellular response to diﬀerent displacement depths or impact severities by
measurement of cellular metabolism at diﬀerent time points post impaction injury.
5.5.3 Cell reactivity
In order to investigate astrocyte reactivity, the astrocyte seeded hydrogels were fixed and
immunolabelled for GFAP, after twenty-four hours of cell culture post-impaction. Reactive
astrocytes increase expression of glial fibrillary acidic protein (GFAP) (Fawcett and Asher,
1999), the principal intermediate filament in mature astrocytes, important in modulating
astrocyte motility, shape and providing structural stability (Sofroniew and Vinters, 2010).
GFAP is expressed at low levels in the cytoskeleton, but is rapidly synthesised in response
to injury, whereby astrocytes develop a reactive phenotype, this process is known as
‘astrogliosis’ (Eng et al., 2000). This makes GFAP an ideal marker for investigation
into astrocyte morphology and reactivity. Astrocytes elicit diﬀerent responses to SCI
depending on the severity of the trauma. In mild/moderate cases of SCI, astrocytes
undergo a mild astrogliosis, which manifests as an up-regulation of GFAP. In more severe
SCI there is a profound up-regulation of GFAP, the astrocyte processes overlap and there
is a loss of individual astrocyte domains. (Sofroniew and Vinters, 2010).
It was found that the average proportion of GFAP positively labelled pixels per image,
increased significantly with increasing displacement depth or impact severity. In contrast
to these findings, in an in vivo experimental model of cortical impact injury, Woertgen
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et al. (2002) found that only neuron specific enolase (NSE), but not GFAP or protein
S100-  which is an astrocyte specific calcium binding protein involved in neurite exten-
sion and axon proliferation (Winningham-Major et al., 1989), showed a relationship with
the severity of trauma in rats, with significantly elevated serum levels of NSE in the early
phase after experimental traumatic brain injury. However, the opposite was found to
be true in the study by Vos et al. (2006), who found that increased GFAP and protein
S100- , but not NSE serum levels were associated with injury severity after subarachnoid
haemorrhage. Likewise, GFAP concentration present in cerebrospinal fluid was present in
diﬀering concentrations depending on disease severity and could be a potential biomarker
for disease severity between mouse models and human patients with Alexander disease
(Jany et al., 2013). There is a large body of evidence to support the increase in GFAP ex-
pression within the spinal cord as a result of spinal cord injury (Fawcett and Asher 1999;
Sofroniew and Vinters 2010; Okada et al. 2017), however whether there is a correlation
between GFAP expression and injury severity, has not yet been fully characterised or sup-
ported. Other studies have found that Vimentin (Ekmark-Lewén et al., 2010) or neuron
specific enolase (Woertgen et al., 2002) were more potent indicators of impact severity,
but most studies aim to maintain the impact severity to be mild, moderate or severe,
there are limited studies that focus on comparing cellular response to diﬀerent impact
severities. However, the study by Ropper et al. (2015) used a reproducible, controlled
compression model of SCI in Sprague-Dawley rats, utilising three diﬀerent loads to result
in mild, moderate or severe SCI and Ropper et al. (2015) found that there appeared to
be a positive correlation between GFAP expression by astrocytes and the severity of the
compression insult. These findings are in accordance with the findings of this study that
found that an increase in impact severity resulted in an increased expression of GFAP.
The images were analysed to validate the findings of the quantification of GFAP ex-
pression using ImageJ. The positive control, which was astrocytes in hydrogels cultured
with 50 ng lipopolysaccharide to stimulate reactivity, showed an enhanced expression of
GFAP compared to the non-impacted control hydrogels, which suggested that the LPS did
increase astrocyte reactivity. All impacted gels showed a clear zone of impact. The zone
of impact resembled the fluid-filled cavity prominent at the injury site in SCI (Bresnahan
et al. 1991; Lee and Lee 2013; Hooshmand Mitra J and Anderson 2014). Although this
study only investigated the primary response to injury, it would be of interest to measure
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the area of the zone of impact over time, which could represent the fluid filled cavity in
SCI in vivo, and investigate whether the zone of impact would increase in size over time
as seen in vivo, as cell viability decreases and infiltrating macrophages/microglia clear
away the dead cells and tissue debris (Popovich et al., 1997).
The area immediately adjacent to the zone of impact contained a high proportion of
reactive astrocytes, expressing high levels of GFAP; this area of the image was charac-
terised as the zone of reactivity. The increase in GFAP expression in the area surrounding
the impact zone was similar to results seen in vivo. Astrocytes showed phenotypic and
proliferative changes, which varied with respect to the distance from the injury lesion in a
mouse contusion model (Wanner et al., 2013). It was found that the astroglia immediately
surrounding the injury site had proliferated, were elongated and overlapping, forming the
glial scar border. Whereas astrocytes further from the injury site were hypertrophic, stel-
late and non-proliferative. There is compelling evidence that reactive astrocytes exhibit
substantial heterogeneity in terms of gene expression, cell morphology and cell function
at diﬀerent distances from lesions in CNS regions (Anderson et al., 2014). Astrocyte mor-
phology with distance from the zone of impact was not investigated as part of this study,
but would be an intriguing in vitro study in the future.
In the microglial seeded hydrogels, there was no significant diﬀerence detected in
CD11b expression between microglial cell seeded collagen gels that had been subjected
to diﬀerent impaction displacement depths, and microglial cell seeded collagen gels that
had not been subjected to an injury stimulus or cultured with 50 ng lipopolysaccharide to
stimulate reactivity. The microglial seeding density may have been too low to represent
in vivo tissue conditions and therefore microglia may not have shown the same behaviour
if the cell seeding density was higher. The low cell seeding density could have masked
any diﬀerences in CD11b expression as a result of the severity of the impaction, but also
the dilution of primary antibody raised against CD11b and secondary antibody may have
required further optimisation.
The cell seeded hydrogels were not stained with Hoechst nuclear stain because the
blue and the green spectra had an emission overlap, which made separating the colours
challenging using ImageJ thresholding techniques. Analysis of the images did not highlight
any visual diﬀerence between the control microglial gels and the microglial gels that had
been subjected to diﬀerent impact severities. In a rat contusion model of traumatic brain
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injury, the peak responses of astrocytes and microglial activation was observed five to
seven days after injury (Avila et al., 2012), therefore it may be that twenty-four hours is
not long enough time past after injury to observe a diﬀerence in microglial reactivity.
The only diﬀerence in the images was that for the greater the impact severity, i.e.
the greater the displacement depth, the larger the void in the centre of the gel, where
the impaction tip had created a void, similar to a cyst or cavity, often associated with
spinal cord impaction injuries in vivo (Lee and Lee, 2013). However, this is likely to be a
physical rather than biological phenomenon.
5.5.4 Cytokine release
The release of cytokines Interleukin-6 and Tumor Necrosis Factor-↵ were quantified at four
hours and twenty-four hours post-impaction at diﬀerent impact displacement depths to
model astrocyte response to diﬀerent impact severities. There was no significant diﬀerence
detected in TNF-↵ secretion between astrocytes that had been impacted to diﬀerent dis-
placement depths (50%, 80% or 100%) and astrocytes that had not been subjected to an
injury stimulus or cultured with 50 ng lipopolysaccharide, after four hours or twenty-four
hours of cell culture post-impaction. There was a significant diﬀerence between the media
only control and all astrocyte seeded hydrogel conditions, which suggested that the assay
was successful, however the assay may not have had a high enough sensitivity as the media
only control was measured to contain approximately 200 pg/mL TNF-↵ which did not
contain TNF-↵, whereas the astrocytes in gels were measured to contain approximately
250 pg/mL TNF-↵, which was a 50 pg/mL diﬀerence in TNF-↵, which may have been
as a result of experimental error. There is also a possibility that encapsulating astrocytes
within collagen hydrogels may stimulate TNF-↵ release, thereby the cells were secreting
TNF-↵ prior to impaction and could not be stimulated further, which would account for
the failure of the positive control, as no increase in TNF-↵ secretion was observed when
astrocytes were stimulated with 50 ng lipopolysaccharide. Future work should allow astro-
cytes in collagen gels a few days to return to an unreactive phenotype prior to subjecting
astrocytes to injury within collagen gels. TNF-↵ is secreted by astrocytes in vivo and ac-
cumulates quickly in the lesion site after SCI (Chi et al., 2008), therefore it was expected
that a similar response would be observed in this in vitro model. However, astrocytes
in isolation may elicit diﬀerent behaviours and reduced cytokine secretion profiles in the
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absence of cell-cell communication from other glial cells. Astrocytes cultured with media
from manganese-exposed (activated) microglial cultures, significantly enhanced mRNA
expression for TNF-↵ and IL-6 (Kirkley et al., 2017). Hippocampal astrocyte cultures
presented increased levels of TNF-↵, IL-1 , IL-6, IL-18 and decreased levels of IL-10 in
vivo after acute systemic inflammation (Bellaver et al., 2017). Future work should inves-
tigate whether cytokine expression can be quantified in this in vitro model by culturing
astrocytes, with a higher seeding density, in the presence of mixed glial cultures, with an
increased sensitivity ELISA, over longer time periods.
Interleukin-6 (IL-6) is a key cytokine released in response to brain injury, which can
cause neuroinflammation, however IL-6 production has also been shown to increase heal-
ing, decrease oxidative stress and apoptosis in transgenic traumatic brain injury mouse
models (Quintana et al., 2008). In the present study the ELISA for IL-6 concentration
displayed a significant increase in IL-6 secretion in all astrocyte seeded hydrogels from
four hours to twenty-four hours and a significantly lower media only control to indicate
that the assay was successful. However, there was a decline in IL-6 concentration de-
tected with an increase in impact severity and displacement depth, which may be as a
result of the physiological injury response or the physical loss of cells from the gels due
to detachment as a result of the impaction tip causing a void in the hydrogel; the greater
the impaction displacement depth, the larger the zone of impaction and void formation.
However, the non-impacted positive control (cultured with 50 ng lipopolysaccharide) also
showed a decrease in IL-6 secretion, which did not suﬀer cell loss as there was no physical
injury stimulus, therefore the decrease in IL-6 secretion may be due to the injury response
resulting in a down-regulation of IL-6 secretion. Decreased IL-6 expression by astrocytes
in spinal cord injury is contrary to the findings of many studies that found an increased
expression of IL-6 release by astrocytes in response to injury (Hariri et al. 1994; Van Wag-
oner et al. 1999; Yu and Lau 2000; Lau and Yu 2001; Burda et al. 2016; Bellaver et al.
2017). However most studies investigating cytokine production in response to injury are
generally in vivo and cannot be decoupled with from interactions with other glial cells
and soluble factors, which may have enhanced IL-6 secretion.
The ELISA’s for astrocyte secretion of TNF-↵ and IL-6 display that secretion of
cytokines by the unimpacted negative control (0% displacement) are high and the positive
control does not result in an increase in cytokine release, thereby suggesting a high degree
254
of background and that it may be possible that the astrocytes are stimulated during
encapsulation within the 3D matrix and therefore may potentially be immune to further
stimulation and cytokine release by injury.
Microglia are activated in response to a number of diﬀerent injuries/pathologies and
it is well known that microglia produce pro-inflammatory cytokines such as TNF-↵ and
IL-6 (Giulian et al., 1994); (Pineau and Lacroix, 2007); (Smith et al., 2012). Microglia
have also been shown to exhibit anti-inflammatory properties by the expression of IL-10
(Thompson et al., 2013), however no conclusion could be drawn from the cytokine secre-
tion by microglia from this in vitro model. There was no significant diﬀerence detected in
TNF-↵ or IL-10 concentration secreted by microglial cells subjected to diﬀerent impact
severities and displacement depths. The negative controls which contained only the pri-
mary antibody or cell free media, displayed a significantly lower concentration than the
cellular gels, which suggested that the ELISA was successfully performed. However, the
hydrogels contained 5 x 104 microglia per 100 µL gel and the seeding density may have
been too low to detect a diﬀerence between diﬀerent impaction conditions. Another rea-
son for the inconclusive results could be that the assays may not have had a high enough
sensitivity to detect subtle diﬀerences in the concentrations of cytokines, produced by a
low number of microglial cells. These microglial experiments would have been repeated
with a higher seeding density if time had allowed and further work should be performed
to optimise these microglial impaction experiments.
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5.6 Conclusion
• The BOSE Electroforce BioDynamic Impaction system was utilised to simulate SCI
within 3D collagen gels and resulted in a promising 3D in vitro model of SCI.
• The BOSE Electroforce BioDynamic Impaction system could produce consistent im-
paction profiles with a tailored impaction profile for short or long term, compression
or contusion injuries with diﬀerent impact severities to mimic in vivo SCI.
• The model successfully assessed the viability of primary astrocytes and microglia
after impaction at diﬀerent displacement depths within 3D collagen gel models over
twenty-four hours.
• A significant diﬀerence in cellular reactivity between a mild SCI (50% displacement
depth) and a severe SCI (100% displacement depth) was measured within four hours
of the impaction stimulus.
• At twenty-four hours post impaction, astrocyte and microglial metabolism was sig-
nificantly higher at 80% and 100% displacement depth, than all other displacement
conditions. This indicated that the greater the impact severity, the higher the cel-
lular reactivity by measurement of cell metabolism, significant within twenty-four
hours of the injury event.
• The in vitro SCI collagen hydrogel model of SCI was successfully used to assess
diﬀerential expression of GFAP by immunocytochemistry after twenty-four hours of
cell culture, post impaction at diﬀerent displacement depths.
• The average proportion of GFAP positively labelled pixels per image increased sig-
nificantly with increasing displacement depth or impact severity.
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Chapter 6
Discussion
Spinal cord injury (SCI) results from a traumatic event such as a road traﬃc accident,
which are the highest cause of SCI in North America, Europe and Australia (Cripps
et al., 2011). Injuries to the spinal cord can have devastating consequences, such as
paralysis, incontinence and respiratory dependency, which can have a large social and
economic burden on society and the health services, including the loss of income and
cost of healthcare (Thuret et al., 2006). SCI aﬀects 23 individuals per million globally,
equating to approximately 180,000 people per annum worldwide (Lee et al., 2014). SCI has
no cure, limited treatment options and poor patient recovery rates following therapeutic
interventions despite numerous clinical trials (Kwon et al. 2004; Fehlings et al. 2011;
Führmann et al. 2017), there is a need for further development of therapeutics to improve
regeneration of the spinal cord following injury.
Despite the variety of injury pathologies associated with diﬀerent types and severities
of SCI, all patients are treated in the same way, which may contribute towards the poor
patient recovery rates. There is a need to develop a better understanding of the mechanics
of SCI and how the type of injury aﬀects the outcome for the patient. A stratified approach
to treat patients in terms of injury severity and personalise the treatment regime may lead
to an increase in patient recovery rates and regeneration.
The general hypothesis underpinning this study, was that the biomechanical properties
of the cell culture matrix, has an influence on neural cell behaviour and regeneration,
which could have important implications in developing biomaterials to treat spinal cord
injury (SCI) in vivo. The study aimed to investigate how an in vitro model of SCI could
be used to advance understanding of how diﬀerent types of neural cells, in isolation or
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in mixed glial cultures, behave diﬀerently when cultured in biomaterials with diﬀerent
biomechanical properties, at rest and during injury.
The absence of therapeutic success may result from the lack of understanding of how
the biomechanical properties of the matrix aﬀect CNS cells. Biomaterials used to treat
SCI should have similar biomechanical properties to native tissue, to allow for a natural
response (Shin et al., 2003a). However, characterising the biomechanical properties of
the brain and spinal cord is challenging due to many other contributing factors which can
aﬀect the mechanical measurements (Fiford and Bilston, 2005). Some of the factors which
can increase or decrease the stiﬀness of the brain are the treatment or pre-conditioning
of the tissues (Gefen et al., 2003), the age of the brain tissue (Sack et al., 2011), the
time between post-mortem and measurement (Oakland et al., 2006), the region of the
brain (Manduca et al. 2001; Hrapko et al. 2006; Garo et al. 2007; Kruse et al. 2008;
Van Dommelen et al. 2010), the species concerned (Tunturi 1978; Hung et al. 1981),
the degree of neurodegeneration and disease (Murphy et al. 2011; Streitberger et al.
2012) and diﬀerent measurement methods such as indentation, rheology and atomic force
microscopy, give a wide range of biomechanical properties from hundreds of pascal to
megapascal ranges, refer to Chapter 1, Table 1.1 for an overview of studies investigating
the biomechanical properties of CNS tissues.
6.1 The eﬀect of matrix stiﬀness on CNS cells
The overall aim of the study was to develop a 3D in vitro hydrogel system, which can
achieve three diﬀerent ECM matrix stiﬀnesses, to investigate how the stiﬀness of the
matrix aﬀects CNS cells. In order to achieve this aim, numerous potential matrices were
investigated to compare biocompatibility with neuroglial cells and how the diﬀerences in
matrix stiﬀness aﬀected neuronal and glial cell phenotypes. It was challenging to find
an appropriate matrix, which supported 3D cell seeding and could achieve at least three
diﬀerent matrix stiﬀnesses. The matrix developed as part of this study was not capable
of 3D cell seeding, which is a limitation of this study as other studies have shown that
neural cells respond diﬀerently when exposed to a soft or a stiﬀ biomaterial. In a study
by Moshayedi et al. (2014), it was found that devices implanted into the brain such as
electrodes, become encapsulated with glial cells, which leads to a loss of functionality of
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the electrodes. However, when a composite foreign body was inserted into rat brains, with
a soft and a stiﬀ end, the results indicated that the stiﬀ end was surrounded by reactive
astrocytes and microglia, experiencing a greater foreign body reaction than the soft end
of the composite foreign body. These results indicated that CNS glial cells responded to
mechanical cues and that adapting the surface stiﬀness of neural implants or therapeutic
interventions for SCI, could minimise adverse reactions and improve biocompatibility.
A large body of research has been performed to investigate the role of matrix stiﬀness
on the growth and survival of neurons in in vitro models. The majority of studies found
that neurite extensions and branching from neurons were found to be greater in softer
matrices when compared to a stiﬀer matrix (Balgude et al. 2001; Flanagan et al. 2002;
Willits and Skornia 2004; Gunn et al. 2005; Leach et al. 2007; Sundararaghavan et al.
2009; Man et al. 2011; Lampe et al. 2013; Tarus et al. 2016; Tanaka et al. 2018). The
combination of a reduced foreign body reaction (Moshayedi et al., 2014) and greater
proficiency for neurite outgrowth on a softer matrix, could have beneficial implications
for design of therapeutic biomaterial interventions to treat SCI.
Although the majority of studies found that culturing neurons in softer matrices,
enhanced neurite outgrowth, Georges et al. (2006) and Norman and Aranda-Espinoza
(2010) found that neurons were insensitive to changes in matrix stiﬀness. This study also
found that neurons were insensitive to synthetic-biologic matrices of diﬀerent stiﬀnesses.
However, it may be that neurons are more sensitive to biochemical cues from diﬀerent
hydrogel chemistries and the synthetic chemistry (Polyethylene glycol diacrylate) under-
pinning the developed synthetic-biologic hydrogel, may have been a limitation of this
study due to the reduced number of cell adhesion sites compared to natural polymers
(Brown and Phillips, 2007). Neurons have demonstrated great neurite outgrowth on soft
three-dimensional collagen gels (Sundararaghavan et al., 2009), protein-laminated poly-
acrylamide gels (Flanagan et al., 2002), three-dimensional engineered elastin-like proteins
(ELPs) hydrogels (Lampe et al., 2013) and fibrin gels (Man et al., 2011). Therefore nat-
ural polymers may result in enhanced neurite outgrowth compared to synthetic polymers
and care should be taken when extrapolating results from in vitro models, which may
have limitations that could aﬀect the results.
Animal models of SCI are useful tools to investigate the primary response to SCI, as the
conditions of the injury, specimen age and region of injury can be controlled, which is not
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possible in human SCI. Rats oﬀer several advantages over other species for models of SCI,
due to low husbandry costs, relatively short life-span and neural anatomy comparable to
humans (Anwar et al., 2016). However, the translation of therapeutic modalities applied
to mitigate the induced SCI in vivo animal models has been with limited success and
findings may not be transferrable to humans (Varma et al., 2013).
In vitro models of SCI allow simplification of complex primary and secondary injury
cascades and cellular responses to specific aspects of SCI such as individual cell responses.
Organotypic slice culture models of the rat spinal cord have been used to assess the
eﬀectiveness of growth factor treatments on nerve regeneration across gaps between spinal
cord slices (Lee et al., 2002). These models are an eﬀective way of investigating the
beneficial eﬀects of potential drugs and biomaterials to treat SCI, where nerve growth
can be quantitatively assessed between slice cultures with physiologically relevant tissue
milieu that can support the cells for several weeks (Dionne and Tyler, 2013). These
methods allow experimental manipulations to the tissue, and exposure of tissues to known
quantities of drugs and growth factors, which would not be possible to quantitate with
accuracy in vivo.
In vitro CNS cell culture models have many benefits and limitations; CNS cells can
be cultured in isolation to simplify the model, in order to study the direct relationship
between the condition or chemical under investigation i.e. the matrix stiﬀness and the
individual cell type, without adding a layer of complexity from cell-cell interactions. Sim-
ilarly cell culture models can be used to investigate the diﬀerences in cell-cell communi-
cation between controlled cell populations (Recknor et al. 2004; Sørensen et al. 2007) and
investigate how diﬀerent cell combinations may result in diﬀerential release of cytokines or
gene expression (Bethea et al. 1999; Chi et al. 2008).To model the spinal cord and various
injury simulations in vitro, the biomaterial should be as similar as possible to the natural
tissue. Hydrogels are often the biomaterial of choice for an in vitro cell culture model, as
they provide a biomimetic environment, similar to the extracellular matrix (Shin et al.
2003a; Smith 2016; East et al. 2010). Hydrogels support cell growth and survival, whilst
allowing control over the biochemical, physical and mechanical properties of the matrix
(Tibbitt and Anseth, 2009).
Some of the limitations of in vitro CNS models is that they are reductionist in their
approach and cannot completely recapitulate the complex in vivo environment (Aurand
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et al., 2012). An in vitro model cannot include all potential involvement from a range
of diﬀerent cell types such as macrophages or endothelial cells. An in vitro model would
not include substantial vasculature, therefore there is a limit to nutrients and oxygen
exchange and inflammatory cells or proteins recruitment (Zhang et al., 2002). Similarly
without vasculature it is diﬃcult to recognise the involvement of chemical inputs such
as hormones which may diﬀuse from the bloodstream. However, in vitro models are a
good first point of call to investigate whether a potential therapy would have a positive
or negative eﬀect on cellular regeneration post SCI. Surgical procedures to create animal
models can be costly and time consuming (Jones et al., 2012). It would be unethical to
study the long-term or chronic eﬀects of SCI in rats and primates (Choo et al., 2007),
therefore there is a need for simplified models of SCI, in which the complex secondary
cascade can be broken down and investigated in vitro to reduce the use of animals used
for long-term SCI in vivo (Thuret et al. 2006; Pleasant et al. 2011).
During the initial stages of this study, the decision was taken to develop a synthetic-
biologic hydrogel, which could change the stiﬀness of matrix by changing the cross-linking
density maintaining the protein concentration. Unfortunately the hydrogel was not capa-
ble of 3D cell seeding due to the UV polymerisation process, which was cytotoxic. The
peptide hydrogels made by PepgelTM in 2014 were self-assembling peptide nanofiber hy-
drogel scaﬀolds. The PRR4 peptide hydrogel contained RGD cell adhesion motifs and
supported good viability of astrocytes and was compatible with 3D cell seeding. However,
this hydrogel was not chosen for further development because to increase the stiﬀness, the
protein concentration would increase; which could aﬀect cellular behaviour regardless of
matrix stiﬀness due to diﬀerences in protein density and number of cell adhesion sites.
The PepgelTM self-assembling peptides were expensive to purchase in small quantities
and the stiﬀer the gel, the more peptide would be used, which would limit the number of
experiments which could be performed. Therefore the decision was taken to develop the
synthetic-biologic hydrogel with the expectation that further development would increase
biocompatibility and allow 3D cell seeding. However this was not achieved and the inves-
tigation was performed in 2D. It has been demonstrated that 3D cell culture environments
are necessary to achieve more physiologically relevant cell responses compared to 2D tis-
sue culture surfaces (Pampaloni et al. 2007; Justice et al. 2009; Balasubramanian et al.
2015). The 3D nature of cell culture systems influence cell structure, adhesion, mechan-
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otransduction and signalling in response to soluble factors that govern cellular function
(Baker and Chen, 2012). Cells grown in monolayer are flat, they adhere and spread freely
on the 2D surface, which forces cells to have apical-basal polarity, whereas when embed-
ded in a 3D matrix, cells assume a non-polar stellate morphology (Mseka et al., 2007).
The two-dimensional nature of the first part of this in vitro model to investigate the role
of matrix stiﬀness on CNS cell behaviour is a limitation of this study, which is why a
three-dimensional collagen gel was chosen for the impaction portion of this study into a
three-dimensional in vitro SCI model. Future work would aim to repeat the experiments
performed on the 2D synthetic-biologic hybrid hydrogel matrix to investigate the role
of matrix stiﬀness on CNS cell behaviour, on a 3D cell seeded self-assembling peptide
nanofiber hydrogel.
Matrix stiﬀness has been found to regulate cell behaviour by controlling cellular trac-
tion forces, generated through actomyosin cellular contractility, powered by ATP hydrol-
ysis (Kolega et al. 1991; Panday 2014). Dissimilar to most mammalian scar tissues, CNS
tissue becomes significantly softer following injury, (Moeendarbary et al., 2017). Astro-
cyte cells have also been found to soften following injury (Miller et al., 2009) or when
stimulated with interferon-beta (Lacour et al., 2016), and the brain has been reported
to decrease in stiﬀness significantly in neurological diseases such as Alzheimers disease
(Murphy et al., 2011).
Interestingly in this study astrocyte cell metabolism was lowest on the softest matrix
(20 Pa) and astrocyte metabolism increased on the stiﬀer (700 Pa) matrix. There was a
significant up-regulation in GFAP expression by astrocytes when cultured on the stiﬀer
(700 Pa) matrix and astrocyte attachment on the surface of the hydrogel, visualised
by the live/dead cell viability assay, increased with the increased matrix stiﬀness. An
increase in GFAP expression, cell attachment and cellular metabolism with an increase
in matrix stiﬀness is indicative of an increase in astrocyte reactivity. The increase in
astrocyte reactivity with an increase in the stiﬀness of the matrix is in agreement with
the findings of the study by Georges et al. (2006) who found that astrocytes had a more
organised F-actin cytoskeleton and displayed a spread morphology on a hard fibrin gel
as opposed to a soft fibrin gel. Similarly astrocytes also showed an increase in markers
of reactivity (GFAP) when cultured in a stiﬀer matrix as opposed to a softer collagen
matrix in the study by Smith (2016), however other factors were changed to increase the
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stiﬀness of the matrix in this study, such as gel hydration, volume and therefore astrocyte
density was also aﬀected, which could have stimulated the increase in astrocyte reactivity.
Although in a 2D study similar to this study, Wilson et al. (2016) also found that astrocyte
reactivity and GFAP expression increased with the stiﬀness of the PDMS matrix when
astrocytes were cultures on an 8000 Pa or 200 Pa matrix. An increase in matrix stiﬀness
has resulted in an increase in astrocyte reactivity, but an increase in matrix stiﬀness has
also been demonstrated to give distinct diﬀerences in cellular morphology (Georges et al.,
2007) and intermediate filament expression (Lu et al. 2011; Min et al. 2015), thereby
supporting the findings of this study.
It is widely known that astrocytes undergo a vigorous response to neurologic in-
sults, which occur rapidly and can be detected within one hour of mechanical trauma
(Mucke et al., 1991). Astrocyte response to injury results in increased expression of
GFAP and many molecular and morphological changes (Sofroniew, 2009), which appear
to be observed when the stiﬀness of the matrix increases, as observed in this study. How-
ever, it has been found that CNS tissue becomes significantly softer following injury in
vivo(Moeendarbary et al., 2017) and has been known to soften with age (Sack et al.,
2011) and disease (Murphy et al. 2011; Streitberger et al. 2012), and astrocyte reactivity
increases, which is contrary to the findings of this study and numerous other in vitro
studies that found that astrocyte reactivity increases with an increase in matrix stiﬀness
(Georges et al. 2007; Lu et al. 2011; Lee et al. 2015; Min et al. 2015; Placone et al. 2015;
Wilson et al. 2016; Smith 2016). This discrepancy between what is known to be true
in vivo and what happens in in vitro models, highlights the limitations of the simplistic
nature of in vitro models. There could be currently unknown factors in vivo, which may
have a more influential eﬀect than the biomechanical properties of the matrix, however
they would not be captured in relatively simplistic in vitro studies.
The stiﬀness of the matrix has been shown to be a regulator of neuronal cell growth in
the study by Balgude et al. (2001), who found that the rate of neurite extension of dorsal
root ganglion (DRG) neurons was inversely proportional to substrate stiﬀness; the softer
the matrix, the higher the rate of elongation. Similarly Gunn et al. (2005) demonstrated
that PC12 neuronal cells presented greater neurite extensions and branching on softer
hydrogels compared to stiﬀ hydrogels and the same was found to be true for many other
studies (Balgude et al. 2001; Flanagan et al. 2002; Willits and Skornia 2004; Gunn et al.
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2005; Leach et al. 2007; Sundararaghavan et al. 2009; Man et al. 2011; Lampe et al. 2013;
Tarus et al. 2016; Tanaka et al. 2018).
Unfortunately neurite outgrowth could not be achieved during this study in two-
dimensional culture, on the surface of the developed synthetic-biologic hydrogel system.
No diﬀerences in cellular behaviour could be detected between DRG neurons cultured on
matrices of diﬀerent stiﬀnesses. It may be that the DRG neurones required supplemen-
tation with greater concentrations of growth factors and should have been cultured for
longer culture periods on hydrogels with higher concentrations of cell adhesion motifs.
However the importance of three-dimensional cell culture environments should not be
overlooked Fawcett et al. (1989), as neuronal cell behaviour largely depends on the mi-
croenvironment. It has been established that three-dimensional matrices are more eﬀective
in stimulating neurite outgrowth than two-dimensional substrates (Hayman et al. 2004;
Lin et al. 2005) because they mimic the native cellular environment, allowing for greater
innate behavioural function (Norman et al., 2009). There is evidence for an involvement
of mechanotransduction in controlling neuronal growth, regeneration, proliferation and
glial cell activation (Franze et al., 2013). Further work should focus on the development
of a three-dimensional hydrogel system to investigate how the neuronal cells respond to
matrix stiﬀness in three-dimensional, as opposed to two-dimensional cell culture.
The findings of this study indicate that microglia are sensitive to the stiﬀness of the
microenvironment; microglia showed a strong preference for the softer matrix. Microglial
metabolism was significantly higher on the 20 Pa stiﬀness matrix compared to the matri-
ces with a stiﬀness of 250 Pa and 700 Pa. It is believed that the microglia may detect the
low substrate stiﬀness and respond by triggering proliferation, which could be responsible
for the increased cell metabolism observed on the softer (20 Pa) matrices. Unfortunately
there was insuﬃcient time to perform a BrdU assay on the microglial cultures to detect
proliferation of microglia on the softer matrix, however this would be of interest in a future
investigation. In a similar study to this study by Bollmann et al. (2015), microglia cul-
tured on matrices of approximately 100 Pa expressed many filopodia-like processes, which
were reduced in number when microglia were cultured on matrices with a stiﬀness of ap-
proximately 300 Pa. This in an agreement with the findings of the study and suggests that
microglial cells are highly sensitive to the stiﬀness of the microenvironment and can result
in changes to microglial morphology by detecting a 200 Pa diﬀerence in matrix stiﬀness.
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The same study found that microglia cultured on matrices of 1000 Pa showed complex
morphologies with lamellipodia-like structures and increased migration and durotaxis on
stiﬀer matrices (Bollmann et al., 2015). A similar behaviour was observed in the study by
Reimer et al. (2018), who observed increased microglial cell spreading on stiﬀ hydrogels;
microglia cells had large spread morphologies and elongated shapes on glass compared to
hydrogels.
After detection of a pathological signal, microglia become activated and migrate to-
ward the stimulus, where they release signalling molecules, proliferate, phagocytose cells
and debris (Kettenmann et al., 2011). Perhaps microglia are capable of a bimodal re-
sponse to matrix stiﬀness, whereby an increase or decrease in matrix stiﬀness triggers a
change in microglial properties with changes to the microenvironment. A decrease in the
stiﬀness of the matrix, as observed in SCI (Moeendarbary et al., 2017), may cause an
increase in microglial proliferation and migration in response to signals of damage and
repair. However, microglia may also respond to signals from a stiﬀer matrix beyond that
of native undamaged tissue and up-regulate the inflammatory response to decrease the
risk of infection from the presence of a foreign body (Moshayedi et al., 2014).
There are a limited number of studies which investigate the role of matrix stiﬀness on
microglial cell behaviour. Although the results from this study have limitations, such that
the method for immunohistochemical labelling of the microglial cells required further opti-
misation, therefore capturing images of the microglial cells on the surface of the hydrogels
was challenging. The results from this study indicate that microglia show a preference
for a softer matrix and further work should be done to investigate a potential bimodal
response to matrix stiﬀness, by using a wider range of hydrogels with stiﬀer mechanical
properties and performing a BrdU assay to investigate microglial proliferation.
Mixed glial cultures of astrocytes, oligodendrocytes and microglia, showed a decreased
cell metabolism, with an increase in matrix stiﬀness. A significant decrease in cell
metabolism was found between the 20 Pa and the 700 Pa stiﬀness hydrogel matrix. The
live/dead assay results were in agreement with the ATP-lite results and indicated a de-
crease in the total area of the gel covered with green labelled living cells, cultured on the
stiﬀer 700 Pa matrix compared to the softer hydrogel matrices.
Fixing and IHC protocol was not optimised for 2D hydrogels and therefore a large
proportion of the cells on the surface of the hydrogels were lost during the wash steps.
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Further work should optimise the fixing and labelling process to decrease the impact of
the process and increase the number of cells adhered to the surface of the gel at the end
of the imaging process.
Most studies in the area of mechanosensitivity to matrix stiﬀness have investigated the
response of neurons (Balgude et al. 2001; Flanagan et al. 2002) and/or astrocytes (Georges
and Janmey 2005; Wilson et al. 2016) to matrix stiﬀness in isolation or in neuron-astrocyte
co-cultures (Georges et al., 2006), however a study of glial response to matrix stiﬀness,
in a mixed glial co-culture could not be found. Therefore future work should investigate
how the mixed glial cell-cell communication aﬀects glial cell response to matrix stiﬀness in
more detail. This study found that mixed glial cell populations had a higher cell viability
and higher cell metabolism on softer matrices (20 Pa), whereas astrocytes were found to
have a higher cell viability and cell metabolism on stiﬀer matrices (700 Pa).
It is hypothesised that microglial cells respond to a soft hydrogel matrix by increas-
ing microglial proliferation, which could explain the significantly higher mixed glial cell
metabolism on the 20 Pa stiﬀness matrix, when compared to the 700 Pa stiﬀness matrix,
when it is known that astrocytes become reactive on stiﬀer matrices and astrocytes are
more numerous than microglia in a mixed glia population.
The increase in mixed glial cell metabolism on the softer hydrogel matrices may be
as a result of microglial release of soluble factors, such as cytokines into the media when
cultured on a soft matrix and microglia may not be stimulated to release the soluble factors
when cultured on stiﬀer matrices. The soluble factors such as cytokines, may cause an
increase in astrocyte reactivity on the softer matrices, which could provide reasoning
behind the increased cell metabolism of the mixed glia cells when cultured on the softer
matrix.
A limitation of using the synthetic-biologic hydrogel for this two-dimensional study
was that the hydrogels became swollen in media, therefore the hydrogels expanded beyond
the dimensions of the initial mould used for polymerisation of the hydrogel solution. This
increased the complexity of the method for cell seeding and cell culture; seven methods
were developed to overcome this limitation but unfortunately collecting enough media
for cytokine analysis by ELISA was not possible. Future work should analyse cytokine
release from cells in three-dimensional matrices of diﬀerent stiﬀnesses to investigate if the
stiﬀness of the matrix is responsible for initiating cytokine release, which could stimulate
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cellular reactivity.
The matrix stiﬀness range used in this study was chosen to be in the region of native
neural tissues, which can vary approximately from 100-500 Pa (Young’s moduli) with
respect to the source of the tissue, time after dissection and testing methods used (Engler
et al. 2006; Lu et al. 2006; Cheng et al. 2008; Christ et al. 2010; Moshayedi et al. 2014;
Smith 2016).
The matrix stiﬀnesses used in this study ranged from 20 Pa to 700 Pa to encompass a
soft, physiologically relevant stiﬀness. The synthetic-biologic hydrogel system was capable
of achieving higher matrix stiﬀnesses, such as 2.9 kPa and 3.9 kPa, however the acrylate-
PEG-NHS linker molecule was expensive and a 3 month period was required post order
to manufacture and ship the chemical. Due to time and budget constraints, there was
insuﬃcient functionalised gelatin to perform all experiments using the stiﬀer matrices.
This is another limitation of this study as diﬀerences in cellular behaviour may have been
more pronounced and more easily detected if the diﬀerences in matrix stiﬀnesses were
larger.
6.2 The eﬀect of impact severity on astrocyte and mi-
croglial cells in a 3D in vitro CNS model
The aim of developing a 3D in vitro SCI model was that diﬀerent impact severities could
be investigated in an ethical context with minimal animals used in experimentation. This
study defined an appropriate impaction protocol to produce repeatable impaction profiles,
which would provide injuries with varying severities from mild to severe SCI. The Infinite
Horizons (IH-0400) impactor had been used to induce spinal cord injury in tethered and
aligned collagen hydrogels at the University of Leeds (Smith, 2016). Similar impactors to
the IH have been used to simulate traumatic CNS injury for in vivo models (Hooshmand
Mitra J and Anderson 2014; Carter et al. 2016; Gattlen et al. 2016; Visavadiya et al.
2016). However, the displacement and velocity parameters of the IH impactor could not
be controlled by the impactor software, this resulted in the impactor tip piercing through
the hydrogel to the base of the mould. The displacement could be controlled manually,
however this was inaccurate, unmeasurable and challenging (Smith, 2016). The BOSE
Electroforce BioDynamic impaction system had been used previously to compress collagen
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hydrogels (Busby et al., 2013) and can control the force, displacement depth and velocity
of the impaction, therefore the BOSE ElectroForce BioDynamic 5110 impaction system
was chosen for development and use with this study. A block waveform programme type
was selected, so that a series of ramps could be selected to achieve an optimised impaction
protocol, which exhibits mechanical outputs similar to those that are exhibited in human
(Wilke et al. 1996; Tencer et al. 1995) and bovine spine (Wilcox et al., 2003).
The BOSE Electroforce BioDynamic Impaction system was suitable for delivering
repeatable, highly tuned impaction profiles for an in vitro SCI model. The software
and BOSE Electroforce BioDynamic Impaction system was capable of more than time
allowed to investigate and future work would involve creating more impaction profiles
and analysing the eﬀects on neural cells under compressive loads, pre-determined forces
and over longer culture periods.
A limitation of this study was that the 20N load cell did not function for a large
proportion of this study, therefore there is a lack of available force data to analyse in this
study, which could have been used to evaluate whether the Bose Electroforce impaction
system was capable of inflicting injuries with similar impaction forces to those experienced
in vivo. Therefore in vivo impaction forces were not investigated as part of this study.
Astrocytes in response to SCI in vivo, surround the lesion, become activated, hy-
pertrophic and extend overlapping astrocytic processes, which provide a barrier around
the injury site called a glial scar (Okada et al., 2017). Glial scarring permanently im-
pedes axonal regeneration and functional recovery in both rodents and humans with SCI
(Lee-Liu et al., 2013). Reactive astrocytes within the glial scar produce inhibitory ex-
tracellular matrix proteins such as chondroitin and keratin sulphate proteoglycans, which
prevent axonal regeneration (Silver, 2016) and reactive astrocytes increase expression of
glial fibrillary acidic protein (GFAP) (Fawcett and Asher, 1999). The expression of GFAP
is measurable and can be quantified in vivo or during in vitro studies, to measure the
reactivity of astrocytes following SCI (Smith, 2016). Pro-inflammatory cytokines, such
as tumor necrosis factor-↵ (TNF-↵), interleukin-1  (IL-1 ) and interleukin-6 (IL-6), are
strongly associated with pathological pain (Zhang et al., 2012), are secreted by astrocytes
and accumulate in the lesion site after SCI (Bethea et al. 1999; Chi et al. 2008). Release of
TNF-↵ and IL-6 can be quantified with an Enzyme-linked immunosorbent assay (ELISA)
and are a useful indication of astrocyte reactivity.
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The type of SCI induced is dependent on the mechanical impact of the injury, con-
tusion models of SCI are designed to inflict a transient, acute injury to the spinal cord,
similar to those experienced during road traﬃc accidents (Cheriyan et al., 2014). SCI
in rodent models have been created by a wide range of methods and devices, however
contusion models of SCI are the most clinically relevant models (Zhang et al., 2014). The
MASCIS impactor was first introduced by Gruner in 1992 and used a weight-drop method
to impact the spinal cord (Gruner, 1992). Unfortunately this method suﬀered from a sec-
ondary rebound impact from the impaction rod, which aﬀected the reproducibility of the
method. The method has been optimised since 1992, but does not produce reproducible
lesions in rats (Zhang et al., 2014). Recent advances in the field have driven the develop-
ment of computer operated impaction devices, such as the OSU impactor or the BOSE
Electroforce BioDynamic chamber, used in this study. These modern impaction systems
deliver highly reproducible, validated impactions with measurable force, displacement and
velocity data. However, most in vivo animal models require vertebral stabilisation to cre-
ate a reproducible SCI, which is generally a weakness of in vivo SCI models as stabilisation
prior to SCI in humans would not be possible and therefore it is arguable that the injuries
are not clinically representative.
One of the objectives of this study was to assess the viability of primary astrocytes
and microglia after impaction at diﬀerent displacement depths within 3D collagen gel
models over 24 hours. Astrocyte seeded hydrogels emitted significantly higher lumines-
cence from the ATP-lite cell viability assay when impacted to 100% displacement depth
than any other displacement depth, four hours and twenty-four hours after impaction
injury. This indicated that the greater the impact severity, the higher the cellular reactiv-
ity, by measurement of cell metabolism. Similarly for microglial seeded collagen gels the
luminescence emitted was significantly higher in the microglial cell seeded hydrogels that
had been impacted to 100% displacement depth, than the non-impacted hydrogels and
the microglial cell seeded hydrogels that had been impacted to any other displacement
depth, at four hours and twenty-four hours post impaction. There are a number of studies
that have also shown evidence of increased astrocyte and microglial activation present at
twenty-four hours post SCI. The study by Schnell et al. (1999) inflicted a spinal cord
lesion in mice using fine iridectomy scissors and observed an acute inflammatory response
within twenty-four hours of the induced injury, a pronounced astrocyte response was also
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present, defined by up-regulation of GFAP and thickening of cellular processes. The early
time-course of microglial activation has also been shown by immunolabelling for OX-42
in the ventral horn of the spinal gray matter of Lewis rats, twelve hours after a spinal
cord lesion was presented (Popovich et al., 1997). Following traditional weight-drop tech-
niques in vivo in Sprague-Dawley rats, a high concentration of extracellular TGF-  was
measured within the impact zone by immunohistochemical evaluation within 24 hours of
injury (O’Brien et al., 1994). These studies strengthen the observation that the cells of the
CNS undergo an immediate response to injury and increase cellular metabolism in order
to produce cytokines such as TGF-  and other proteins involved in glial cell reactivity
such as GFAP or OX-42 (an antibody designed to detect CD11b (Jeong et al., 2013)).
The eﬀect of impaction displacement depth on the levels of extracellular IL-6, IL-10
and TNF-alpha expression in microglia and astrocytes, as determined by Enzyme-linked
immunosorbent assay (ELISA) was also investigated as an objective of this study. Unfor-
tunately no significant diﬀerence was detected in TNF-↵ secretion between astrocytes that
had been impacted to diﬀerent displacement depths (50%, 80% or 100%) and astrocytes
that had not been subjected to an injury stimulus or cultured with 50 ng lipopolysac-
charide, after four hours or twenty-four hours of cell culture post-impaction. TNF-↵ is
secreted by astrocytes in vivo and accumulates quickly in the lesion site after SCI (Chi
et al., 2008), therefore it was expected that a similar response would be observed in this
in vitro model. Similarly, no significant diﬀerence was detected in TNF-↵ concentra-
tion secreted by microglial cells subjected to diﬀerent impact severities and displacement
depths. There is a possibility that encapsulating astrocytes and microglia within collagen
hydrogels may stimulate TNF-↵ release, thereby the cells were secreting TNF-↵ prior
to impaction and could not be stimulated further, which would account for the failure
of the positive control, as no significant increase in TNF-↵ secretion was observed when
astrocytes were stimulated with 50 ng lipopolysaccharide. The sensitivity of the ELISA
may also have been too low to detect low concentrations of TNF-↵. Optimisation of the
ELISA by using a increased sensitivity ELISA and an increase in cell seeding density, may
be suﬃcient to detect diﬀerential expression of cytokines in an in vitro SCI model in the
future. Similarly no significant diﬀerence was observed in IL-10 secretion by microglia
when subjected to impaction injuries with diﬀerent displacement depths. The controls
(media only, no primary antibody) for the IL-10 ELISA released a significantly lower
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concentration of IL-10 than the cellular hydrogels; this suggested that the assay was suc-
cessful and that impaction of microglia does not stimulate secretion of IL-10. Microglia
have been shown to exhibit anti-inflammatory properties by the expression of IL-10 in
vivo (Thompson et al., 2013), however it may not be the mechanical force of the impaction
that stimulates the release of IL-10. Interleukin-6 (IL-6) is a key cytokine released in re-
sponse to brain injury, which can cause neuroinflammation, however IL-6 production has
also been shown to increase healing, decrease oxidative stress and apoptosis in transgenic
traumatic brain injury mouse models (Quintana et al., 2008). This study found that the
concentration of IL-6 decreased with injury severity and displacement depth, however all
cellular conditions increased in IL-6 concentration between four and twenty-four hours of
cell culture. The media only control showed significantly lower concentration of IL-6 than
all the cell-seeded hydrogels, which indicates that the ELISA was successful, however the
positive control which was a microglial seeded gel cultured with 50 ng lipopolysaccharide
to stimulate reactivity, was lower than the non-impacted microglial gels, which suggested
that stimulation of cells by impaction decreases release of IL-6. Decreased IL-6 expression
by astrocytes in spinal cord injury is contrary to the findings of many studies that found
an increased expression of IL-6 release by astrocytes in response to injury (Hariri et al.
1994; Van Wagoner et al. 1999; Yu and Lau 2000; Lau and Yu 2001; Burda et al. 2016;
Bellaver et al. 2017). However most studies investigating cytokine production in response
to injury are generally in vivo and cannot be decoupled from interactions with other glial
cells and soluble factors, which may have enhanced IL-6 secretion.
Another objective of the study was to assess diﬀerential expression of cellular mark-
ers such as GFAP and CD11b after 24 hours of cell culture, post impaction at diﬀerent
displacement depths. This objective was successfully achieved and the study found that
for astrocytes, the average proportion of GFAP positively labelled pixels per image, in-
creased significantly with increasing displacement depth or impact severity. Unfortunately
for the microglial seeded hydrogels, there was no significant diﬀerence detected in CD11b
concentrations between microglial cell seeded collagen gels that had been subjected to
diﬀerent impaction displacement depths. There is evidence to support the increase in
GFAP expression within the spinal cord as a result of spinal cord injury (Fawcett and
Asher 1999; Sofroniew and Vinters 2010; Okada et al. 2017), however whether there is a
correlation between GFAP expression and injury severity, has not been fully characterised
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or supported. However similarly to the findings of this study, the study by Ropper et al.
(2015) used a reproducible, controlled compression model of SCI in Sprague-Dawley rats,
utilising three diﬀerent loads to result in mild, moderate or severe SCI and Ropper et al.
(2015) also found that there was a positive correlation between GFAP expression by as-
trocytes and the severity of the compression insult. The area immediately adjacent to the
zone of impact contained a high proportion of reactive astrocytes, expressing high levels
of GFAP; this area of the image was characterised as the zone of reactivity. The increase
in GFAP expression in the area surrounding the impact zone is similar to results seen in
vivo; whereby astrocytes show phenotypic and proliferative changes, which varied with
respect to the distance from the injury lesion in a mouse contusion model (Wanner et al.,
2013). Astrocyte morphology with distance from the zone of impact was not investigated
as part of this study due to time constraints, however a more in depth visualisation of
astrocyte morphology with distances from the injury site would be an intriguing in vitro
study in the future. It is unclear why there was an upregulation of GFAP in the impacted
astrocyte seeded hydrogels and that there was not a clear upregulation of CD11b in the
impacted microglia seeded hydrogels. The reason may be due to the seeding density,
which remained constant with the seeding density for astrocytes. However the microglia
seeding density was not optimised and therefore may have produced a diﬀerent response
if the microglial seeding density was greater. This is a limitation with this study and
would be a suggestion for future work to increase microglial seeding density. Although
the microglial seeding density may not have been an impeding factor, the expression of
CD11b may not have increased significantly within twenty-four hours of analysis, the up-
regulation of CD11b may be slower than the upregulation of GFAP and therefore may
have been apparent if the study was performed for a longer period of time.
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Chapter 7
Further work
Regarding the development of a 3D in vitro SCI model to investigate how the mechanical
properties of the matrix aﬀect CNS cell behaviour, the outcome of the study was positive
and the objectives were met. However, the main limitation of this study was that the
developed hydrogel, which could achieve a range of diﬀerent matrix stiﬀnesses, could not
be used to culture cells in 3D due to the toxicity of the UV polymerisation step. This
synthetic-biologic hydrogel was not able to support neurite outgrowth of neurons in two-
dimensions. A 3D collagen gel was used to investigate the CNS cell response to impaction
injury, whereby diﬀerences in cellular metabolism, GFAP expression and cytokine release
as a result of diﬀerent impact severities, could be quantified by ATP-lite, IHC and ELISA.
The model showed potential to be a clinically relevant tool in the future, however there
are improvements which could be made to progress the functionality of the model.
7.1 Approach to future work
In terms of the development of a hydrogel for use in 3D in vitro SCI model to investigate
how the mechanical properties of the matrix aﬀect CNS cell behaviour, there would be
four key areas where improvements should be made. Firstly, the development of a hy-
drogel which allows 3D seeding of cells, supports neuronal growth and can be formulated
to achieve a range of diﬀerent matrix stiﬀnesses. Secondly, further optimisation of cells
used in the study, in isolation, co-cultures and with larger cell numbers. Thirdly, further
development and optimisation for assays and types of assays utilised to analyse cellular
behaviour would be beneficial. Lastly, the BOSE Electroforce impaction system allows
273
for investigation of many diﬀerent mechanisms of injury and measurement of force, dis-
placement and velocity data, further work should be performed to characterise diﬀerent
mechanisms of injury, and optimise so that they are equivalent to in vivo SCI.
7.1.1 Development of hydrogel
Further hydrogel matrices should be investigated, such as commercial self-assembling
peptide hydrogels, to investigate how the stiﬀness of the matrix aﬀects CNS cells during
normal cell culture conditions and compared with CNS cell behaviour when exposed to
diﬀerent mechanisms of injury in 3D. Matrix forces are transmitted diﬀerently to cells
in 2D and 3D environments (Pedersen and Swartz, 2005), therefore it is important that
this study be repeated to analyse CNS cell behaviour in three-dimensional hydrogels with
diﬀerent matrix stiﬀnesses. Once resting cell behaviour has been characterised on matrices
of diﬀerent stiﬀnesses, the models should be exposed to injury simulations to analyse the
diﬀerence in cellular responses as a result of the combination of matrix stiﬀness and
mechanism of injury. There is a wealth of potential hydrogel systems which could be
more appropriate for this model than the developed synthetic-biologic hybrid hydrogel
developed during this study. The UV polymerisation step was toxic to cells, however
higher wavelengths of light (405 nm) would be less damaging to cells and potentially
more suitable than the 365 nm UV light used in this study. The biologic linker (gelatin)
used in this study could also be developed upon and may be more biocompatible with
laminin or fibronectin. Further development is required to achieve 3D cell seeding within
a synthetic-biologic hybrid hydrogel matrix.
7.1.2 Cell combinations, types and cell seeding densities
This model was used to investigate the how astrocytes, microglia, neurons and mixed glial
cell populations behave on matrices of diﬀerent stiﬀnesses. However, the matrix was not
compatible with neurons and there was insuﬃcient hydrogel matrix to investigate how
oligodendrocytes behave on matrices of diﬀerent stiﬀnesses. The response of oligoden-
drocytes was not investigated in this study, but it has been shown previously that stiﬀer
matrices inhibit branching and elongation of oligodendrocytes (Urbanski et al., 2016). It
would be of interest to study the role of matrix stiﬀness on oligodendrocyte and neuronal
cell behaviour.
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Unfortunately due to time constraints only astrocytes and microglial response to im-
paction injury was investigated. Further work should expand the number of cell types
and investigate the neuronal, oligodendrocyte and mixed glial response to injury in ad-
dition to astrocytes and microglial cell models. The cell seeding density should also be
optimised for each cell type for further studies, as it is believed that the microglial cell
seeding density used in this study, was chosen to be consistent with the astrocyte seeding
density, however it may be relatively low for microglia and therefore analysing diﬀerences
in CD11b expression or cytokine release was challenging with a low cell population density
and could be improved with a higher microglial seeding density.
7.1.3 Further assay development
Further assays and mechanisms of analysis should be investigated to extract as much in-
formation as possible from each model. It would be of interest to characterise the response
of astrocytes, neurons, microglia and oligodendrocytes in isolation and in mixed glial cul-
tures, to investigate how matrix stiﬀness aﬀects cells in isolation and in co-cultures. There
is an abundance of potential work to be performed in this area, which could fully char-
acterise protein expression by IHC, cell proliferation by BrdU staining, cellular reactivity
by ATP-lite, gene expression by PCR, cytokine release by ELISA and investigation into
morphology in three-dimensions by confocal microscopy utilising tiled, Z-stack images
to analyse cell shape, cell size, cell number, number of projections and over diﬀerent
incubation periods for short of long term analysis.
7.1.4 Mechanisms of Injury
The Bose Electroforce BioDynamic impaction system has the potential of high impact
contusion or slow/low-impact compression injuries with a large number of impaction pro-
files with controlled force, displacement or velocity. It would be of interest to investigate
whether matrices of diﬀerent stiﬀnesses aﬀect cellular regeneration after injury by diﬀer-
ent injury mechanisms. The Bose Electroforce BioDynamic impaction system was able
to successfully simulate contusion injury representative of in vivo SCI and the impaction
system is able to oﬀer other mechanisms of injury, which could be used to further in-
vestigate various forms of SCI in vitro in hydrogels with diﬀerent mechanical properties.
Impaction tips were designed for use in this study, however only a rounded cone shaped
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impaction tip was utilised during this investigation, future work could investigate the
eﬀects of diﬀerent geometries of impaction tips on cell responses to injury such as large,
flat or small, pointed impaction tips. There are a range of potential mechanisms of injury
which could be a focus for further research, such as tensile strain/distraction, transection
or compression.
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Chapter 8
Conclusion
The primary aim of this study was to develop a 3D in vitro hydrogel system, which
can achieve three diﬀerent ECM matrix stiﬀnesses to investigate how the stiﬀness of the
matrix aﬀects CNS cells.
The secondary aim of this study was to investigate a mechanism for simulating repro-
ducible injury for a 3D in vitro model of SCI, to investigate how diﬀerent matrix stiﬀnesses
aﬀect CNS cells in an injury simulation
• A synthetic-biologic hydrogel was developed which could achieve a range of diﬀerent
matrix stiﬀnesses, however the matrix was not compatible with 3D cell seeding due
to the toxic photo-polymerisation step.
• Astrocytes when cultured in isolation, had a higher astrocyte metabolism, viability
and showed an increase in GFAP expression when cultured on a stiﬀer hydrogel
matrix.
• Microglia had a higher cell metabolism on the soft hydrogel matrix compared to
both the stiﬀer hydrogel matrices.
• Mixed glial cultures elicited a higher cell metabolism and a higher cell viability, on
the softer matrices, compared to the stiﬀer matrix.
• This study represents a step forward in being able to quantitatively measure the
eﬀects of impaction on cells in a 3D in vitro collagen SCI model. The BOSE Elec-
troforce impaction system is a suitable contusion device for use with an in vitro 3D
hydrogel model of SCI.
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• An impaction profile was designed with diﬀerent impact severities by displacement
depth, that successfully simulated spinal cord injury.
• The model was able to identify and accurately quantify an increase in astrocyte and
microglial cellular metabolism and astrocyte GFAP upregulation, with an increase
in injury severity or displacement depth.
• This collagen gel system could provide valuable insights into how neurons and glial
cells behave in isolation or in co-culture combinations to explore cellular mechanisms
which may progress the translation of this research into therapeutic advances.
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Chapter 9
Appendix
9.1 Appendix A
9.1.1 Growth curve to determine the appropriate cell seeding
density
A growth curve was carried out to investigate the appropriate cell seeding density of
C6 astrocyte-like cell line seeded into hydrogels and for how many days the experiment
would be viable at each cell seeding density. Figure 9.1.1 indicated that 5x104 C6 cells
per 100 µL hydrogel was the most appropriate seeding density for a 2-3 day experiment.
This is the highest C6 cell seeding density to allow for the highest potential absorption
for cell viability assays (ATP-lite or MTT assay), however any higher than 5x104 C6 cells
per per 100 µL hydrogel, results in cell death due to competition for resources beyond day
3. Primary astrocytes have a much lower growth rate compared to C6 cells and therefore
a higher initial seeding density of 1x105 per 100 µL hydrogel used.
322
Figure 9.1.1: MTT cell viability assay of a C6 growth curve showing data from day 1 to
day 5, left to right for each cell seeding density, 0, 1x103, 5x103, 1x104, and 5x104 C6 cells
per 100 µL hydrogel. Error bars indicate 95% confidence interval.
9.2 Appendix B
9.2.1 Commercial hydrogels, rheology and cell viability data
In chapter 3, a range of commercially sourced biocompatible gels were acquired and
tested for compatibility with C6 cells. One of the main limitations with the BiogelX
peptide hydrogel was that it was challenging to produce a hydrogel which did not have
large clumps of cells trapped within the matrix (Figure 9.2.1 A-C) and bubble formation
within the matrix (Figure 9.2.1 D). The BiogelX hydrogels had high cell viability despite
the clumping and bubble formation however, there was little diﬀerence between the soft
and stiﬀ hydrogels for the BiogelX peptide hydrogels (Table 9.1).
The rheology and cell viability data for the commercially available hydrogels is high-
lighted in Table 9.1. The mechanical properties of the commercially available hydrogels
were characterised by rheology to investigate the complex shear modulus. The results
showed that the commercially available hydrogels were relatively soft and under 100 Pa
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Figure 9.2.1: Live/dead assay images of BiogelX hydrogels. A) BiogelX103 Soft stiﬀness
B) BiogelX203 Medium stiﬀness C) BiogelX403 Stiﬀ hydrogel, D) Example of bubbles
and cell clumping throughout all three matrices.
complex shear modulus. The synthetic hydrogels could be formulated with diﬀerent poly-
mer concentrations or UV exposure periods to achieve a range of stiﬀnesses, however cell
viability was low (Table 9.1).
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Table 9.1: Rheology and cell viability data of commercially available hydrogels, rheology
performed at 1Hz frequency, 0.5% shear strain at 37 °C, n=3. Cellular gels stained with
Live/dead and hand counted using ImageJ cell counter plugin, 5 gels per hydrogel, 5
images per gel.
Hydrogel Shear modulus (com-
plex component) Pa
Proportion of
green labelled cells
(live/dead)
BiogelX Soft 20.59 63%
BiogelX Medium 27.15 65%
BiogelX stiﬀ 38.15 71%
Tebu-Bio/HyStem 112.9 5%
Collagen gel 5.903 92%
PEG 700 1:10 UV 60 SECONDS 4025 32%
PEG 700 1:10 UV 30 SECONDS 1191 35%
PEG 700 1:15 UV 60 SECONDS 1100 27%
PEG 700 1:15 UV 30 SECONDS 415.5 31%
PEG 700 1:20 UV 60 SECONDS 158 27.8%
PEG 700 1:20 UV 30 SECONDS 69.5 29%
PEG 700 1:25 UV 60 SECONDS 209 19%
PEG 700 1:25 UV 30 SECONDS 96.25 21%
PGR2t Insuﬃcient sample 62%
PRR4 Insuﬃcient sample 83%
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9.3 Appendix C
9.3.1 Development issues of gelatin hydrogel with synthetic PEG
cross-links
The gelatin hydrogel with synthetic cross-links formed bubbles during the polymerisation/cross-
linking reaction which made the gels very diﬃcult to seed with cells and produce good
quality images (Figure 9.3.1a and 9.3.1b). To combat the bubble formation, the gels were
formed under vacuum (Figure 9.3.1c) however, the vacuum removed the hydrogel solution
and no hydrogels were remaining in the well plate after the polymerisation period had
ended (Figure 9.3.1d).
(a) Immediate bubble formation (b) Bubbles post UV-polymerisation
(c) Gels under vacuum (d) Gel solution post-vacuum
Figure 9.3.1: The gelatin-PEG hydrogels (A) produced bubbles during the cross-linking
process. (B) Bubbles continued to form post UV-polymerisation when incubated at 37°C
in 5% CO2. Methods were attempted to eliminate the bubbles, including (C) polymeri-
sation under vacuum, however this exacerbated the bubble formation and (D) prevented
formation of hydrogels under vacuum.
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9.4 Appendix D
9.4.1 Calculating the amount of gelatin and PEGDA cross-links
The amount of gelatin and PEGDA crosslinks was calculated using the following equa-
tions:
Moles of Acrylates =
Mass of PEGDA (g)
Molecular Weight of PEGDA
⇥ 2 (9.1)
Moles of Lysines = Mass of Gelatin (g)⇥Moles of functionalised gelatin (9.2)
Moles of functionalised gelatin = 3.1⇥ 10 4 ⇥ 0.8(80% functionalised gelatin) (9.3)
Excess Ac-Ac to Ac-Lys =
Moles of Acrylates
Moles of Lysines
(9.4)
9.4.2 Confirmation of functionalisation of gelatin and eﬃcient
dialysis
Fourier-transform infrared spectroscopy (FTIR) was performed as shown in Figure 9.4.1
to confirm that the gelatin had been successfully functionalised. This was shown by the
presence of the carbonyl group at wavenumber 1635 cm 1. The spectrum also showed that
the dialysis was necessary to remove the peak at wavenumber 1560 cm 1, which was the
degraded linker molecule (hydrolysed N-hydroxy-succinimide (Ac-PEG-OH)). The peak at
2878 cm 1 wavenumber was the presence of OH group in water, this has been successfully
removed by freeze drying gelatin.
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Figure 9.4.1: FTIR spectrum indicated that the gelatin had been functionalised by the
presence of the carbonyl group peak at wavenumber 1635 cm 1, the dialysis removed the
Ac-PEG-OH peak at wavenumber 1560 cm 1. The peak at 2878 cm 1 wavenumber is the
presence of OH group in water, this had been removed by freeze drying.
9.5 Appendix E
9.5.1 Engineering diagram for the BOSE Electroforce impaction
tip designs
In order to determine if the BOSE Electroforce impaction system could be used as a
contusion device for use with an in vitro 3D collagen gel model, impaction tips had to
be designed and manufactured which could produce repeatable impaction profiles with
diﬀerent impact severities, similar to impaction parameters in spinal cord injury in vivo.
Figure 9.5.1 details the diagram submitted to the School of Mechanical Engineering,
University of Leeds, for manufacture of the custom impaction tips which were used in this
study and the development of a repeatable impaction profile.
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Figure 9.5.1: Engineering request diagram with the impaction tip designs
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